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Abstract
A study of patient outcomes in an acute hospital
Outcome measures have been developed in an acute hospital for specific patient groups 
(primarily cholecystectomy, diabetes, coronary angioplasty and knee replacements). For 
each condition a set of indicators was derived which ranged from clinical and laboratory 
measures to measures of general health status. All indicators attempt to show changes 
in patient health over time.
It has been shown possible to collect the necessary data for such outcomes measures. 
The costs and methods of data collection varied between conditions. Patient completed 
questionnaires were found to be particularly useful and in inpatient studies have given 
high response rates (over 95%) for postal follow-ups and have been validated by 
interviews.
The differing ability of the various indicators to show clinical changes has been 
demonstrated. In all specialties there was found to be generally high levels of association 
between different indicators. The information collected on patient outcomes was presented 
at meetings of the various clinical teams and the value of the information in promoting 
practical change was examined. It was concluded that different indicators have different 
value in such reviews and that three key characteristics are identified. The first concerns 
whether the measures reflect clinical or patient’s perceptions of health. The second 
concerns the extent to which an indicator is a direct measure of health or a proxy (or 
process) measure. The third concerns the extent to which an observed outcome indicator 
can be linked to particular processes of care.
The study has generated support from the clinicians and it is suggested has changed their 
views on how they judge their own performance. In some instances practical changes 
have resulted form the presence of the outcome information. The potential future roles 
for outcome measurement in the health service is discussed.
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Chapter 1 Introduction
This thesis describes work undertaken during the CASPE/Freeman outcome project
established in autumn 1988. Its aims were to...
"..develop and pilot., methods o f assessing the outputs and or outcomes in a way 
meaningful to both clinicians and managers" (CASPE proposal to DoH 1988).
As such the project was aimed in the first instance to explore the relevant dimensions of 
outcome and possible methods of measurement in specific areas of hospital activity. 
Following on from the successful agreement and measurement of outcome, are the 
questions over the value of such outcomes in practice. Progress made in addressing these 
questions will be discussed.
The project, which has been managed by the author, attempted to develop ways in which 
health service information and management systems could incorporate assessments of the 
impact of health services on health and everyday life. There has always been a concern 
with the outcomes of care yet measurement of these within the service has in the past 
been limited. Indeed in many ways the health service is only now grasping the ways to 
monitor its processes and costs -something that is held to be considerably easier (and less 
costly) than outcome measurement.
To date the measurement of outcome has tended to be limited to research settings - as 
discussed later. Yet there is a growing view in the service that it is now time to tackle 
some of the difficult problems of outcome measurement (Mills 1987). In particular 
clinicians and health service managers should be able to assess the quality of their 
management by explicitly monitoring the patient benefit that results. The organisation 
and practice of care should seek to maximise those benefits when they do exist and stop 
doing things when no benefit exits.
The interest in outcome measurement since the project began has grown considerably.
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There are many reasons for this including
the technology required to process information of this sort has become more 
accessible (both in terms of computer hardware and software) 
the changes envisaged by the latest White Paper "Working for Patients" 
(Department of Health 1989) emphasised the importance of monitoring outcomes 
as well as including explicit quality clauses when contracting for health services 
the growth of medical audit (Royal College of Physicians 1989; Royal College of 
Surgeons 1989) has prompted a number of investigations into process and 
outcome (Hopkins 1990)
a growing awareness of the uncertainty surrounding the benefits of some forms 
of medical practice and the resulting examination of variations in care (Ham 1988, 
Anderson & Mooney 1990) and appropriateness of care (Soloman et al 1986, 
Chassin et al 1987a; Chassin et al 1987b) .
the development of health status measurement itself - and its scientific 
respectability (Reisenberg & Glass 1989, Brook & Kamberg 1987).
These, and no doubt other, pressures have resulted in the growing interest in outcome 
measurement. Despite this enthusiasm there is still considerable uncertainty of the 
techniques to use and very little experience in the field.
Outcome measurement is a broad term which can use a variety of methods and
measurement techniques in a variety of settings - as discussed in Chapter 2. The
common factor between all these approaches lies in the need for a consistent definition
of outcome . Donabedian defined outcomes as:
" a change in a patients* current and future health status that can be attributed 
to antecedent health care. " (Donabedian 1985 p256)
This brief definition is important in identifying two of the recurrent themes of outcome 
measurement. The first is the idea of the patient’s health status and how we define and 
measure that. Second is the notion of causality and the difficult questions of when (and 
how) health care interventions bring about the desired changes in health.
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Aims of the study
The study has been conducted in a number of different specialties at the Freeman hospital 
between from 1988 to Summer 1991 using specific patient types covering 
cholecystectomy, diabetes, coronary angioplasty, care of the elderly, rheumatoid arthritis, 
urology and knee replacements.
The study has collected and reported outcomes to consultant teams or specialty 
management groups proposed in the resource management process (Freeman Hospital 
1990). The initial aims were to integrate information into the resource management 
process and so use outcomes data with clinicians and managers. One of the reasons the 
project was based at the Freeman was the level of its information systems and knowledge 
in information handling - which were felt to be ’above the average’ of those in the 
country. In addition, as a pilot site for resource management, the hospital was about to 
embark on a series of organisational changes which would seek to encourage the role of 
clinicians as managers and the use of activity and financial information.
The development of indicators should take place across a whole specialty so that the 
resulting measures could be integrated with resource management information. As a start 
down this route, this pilot study was restricted to selected conditions in secondary care.
The speed of change required for resource management to develop and become embedded 
in the hospital was overestimated. Often the organisational and information structures 
required for resource management were not yet in place (or just coming into place). 
There was therefore no easy marriage between the resource management process and the 
rapidly developing outcomes information. Review of the outcome information was 
therefore focused on groups of relevant clinicians and local managers in the first instance. 
At the same time the value of the information to a wider audience - including managers 
(clinical and non-clinical) has always been considered.
In many respects the examination and review of the outcome information was in setting
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similar to that of clinical audit (Shaw 1989a; Shaw & Costain 1989). Certainly work 
with clinicians followed the cyclical process of audit (Royal College of Physicians 1989; 
Batstone 1990) namely identifying the standards of care, the means to measure these and 
reviewing results to identify necessary actions.
A major thrust of the work was concerned with evaluating how clinicians used the 
information and in particular its value in enabling them to ’close the feedback loop* 
without which audit has been memorably described as *a pious exercise in self- 
congratulation’(Smith 1990).
The project used a number of working hypotheses as the basis for measuring progress 
towards the desired aims. More specifically these were:
a. That it is possible to agree with clinicians acceptable operational definitions of 
outcomes and identify the information to monitor these.
b. That it is possible to collect the agreed outcome information and report back 
results.
c. That outcome information would prove useful either in clinical practice, in the 
running of a local service or in wider management issues ? That is that outcome 
information could and would lead to practical change?
These have been addressed in this thesis as well as more general issues examining the 
similarities and differences of approach in the different specialties.
It is important to stress that the outcomes obtained were measured relative to the 
contribution made by the hospital. They therefore attempted to represent the marginal 
health benefit to patients receiving care in this setting. This may not necessarily 
correspond to the potential outcomes for the population of eligible patients nor can the
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results describe what would have happened anyway or what happens to those patients who 
do not receive treatment. These are inevitable limitations to this type of approach.
Chapter 2 discusses some alternative approaches to outcome measurement that have 
influenced the measures and methods used in this study. The actual methods of agreeing 
outcome indicators are described in Chapter 4. Chapters 5 to 8 give the detailed results 
obtained from the various specialties and includes information on the indicators examined 
and the descriptions of changes in each indicator, relationships between indicators and a 
preliminary analysis of the effect of presenting patient characteristics on outcome 
expressed in these terms. Finally at the end of each of these chapters is a short section 
describing how the results have been used to date.
Chapter 9 gives an overall summary of the results obtained from the different specialties 
in general terms whilst Chapter 10 discusses general conclusions from the project and the 
potential for the wider development of outcome measures within the health service. The 
appendixes provide examples of the questionnaires used, reports generated and notes of 
discussions with clinical staff.
The project team has been managed by the author of this thesis who has been reponsible 
for discussing and agreeing outcome indicators with clinical staff, the development of 
methods of data collection and reporting as well as analysis of the data.
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Chapter 2 Approaches and purpose in outcome measurement
Some ambiguity exists about the methods and purpose of outcome measurement. The 
term can often embrace a number of distinct methods in different contexts as Lohr points 
out:
"Patient outcomes are an immensely complex construct. They span the 
range o f results that proceed from (or are presumed to be associated with) 
the provision o f health care services. They are measured both directly and 
indirectly over differing periods o f time and with varying degrees o f 
objectivity, reliability and validity. " (Lohr 1988 p38)
Examples of the range of potential uses of outcome measurement includes those listed in 
Table 2.1 where a variety of approaches are described.
As Table 2.1 shows, the assessment of outcomes using standardised methods of 
assessment may be part of basic clinical practice. Whilst basic clinical care should 
naturally involve assessments of changes in health, the methods by which such 
assessments are made are typically proxies (of varying validity) for real changes in 
health status. There have been those who advocate using sophisticated outcomes 
assessment tools as part of routine clinical practice (Deyo & Inui 1984, McEwen 1988, 
Dickinson & Young 1989, Nelson & Berwick 1989, Nelson et al 1990).
In particular there is claimed to be an advantage in using standardised instruments, 
typically patient completed questionnaires, to assess general health from the patient’s 
perspective and improve doctor-patient communication. Nelson and Berwick suggest 
some specific barriers that must be overcome if such tools are to be used in clinical 
practice and these include the practical issues of convenience of administration and 
acceptability to patients (they should be simple and not confusing). However they 
suggest that a greater obstacle lies in the lack of conviction among clinicians of the value
16
Table 2.1. Different approaches to outcome measurement
Approach Case types -coverage Issues/aims
Clinical
management
Individual patients Assessment of outcomes of 
individual patients for clinicians.
Clinical trial Strictly controlled, 
specific patient types.
Comparing between therapies with 
controls possible with randomisation 
and typically strict entry criteria
Comparison 
of process
Diagnostic or treatment 
categories across sites
Correlation between outcome 
variation and different processes of 
care. Post-hoc standardisation for 
confounding variables.
Clinical audit Diagnostic or treatment 
categories - usually one 
site.
Examination of outcome achieved 
against expected standards in your 
area.
Routine
Quality
controls
(Provider)
May be with reference 
to one case type, 
specialty or hospital 
wide.
eg adverse occurrence screening 
avoidable deaths
Routine
Quality
controls
(Purchaser)
Specialty/service type 
or resident population.
Specific clauses in contracts. 
Standardised Mortality Ratios. 
Notifiable diseases.
Planning &
resource
allocation
Service type or specific 
or new treatments
Comparison of benefits obtained. 
Comparisons of cost and benefit.
Confidential
enquiries
Adverse events in 
particular services
Detailed examination of individual 
cases by expert panels.
of such tools (Nelson & Berwick 1989). A similar conclusion has been offered by Deyo 
and Patrick (Deyo & Patrick 1989) who advocated better education of health professionals 
and:
",.a ’laboratory' to provide measurement services to investigators and 
clinicians may make use o f these scales more attractive " (Deyo & Patrick 
1989 pS254)
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More commonly, outcome measurements are part of detailed clinical research or trials. 
These compare outcomes for a very specific subset of patients and ideally with double 
blind randomisation of treatment or control groups (Cochrane 1972) to assess the 
effectiveness of different therapies. The current view is that such trials should include 
not just technical measures of success but also general health status measures (Brook and 
Kamberg 1987; Bombardier et al 1986). However it has been pointed out that quality 
of life measures are too often considered secondary to ’medical outcome’ measures and 
are "added as an afterthought once the design, data collection and analytic techniques 
have been specifted" (Bergner 1989 P S148).
The observation of wide medical practice variations has prompted a variety of studies to 
examine the relationships between variations in process and the resulting outcomes. Roos 
and colleagues have usefully identified some of the alternative strategies adopted to 
examine this question and distinguish between studies according to the level of data 
collected (Roos et al 1990) ranging from cross sectional studies using hospital discharge 
abstract data to more detailed prospective analyses of longitudinal changes in cohorts of 
patients.
A popular approach at the moment is to use outcomes in evaluating non-controlled 
comparisons of process. A number of studies use retrospective or prospective 
examination of outcomes for one or more different processes of care. Thus for example 
one large multicentre study used sophisticated outcome measures to examine different 
approaches to prostatectomy (Wennberg et al 1988; WHO 1988). This model is currently 
favoured in the USA where national funding is supporting a number of Patient Outcome 
Research Teams (PORT’s) (Salive,Mayfield and Weissman 1990). These teams are 
made up of groups of experts who are investigating outcomes of prostate disease, acute 
myocardial infarctions, knee replacements, cataract management and back pain.
Another approach, the Medical Outcomes Study (MOS) in the USA developed as a large 
multi-centre comparison of outcomes for a number of different disease categories (Tarlov 
et al 1989, Wells et al 1989, Stewart et al 1989). Its aims were twofold - the first being
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an exploration of the effects of different organisations and styles of care on outcome (and 
was related to earlier RAND studies (Brook et al 1979)). The second aim was the 
development of more practical tools for monitoring outcomes. On this latter point the 
study led to the development of a relatively short health status questionnaire 
(Stewart,Hays & Ware 1988) as well as tools for examining patient satisfaction (Ware 
et al 1990). Moreover, the project championed practical outcome measurements across 
a range of disease types in the way advocated by Ellwood as part of ’outcomes 
management’ (Ellwood 1988). His view is that information on outcomes should exploit 
sophisticated computing technology, statistical methods and measurement techniques to 
provide ways of assessing the effectiveness of different processes thereby guiding the 
practice of medicine, the management of health services and the choices made by 
patients. Though others are more cautious about the possible benefits (Epstein 1990) 
there appears to be considerable potential in the overall approach.
A more localised approach is to use outcome measurement in some form of medical audit 
as this study has done. There has been a growth in the field of medical audit in the past 
two years (Shaw 1989b; Hopkins 1989). Though most audit activities typically examine 
process of care (Gruer et al 1986; Spiby & Prater 1989) there is a growing interest in 
the addition of outcome measures. However, with a few notable exceptions there is little 
practical experience (Hopkins & Costain 1990) of their development and use.
Beyond the introspective processes of audit within a department there is the potential for 
examining outcome at a hospital or service level as part of an overall approach to quality 
assurance. Once again process measures are more typical, but there are some examples 
of where outcome indicators can be used in this setting. One is the practice of 
monitoring the frequency of ’adverse occurrences’ recorded in hospitals (Craddick & 
Bader 1983; Brennan et al 1990). Such occurrences may be direct or indirect measures 
of patient health for example peri-operative deaths, and act as a trigger for further 
investigation. Other alternatives include the use of specific mortality or morbidity data 
(Middleton 1987).
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At the level of district or regional health planning, outcome measures typically consist 
of mortality data either as standardised rates or relating to specific disease types as in the 
indicators of avoidable deaths (Charlton et al 1983; Charlton,Bauer & Lakhani 1984). 
Similar techniques are advised for district and regional health authorities seeking to 
monitor the general health and outcome of their resident population. Such indicators 
provide an input to planning and strategic management of services, typically by 
identifying potential problem areas in current provision. Though there is much 
speculation on the inclusion of outcomes in the contracting process, there is as yet little 
practical experience of which measures to use.
At regional or national level outcome measures may be associated with evaluations of 
specific programmes or services , for example the evaluation of heart transplant 
programmes (O’Brien et al 1988). Similarly national audit systems such as the 
Confidential Enquiry into Peri-operative Deaths (Buck,Devlin & Lunn 1987) exist. Such 
studies examine individual cases as well as aggregating data to consider issues on a wider 
scale and identify where processes of care are linked to outcome.
Finally there are questions of resource allocation using singular measures of health benefit 
-like the Quality Adjusted Life Year (Boyle et al 1983; Williams 1985 ; Gudex 1986). 
Such studies are not aimed at the level of individual patients but assess the need for 
investments in different health care programmes by comparing costs against expected 
benefits to health. Such comparisons are not without problems (Drummond,Teeling- 
Smith & Wells 1988; Smith 1987).
As well as variety in the applications of outcome measures, there are a number of 
different methodological approaches or instruments that can be used.
Clinical/laboratory measures o f success
Later chapters describe a variety of measures which have traditionally been used by 
clinicians to determine the success of treatment, for example changes in anginal pain 
(Cambeau 1976) following PTCA or levels of blood glucose in diabetes (Nathan et al
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1984). Such measures form the basis of most clinical research and are critical to the
development of medical knowledge about the success or failure of treatment. One of the
problems with such measures is the extent to which they measure a physiological process
rather than a true patient outcome. As Fries observed:
* Process measures achieve their value only to the extent to which they 
serve as accurate proxies fo r outcome measurement. Thus sedimentation 
rate accurately quantifies fatigue*, and i f  fatigue* is part o f patient 
discomfort, and discomfort is an outcome, then sedimentation rate may 
have value as a surrogate outcome measure, conveniently and accurately 
ascertained. " (Fries 1983 p 697)
Thus the use of such clinical measures must be based on a belief that they represent (to 
the best of our knowledge) reasonable proxies for genuine patient health problems.
Measures o f standardised mortality rates
The measurement of mortality rates is one of the best established of all outcome 
measures. It can be expressed relative to a geographical region (standardised for age, 
sex, and other possible factors) as an index of health among a population and by 
implication as an indicator of the performance of health services. A more specific 
approach is to consider mortality rates for specific conditions amenable to treatment 
(Rutstein 1976, Charlton et al 1983, Charlton Bauer & Lakhani 1984). The main problem 
with such measures include the frequency with which deaths will occur and the resulting 
statistical significance of variation, the relevance of mortality as the sole description of 
outcome of care and finally the problems of linking the processes of care to the outcome. 
Nevertheless mortality must always be considered part of the range of outcomes.
Measures o f morbidity
In some circumstances the observation of the existence or prevalence of certain disease 
states within a population can be taken as an indicator of the outcomes of care provided. 
Typically such measures will reflect on the outcome of primary care, prevention or 
screening. For example admissions to hospital of patients with acute diabetic ketoacidosis 
may be considered to reflect on the local health service’s ability to detect the signs of 
diabetes.
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Measurement o f general health status/quality o f life/well-being 
The past few years have seen a growth in the acceptability and application of measures 
which attempt to define general health status (Spilker at al 1990) as described earlier. 
In the first instance there were a number of measures which attempted to represent a 
broader definition of patient health than simple clinical indicators. One approach was that 
developed by Rosser and colleagues which was based on professional judgements of 
patient health along axes covering disability and distress (Rosser & Watts 1976) and has 
been used in an attempt to weight the value of different states (Rosser & Kind 1978). 
The resulting matrix has been used in cost utility analyses (Williams 1985).
In contrast to measures derived by a professional assessments, a variety of tools (usually 
patient completed questionnaires) have been developed which attempt to identify key 
constructs of ill health drawn directly from the patients. These are increasingly being 
used as part of outcomes assessments and are discussed in more detail later.
Measures o f patient satisfaction
In addition to changes which are considered part of patient health, there has also been a 
growth in studies examining patients* views on the acceptability or otherwise of the 
process of care (Cleary & McNeil 1988, Mclver & Carr-Hill 1989, Fitzpatrick 1990).
Quality Adjusted Life Years
The examination of cost-effectiveness requires instruments to examine both relative costs 
and utility as in the QALY - quality adjusted life year (Gudex 1986). Such measures are 
typically applied to examine different health care programmes rather than individual 
patients or treatments. Central to the concept is some measure of health benefit that is 
common (and commensurable) for different patient types. As such the calculation of 
QALYs is secondary to the examination of changes in patient health undertaken in 
outcomes measurement.
Adverse occurrences
A popular method of quality assurance that has been widely used in the USA is the
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monitoring of specific health events which can be considered to be undesirable or 
avoidable consequences of treatment (Craddick & Bader 1983). Thus for example post­
operative complications can be considered a short term outcome measure.
Readmission rates
The monitoring of réadmissions to hospital has the advantage that much of the data 
required is already collected in some form and has been advocated as a useful measure 
of quality (Chambers & Clarke 1990). In this case the problem is to identify when the 
fact of readmission is an appropriate proxy for deleterious changes in health status.
In conclusion it appears that the field of outcomes measurement is broad and encompasses 
a variety of different approaches and techniques. None of these exactly matches the 
requirements for this study. Therefore a variety of methods from the literature have been 
used in the formulation of appropriate outcome measures. Given that the main purpose 
of the study was to develop measures which were of value to clinicians and managers, 
a prospective approach has been adopted and one that seeks to examine changes in patient 
health status following treatment. Given the uncertainties over what were the right 
measures to use and over the performance characteristics of the various measures, a range 
of measures were used including clinical and laboratory values, general health status, 
adverse events, mortality and réadmissions. Though it was recognised that ideally patient 
satisfaction should also be included such measures were rarely used in the belief that the 
exploration of their use was being undertaken elsewhere.
Chapter 3 discusses the methods used to identify the relevant indicators and the methods 
of data collection.
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Chapter 3 Methods - Identifying outcome indicators and methods of 
data collection
A. Organisation
The research team has changed in structure during the project. It eventually consisted of 
two research assistants (nurses) and a project manager (the author of this thesis). For the 
first year there was medical input from a community physician. The team was based in 
an office centrally within the hospital. In addition support was given by the Department 
of Public Health of Newcastle Health Authority.
Progress was monitored through a steering group chaired by the authority’s Director of 
Public Health, and consisting of representatives of the various clinical groups and 
managers. Steering group meetings were held every 1-2 months throughout the project. 
The current membership of the steering group is shown in Appendix 1
B. Developing Local Outcome Criteria
The project worked within individual specialties and in each attempted to outline those 
changes in patient ’health’ that occurred over time after a particular intervention. For 
acute cases the study compared observations made before hospital treatment to similar 
observations at discharge, 3 months and/or 12 months later. For chronic conditions 
observations were made at each contact with the patient and/or at annual review. The 
changes identified were then compared to agreed standards of what one might expect to 
have occurred over these time periods.
In each specialty the following steps were needed to establish the agreed range of 
outcome indicators and methods of data collection:
i) Choose suitable reference group of patients (or treatments) for study
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ii) Identify expected changes in health over relevant time intervals
iii) Identify potential effect modifiers
iv) Identify data required to monitor changes
v) Identify best methods of data collection
vi) Pilot and undertake data collection
vii) Validate data
viii) Feedback results, review database and monitor any actions resulting 
These stages are described in more detail below.
i) Choosing Suitable Reference Groups
In most specialties it was not practicable to monitor routinely a wide range of outcome 
measures across all possible case types. Measures such as death rates, readmission rates 
etc might be collected at this level but more detailed information would need to be 
restricted to a subset of specific treatment or patient types. The choice of a reference 
group was used to focus discussion, the choice of group being guided by the following 
criteria:
* Volumes of cases had to be sufficiently large to enable reasonable 
statistical results and represent a sizeable proportion of the specialty 
workload
* Significance in terms of health to the patient
* Capable of reference to an agreed standard
* Relevance to specific processes or areas of contention or uncertainty in
care
* Practicability of data collection
In many circumstances the outcome measures were relevant across different disease 
groups - for example avoiding death or ’improving well-being* applies to almost all 
patients. However even with these common measures there will be variations between 
case types in, for example, the choice of relevant time periods between measurements,
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the effect of different presenting characteristics and the likely standards for comparison.
The scale of the made it necessary to examine a small number of well-defined patient 
groupings rather than seeking measures which would necessarily embrace all case types 
within a specialty. It was recognised that common indicators or data elements may arise. 
The use of selected conditions as tracers also meant that the data collection methods could 
be tested and improved gradually.
ii) Identifying expected changes in health
Having agreed a reference group the next step was to agree the outcomes one might 
expect to see and at what time periods. For some conditions - typically those resulting 
in an acute inpatient episode - the outcomes were the changes noted between admission 
to hospital and 3 months and 12 months later. In the case of chronic conditions, it was 
necessary to consider longer time-scales, the outcomes being concerned with marginal 
changes in the patient’s health over time. These may be in terms of positive 
improvements in the patient or alternatively in the avoidance of a deterioration in health. 
The first time period typically started at the first contact with the service, for example 
newly diagnosed diabetics, and continued until a follow-up clinic or annual review. 
There are no clearly defined endpoints in chronic care.
The indicators that were discussed typically considered different dimensions of outcome 
as potential candidate measures. They ranged from specific clinical and laboratory 
assessments to more general descriptions of health and the patient’s ’quality of life’. It 
is becoming increasingly accepted that the patient’s perspective is critical to assessing the 
effectiveness of health care and there is growing experience in polling patients on 
different aspects of their health, quality of life or satisfaction with treatment (Fries 1983; 
Bergsma et al 1988; Leighton-Read et al 1987).
Where possible expected standards were agreed but given the novelty of some of the 
measurements - for example those attempting to reflect patient’s well-being - this was not
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always possible in anything other than general directional terms such as "all patients 
should show improvement".
ill) Identifying potential effect modifiers
In monitoring the outcome of care it was important to identify those characteristics of the 
patients which at presentation are known or thought likely to affect the eventual outcome. 
This is particularly importanat in the case of outcome monitoring in secondary care where 
potential improvements may be limited by a patient’s previous medical history. These 
variables can be used to define subsets of patients which are expected to achieve different 
outcomes. Thus for example the expected outcomes for young, otherwise healthy 
cholecystectomy patients may be different from that expected for elderly patients 
presenting with significant co-morbidities. The practical importance of these variables 
in explaining observed differences in outcome were evaluated once results became 
available.
In this area there was a tendency to be over-precise at the outset in defining what were 
the relevant patient characteristics to consider. Each extra item of information has a cost 
in terms of its collection and analysis and this had to be balanced by the importance of 
that additional data in assisting the interpretation of the results. A distinction should be 
made here between those variables which are always likely to affect the outcome of care 
eg age which may require the database to be subdivided before analysis, and those where 
the particular presenting characteristics are important in relatively rare circumstances. 
These will not require separate groupings of patients but can be considered as possible 
explanatory variables when results emerge. For example very obese patients can make 
cholecystectomies more difficult and one might expect the outcomes for these patients 
to be worse. However in practice relatively few patients are sufficiently obese for this 
factor to become important. Where this is the case it may be that only a few will suffer 
outcomes that are significantly worse than other patients and thus though obesity can be 
a subsequent explanatory factor as to why any one patient achieves a worse outcome - 
it is not a sufficiently discriminating variable by which to subdivide the patient database 
a priori. The key issue in determining potential effect modifiers is the strength of the
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causal link between the nature of the patient, the process of care and the eventual 
outcomes.
iv) Identifying data required to monitor changes
In most cases the relationship between the outcome indicator and the type of data required 
to create it is straightforward. Looking at outcomes from the clinician’s perspective, it 
is reasonable to take the view, at least initially, that if the information is important for 
the clinical assessment of a patient it will already have been collected in some form. 
Such basic clinical observations and descriptions of patients while they are in hospital 
should be mirrored in the medical records. If this is not the case then one must ask "Is 
this information really important?" or "Is its absence attributable to poor note-keeping?"
Even if the information was already collected, some changes were needed in the method 
of recording or the definitions used. Such changes should improve the general consistency 
of recording.
It was agreed that the clinician’s perspective was not the only viewpoint from which the 
outcome of care should be examined. The patient’s perspective was also important in 
assessing the success of an intervention and it was here that new data collection systems 
were required. The choice of instrument is discussed later but in general an existing 
established instrument was chosen where possible.
y) Identifying the best methods of data collection
Although not constrained by the original design, the methods of data collection which 
have developed have shown strong similarities across specialties although not all 
specialties require the full spectrum. Some specialties use only a selected combination of 
those available. The methods used are shown in Table 3.1
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Table 3.1 Summary of information capture methods
Source
Presenting demographic /clinical 
details
Notes
Computer systems
Patients symptoms/problems /health 
status
Patient completed questionnaires in 
hospital or by postal follow-up
Details of events in hospital Pro-forma completed by clinicians or 
from notes/computer systems
Details of events after discharge Patient, other hospital computer 
systems, GPs.
Though existing data sources, when supplemented with information from patients, could 
provide much of what was required, at some stage there had to be extra data collected 
by clinical staff. Additional data collection of this kind had to be justified on the grounds 
that:
- it replaces/improves existing data collection methods
- it provides other significant benefits as information
- it is considered essential for the review of outcomes
vi) Piloting and undertaking data collection
The pilot stages of data collection in each specialty raised questions over the 
feasibility of collecting certain items of information, particularly on a continuing 
basis. Different ways of data collection emerged and these were evaluated in terms of 
the reliability and consistency with which data could be recorded and the value that 
information will add. Issues also emerged over the definitions used, for example how 
is unstable angina defined or what constitutes a relevant co-morbidity? The results of
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these are presented in later chapters on the data collection methods in individual 
specialties.
The review of data collection systems and definitions formed a part of the feedback 
process and the discussion of results. The data collection systems had to be capable 
of undergoing an iterative development which responded to demands for new items of 
data without losing the necessary stability of key data items needed for longer term 
trend analysis.
vii) Validating data.
Considerable efforts have been made to check the reliability and accuracy of the data 
collection systems. It became clear during the course of the project that many data 
items could present problems in terms of either variation in definitions, the 
consistency of recording, missing data or inter-rater reliability. A variety of methods 
were used to check on the validity and accuracy of data, the results of these exercise 
are presented later where appropriate.
The methods included
- re-abstracting data from notes to compare to questionnaires
- checks versus other computer data bases
- interviews of patients
- repeating tests (typically on patients)
- checking of empirical relationships between outcome indicators.
viii) Feeding back the results
The purpose of collecting outcome information was to inform clinical practice and 
identify possible areas for change. This was undertaken within a clinical framework
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with results being presented at regular meetings with the clinical staff concerned and, 
in some circumstances, managers.
Data were fed back which consisted of:
- summaries of changes in individual patients
- specific reports on patients with 'poor outcomes’
- changes that have taken place on an aggregate basis, and when subdivided into
key groups. Some of these groups will inevitably be defined by patients’
presenting characteristics.
Assessing the effectiveness of outcome information.
The assessment of the effectiveness of the information itself was based on three
approaches.
1. Data for each specialty were reviewed at appropriate intervals with the clinical 
staff concerned. The data were presented in the form of a report and discussed 
with a pre-arranged agenda. Minutes of each meeting were prepared and 
particular actions noted. In addition reports were circulated to the Steering 
Group or to other interested parties who may not have been at the original 
meeting eg nursing staff, managers, clinicians in other hospitals.
2. A diary was kept in the CASPE office to record relevant events during the 
course of the study. In particular a wide range of responses from the clinicians 
was noted including areas where they had either expressed a particular interest 
or concern about the information. Similarly it was noted if particular actions 
had resulted from the outcome information - or the presence of the study.
Though not wonderfully effective, the diary helped keep track of some of the 
issues.
3. At the end of the project clinicians were asked some general questions about the
31
success or failure of the project. The issues are discussed in Chapter 9 and the 
responses to the survey in Appendix 3.
These various sources of information have been collated and presented in the results 
sections of this study.
C. Outcome information and resource management
The Freeman hospital was one of the national pilot sites for resource management. 
Two reasons why the study was based at the Freeman were the basic standard of the 
information systems in the hospital and the interest of clinicians and managers in 
developing information systems to assist in the management of clinical services. It 
was also hoped that the organisational change associated with resource management 
would provide a focus for the use of outcome information.
In particular the use of the main hospital information system was explored. Methods 
of linking the basic information on the main hospital systems (the case-mix computer) 
to the micro-computer used in this study were developed. Ideally the link is based on 
hard wiring the micro-computer to emulate a terminal to the main system. Software 
which periodically dumps data from the case-mix system (either directly or through 
floppy disks) to the micro-computer was developed. This could then be linked up to 
the outcome data bases.
The advantages of this type of link are that it avoids unnecessary inputting of common 
data - including diagnostic and demographic information. It also allows for checking 
on re-admissions and provides access to a larger database of patient episodes. These 
links have been shown to be possible though they have not become part of the basic 
routine this study. This was mainly because the efforts required to write the software 
would not be justified by the volume of cases in this pilot study. It was easier to re­
type the data where necessary.
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D. Selecting measures of patient function and health status
From the early stages of the project it became clear that a picture of outcomes would 
not be complete without some estimate of the patients overall function/health 
status/quality of well-being/quality of life - the terms are often used inter-changeably. 
Their use also differs slightly across the Atlantic, for example measures of ’Functional 
Status’ in the USA include what this report would tend to describe as general health 
status measures eg the Sickness Impact Profile (Brooks et al 1990).
The chosen term for this study is usually health status - in effect attempting to 
operationalise a definition of health. Quality of life was considered a broader 
description and included elements which may not have been able to be influenced by 
the health service. Functional status is taken as a more limited measure of the 
patient’s physical abilities.
There are a great many instruments which have been developed in this area - one 
recent review of the literature merited a supplement to Medical Care and ran to 70 
pages (Spliker et al 1990). These measures vary in what are deemed to be the 
relevant dimensions of health though there are often common themes, for example 
Ware suggests five generic health concepts physical health, mental health, social 
functioning, role functioning, general health perceptions (Ware 1987). Not all 
measures cover this spectrum. Some measures (usually older ones) specialise in basic 
activities of daily living and basic patient function, for example the Barthel Scale 
(Mahoney & Barthel 1964). Others are almost exclusively concerned with 
psychological well-being .
Not all measures are claimed as appropriate for all case types, some are used in 
analysing only a particular disease or population groups, for example two standards in 
arthritis include the Health Assessment Questionnaire (Fries et al 1980; Kirwan & 
Reeback 1986) or the Arthritis Impact Measurement Scale (Meenan et al 1984). It is 
unfortunate that the use of these scales tends to cluster in certain patient types (eg
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Arthritis) leaving areas where none have been tried. A great number of these 
indicators have been developed in one particular setting and have been tested by other 
researchers.
Choosing an instrument was therefore difficult. The criteria used to select an 
instrument were therefore:-
a. Established and reasonably well validated tool used in more than one study in 
the UK
b. Used in similar patient group - or if not the questions were deemed to be 
relevant to that patient group.
c. Expected to show longitudinal change following intervention - in many cases
there was little evidence of where scales had been used to show changes after 
treatment.
d. As quick and easy as possible to administer - which effectively means self­
administered by the patient and no longer than necessary.
e. Other things being equal a generic measure rather than a specific one.
These questions arose at some time in each specialty. There was the potential to 
standardise on one instrument across all cases yet this was rejected in favour of local 
specificity. Thus the goal of developing indicators relevant to a particular specialty 
was placed above the ability to make comparisons between specialties.
In fact as the project developed there was a growing interest in comparisons between 
conditions and by the end data was available from the same instrument on a variety of 
case types. In cholecystectomy and angioplasty the instrument initially selected was 
the Nottingham Health Profile henceforth NHP (Hunt at al 1986). This is a 38 item 
self-administered questionnaire scored according to the weighted sum of positive 
responses on six dimensions energy, pain, social isolation, emotional reactions, 
mobility, and sleep. In addition seven separate questions on how health affects 
lifestyle are included in Part II of the scale.
The NHP was selected for its ease of use and application and most importantly,
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though it was originally developed as a population survey tool it had been shown to 
demonstrate longitudinal change (Buxton et al 1985; O’Brien et al 1988), and had 
been used for surgical patients (Hunt et al 1986; Black, personal communication).
The instrument has been criticised for its sensitivity at differentiating illness (Kind & 
Carr-Hill 1987) when its modal response in fairly healthly people is zero and because 
there is co-variation between its dimensions and redundancy in items. The problem 
that most people score zero on the scale is largely accepted , and this had to be 
recognised as an important limitation in some settings. However others have found 
the instrument to be sufficiently sensitive to differentiate within and between patients 
with chronic illnesses (Jenkinson et al 1988). In practice it soon became clear that the 
instrument did appear to be working as it should in the groups we studied and later 
results show the demonstrable changes that occur following treatment and differences 
between patient groups.
The weighting system has also come in for some recent criticism (Jenkinson 
Pers.Comm.) and the value of the actual weights and the methods used in weighting is 
questioned. The data collected in this study could be used for further investigation of 
this issue.
Despite this the NHP is still one of the most widely used of all such tools and held the 
most promise. The biggest area of uncertainty was over its ability to show change in 
the short term for elective surgery - a doubt expressed to us at the outset by one of 
the scale’s developers.
The NHP provides six separate scores - one for each dimension. It is suggested that 
these are not aggregated but considered separately as a profile of the patients health. 
For most of the project results and all reports to clinicians this was the case.
In most cases the results in this report are presented in that way. However in this 
report aggregated scores were also calculated. There are a number of possible 
methods of aggregation (see Buxton et al 1985). The one chosen was simply to 
weight all dimensions equally and calculate a combined average. The aggregation was
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used to explore when relationships to other variables may exist and simply to reduce 
the volume of tables.
The other measures used included the Sickness Impact Profile (Bergner, Bobbit & 
Carter 1981) used in diabetes. In this case the NHP was rejected largely on the 
grounds that too few patients would score. The complete SIP runs to 136 questions in 
12 categories which was felt to be too much. However the categories are scored 
independently and so the diabetes results were based on only four categories selected 
after a trial of the full SIP on fifty patients. The four categories were chosen as 
representative of the full instrument and because they tended to elicit most responses.
More specifically they were:- 
Ambulation (from the physical dimension)
Social Interaction (from the psychosocial dimension)
Home management/housework (independent category)
Recreations and pastimes (independent category)
In Rheumatology (and early in orthopaedics) the Health Assessment Questionnaire was 
selected (HAQ)(Fries 1983). This instrument has almost come to be standard in 
Rheumatology though it is not without its problems (Leighton-Read,Quinn and Hoefer 
1987; Fitzpatrick et al 1989). In particular it is very ’functional’ in the sense that it is 
concerned mainly with the ability to perform everyday tasks. It represents therefore a 
narrower view of health than either the SIP or NHP. There was also some concern 
expressed about its ability to differentiate between ’severely ill’ patients, where the 
maximum score is felt to be insensitive to beneficial change. For these reasons 
comparative studies of the NHP and HAQ are underway in rheumatology.
After early trials with the HAQ in orthopaedics a decision was made to move to the 
NHP where the items were considered more relevant. The HAQ proved not a 
particularly inspired choice for knee replacements as much of it concerns basic 
function of the upper body.
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Finally it is worth noting a recent development from the Medical Outcomes Study 
where one questionnaire (36 items) is felt to be applicable to a broad spread of case 
types (Stewart et al 1989). This would be an attractive option for similar work 
provided its applicability in the UK could be demonstrated.
Validating NHP scores through patient interviews.
Given the uncertainties about the choice and use of the self-completed health status 
questionnaires, studies of the validity of the NHP were undertaken to check for 
possible problems in completion of the forms and to identify whether observed scores 
were related to those made by an independent assessment. Validity can refer to a 
number of different characteristics of a measurement and using different terms - 
construct, content, face, convergent, parallel, predictive, etc. A popular cliche has it 
that ’there is no gold standard’ with which to evaluate such measures. In this case 
evidence of the ’construct’ validity of the scores was sought by comparing observed 
scores to the judgements made by raters (clinically trained) following patient 
interview.
In three specialties (orthopaedics, general surgery and cardiology) a random selection 
of patients were chosen for validating postal questionnaires and NHP forms. These 
results were combined with a similar exercise undertaken to examine a stratified 
sample of diabetes patients (selected to include extreme NHP scores) to make a total 
of 56 patients.
The visits utilised a semi-structured interview covering the main points of the 
questionnaires. For any one condition the same assessor was used. Three different 
assessors were used in total. The researchers (who had not seen the patients’ forms 
beforehand) were asked to make their own assessment of the patients health-related 
problems using simple categories on a four point ordinal scale ranging from ’No 
problems’ to ’Severe problems’ (Appendix 3). Interviews were semi-structured 
around key questions representative of the different dimensions of the NHP. Ratings
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were made for each dimension. The results of the researchers assessment were then 
compared to the previously completed patient questionnaire. Table 3.2 summarises 
the results when the actual score across all the different cases (taken from four 
different conditions) are compared to the raters assessment (on a scale 1 to 4).
The analysis was based on the Kruskal Wallis oneway analysis of variance with ranks 
(NHP scores are typically not normally distributed) . The mean rank of the actual 
NHP scores are shown for the different assessments by the raters. Significant 
correlations are shown on all dimensions except energy.
There were significant differences between the mean scores for each condition so 
scores were standardised to remove the difference between mean NHP scores of each 
condition. The results are similar using these standardised scores. These 
relationships therefore hold despite possible variation in the way different raters 
scored patients.
This exercise suggests that most of the dimensions are roughly in accord with the 
perceptions of an interviewer. The lack of a clear relationship with regard to energy 
has - in retrospect - been attributed to the problems in framing the question at 
interview. It was found difficult to discuss what may appear as a rather abstract 
concept. It also interesting to note that the NHP itself has only three questions in this 
dimension and each is correspondingly weighted rather highly. This would tend to 
make the scale more ’volatile’ and could account for the discrepancy. The empirical 
analyses reported later comparing the NHP dimensions to other health indicators has 
not revealed energy to be especially different in its behaviour. Given the 
performance of the scale as a whole we have therefore concluded that it is behaving 
largely as expected. In cholecystectomy some test-retest studies have also been 
undertaken (reported in Chapter 5) with satisfactory results.
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Table 3.2 Mean rank of NHP scores against raters assessment and significance of observed 
relationship by one way analysis of variance by (a) ranks of unstandardised scores and (b) 
means of scores standardised for condition.
Mean Ranks Raters assessments of problems Significance.
None Minor Moderate Severe (a) (b)
Energy 25.1 24.9 27.8 38.1 .110 .872
Pain 18.0 28.1 37.6 38.9 .0023 .0005
Emot 21.9 27.3 31.8 43.7 .0083 .0087
Sleep 14.3 29.7 27.9 41.0 .0001 .0055
Soc Is 22.5 30.3 34.4 44.9 .0005 .0028
Hobi I 11.4 28.7 40.4 38.2 .0000 .0000
Comb 16.1 30.2 41.9 53.0 .0000 .0016
E. Statistical Methods
A variety of statistical methods have been used in analysis of the data. Guidance on 
the choice of tests was mainly based on one source (Blalock 1981). Where the 
distributions of continuous variables were considered ’normal* the test included the t- 
test of differences between two samples, analysis of variance for examining 
differences in a continuous variable between categories and product moment 
correlation and regression between two or more variables.
Many of the data elements studied, and in particular the health status measures, were 
not normally distributed which required the use of non-parametric tests where there is 
no assumption of ’normality*. Comparisons between paired samples which was based 
on the Wilcoxon rank sum test and comparisons against categorical variables based on 
the Kruskal-Wallis analysis of variance with ranks or the Mann-Whitney U test where 
only two categories were compared. Association between two variable was based on 
Kendall’s tauy. Comparisons of the distribution of two categorical variables was based 
on tests of Chi-squared, with the use of McNemar’s test for 2 by 2 tables.
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Chapter 4 Care of the Elderly
A. Introduction
The inclusion of inpatient care of the elderly was the last major strand to be added to the 
study. The reasons for its inclusion were firstly to test whether outcome data could be 
collected about a very different type of care to that of the other studies, and secondly the 
interest of the clinical staff and a desire to be involved in the project. The exploration 
of ways to monitor outcomes in this patient group is one of the least developed in clinical 
care.
The inpatient geriatric service at the Freeman Hospital is primarily based on a model of 
rehabilitation described by Grimley Evans (Grimley Evans 1983). There are few 
emergency admissions, all patients arrive at the ward either as an elective admission or 
through one of the other specialties in the hospital.
The study was centred on the one 30 bedded geriatric ward, for which there are two 
consultants both of whom have been closely involved with the study. As well as the beds 
in the acute hospital the department also covers two satellite hospitals and includes a day 
hospital.
The development of outcome measurement for this group of patients is in some ways less 
well advanced than for others. For example many clinical trials specifically exclude 
elderly patients. There are a number of studies which have sought to evaluate care of 
elderly patients typically by examining particular institutional settings for care. Thus for 
example the effectiveness and efficiency of day hospital care has been examined 
(Donaldson et al 1987; Gilleard 1985; Macfarlane et al 1979; Reifler et al 1981) and 
compared to other settings (Sherwood,Morris & Ruchlin 1986).
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The second area of work concentrates on specific disease groups within the elderly - of 
which the treatment of stroke has served as the model for outcome assessment (Van 
Swieten et al 1989). Other than disease or program specific studies there is relatively 
little known about the general outcomes of patients discharged from geriatric wards in 
a hospital.
B. Data set and data collection 
Identifying the Outcome Indicators
The agreement on the outcome indicators and data set in geriatrics took place over a 2-3 
month period and discussions included representatives of the various professional groups 
in the clinical team. The involvement of disciplines other than medicine has been greater 
in this project then in the others.
As discussions developed it became clear that the emergent indicators were applicable to 
the majority of admissions and not to specific diagnostic categories. The medical 
classification of geriatric patients is difficult because patients typically suffer from a 
number of different disease conditions. Given the complexity of the medical problems 
it appears that in care of the elderly the types of goals for most patients tended to be 
similar despite differences in the nature of the underlying medical condition. There were 
however two important exceptions to this:
- patients admitted for terminal care.
- patients admitted for investigation only.
It was therefore agreed to develop indicators that could be applied to all patients except 
these two types of admission thus effectively including the majority of the specialty’s 
workload.
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Outcome Indicators
The following list of outcome indicators contains one important omission. It was noted 
that ideally the patient's views on their own health should be polled but administration 
of one of the standard health status instruments (as in the other specialties) presented 
particular difficulties. Neither do the measures incorporate assessment of handicap that 
is the effects on a persons 'role' but concentrate on disability (there ability to perform 
'tasks'). Whilst such measures would be desirable no wholly satisfactory instruments 
have been found.
Avoidance o f death
It was agreed that in general there should be as few deaths as possible for admitted 
patients either during the stay or shortly after discharge. It was recognised that in 
individual cases death may not necessarily be undesirable, yet for the group as a whole 
it was. It is clear that the interpretation of this information would be different in 
geriatrics than from the other specialties.
Improvement in basic patient junctional abilities
One of the features common to the care of elderly patients is the desire to improve some 
of their basic abilities to perform everyday tasks. There are a number of instruments 
available for such assessments (Applegate, Blass & Williams 1990). There is also a 
growing realisation that such assessments are essential in screening (Williams 1990) and 
monitoring elderly patients (Dickinson & Young 1990).
The choice of an appropriate scale took some time and involved testing - and eventually 
rejecting the Creighton Royal scale and the Office of Population, Censuses and Surveys 
(OPCS) Disability scale (Martin,Meltzer & Elliot 1988). The OPCS scale was 
recognised to be comprehensive and much more sophisticated than the alternatives. It 
was tried in practice by giving it to a number of professionals to complete. Though it 
showed a sophisticated breadth of issues the process of completing the questionnaire 
proved too unwieldy to be practicable. The major problems were its length and
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uncertainty about the correct process for completion. It was recognised that as the scale 
would be completed by a number of different personnel, simplicity was of the essence.
Eventually the Barthel scale (Mahoney & Barthel 1965) was chosen. This is a simple 
scale assessing ten items concerned with daily living and scoring each on between 2 and 
4 categories ranging from complete dependence to independence. Despite its relative 
simplicity this scale is one of the most widely used (Collin et al 1988; Wade & Collin 
1988) in particular its content was considered relevant, the individual items covered the 
main objectives independently identified by clinical staff. Though there are a number of 
specific rules for completion these are relatively straightforward.
The simplicity of the scale also meant that it was possible to record not just the present 
status of the patient, but also the expected goals for that patient. Thus for each item 
improvement could be expressed relative to specific goals for that patient.
The disadvantages with the scale concern its lack of sensitivity for different patient 
groups, and modifications have been suggested, and the system of scoring. This is rather 
rudimentary and does not attempt to inter-relate scores across different items as some 
others do (Nouri 1987). As a measure of disability it is also criticised for its limitation 
to aspects of self-care and so does not represent the full range of problems that patients 
may face (Ebrahim 1990).
Finally it should be noted that the selected scale measures disability rather than handicap 
(Ebrahim 1990).
Independence o f home environment
The home environment was recorded on admission, discharge and at follow-up on a 
simple ladder scale which ranged from living at home to living in long-term institutional 
care. A value judgement was made that, in general, the top of the ladder is ’better’ than 
the bottom. It is important to stress that this judgement applies to the population of 
patients as a whole rather than any one individual.
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Alleviation o f acute medical condition
It was recognised that a key role of the service was treating acute conditions of the 
patients. However with complex disease patterns in these patients success in this respect 
is difficult to assess in an objective fashion - other than by the knock-on effects on 
patient’s functional status. Therefore the clinician’s judgement was used as a simple 
indicator. In particular staff were asked to assess the patients against three questions:
- Has the medical condition improved?
- Is the patient better than before?
- Have the overall goals been achieved?
It was intended that these be used more as a method of identifying specific patients where 
treatment had not been successful rather than as an aggregated indicators of performance. 
In practice the data has been little used but served as a useful check on change in patients 
when viewed with other indicators.
Minimal deterioration in mental health/awareness
In addition to changes in basic function it was recognised that there should not be 
deterioration in the patient’s mental condition, and in some cases a positive improvement. 
The ten point mental health score (Qureschi & Hodkinson 1974) which forms part of the 
admitting routine has been used. Whilst collection of the data on admission has given few 
problems it was not routine to administer the test again on discharge. Consequently there 
were very few patients with observation at both points. Therefore the information has 
been used to identify patients with severe confusion as a complication of their presenting 
condition.
Minimise strain on main care givers where appropriate
In some cases it was recognised that an additional goal of the service was to reduce the 
burden on informal carers. There is considerable research into the emotional well being 
of care givers of the elderly demented. The evidence suggests that carers can suffer from 
a variety of health-related problems including psychological problems, stress and stress- 
related physical problems (Gilhooly 1984; Gilleard et al 1984) though the evidence is not
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unequivocal (Eagles et al 1987). A variety of scales have been developed (for a review 
see Baumgarten 1989) but there is little consensus on which instruments to use in which 
circumstances and little comprehensive testing of the validity of scales in different 
contexts.
In this study, the stress on the care-giver was considered most important and therefore 
a simple questionnaire was used (Robinson 1983). This was given to the main care 
givers (when appropriate) and sent out at follow-up. Initially, this was used with all 
patients. However in many cases it was clearly inappropriate, for example where there 
was no identifiable main care giver or when the patient was in the charge of professional 
carers. Therefore it was decided that the instrument should be used on a limited selection 
of patents identified when:
the patient had an easily identifiable main care-giver (and not multiple 
professional carers)
the care-giver lived close enough to be directly involved in day to day care
the main care-giver was physically able to complete the questionnaire eg not
blind, or did not have severe arthritis in the hand
the patient was not in residential or long-term hospital care
the patient was not admitted for terminal care
Timing of observations
The relevant timing of measurements was agreed as at admission (to give the baseline 
values), at discharge and then three and twelve months after discharge. The identification 
of the individual goals for the patient related to the time of discharge and were not 
collected at follow-up. It was recognised that the initial baseline values would correspond 
to a period of the first few days of the stay rather than the actual day of admission. In 
the event of patients being readmitted to the Freeman Hospital, a new episode was 
initiated and the previous episode was considered to have ended.
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Data Collection
Patient identification/baseline data
Most of the patients admitted to the care of the elderly ward were eligible for the study. 
The exclusions were those admitted for terminal care or investigations only. The baseline 
information on age, sex, diagnoses etc. was taken from the notes soon after admission. 
This data included the mental test score and previous medical history which are part of 
the normal clerking information collected by medical staff. This data abstraction onto 
a pro-forma was undertaken by a member of the medical staff (CASPE staff standing in 
when necessary).
Functional status and accommodation
The main assessments of items in the Barthel score and goals for the patients were 
originally designed to become part of the social round - when discussions amongst the 
clinical team review all patients. It was the designated task of one member of staff to 
note down the issues as and when they were discussed. In some cases the use of the 
structure provided by the Barthel was said to have helped clarify discussion on individual 
patients and to ensure that all the relevant issues had been addressed - rather like a 
checklist. There does seem to be some potential benefits for using such scales in this 
context (Dickinson & Young 1989). However this practice has tended to lapse with a 
change of personnel. If the data was not collected during the social round then it was 
completed afterwards by the medical staff in discussions with the primary nurse for that 
patient.
Care-Givers Strain Scale
It had been agreed that it was the nurse’s responsibility to administer the care giver strain 
scale where appropriate. The relevant individuals and their addresses were recorded in 
a central register (something that was not in place before). Carers were given a form 
to complete on the ward by the nurses.
Follow up scales were sent out by post after preliminary checks on the patients 
whereabouts and checks to ensure that the patient was still alive.
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Discharge information
At discharge the summary details of the stay were completed by the medical staff together 
with the further Barthel score (from the social round).
Follow-ups
The process of following up patients after discharge has proved a problem. The main 
difficulty has been that postal methods have not been used. Follow-up information was 
therefore obtained:
at out-patient appointment for those patients who have a scheduled visit. The 
relevant forms are added to the notes and completed by medical staff, 
at the day hospital for those patients who are visitors.
from satellite long-stay hospitals where medical staff will be seeing the patient or 
by telephone to local nursing staff.
from local nursing homes where after initial approaches a telephone call is used 
to check on the status of the patients.
In some cases when the patient was not seen directly, staff at other institutions were 
asked about the status of the patient over the telephone. The simplicity of the Barthel 
scale lends itself to this method of data collection though validation of the results 
obtained has been necessary.
Some patients may not fall into any of the above categories. Though a routine out-patient 
visit after the stay has been suggested as a requirement of care it was agreed that if the 
only reason for the visit was to collect the data this was not acceptable. Thus an 
estimated 15% of patients were due for follow-up but not contacted. The whereabouts of 
this group are being examined for a complete 12 months follow-up.
Finally there was a problem in identifying when patients had died, as others have noted 
(Walters 1990). The routine was to check carefully through hospital computer systems 
and then all locally notified deaths in the district (most of the patients will be residents). 
In some circumstances local GPs were contacted.
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Validation o f Barthel Scoring
Whilst the simplicity of the Barthel scale is one its great advantages, there is the potential 
problem that the scoring depends on following some simple rules, and that some 
interpretation of dependence and independence have to be undertaken by the rater. There 
is a danger that the instrument might be unduly influenced by whoever completed it. 
Therefore two checks were made on the scoring of the Barthel chart when the same 
patient was scored by different raters or under different conditions.
The process of scoring the items of the Barthel via telephone through discussions with 
carers in another institution was checked for 20 patients by visiting the carers and patients 
shortly afterwards. In addition the assessments made during the social round were 
compared to those made by the primary care nurse (who knew the patient but may not 
have been part of the meeting) or by a nursing auxiliary on the ward.
The results of the pairs of evaluations were compared. Though not all the results were 
consistent they did show a generally high level of association. Table 4.1 shows the 
association between individual items and the total score using Kendall’s Tauy and the 
number of patients where the scores were exactly the same. Most items on the scale 
show highly significant associations between the two scores. The exceptions appear to 
be ’Grooming’ and ’Transfer’ where the ratings appear less reliable.
For the total score it is clear that the two ratings did not produce exact matches despite
Table 4.1 Associations between repeat administration of Barthel scale comparing telephone with direct 
Beasurenent and social round with primary care nurse assessment.
Telephone Check Ward Check
n=20 n=11
#Same Tau Sig #Same Tau Sig
Bowels 14 .667 .0006 10 .720 .004
Bladder 17 .909 .0000 10 .554 .019
Grooming 16 .404 .039 9 .32 ns
Toilet 16 .800 .0001 7 .57 .014
Feeding 16 .806 .0001 7 .46 .04
Dressing 16 .727 .0003 9 .69 .004
Mobility 16 .700 .0003 11 1.00 .000
Transfer 13 .571 .0023 8 .67 .005
Bathing 20 1.000 .0000 8 .72 .002
Stairs - - - 9 .41 ns
Total 6 .817 .0000 2 .659 .001
48
the high degree of association. The results were examined using the method of Bland & 
Altman (Bland & Altman 1986) of comparing continuous variables, which in this case is 
a necessary assumption. The difference between the two scores was examined and 
plotted against the original assessment - Fig 4.1. It is clear that in one patient there is 
a major discrepancy between the two scores, this may be related to a change that 
occurred between the original scoring and subsequent validation, but in general the 
agreement was reasonably good.
Fig 4.1 Plot of difference between interview and telephone scores 
versus interview score (n=20).
Difference
(Interview-telephone score)
I_______I
l o l  13.4 16.4
9 12 15
Interview score
There was no difference in the mean scores with the two methods so no apparent bias. 
The standard error of the difference suggest that most observations fall within the 95 % 
confidence intervals which roughly equates to plus or minus 1 point on the full scale. 
This was not considered to be an important difference from a clinical perspective. It is 
suggested that this could be used as a ’rule of thumb’ when using the Barthel score. 
There does not appear to be any relationship between the differences between the ratings 
and the absolute level of the score.
It became clear during this exercise that the potential difficulties with this instrument
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were:
1. A knowledge of the guidelines for completion of the Barthel was important. The more 
staff that were involved in collecting data the more problems were likely to arise in 
this respect. In particular the measure requires distinguishing between what the 
patient actually does rather than what the patients is felt capable of doing.
2. Very few patients could get in and out of the bath without assistance, or if they could 
staff did not let them for safety reasons. Thus most cases scored zero on this item.
3. In some cases the score could change quite rapidly (within a day or two) as the patient 
recovered from an acute illness. In some cases it may be that this change does not 
really reflect improvements due to the care given. Hence the use of the expected 
goals for the patients used in this study, or the proposed measurement of ’pre-morbid’ 
states suggested by others (Royal College of Physicians Working Group on Functional 
Assessment 1990).
4. The item on ’Stairs’ created problems for completion on some patients when there was 
really no need for the patient to go up and down stairs either in the hospital or in their 
normal home environment.
B. Data analysis
The section on data analysis is concerned with three key questions:
1. Do the indicators show significant changes in hospital or during the period to follow- 
up?.
2. Are the indicators related to each other?
3. Are the indicators influenced by the presenting characteristics of the patients?
Data on the care giver strain scale has been analysed separately and is briefly summarised
at the end of this section.
As yet only 11 patients who have not been readmitted and have survived are due for a
12 months follow-up. The detailed results of the 12 month follow-up have therefore not
been presented as the numbers are too small. However it is known that some patients
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have died after the three month follow-up and this fact has been used in estimating 
survival rates.
Changes in indicators
(i) Deaths and réadmissions
It is inevitable that a substantial proportion of these elderly patients will die in hospital - 
even when admissions for terminal care are excluded. Table 4.2 summarises the numbers 
of cases studied for the sample who have reached discharge and those who have reached 
the time of their three month follow-up. For the sample followed to 3 month follow-up 
53 of the patients died during the hospital stay and a further 39 cases up to follow-up. 
Fig 4.2 shows the survival curve in successive months - using cases where the date of 
death was known.
Table 4.2 Numbers of patients and response rates
Total rehab patients admitted to 1-12-90 = 404
died in hospital = 65 (16.1%)
discharged = 339 (83.9%)
Total patients admitted to 1-9-90 = 292
died in hospital = 53 (18.2%)
died to follow-up = 39 (13.4%)
readnitted to 3m = 15 (5.1%)
ok at follow-up = 139 (47.6%)
not contacted = 46 (15.8%)
There were a number of patients discharged who did not receive a follow-up as discussed 
earlier. It is assumed that these patients are still alive and have not been re-admitted to 
another hospital. Fig 4.2 suggests that the rate at which patients died was fairly constant 
over the three months following admission (average length of stay is of the order of one 
month). These numbers probably slightly underestimate the numbers that have died.
In addition 15 patients (5.1%) had been readmitted to the Freeman Hospital. The 
procedure in these cases was to consider this event as an endpoint of the first admission. 
Data collection was then started to assess the outcomes of the second inpatient episode.
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Fig 4.2  Estimated survival following admission to  g e r ia tr ic  ward.
Survival a f t e r  a d m i s s i o n
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(ii) Functional status
Table 4.3 summarises the changes in Barthel scores between admission and discharge. 
There was a significant improvement in aggregate scores (p< .001 using Wilcoxon ranks 
sum). The mean scores increased from 11.7 on admission to 14.5 at discharge. Table 
4.3 also clearly shows that in terms of the total Barthel score few patients who survived 
had a lower score at discharge and even fewer had scores greater than 2 points lower. 
The distributions of scores at both admission and discharge showed a high proportion of
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scores over 17 - indicating relatively less disability. As a result of this there were clearly 
some end effects with this scale potential for improving scores was considerably reduced 
if the initial scores are high.
These improvements in the total Barthel score were matched by highly significant 
improvements on each of the individual items as shown in Table 4.4. which summarises 
the changes in the individual items of the Barthel scale between admission and discharge. 
The proportion of cases recording a particular score are shown together with the means 
scores for that item and the proportions getting ’better’ the ’same’ or worse’. The higher 
the score the greater the independence of the patient.
There were certain problems of specificity with this scale as can be seen fairly clearly 
from this table in that the most common scores were those indicating the greatest 
independence, that is the highest score. Typically most patients had the same score on 
any one item at admission and discharge. Those items with a scale of four categories 
benefit in this respect in that they allow a finer gradation of independence and 
consequently cases were more likely to show change. Despite these limitations on any 
one item there was an observed 15-30% of patients who showed an improvement. When 
all items were added together 60% of cases showed some improvement which suggests 
that the total scale performed better than any one part.
Interestingly the change in ability to cope with stairs showed little overall improvement - 
problems were found in scoring this item as either stairs were not available for testing 
or the task was deemed to be irrelevant. The other items that showed less improvement 
were ’Eating’ and ’Bathing’. The aggregate score appeared to be more sensitive than the 
individual items. Given the breadth of coverage of the scale, it is perhaps not surprising 
that few patients suffered from problems on all the items. The pattern, as expected, was 
that most patients had only one or two items on the scale that were amenable to change.
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Table 4.3 Changes in  Barthel scores - admission to  discharge (n=314)
Admission: Mean = 11.74 Std Dev = 5.58
Discharge: Mean = 14.45 Std Dev = 5.01
Sig Difference p<.0000 (Wilcoxon Signed ranks tests)
Crosstabulation:
Scores
on
Admission
Distribution of scores on discharge
Count 
Tot Pet < 2
-  1
3-4 5-6 7-8 9-10 11-12 13-14 15-16 17-18 19-20
Row
Total
< 2 2 3 4 1 2 2 1 1 1 17
.6 1.0 1.3 .3 .6 .6 .3 .3 .3 5.4
3-4 1 5 2 3 1 4 2 2 1 21
.3 1.6 .6 1.0 .3 1.3 .6 .6 .3 6.7
5-6 1 3 1 3 8 1 4 3 4 1 29
.3 1.0 .3 1.0 2.5 .3 1.3 1.0 1.3 .3 9.2
7-8 1 2 5 10 5 1 4 7 2 37
.3 .6 1.6 3.2 1.6 .3 1.3 2.2 .6 11.8
9-10 1 1 2 7 6 5 4 5 31
.3 .3 .6 2.2 1.9 1.6 1.3 1.6 9.9
11-12 1 2 5 5 9 9 5 36
.3 .6 1.6 1.6 2.9 2.9 1.6 11.5
13-14 6 6 8 6 26
1.9 1.9 2.5 1.9 8.3
15-16 1 1 1 5 13 5 26
.3 .3 .3 1.6 4.1 1.6 8.3
17-18 1 1 25 12 39
.3 .3 8.0 3.8 12.4
19-20 1 51 52
.3 16.2 16.6
Total 1.6 4.1 2.9 4.5 8.0 7.6 8.9 10.5 23.6 28.3 100.0
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Table 4.4 Changes (n the scoring of items of the Barthel admission to discharge
Percentage of cases with particular scores, means at admission and discharge and the percentage 
who are 'better'(B), the 'same'(S), or 'worse'(U).
X cases n=339 Admission Score Discharge Score Changes in score
Item 0 1 2 3 0 1 2 3 Mean
Admit
Mean
Disch
B S W
Bowels 20.1 8.6 71.4 8.0 6.8 85.3 1.51 1.77 19 77 4
Bladder 29.8 10.9 59.3 . 18.3 10.0 71.7 . 1.30 1.53 22 73 6
Grooming 57.5 41.9 0.6 - 31.0 67.0 0.6 - 0.43 0.68 28 68 4
Toilet 25.7 35.7 38.6 10.0 26.5 63.1 1.13 1.53 34 63 3
Eating 8.0 25.4 66.4 . 2.9 20.4 75.8 . 1.58 1.71 15 82 3
Dressing 23.3 44.8 31.6 _ 9.1 33.3 56.6 . 1.09 1.47 36 60 4
Bathing 1.2 92.3 6.5 . 87.6 10.6 0.0 . 0.05 0.11 5 94 1
MobiIi ty 31.6 19.5 5.0 44.0 11.2 14.2 8.0 66.4 1.76 2.29 35 62 3
Transfer 12.7 20.4 15.9 51.0 1.8 11.2 13.0 73.7 2.05 2.58 34 63 3
Stairs 0.6 46.3 6.8 23.9 .6 34.5 8.6 31.3 1.32 1.47 12 84 4
Combi ned - - - - - - - - 11.74 14.45 63 32 5
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This can be seen when the individual goals are examined. Table 4.5 shows for individual 
items of the Barthel score at admission and discharge, the proportion of cases who were 
better than, equal to or less than the stated goal. It can be seen that in the majority of 
cases (60-75%) the goals on any one item were equal to the admission score. The 
potential to show improvement is only therefore possible in the remaining 25-30%. The 
results at discharge suggested that there were few patients (excluding deaths) where the 
desired goals had not been achieved (less than 10%) leaving most cases with a discharge 
status equal to or above the individual goals.
The best performance against goals were seen for items covering ’Bowels* and ’Bladder*. 
The worst were for ’Grooming’, ’Dressing’ and ’Transfer*.
Table 4.5 Individual goal setting by items of Barthel scale.
Percentage of cases where goals are greater than or less than admission or discharge 
Barthel ratings n=339.
Goal 
>admi t
Goal 
=admit
Goal
<discharge
Goal
=disch
Goal
>disch
1 Bowels 24.5 75.5 1.5 87.6 12.9
2 Bladder 27.7 72.0 3.6 80.8 15.7
3 Grooming 30.4 69.6 6.8 80.2 13.0
4 Toilet 39.3 60.2 7.0 81.1 12.1
5 Eating 12.1 87.9 5.3 88.5 6.0
6 Dressing 39.8 59.9 7.4 79.1 13.6
7 Bathing 7.1 92.9 2.1 93.5 4.4
8 Mobility 40.1 58.4 6.8 80.5 12.7
9 Transfer 36.6 63.4 7.4 80.2 12.3
10 Stairs 13.3 85.5 5.6 86.4 7.9
Table 4.6 charts the discharge and follow-up Barthel scores for those patients that
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Table 4.6 Changes in  Barthel scores from discharge to  follow-up (n=138).
Mean at admission = 12.386 Std Dev=5.05
Mean at discharge = 14.73 Std Dev=4.97
Mean at follow-up = 13.500 Std Dev=5.59
Follow-up sig greater than admission p=.0061 
Follow-up sig less than discharge p=.0002
Score
at
discharge
Distribution of scores at follow-up
Count 
Tot Pet <2 3-4 5-6 7-8 9-10 11-12 13-14 15-16 17-18 19-20
Row
Total
<2
if
2 2 1 1 1 1 8
1.4 1.4 .7 .7 .7 .7 5.8
3-4 1 1 2 1 1 1 1 8
.7 .7 1.4 .7 .7 .7 .7 5.8
5-6 2 1 1 2 1 7
1.4 .7 .7 1.4 .7 5.1
7-8 1 2 1 4
1.4 .7 2.9
9-10 3 2 2 1 2 10
2.2 1.4 1.4 .7 1.4 7.2
11-12 1 2 3 2 1 2 2 1 14
.7 1.4 2.2 1.4 .7 1.4 1.4 .7 10.1
13-14 1 1 1 2 5 2 12
.7 .7 .7 1.4 3.6 1.4 8.7
15-16 2 2 6 8 18
1.4 1.4 4.3 5.8 13.0
17-18 1 2 2 12 12 29
.7 1.4 1.4 8.7 8.7 21.0
19-20 1 2 7 18 28
.7 1.4 5.1 13.0 20.3
Column 3 4 5 8 11 9 10 15 30 43 138
Total 2.2 2.9 3.6 5.8 8.0 6,5 7.2 10.9 21.7 31.2 100.0
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survived to the three month time period. The general pattern appeared to be of little 
change after discharge - the scores at follow-up remained significantly higher than at 
admission for paired data but there was no significant change from discharge. It 
appeared that the beneAcial effects of the hospital spell in terms of improving Barthel 
scores were limited to the in-patient stay with patients remaining fairly stable after that. 
It is interesting to observe that there were a handful of quite severely disabled patients 
on discharge who had subsequently improved to 3 months (presumably most will be in 
some other care setting). Very few show residual scores less than say 5.
(in) Accommodation status
Table 4.7 summarises the accommodation status of patients at admission and discharge 
for those patients who survived. The four categories used here were abbreviated from 
the ten categories that were used on the data collection form and represented a scale, as 
expressed by the clinicians, of ’desirability* of the home environment, in effect a 
preference for the patient to be independent.
There was relatively little change between the various categories. The most common 
category for the survivors was the 64% of cases who were admitted from home and 
discharged home. All changes were ’for the worse’ according to the pre-determined
Table 4.7 Changes in accommodation status - Admission to discharge (n=138)
Accommodation on discharge
Count 
On % Total Home ResCare Rehab LT care
Row
Total
Home + 88 10 7 10 119
(Shelt) 63.8 7.2 5.1 7.2 86.2
Resid Care 11 4 15
8.0 2.9 10.9
Rehab Hosp 1 1
.7 .7
LT Care 2 2
1.4 1.4
Column 88 21 8 16 138
Total 63.8 15.2 5.8 11.6 100.0
preferences expressed by clinical staff and in particular a number of patients admitted 
from home are inevitably discharged somewhere else. The fact that no cases move up 
the scale of independence from long term care to home, lends a little validity to the
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ranking of these categories. Comparing the accommodation at discharge to three months 
reveals relatively little change amongst patients once they had left hospital. The biggest 
changes were for 8 patients who moved between rehabilitation in hospitals and long term 
care.
(iv) General ratings
At discharge clinical staff were asked to assess whether goals of patients had been 
achieved, whether the medical problems had been resolved and if the patient was 
generally better. The results (shown later in Table 4.9) show that for the majority of 
cases (around 80%) the answers to these cases were positive. More specifically on the 
assessment of medical goals 74% of patients were scored as ’Better’, with only 20% the 
’Same’ and as few as 2% as ’Worse’.
Almost identical results were seen for the assessment of general status 71% ’Better’, 
24% ’Same’ and 2% as ’Worse’. The questions on whether the overall goals had been 
achieved showed less confidence in the benefits of care, for 78% of cases the answer 
being ’Yes’, 9.1% ’Unsure’ and 9.1% ’No’. This item was originally included as a 
screening method to pick out non-responding patients. The relationships between these 
assessments and the other indicators are discussed later as well as the relationship 
between them.
Relationships between indicators
Barthel score and accommodation
There were strong and statistically significant links between the admitting Barthel scores 
and the accommodation status of patients. This is as one would expect, patients who 
have come from other institutions score on the whole lower than those who have been 
living at home. The mean values of the Barthel scores by admitting accommodation status 
are shown in Table 4.8(a). The gradient in scores roughly matches the gradient 
developed by clinical staff when developing a classification of accommodation. One 
contentious point in these results was the status of sheltered accommodation, the Barthel 
scores for this group of patient suggest an independence level equivalent to those living
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at home (it has been included in this group in the simpler four point scale used earlier). 
Scores for patients admitted from residential care are notably lower.
Table 4.8(a) Mean Barthel scores on admission by home environment
Barthel Score
Mean Std Dev Cases
For Entire Population 11.7420 5.5841 314
16.0000 0.0 1
1 Home alone 12.4286 5.5233 63
2 Home+social services 13.7358 4.8799 53
3 Home +prof 12.2500 4.3995 20
4 Home + other 11.4706 5.7649 119
5 Sheltered accommodation 12.6250 6.4323 24
6 Residential care LA 8.0000 3.3040 25
7 Residential care Private 6.0000 0.0 1
8 LT care rehab 7.5000 .7071 2
9 LT care 5.0000 4.9666 4
P LT care private 3.0000 2.8284 2
Table 4.8(b) shows the Barthel scores according to accommodation on both admission, 
discharge and at 3 month follow-up using the simpler 4 categories. The significant 
differences between Barthel scores according to accommodation status at admission to 
hospital were also found to exist on discharge from hospital. Thus patients discharged 
’home’ had significantly higher scores than those discharged to residential care. 
Considering the net change in Barthel score there are no differences between the groups - 
all show an improvement of between 1.5 and 3 points on the scale.
Table 4.8(b) Mean Barthel scores at admission, discharge and change according to home environment 
at admission and discharge.
Mean Barthel scores 
by admission environment
Mean Barthel scores 
by discharge environment
No. Admit D i sch Change Admit Disch Change
Home 289 12.2 15.1 3.0 13.1 16.4 3.4
Resid 30 8.0 10.1 2.6 9.9 13.6 3.7
Rehab 2 7.5 9.0 1.5 8.7 10.5 1.9
LT Care 5 6.2 8.4 2.2 8.5 7.2 - .61
Significance p<.001 p<.001 ns p<.001 p<.001 pK.OOl
Table 4.8(c) classifies patients into those who have remained at the same level of 
accommodation status against those who have ’slipped’ down the ladder. There are 
significant differences between admission scores, discharge scores and change in Barthel 
for these two groups. The improvements in patients who remained at the same level of 
accommodation was slightly better.
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Barthel scores vs survival
The Barthel scores for patients who die during the hospital stay were significantly lower 
than for the survivors (Table 4.8(c)) the average score for survivors was 11.7 against an 
average of 4.4 for those that die (p< .0(X)1). When the Barthel scores of patients who 
die after discharge were compared with those that survive there were no significant 
differences in either admitting score, discharge score or change in score.
The identification of lower Barthel scores in those who die in hospital was as expected 
and the absence of such an association for those that die after discharge presumably 
reflects the fact that lowered scores tend to be associated fairly closely with the short 
times just before the patient dies. It is dangerous to read too much into the observed 
relationship between low Barthel scores and survival - and in particular to infer some 
form of causality.
Table 4.8(c) Mean Barthel scores and accommodation changes against other indicators (np314) 
Kruskal-Uallis analysis of variance by ranks (Barthel scores);
Admission
Barthel
Discharge
Barthel
Change in 
Barthel
Accom
Same
Accom
Worse
Ok to 3m 11.67 14.5 3.0
Died in hosp 8.39 - -
Died to 3m 12.33 13.8 2.3
p=.0000 ns ns
Accom Same 12.2 15.4 3.2
Lower 9.9 11.3 2.0
p=.0017 p=.0000 p=.016
Gen Better 11.6 15.0 3.7 82% 19%
Same 12.0 13.2 1.5 63% 38%
Worse 11.6 7.4 -4.2 20% 80%
ns p=.0012 p=.000 p=.001
Medical Better 11.9 15.1 3.5 80% 20%
Same 11.0 12.7 1.9 66% 34%
Worse 11.3 9.3 -2.0 29% 71%
ns p=.0002 p=.0001 p=.004
Goals Yes 12.1 15.1 3.2 81% 20%
Unsure 11.0 12.9 2.7 74% 26%
No 8.5 9.7 1.6 36% 65%
p=.0018 p=.000 ns ps.OOO
Barthel scores and accommodation vs General ratings
The results of the summary questions completed at discharge by clinical staff are shown 
in Table 4.9. The three questions were:
- Has the medical condition improved?
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- Is the patient better than before?
- Have the overall goals been achieved?
Table 4.9 shows the high degree of inter-relationships between the three simple summary 
questions. In 84% of cases there was direct agreement between the achievement of 
medical goals and improvements in general health.
When the Barthel scores were compared to the summary made at discharge there was in 
general agreement between the two assessments (Table 4.8(c)). Thus the discharge 
Barthel scores and the change in Barthel scores were significantly worse for cases where 
the medical problems were classified as ’Worse’ and where the general status was 
’Worse’. Similarly these
Table 4.9 Relationships between summary assessments (np339)
Overall improved Medical Goals
Yes Unsure No Better Same Worse
General status?
Better 214 18 8 226 14 0
Same 51 11 17 23 54 2
Worse 0 1 6 0 0 5
Medical Goals?
Better 223 16 9
Same 41 13 14
Worse 0 1 6
patient tend to have slipped down the ladder of accommodation status which indicates 
some consistency between the ordinal scale of accommodation and the perceived goals 
of care.
With respect to the general achievement of goals it is interesting to note that patients 
where the goals were not met tended to have lower scores on admission as well as at 
discharge. Presumably this category of patient includes ones who were relatively 
dependant and though some improvement was achieved the expectations were higher. 
The reasons for this need to be explored further.
Barthel vs Mental Test Score.
When the admitting mental test scores were examined there was a weak link to overall 
Barthel scores. Patients with low mental test scores (below 5) showed in lower Barthel
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scores, the mean values on the Barthel are shown in Table 4.10. There is little variation 
in mean Barthel scores between the relatively less confused patients, scoring greater than 
5 on the mental test score.
Table 4.10 Mean admitting Barthel scores by scores on abbreviated mental test
Mean Std Dev Cases
For Entire Population 11.7420 5.5841 314
Test score = 0 or not recorded 11.6126 5.6844 111
Test score = 1 7.2727 5.6761 11
2 9.7143 4.8206 7
3 11.6250 5.9507 8
4 9.9167 4.3161 12
5 12.7000 5.3222 20
6 12.3158 5.5783 19
7 12.4783 5.6638 23
8 11.8276 5.6446 29
9 11.8750 5.6383 32
10 12.8571 5.4753 42
Once again this relationships is expected as patients with severe confusion will tend to 
be more dependent. This can be seen as supporting evidence for the validity of the 
Barthel scoring.
The effects of presenting characteristics.
There were relatively few presenting characteristics which were thought to be possible 
effect modifiers. The effects of these variables against the mean Barthel scores from 
admission to discharge, as well as the relationship to survival and accommodation status 
are shown in Table 4.11. As in other specialties the analyses presented are basically 
exploratory bivariate comparisons between outcome indicators and presenting variables 
designed to assess which show the strongest relationships to observed outcomes. There 
is undoubtedly some interaction between the presenting variables and more sophisticated 
analysis could minimise these effects and explain the results more fully.
There appeared to be some links between age and the outcome indicators though the 
differences were not large. Younger patients (under 70) showed a greater improvement 
during the stay together with slightly better survival rates and fewer accommodation 
changes. Presumably this reflects a proportion of these patients where the acute illness 
is more significant than chronic longer term problems.
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Table 4.11 Barthel scores and accommodation s ta tu s  by presen ting  c h a ra c te r is t ic s  (nFs404)
Characteristic 
(X cases)
Admit.
Barthel
Disch.
Barthel
Change
Barthel
Survive Died
in
Hospital
Died
to
3m
Accom
Same>worse
Marital Married(31X) 11.4 13.9 2.8 66% 28% 5% 89% 10%
Status Single (12%) 11.5 15.5 4.1 88% 6% 6% 80% 21%
Widow (57%) 12.1 15.0 3.1 69% 23% 8% 73% 27%
ns ns ns p=.006 ns
Consult =A (58%) 12.6 13.6 2.6 73% 21% 5% 80% 20%
=B (42%) 10.4 15.0 3.5 72% 20% 9% 72% 28%
p=.004 P=.012 p=.036 ns
Sex Male (48%) 11.5 13.6 2.5 68% 27% 5% 80% 20%
Female (52%) 11.9 14.9 3.2 75% 17% 8% 75% 25%
ns p=.022 ns p=.04 ns
Age (Mean years) 81.4 81.4 85.0 81.1 82.9
p=.0253 p=.037
Age Band <70 (5%) 9.1 14.8 5.7 82% 14% 5% 75% 25%
71-80 (38%) 11.4 14.8 2.9 77% 22% 1% 86% 15%
81-90 (47%) 12.7 15.6 2.5 70% 20% 11% 71% 29%
>90 (9%) 11.0 15.1 3.1 69% 20% 11% 66% 35%
p=.023 ns p=.01 p=.011 p=.019
Complies =1 (19%) 11.8 14.5 2.9 81% 17% 3% 73% 27%
2 (28%) 12.5 15.2 3.1 80% 13% 7% 79% 22%
3 (29%) 11.8 14.4 2.8 75% 20% 5% 74% 26%
=4 (18%) 10.6 14.3 3.8 60% 28% 7% 81% 19%
=5 (6%) 12.3 13.0 1.2 59% 33% 1% 90% 10%
ns ns ns p=.013 ns
Differences between the sexes mean Barthel scores can be seen on discharge, where 
women score slightly higher than men (p=.022) and in survival where a higher 
proportion of women survive hospital (p=.04) these effects were not strong. Marital 
status appeared not to affect the Barthel scores or accommodation but was related to 
survival. Single patients appeared less likely to die in hospital or at three months 
afterwards. Though it is interesting to speculate on the reasons why this is so, it does 
not seem likely to be causally related to the processes of care.
There appeared to be some differences in the admitting patterns of the consultants. 
Consultant B admits patients with on average lower Barthel scores yet discharges them 
with higher ones. The survival rates and changes in accommodation status are similar 
for the two consultants.
Finally the results on the index of complications, based on the number of different organ 
systems with active disease, did not appear to be related to mean Barthel scores or
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accommodation status, though there was a link with survival where patients with more 
complex disease were more likely to die (p=.013). It is recognised that this initial 
method of classifying complications is crude and that a more sophisticated approach may 
reveal stronger relationships. Alternatively it may be argued that the link between 
functional ability (as measured by the Barthel) and diagnostic classification will always 
be weak and confounded by the natural variability in the severity of any one disease as 
well as the mix of diseases present in any one patient.
Care Giver Strain Scale
The care giver strain scale was only applied to a subset of patients, and the results to date 
have been rather limited. The analysis of this particular indicator is therefore considered 
separately. The basic distribution of the strain scale is shown in Fig 4.3 and clearly 
demonstrates that despite problems in selection of appropriate patients and carers the 
scores were fairly evenly distributed around the mean of 5.9 (Std Dev=3.3). Relatively 
few carers score either zero or over 10 - that is at the extremes of the scale.
When the individual items were examined the frequency with which any one item ticked 
range from 22% "It is a financial strain" to 75% "Some behaviour is upsetting".
Apart from these two extremes most items were ticked in around 50% of carers 
answering ’yes’. The scale was weakly related to the admitting Barthel score in the type 
of relationship one might expect: the more independent the patient the lower the score 
on the strain scale. No strong relationships were observed between the strain scale and 
changes in Barthel, accommodation or mental test score.
Fig 4.3 Distribution of total scores on care giver strain scale (n=131).
COUNT S t r a i n  Score
9 0.0
10 1.00
6 2.00
7 3.00
15 4.00
11 5.00
8 6.00
19 7.00
16 8.00
9 9.00
13 10.00
6 11.00
2 12.00
I .................... I ..................I .....................I ....................I .................... I
0 4 8 12 16 20
Histogram Frequency
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Table 4.12 Responses to  a sample of care giver s tra in  scale n=73
%'Yes'
1. Sleep is disturbed......................52.1
2. It is inconvenient......................47.9
3. It is a physical....................... 63.0
4. It is restricting...................... 65.8
5. There have been family disruptions........47.9
6. There have been changes in personal plans..46.6
7. There have been other demands............ 45.2
8. There have been emotional............... 43.8
9. Some behaviour is upsetting............. 75.3
10. It is upsetting that............ 54.8
11. There have been work adjustments..28.3
12. It is a financial strain.........21.9
13. I feel completely overwhelmed.......... 54.8
In cross section it would appear that the items selected in the scale are appropriate for 
considering the problems of carers in this type of population.
Fig 4.4 Changes in Barthel score versus changes in strain scale from admission to 3 months (n=19)
13.75-
Change
B ar the l
11
8.25
5.5-
2.75-
-2.75-
-5.51
-8.25
-10 .4
3 6- 1 2 9 6 3 0
Change in  s t r a i n  s c a l e
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Only a handful of cases were available to look at the changes in the scale that may have 
occurred between admission and the three month follow-up. The mean score on 
admission for the twenty cases was 5.25 (Std Dev=3.6) and at follow-up 5.35 (Std 
Dev=4.3). Though the mean showed no change, individual scores have changed, by as 
much as eight points in some cases.
Fig 4.4 shows that there was some correlation between changes in stress and changes in 
dependency for the few cases which have follow-up results (Correlation coefficient=.59 
p <  .01). This is a promising result when considering the validity of the stress scale and 
changes in the scale.
Conclusions on Data Analysis
The analysis of the data has shown that the indicators used to study outcomes in care of 
the elderly can rely heavily on two issues - survival and functional ability as measured 
by the Barthel scale. The other indicators, that is monitoring changes in accommodation 
status, mental test score and strain on the main care giver have shown little longitudinal 
change though they may well be valuable as information which describes, in cross- 
section, the patient population.
It is clear that significant improvements can be seen in the Barthel scores of patients from 
admission to discharge. The scale suffers from the fact that it is insensitive to changes 
in the more independent patients (approx 30% of the admitting population to this 
hospital). For the study of care of the elderly in other settings eg the day hospital, this 
is liable to be a more serious problem. One reason the scale was originally chosen was 
because it was felt that the individual items represented the basic problems that patients 
presented and which were likely to change as a result of the hospital stay. At the same 
time it was recognised that not all patients would suffer from all the possible problems. 
It would have been possible to consider improvements in terms of the specific items 
rather than aggregated score though the analysis would have been correspondingly more 
complex. On the other hand, by using the whole scale especially when only one or two 
items may be relevant, requires the assumption that the relative weighting of the items
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were representative of the relative importance of the particular problems that make up the 
scale. Thus a one step improvement in bladder control is considered equivalent to a one 
step improvement in ability to dress oneself. Compared to other measures of general 
health status this weighting is certainly crude but at a simple level the total scale appears 
to work reasonably well.
The Barthel scale behaves largely as predicted in that it is related to survival, 
accommodation status and mental test score. Thus patients who die in hospital tend to 
have lower scores on admission, those admitted from home tend to have higher scores 
than those admitted from residential care, and those with severe confusion tend to have 
lower scores than those without. Similarly the Barthel scores, and changes in these 
scores broadly agree with the summary judgements made by the clinical staff at 
discharge.
There are advantages in using the combined Barthel score which appears to work better 
in showing improvement during the hospital stay than any one of its individual 
components. Very often patients will score the maximum on a number of individual 
components and the potential for improvements in scores are limited to the few remaining 
items. The combined score on the other hand aggregates across dimensions to give 
potentially a finer gradation for the assessment of improvement or deterioration in 
function. The observed changes in patient’s function are in most cases limited to the 
course of the hospital stay. Changes after discharge (other than deaths) are much more 
limited though the improvements observed in hospital tend to be maintained and there is 
no deterioration. The assessment of patients’ home environment does show the types 
of changes expected as patients become more dependent, though these changes are 
largely mirrored by information in the Barthel score. The changes in accommodation 
status are greatest between admission to hospital and discharge with relatively little 
change after discharge and to the three month follow-up. Using an ordinal scale of 
different forms of accommodation with some preferred to others, a few patients fall down 
the scale from admission to discharge. This fact in itself is not necessarily bad as long 
as discharge destinations are deemed appropriate. It is more useful in a comparative 
sense to ensure that either over time or against other institutions, the proportion of cases
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unable to return home is not very much lower than expected. Perhaps this information 
is best used when specifically linking levels of disability with particular forms of 
accommodation.
The indicators have not been found to be particularly sensitive to some of the basic 
presenting characteristics of the patients. The age of the patient appears to be the most 
important with the younger age group (under 70) faring better in terms of function and 
survival. The fact that no strong relationships are seen between the simple index of 
active disease and the various indicators may be a reflection of the rather simple way in 
which active disease are recorded and in this case summarised. It would be useful to 
have a more sophisticated way of dealing with information on the medical problems of 
the patients yet when the combinations and interactions of diagnoses can be so complex 
this will prove difficult.
D. Review Process
To date the feed-back of the results in geriatrics has been limited. One problem has been 
to identify an appropriate forum for discussing methods and results. Amongst the various 
alternatives have been individual meetings with clinical staff, and larger multi-disciplinary 
audit groups.
The project involved a variety of clinical staff in some role and they have all offered their 
support and have undertaken much of the basic data collection and organisation. In fact, 
at the request of the staff the project has now been extended to the day hospital where 
considerable efforts have already been made in identifying what data should be collected 
and how to achieve that (pilot questionnaires are shown in Appendix 7). There has been 
a commitment to the project from staff at a number of levels and this has been very 
encouraging.
Data collection and analysis has not been without problems and changes have had to be
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made during the course of the project to improve these. It is difficult to know how much 
of this process of data collection, which has changed and evolved over time, would be 
applicable in other hospitals. The actual process of the study itself has had a number of 
effects on the practice of information collection within the department. In particular:
1. The identification of the main care givers is now done explicitly by nursing staff and 
recorded centrally
2. The identification of where the patient goes on discharge is now collected centrally 
whereas before the information could be in a variety of different locations or not 
known at all.
3. At one stage, the recording during the social round of the Barthel score and 
accommodation status and the goals for that patient was felt to have improved and 
helped focus discussions. However, changing personalities have meant that 
completion of these forms has been carried out in a variety of different ways and that 
this improvement may not have been sustained.
4. Nurses have become more involved in assessing patients and in particular have 
undertaken, where relevant, the completion of mental test scores on discharge. 
Previously MTS scores were not noted on discharge.
In addition to these changes in information processing there are some other examples of 
where the study has had some, albeit limited, impact. Though there were problems with 
the administration of the care giver strain scale and it has yet to show benefits as a 
longitudinal measure, there has been an increasing interest especially amongst nurses in 
the responses received. In fact the forms appear to be used as a screening tool to help 
identify carers under particularly high levels of stress and to draw this to the attention of 
the ward nurses. In some cases the severity of the responses has surprised staff - the 
proportion of carers who have ticked T feel completely overwhelmed’ has caused 
comment. Since the start of the project, there has been a move initiated by the manager 
of services for the elderly (covering the Freeman Hospital and, as was, two satellite 
hospitals) in collaboration with clinical staff, to set up a support group for relatives and 
carers.
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Discussions with medical staff have to date been inconclusive. There has been a growing 
confidence in the validity of the results and the initially rather defensive reactions have 
been largely overcome. There now appears to be considerable potential in using the data 
rather more aggressively, in particular to monitor the inter-relationships of functional 
status, accommodation environment and length of stay in the hospital. The observed 
lengths of stay for some patients was slightly longer than expected and the expected 
differences in lengths of stay between consultants has not emerged. However suspected 
differences between the two consultants in the admission patterns has been confirmed. 
In many ways the data has prompted a variety of questions about how the service 
operates, and whether this can be improved.
For example the relationship between average dependency on the ward, nurse staffing 
levels and the current methods for assessing nursing workload are being explored. As 
yet there are not clear links between the outcomes achieved and particular process of care 
that can be changed to improve results. As one consultant put it in response to our 
questionnaire (Appendix 3):
"It has focused our attention on what we are doing and will help us to think about
it more and audit our work more often and more carefully
The interest in continuing outcome monitoring is felt to provide a good opportunity for 
ensuring that changes in service delivery enhance (or at least do not detract) from patient 
care.
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Chapter 5 Cholecystectomy
A.Introduction
The choice of cholecystectomy patients as an appropriate group for the outcomes study 
was made at its outset. It was chosen as a high volume surgical case type which involved 
relatively standard operating room procedures and techniques, and was thought to yield 
a fairly homogeneous set of outcomes. It was thought to provide a typical example of 
surgical workload in an acute hospital that would be suitable as a test bed for producing 
outcome measures. There were four general surgeons who perform the operation at the 
Freeman Hospital (though one relatively infrequently) and all were involved in the project 
and analysis of results.
Cholecystectomy (removal of the gall bladder) is one of the most common surgical 
procedures performed. The procedure is recommended when gall stones block or 
partially obstruct either the cystic duct or common bile duct (choledocholithiasis) 
producing symptoms such as biliary colic, jaundice etc.
The severity and acuity of symptoms can vary, in some cases the patient will present with 
very severe biliary pain as they are undergoing an acute attack of cholecystitis. With 
acute attacks surgery may be performed as urgent or emergency though where possible 
medical management to control pain is preferred until the patient is stabilised. Early 
surgery is preferred to a delay of a few weeks or even months. In some cases the patient 
will experience a series of such attacks . In chronic cholecystitis the symptoms may be 
less acute though rumble on for some time. When the patient experiences only relatively 
mild symptoms (eg belching, fatty food intolerance) the use of surgery is controversial. 
In some cases gallstones may be asymptomatic or silent. Under these circumstances it is 
unclear whether it is best to operate or not, the current wisdom falling down just in 
favour of waiting until symptoms appear (For a review, see Soloman et al 1986).
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There have been links demonstrated between the presence of gall stones and the 
emergence of subsequent cancer of the gall bladder (Diehl et al 1989) though the risks 
of this are balanced by the incidence of surgical complications (Finlayson 1989; 
Ransohoff et al 1983) and again the use of surgery is equivocal.
In the Freeman Hospital, which does not routinely admit emergencies, most of the 
approximately 150 operations a year are elective. The operation itself is intermediate in 
scale, taking about 30-60 minutes in theatre, and with a fairly long length of stay post- 
operatively (1-2 weeks).
The rates with which the procedure is performed (relative to a base population) have been 
shown to vary by geographic regions (Opit & Greenhill 1974; Roos & Roos 1981; 
Cageorge,Roos & Danziger 1981) and by country (Vayda 1973). One analysis of the 
literature (Soloman et al 1986) summarised the possible explanations for this variation as 
follows:
imprecise understanding of the disease itself and the differences between 
physicians in interpreting and recognising the signs of gall bladder disease; 
the use of different surgical indications, when making the decision to operate. For 
example one study found consultations before surgery reduced the rates. (Bunker 
1970);
the mix of patients and possibility that there may be greater gall bladder disease 
or ’need’ in some areas;
consumer characteristics, for example education, pain tolerance - though findings 
on the effects of these issues are inconsistent; 
access to care;
method of payment and organisation of care, for example in the US fee for 
service tends to increase usage compared to prepaid group practice (LoGorfo 
1979);
availability of resources (mainly hospital beds) and skilled physicians, and
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the characteristics of the physicians.
In view of this variability it is not surprising that there are a number of studies looking 
at the criteria for appropriate cholecystectomy (Soloman et al 1986; Scott & Black 1991).
Given the right indications the procedure is felt to be effective. Potential problems of 
surgery include an operative mortality rate of 1-2% (Mitchell & Morris 1982) and a 
variety of post-operative complications. Of the alternatives to the procedure, the use of 
chemical therapy to dissolve stones has been the subject of a number of trials, though it 
has proved not to be effective (Bateson 1984). More recently the technique of endoscopic 
removal of gall stones (ERCP) has been used, typically on patients for whom open 
surgery is not advised. The latest alternative to surgery, using lithotripsy to smash gall 
stones is currently being evaluated (Milner et al 1989, Chiverton et al 1990).
B. Data set and data collection 
Identifying the Outcome Indicators.
Initial discussion with the general surgeons, drawing on the relevant literature, sought to 
identify the expected changes in patient health before treatment and following the 
procedure. This formed the basis for the identification of the outcome indicators and the 
recognition, where possible, of the standards to be used for comparison. The discussions 
focused on the changes in health that were expected, the appropriate time periods at 
which to take measurements, possible confounding variables, data definitions and methods 
of collection as discussed in Chapter 3. The starting data set was developed through a 
series of discussions with one or two of the surgeons over a period of about two months. 
Some minor changes have been made during the course of data collection.
The outcome indicators are summarised in Table 5.1 which gives a brief summary of how 
data was obtained and the standards that were agreed at the start of the project.
74
Table 5.1 Summary of Key Outcome Ind ica to rs fo r  cholecystectomy
Indicator Information collected by Standard/Goal
Successful treatment Pro-forma completed by surgeon Minimal perioperative 
complications
Ireatment 
complication
Pro-forma on discharge - key list including 
MI. infections.DVT etc.
Minimal complications
Symptom/problem
relief
Patient completed checklist of symptoms on 
admission and postal follow-up
No residual symptoms 
or
Net improvement
General Well-being a. NHP form on admission and postal follow- 
up.
b. Summary health status question
Improvement on 
baseline
Adverse events after 
discharge
a. Réadmissions (from patient and/or 
hospital computer systems)
b. General questions on improvement
No related 
réadmissions
No additional problems 
at follow-up
Deaths Pre-follow-up checks on hospital PAS and DMA 
lists.
Minimal
Outcome Indicators
1. Mortality
Though small it was agreed that operative and post operative mortality would be 
observed. Typically the literature refers to deaths in hospital (Mitchell and Morris 1982, 
Solomon et al 1986), where rates of 1-2% are expected, or alternatively to studies of 
surgical mortality considered up to 30 days post-operatively, with the choice of time 
period here having a significant effect on the results (Bradbeer 1989). In this study it 
was thought necessary to follow-up at fixed points after discharge (agreed to be 3 and 12 
months) though the actual date of death could be recorded if needed for comparative 
purposes. Deaths may not be related to the procedure or the disease, therefore the details 
of such cases were reviewed individually with additional details taken from patient case 
records.
2. Relief o f symptoms
There are a number of typical symptoms of cholecystectomy which cause varying degrees 
of discomfort and distress to patients. Following the procedure, it was assumed that any 
pre-operative problems of the patients should have ’cleared up’ or at least improved. Not 
all patients would have every symptom so baseline data on presenting symptoms would
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be required. The symptoms used were pain, abdominal distension, flatulence, vomiting, 
bowel problems, intolerance of fatty foods and loss of appetite.
The most important symptom was agreed to be pain. In order to provide some clear 
guidance on the severity of pain it was agreed that a working definition would be 
'abdominal pain for which the patient takes some form of analgesia'. The questionnaire 
was worded accordingly.
During the course of the study additional information was collected on the nature of any 
bowel problems. The original non-specific question was retained but two extra questions 
were added to determine whether these problems were due to either diarrhoea or 
constipation.
3. Operative and post-operative complications.
It was recognised that some patients presented problems while actually in theatre either 
as a surgical or anaesthetic complication. This can be regarded in one sense as a very 
short term outcome, and in another as a potential predictor of later problems (Pettigrew, 
Bums and Carter 1987). Additionally there are a number of complications that the patient 
may experience following surgery. An agreed list of such post-operative complications 
was drawn up and included:
- Wound infection
- Deep Vein Thrombosis/Pulmonary Embolism
- Urinary Retention
- Cardiovascular complication
- Intra-abdominal infection
- Post-operative bleeding
- Respiratory infection
- Central nervous system complication
- Septicaemia
- Renal failure
- Other (to be specified)
4. Major health events following discharge
It was agreed that following discharge there should be few major health problems - in 
particular problems serious enough to warrant readmission or visits to accident and
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emergency departments or to a GP should not occur as a result of this procedure. The 
presence of these events was therefore used as a proxy for a deleterious change in patient 
health status (Chambers & Clarke 1989).
5. Improvement in general well-being
In addition to the obvious clinical changes one of the expected outcomes of the procedure 
was that the patient would feel better in themselves and resume normal activities, 
undisturbed by their earlier health problems - "joie de vivre" as it was described by one 
surgeon. It was agreed that this outcome should be captured by using a general health 
status instrument such as a patient-completed questionnaire. Chapter 2 discusses the issues 
around choosing such an instrument, the selected one being, in this case, the Nottingham 
Health Profile (NHP). Once again due to the degree of variability expected between 
presenting patients it was agreed that an improvement in NHP score would be a better 
indicator of success than a single post-operative score. This therefore required the pre­
operative assessment of health status to act as a baseline. Additional to the NHP was a 
single summary question (with 5 point reply scale) and two validating statements "I have 
health problems I did not have before" and "I feel no better than I did before" seeking 
patients’ agreement or disagreement.
Timing of observations.
The timing of when outcome measures are taken is critical to their interpretation. It was 
agreed that pre-operative baseline data were needed as well as details around the time of 
the operation and at discharge. There was much discussion about the timing for follow 
up measurements post-discharge. Routine clinical practice is for patients to come to an 
outpatient appointment six weeks after the operation Using this as the outcomes follow- 
up was considered (with a view to less expensive data collection), but it was considered 
that patients at this stage still suffered from a variety of transitory complaints which 
would confuse the picture of their overall health. Therefore a follow-up at three months 
was chosen as a point at which it would be safer to make judgements about their long 
term health status. In addition a second follow-up at 12 months was used to check that 
any good results at three months were maintained and not simply a short term artefact.
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Other data, and process and confounding variables.
In addition to the data required to actually measure outcomes it was recognised that 
information on potential confounding variables would need to be collected in order either 
to explain particular results or at least to check that variations in outcomes had not been 
caused by variation in another factor for example age. The identification of which factors 
to include has to be pragmatic and experience suggests there is a tendency to include too 
many. Additionally some basic items of data concerning process need to be included since 
there is genuine interest in whether any relationship can be observed between certain 
process measures and outcomes obtained.
Further additional administrative information was required including the patient’s address 
and telephone number if possible. These were used for post-discharge follow-ups and 
validation checks.
Information on the presenting characteristics of patients included basic details of age (or 
date of birth) and sex and were taken from the standard hospital identification label used 
on all request forms. The hospital number was used as the key identifier. The most 
important clinical descriptors of the presenting patient were agreed to be:
Indications for surgery - classified into one of eight mutually 
exclusive categories ranging from acute to asymptomatic. This 
classification has caused some problems as discussed later. 
Elective/urgent/emergency admission 
Frequency of abdominal pain 
Time since onset of symptoms
Co-morbid disease by organ system, typically based on active co- 
morbid conditions
Medication. This was collected in the early stages of the project as 
a check on the active co-morbidities. Though it fulfilled this role 
reasonably well it did prove time consuming to collect and was 
therefore dropped in later stages of the project - a more precise 
definition of an active problem was used instead.
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Occupation. Again this was collected in the early stages in order 
to determine social class. However this proved difficult to collect 
reliably and was dropped. It was agreed that any investigation of 
class effects could use post-code data and a socioeconomic 
grouping such as ACORN.
Obesity
Smoker/Non Smoker 
Assessment of surgical risk 
Process measures of the operating surgeon/consultant such as pre and post-operative 
length of stay were also examined. The analysis section later in this chapter considers the 
relationships between the most important of these variables and the outcome indicators.
One ’composite* patient characteristic was introduced as a result of problems found in the 
recording of the indications for surgery. The variable called ’acuity’ was a simple 
ordinal scale intended to differentiate between patients using data from the indication for 
surgery, whether surgery was elective or emergency, the time since onset of symptoms 
and the frequency of reported pain. The variable was defined as:-
Acuity: = 1 Emergency/urgent surgery, acute pancreatitis, cholangitis
= 2 Acute or history of acute cholecystitis with more than four periods 
of pain reported in past year.
= 3 Biliary pain less than 4 times in past year 
= 4 Asymptomatic (No biliary pain).
Data Collection
Data collection was based on a series of questionnaires completed either by the patient, 
the surgeon, the consultant, or a research nurse. The study has always sought to 
encourage data collection using existing processes, resources and ideally existing data in 
an attempt to make the collection of outcome information as easy as possible. In general 
surgery, the team also had the services of an established part-time research nurse who 
participated in this project and who proved invaluable in the co-ordination of basic data 
collection.
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1. Patient identification
The process of identifying appropriate patients for the study was carried out on the wards 
by talking with one of the two key ward sisters and checking with consultants’ secretaries 
if any eligible patients had been admitted. Cholecystectomy patients at the Freeman 
Hospital tended to be concentrated on two wards on the same floor, which contributed 
to the success of this approach. The system by and large worked well though some 
problems in patient capture were experienced if communications broke down temporarily, 
project staff covered for absence, holidays etc and checked the relevant wards every 
week. There were only a few cases where the procedure was performed before the 
research team had managed to contact the patient. Two patients were subsequently 
excluded from the study due to the presence of cancer being known in advance in one 
case, and in the other, because of a complex operation involving a variety of other 
procedures confounding any results.
With potentially four independent consultant surgeons to consider, making sure all 
patients were recruited was a problem. Identification of patients was labour intensive and 
sometimes rather late. However other approaches were determined to be impractical (and 
experience in the validation studies has verified this). More specifically, identifying 
patients as they are taken from the waiting list was wasteful in that many patients never 
arrived (for one reason or another), and others appeared unannounced. Similarly using 
the theatre lists as a check on who was to have the operation was not possible as the lists 
were prepared less than a day before the sessions, leaving too little time for the baseline 
measures to be taken. Theatre lists, obtained from the computer system, were however 
scanned to check if any cases had been missed.
2. Pre-operative patient questionnaire and background information
Once identified, patients were asked if they would like to cooperate with the study by 
the research nurse who handed them a letter of explanation and the symptom and NHP 
questionnaires for completion. These were collected by ward nursing staff.
Usually information concerning the indications for surgery and medication was collected 
at the same time from the medical notes. If necessary this data could be collected
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retrospectively.
3. Procedure details
Any problems encountered during the operation were recorded by the surgeon on a 
simple form kept in theatres. Though not in the original data set, during the course of 
the study an assessment of risk (of adverse outcome) was added to the data at the request 
of the surgeons. This was completed preoperatively using a standard pro-forma kept in 
theatres. The same sheet identifies any operative or anaesthetic problems that may arise.
4. Discharge information - post-op complications
The simple check list of possible post-op complications encountered was completed on 
discharge. Originally this form was attached to the summary abstract form completed 
by all consultants before cases could be coded. This was later changed so that the form 
was completed by the research nurse based on evidence in the notes.
5. Follow-up information
The follow-up information came mainly from the patients, who were asked to complete 
questionnaires (the same as the pre-operative ones) looking at symptoms and general 
health status. Patients were also asked additional questions covering re-admissions to 
hospital, and other adverse events. If no response was forthcoming within a month a 
reminder with duplicate form was sent out automatically. Follow ups were carried out at 
three and twelve months after discharge.
Some patient outcomes were examined in more detail within the reporting system and 
where patients had died, their notes were used as the basis for short individual reports.
6. Data Inputting
All the data were input to a micro-computer using compiled dBase software. All input 
program were written by the research team. The estimated costs of data collection are 
discussed in Chapter 9.
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Validation
Three checks on the accuracy and validity of the collected information were used:
1. Retrospective comparison to notes
An audit was carried out on 20 sets of notes to ensure completeness and accuracy of 
recording of all the basic data elements in the presenting characteristics, and in the 
operative and post-operative complications of patients. The results of that process are 
described below.
Indications for surgery there were some significant differences between the 
indications when re-abstracted from the notes which highlighted some ambiguity in 
the precise meaning of the terms ’chronic cholecystitis’ and ’history of acute 
cholecystitis’. In the analysis therefore an additional reclassification on an acuity scale 
was used to overcome this. However the most important distinctions for the acute 
conditions were accurately identified.
Co-morbidities the forms were largely accurate though there was a tendency not to 
include disease which occurred a number of years before.
Pain in last year ;- general agreement on the frequency of biliary pain (typically at 
the most extreme end of the questionnaire’s scale).
Symptoms .*- typically the questionnaires recorded more symptoms than the notes. 
This in itself may not be a significant problem.
2. Patient interview
A random sample of patients was selected to validate the postal questionnaires and 
NHP results. Visits by CASPE researchers utilised a semi-structured interview 
covering the main points of the questionnaires. The researchers (who had not seen 
the patients’ forms) were asked to make their own assessment of the patient’s 
problems using simple categories (see Appendix 2). The researcher’s assessment was 
then compared to the actual patient questionnaire results and the following points 
noted.
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Time since diagnosis/symptom onset:- Agreement on the time since symptom onset 
was found in all cases while the timing of diagnosis agreed in 9 out of 13 cases. It 
was concluded that the time since onset of symptoms was a rather more reliable guide 
than time since diagnosis .
Overall health rating:- In most cases the general assessments on the scale (poor-fair- 
good-very good) agreed between those taken at interview and the questionnaire results 
(9/13 preoperatively 7/13 postoperatively). When differences did occur they were 
never greater than one point on the scale. The change in health rating showed similar 
agreement. There was no observed bias for questionnaires to record either higher or 
lower than interview.
Events after discharge:- There was no case that had been readmitted among the 
sample (as shown by interview and questionnaire). In three cases there had been 
visits to a GP which were not recorded on the forms. In fact in one case this was due 
to a visit after the questionnaire had been returned, while in the others the visit was 
part of a ’routine’ which was not related to the operation (the questionnaire asks 
specifically about visits relating to complications following the operation).
Nottingham Health Profile :- Results were pooled with similar interviews from other 
studies and are reported in Chapter 3. The comparisons of actual NHP scores to the 
assessments made by the interviewer were satisfactory (and highly significant) for all 
except one dimension showing a high degree of association. The exception was the 
score for ’Energy’, where little association was shown, however problems were noted 
at interview with the phrasing of the validation question for this dimension. It was 
concluded that by and large higher scores on the NHP were associated with the 
interviewers’ assessment of more severe health problems.
Symptoms :- There were some discrepancies in the recording of symptoms. The 
results, pooled for all symptoms, are shown in Table 5.2(a). There were significant 
numbers of cases pre-operatively where symptoms revealed at interview were not on 
the form, as well as vice versa. The follow up comparison showed greater agreement
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but there were fewer positive symptoms to report. It appears that the reliability of 
recording a particular symptom is not too high and that great reliance cannot be placed 
on it.
Table 5.2 (a) Coeparison of questionnaire with interview responses - Presence of individual 
symptoms as reported fay patients.
Questionnaire Yes
No
Pre-op
Yes
17
11
Interview
No
14
49
Follow-if> 
Yes No
6 6
3 76
Table 5.2(b) Comparison of NHP scores before admission to those obtained in hospital (np19)
NHP Dimension # agree Mean
Difference
Tauy Probability
Energy 15 8.6 .715 .0001
Pain 11 3.3 .832 .0000
Emotional Reactions 8 6.6 .740 .0000
Social Isolation 10 -3.1 .789 .0000
MobiIi ty 12 -.1 .801 .0000
Part II 13 6.8 .735 .0001
Combined Score 12 * 3.1 .856+ .0000
+ Pearson correlation coefficient*.957 (p=.0000)
However across the two methods (questionnaire and interview) the total number of 
problems reported was significantly correlated pre-operatively (Kendall’s taUb=.415 
p=.04) and at follow-up (Kendall’s tauy=.546 p=.02). There was a clear
improvement in the total numbers of symptoms reported between pre and post­
operative conditions.
Interpreting the differences in symptoms reported is complicated by differences that 
one might expect when eliciting information through interview and through 
questionnaire. The questionnaire explicitly prompts a number of conditions in a way 
that is more insistent than at interview. There is some tendency for the questionnaire 
to record more individual problems. Additionally, the elapsed time between 
completing the form and interview was up to 6 weeks during which time problems -
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or their perceived significance to the patient may change. Finally, there must be some 
uncertainty about how consistent the patient will be with respect to reporting any one 
symptom as being problematic although with pain showing a greater degree of pre­
operative agreement than other symptoms, it is possible that the patient’s perception 
of pain as a problem may provide a useful marker.
3. Comparison o f pre-admission and admission NHP
One of the possible dangers of giving the NHP form to patients who were already in 
hospital (in bed) was the danger that the form may ’over-state’ their problems as they 
adopted a ’sickness’ role. Thus comparisons of a form completed in hospital to the 
follow-up, completed at home, may become invalid. Therefore 19 patients were sent 
the form in advance to complete at home , and then given a repeat form (with 
apologies and explanation for the repetition) once in hospital. The scores on the two 
forms were compared.
The results in Table 5.2(b) show that there was no significant difference between the 
pre-admission scores and admission scores. The two scores were highly correlated. 
The tendency was for pre-admission scores to be slightly higher than those completed 
in hospital. A few individual patients did show sizeable variation between the scores, 
typically across a number of dimensions.
4. Internal consistency on empirical results
There were some items of data collected which duplicated other measurements. It was 
hypothesised that where this happened the two results, using different approaches, 
would be significantly associated. The results section shows these relationships 
largely supported internal consistency. In particular, as Table 5.6(a) shows the mean 
NHP score for Pain was significantly associated with pain reported elsewhere in the 
questionnaire.
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C. Data Analysis
The analysis of results in cholecystectomy concentrates on a number of key questions:
1. Do the indicators show significant changes following cholecystectomy?
2. Are there relationships between the indicators that confirm they are behaving as 
expected? Can they be thought to represent the outcome of the care given?
3. Are the indicators sensitive to the presenting characteristics of the referring 
population?
Deaths
At the start of the study the numbers of patients who died was expected to be very low 
(1-2%). Only two cases died in hospital after the procedure. In fact, with mortality 
assessed at 3 months and 12 months post-op the numbers have been higher than expected. 
These cases tend to have been reviewed individually and not used in further statistical 
analyses. The deaths tended to be restricted to patients with cancer of some form, 
patients with complex disease where the Freeman Hospital had been used as a tertiary 
referral or to the elderly.
Changes in the indicators to 3 months (Tables 5.3(a) - 5.3(e))
Symptoms
Changes in the presence of individual symptoms are shown in Table 5.3(a). There was 
clearly some variability in the prevalence of the symptoms before operation, ranging from 
30% of cases reporting "loss of appetite" to 68% of cases who "cannot tolerate fatty 
food". It is clear that patients did not appear to suffer from all the symptoms, the 
average number reported being 3.3. For each symptom there were some cases who 
appeared to suffer from the problem after the operation but not before - the most marked 
symptom in this respect being "bowel problems" . The conclusion here would seem to 
be that either this represents uncertainty in the reporting of these symptoms (which seems 
more likely) or that problems have been created by the hospitalisation itself. The 
observed prevalence of any one symptom must therefore be expected to include a number
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for which confidence intervals can be calculated.
Table 5.3(a) Symptoms/Problems before and 3 months after choIecystectomy (n=149) 
Mean No. Symptoms/problems per patient: 
ns=p>.05
Pre-op=3.30 sd=1.77 
Follow-up=1.67 sd=1.6
% cases No-
No
Yes-
No
No-
Yes
Yes-
Yes
Sig Prevalence 
[ 95% Conf. limit]
Net
change
Prop
change
1 Pain 55.7 27.5 6.7 10.1 .000 37.6 [ 30-45 ] 20.8 55.3
2 Flatulence 34.9 33.6 8.1 23.5 .000 56.5 [ 49-65 ] 25.5 45.1
3 Dist. 
Abdomen
46.5 28.2 4.7 21.5 .000 49.7 [ 42-58 ] 23.5 47.3
4 Vomit 39.6 46.3 3.4 10.7 .000 57.0 [ 49-65 ] 42.9 75.3
5 Bowel 54.4 18.1 14.8 14.8 ns 32.9 [ 25-40 ] 3.3 10.0
6 Appetite 59.1 18.8 10.7 11.4 ns 30.2 [ 23-38 ] 8.1 26.8
7 Fatty Food 27.5 43.6 4.7 24.2 .000 67.8 C 60-75 1 38.9 57.4
Table 5.3(b) Events in hospital
Peri-operative complications = 29 cases (20.IX) 
Explore Common Bile duct = 7 cases 
Empyema/pus = 3 cases
'Anaesthetic/recovery* = 3 cases
Post-operative complications = 33 cases (22.9%)
Urinary Retention =10 cases
'Drain problems' = 7 cases
Resp infection = 4 cases
Table 5.3(c) Events after discharge
Visits to Accident & Emergency = 12 cases (8.3%)
Visits to GP = 31 cases (21.5%)
Readmission = 8 cases (5.6%)
New Health Problems = 10 cases (6.9%)
Feels no better = 35 cases (24.3%)
Table 5.3(d) Summary Health Status - Pre-operative vs follow-qp assessments
N/R=Not recorded Sig Chi-squared p<.0001
Pre-op assessment versus follow-up (3 months)
Follow-up assessment
Pre-op
Count
Total
N/R Poor Fair Good Very G. Total
N/R 1 2 3
Poor 1 3 10 5 1 21
Fair 2 1 23 25 3 54
Good 2 1 17 22 15 55
Very Good 1 5 10 16
Column 3 5 52 60 29 149
2.0 3.4 34.9
Row
40.3 19.5 100.0
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Table 5 .3 (e )  Changes in  Nottingham Health P ro f i le .  Mean scores before and a f te r  choIecystectomy
Mean Std Dev Median XZero
ssxsssFolloW-Up==== 
Mean Std Dev Median X Zero SigCp)*
Energy 35.48 38.30 24.0 44.3 20.88 32.08 0.0 63.1 <.000
Pain 27.80 29.28 19.7 32.9 10.13 20.99 0.0 68.5 <.000
Emotional R. 16.58 19.89 9.3 40.9 7.55 16.34 0.0 70.5 <.000
Sleep 29.09 28.44 21.7 27.5 18.02 25.77 0.0 53.7 <.000
Soc. Isol 7.51 16.93 0.0 79.2 6.01 15.33 0.0 81.9 .31
MobiIity 14.25 21.36 0.0 54.4 10.90 17.46 0.0 61.1 .12
Part II 25.10 28.75 14.3 43.6 10.72 21.40 0.0 73.8 <.000
Combined 21.78 18.53 18.1 8.1 12.24 15.21 6.1 34.2 <.000
Uilcoxon signed pairs test.
It is worth noting that there was a high proportion of residual symptoms reported 3 
months after the procedure - even if the problem was present at admission it had not 
necessarily disappeared by the first follow-up.
Table 5.3(a) shows improvements expressed in two ways, the first is the net change in 
percentage of patients reporting a problem, comparing before and after the operation. 
This represents the percentage of patients showing *Yes-No’ movements less the 
percentage showing *No-Yes* changes. The second method is to express this change 
relative to the proportion of patients with that problem before the operation.
The results show clear and significant reductions in the reported incidence of pain, 
flatulence, vomiting, abdominal distension and tolerance of fatty foods. The changes 
were tested using McNemars test. There was little or no overall change in the incidence 
of bowel problems or loss of appetite.
In addition to changes in individual symptoms, an aggregate score was calculated to 
represent the total number of symptoms/problems reported. This score weights all 
symptoms equally - in the absence of any better knowledge. Using this score patients 
were observed to report significantly fewer symptoms/problems at 3 month follow-up 
(1.67 compared to 3.3 p <  .0001).
This pattern of results has been consistently demonstrated during the course of the 
project. One area of concern has been the lack of change in the incidence of bowel
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problems which prompted the question of whether this was due to constipation or 
diahorrea - the latter having significant clinical implications. The forms were amended 
to ask directly about these two problems (whilst retaining the original question). To date 
there appears to be no clear pattern of either complaint diarrhoea or constipation, 
predominating at follow-up. The results are in general internally consistent in that 
patients who report a ’bowel’ problem also tend to report either one of diarrhoea and/or 
constipation (not both).
Events within hospital
The incidence of complications at the time of operation was simply based on the 
comments made by surgeons at the time. As this was not based on a specific schedule 
of questions it must be considered to be relatively sensitive to differences in recording 
practice. Most commonly cited was that exploration of the common bile duct had been 
necessary. Otherwise the comments made were fairly diverse and included problems with 
adhesions, necrosed or shrunken gall bladders etc.
Post-operative complications were based on a checklist of common problems that may 
arise and hence recording could be considered more reliable. In most cases the reported 
problems were relatively minor in clinical terms - with urinary retention being the most 
common. There were a number of reported problems involving t-tubes and drainage 
during the post-operative period.
Events after discharge
Following discharge, there was a relatively high incidence of events though the value of 
quantifying some of these was questioned. Perhaps the most significant indicator is the 
5.6% of cases readmitted. Some of the réadmissions were related to the original 
cholecystectomy whilst others were not.
The reasons quoted included :
- ’Replace blocked arteries in stomach’
- ’Infection in wound’
- ’Road traffic accident’
- ’Pain and sore around wound’
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- ’Scar tissue turned septic’
- ’To convalescence’
- ’Pain and vomiting’
- ’Pain and coughing up blood’
- ’Heart attack’
- ’Distended stomach’
Not all of these were relevant to the prior surgery and it was clear that assessing the 
success of the procedure based simply on the total of re-admissions would inevitably 
include some false positives. The distinction between relevant and irrelevant ré­
admissions was found to be hard to make in advance and the reasons for readmission 
given by patients tended to be limited. It was decided that the best way to analyse these 
events is to consider them individually although with such an approach retrieving the 
relevant data can be time consuming.
Summary health status
The simple grading of patients health from poor to very good showed a significant change 
after the procedure. There was some natural variability between patients in how well 
they felt, with a substantial number even rating their health as ’very good’ just before 
surgery. After surgery, 45 out of 144 patients gave the same rating as before though the 
net trend was to improve (Chi-squared p <  .(XX)1) , typically by one step up the ordinal 
scale. A few patients reported their health at 3 months as worse than pre-operatively.
Two simple questions were asked of patients as a check on this and other information. 
7% of patients reported ’health problems they did not have before’ and 24% reported that 
they felt no better than before. The links between this information and the other 
indicators are discussed later. '
Nottingham Health Profile
The Nottingham Health Profile is scored as the sum of weighted responses in each of six 
dimensions, the range being from 0% to 100% on any one dimension (higher scores 
indicate ’worse health’). In addition seven questions on Part II asked about the effects 
of health on everyday life. The results of Part II questions are shown in similar fashion 
to the other dimensions by giving each positive response an equal weight. In addition the
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Fig 5.1 NHP distributions before cholecystectomy. Percentage of cases with 
given scores for each dimension.
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six scores were combined into a single score - based on weighting each dimension equally 
(as discussed in Chapter 3). It is noted that summaries of Part II responses and 
combining score was not recommended by the developers of the profile (Hunt,McEwen 
& McKenna 1986) and is used in this context in order to simplify the presentation of 
results.
The results showed significant improvements following the procedure in most of the 
dimensions and in the combined score. The general pattern of scores on admission were 
broadly in line with those expected for this type of patient with higher scores for 
’Energy’ and ’Pain’, than say for ’Mobility’ and ’Social Isolation’. The dimensions with 
higher scores on admission were also those that showed significant changes compared 
with the follow-up. The variance of any one dimension was typically fairly large the 
standard deviation being approximately equal to the mean. One would expect greater 
confidence in estimates of the mean score with larger sample sizes.
The distributions of scores on all dimensions (Fig 5.1) were highly skewed with a 
substantial proportion of cases scoring zero - especially for the follow-up score. The 
effects were seen in the most extreme in the dimension covering ’Social Isolation’ where 
for the admitting scores 19% of patients scored zero. A number of patients (8%) failed 
to score on any of the main dimensions. The skewed distribution resulted in the follow- 
up scores on all dimensions having a median score of zero (see Table 5.3(e)). The highly 
skewed nature of the distributions required non-parametric tests of statistical significance.
Changes in Indicators to 12 months (Table 5.4)
Table 5.4 summarises the indicators for the 80 patients who have received a 12 month 
follow-up in addition to that at three months. The changes to three months of this subset 
of cases echoed the changes seen in the overall population. It is clear that subsequent to 
the three month period there was little change in the symptoms/problems reported by 
patients, the summary health status or in the NHP. The observed differences were not 
significant between three and twelve months.
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Table 5 .4  Change in  in d ica to rs  to  twelve months (n=80)
Admission 3 months 12 months
Prevalence of symptoms
% cases
Pain 41.3 17.5 17.5
Flatulence 60.0 36.3 32.5
Distended abdomen 53.8 28.8 35.0
Vomiting 62.5 16.3 11.3
Bowel problems 25.0 32.5 36.3
Appetite 33.8 27.5 26.3
Fatty Food 70.0 33.8 35.0
No. Symptoms (mean) 3.46 1.93 1.94
Readmitted (% cases) - 6.3 17.5
Go GP (% cases) . 22.5 28.8
A&E visit (% cases) 6.3 16.3
More Health problems <%) . 2.5 13.8
No Better (%) . 26.3 27.5
NHP means Energy 38.9 24.4 23.6
Pain 26.0 12.1 10.5
Emot. R 15.5 8.1 7.7
Sleep 27.1 20.7 20.8
Soc.Isolation 7.5 5.9 5.8
Mobility 13.3 13.2 12.7
Part II 24.2 12.3 11.0
Comb 21.4 14.1 13.5
Summary =Poor (%) 17.5 2.5 3.8
Health =Fair 42.5 41.3 25.0
Status =Good 32.5 43.8 50.0
=V.good 7.5 12.5 16.3
Of the other indicators there was a notable rise in reported réadmissions from 6.3% of 
cases at 3 months to 17.5% at 12 months after discharge. Similar rises in the reported 
incidence of visits to A&E departments occurred during this period. Looking at the 
reasons given by patients for these events they tend to be unrelated to the 
cholecystectomy procedure. It appears that other health events are creating some false 
positives on these two indicators.
The reasons quoted for re-admissions include:
- ’Cyst in throat’
- ’Broken collar bone due to fall’
- ’Severe chest infection’
- ’Heart attack’
- ’Tear duct op - for glaucoma’
- ’Broken ankle’
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- ’Bladder repair, prolapse leg/back’
- ’Day patient - twice for bladder’
- ’D&C’
- ’Wound open due to infection’
It would appear that to monitor specifically the effects of the cholecystectomy a three month 
follow-up is appropriate - a longer time interval tends to decrease the specificity of some of 
the indicators.
Relationships between indicators
There are a variety of ways in which the relationships between indicators can be examined 
though not all can be reported here. The most important observations about the relationships 
within and between indicators are described below.
There were high correlations between individual dimensions o f the NHP and between 
symptoms.
Correlations within NHP
With the NHP there were highly significant correlations between rank scores of 
different dimensions. The combined score was also closely related to the individual 
dimensions. Table 5.5(a) shows the rank correlation coefficients between the NHP 
dimensions and their statistical significance (all except one correlation being p <  .001). 
The results show considerable overlaps between the dimensions, patients scoring high 
on one dimension are also likely to score high on others. In general the dimension
Table 5.5(a) Correlations (rank) between dimensions of the Nottingham Health Profile (n=143)
Scores at admission
Correlations: Energy Pain Emot.Reac Sleep Sodsol Mobility Part II Combined
Energy 1.0000 .4704** .5501** .3670** .4167** .5323** .5237** .8254**
Pain .4704** 1.0000 .5872** .4195** .2988** .5194** .4695** .7556**
Emot Reac .5501** .5872** 1.0000 .3712** .4378** .4103** .5474** .7201**
Sleep .3670** .4195** .3712** 1.0000 .2235* .3614** .2790** .6440**
Soc Isol .4167** .2988** .4378** .2235* 1.0000 .3584** .2924** .5320**
MobiIi ty .5323** .5194** .4103** .3614** .3584** 1.0000 .4944** .7187**
Part II .5237** .4695** .5474** .2790** .2924** .4944** 1.0000 .5978**
Combined .8254** .7556** .7201** .6440** .5320** .7187** .5978** 1.0000
1-tailed test: * p<.01 ** p<.001
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Table 5.5 (b) Frequency of cases with symptom pairs - percentage of cases on admission suffering 
from two symptom/problems (np149)
Percentage cases 
with two problems
Prevalence Pain Flat. Abdo.
Disten.
Vomit Bowel Appet.
1 Pain 38% _
2 Flatulence 61% 27 _
3 Distended Abdomen 50% 26** 42** _
4 Vomiting 56% 25 39* 35**
5 Bowel problems 32% 13 20 19 19 _
6 Appetite 32% 13 18 14 19 17** .
7 Fatty Food 67% 29 48*** 41*** 46*** 21 19
* p<.05 Chi-squared
** p<.01 
*** p<.001
covering ’Social Isolation’ showed weaker correlations with the other dimensions. 
The correlations with the summary Part II scores were also fairly low - although 
given that this dimension was not supposed to be scored in this way this is hardly 
surprising. It had been hoped that the Part II score may give a general summary 
of the whole of the NHP, but it appears that the combined score performs much 
better in this role as a statistical representation of the six dimensions. This is not 
to suggest that the six scores are unnecessary for interpretation of changes (see 
Chapter 3) and in outcomes monitoring in general.
Similar high correlations between the dimensions of the NHP were observed 
comparing the follow-up NHP scores.
Links within Symptoms
Table 5.5(b) shows the prevalence of presenting symptoms/problems and the 
proportion of cases suffering from two problems in the various pairing 
combinations. When the presence of symptoms were compared (in this case in 
pairs) with what might be expected by chance, there were once again a high 
number of significant relationships.
It appears that the symptoms fell into two groups each with high internal links - one
group covering pain, abdominal distension, flatulence vomiting and tolerance of fatty
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food. These symptoms tended to cluster in patients. The other group covered poor 
appetite and bowel problems which show no close correlations with any other 
symptoms other than themselves. It should be noted that these two questions require 
a negative answer to indicate a problem - the reverse of the other group which may 
partly explain the difference. In addition they are the least specific of the symptoms 
and the only symptoms not to show a significant change to three months. The fact 
that their behaviour is so different from the rest must raise questions over their 
validity or reliability of capturing the data.
There was general agreement between the overall symptom scores, the summary health status
and NHP scores.
The relationships between these indicators were all positive and tended to be 
statistically significant as shown in tables 5.6(a)-5.6(c). Thus in general, high values 
on the NHP tended to be accompanied by higher incidence of reported symptoms and 
lower summary health status as described by the patient. These relationships held 
when comparing across either the data sets at admission or at follow-up.
Table 5.6(a) shows the significance of observed relationships between individual 
symptoms and the dimensions of the NHP using the Wilcoxon rank sum test. It is 
reassuring to observe highly significant relationships between pain scores on the two 
measures. In fact pain, distended abdomen, vomiting and intolerance of fatty foods 
all appeared to be linked to the NHP. It should be noted that flatulence did not 
appear to be linked to any dimensions of the NHP. Interestingly, given earlier 
provisos, poor appetite and bowel problems showed links but these were much 
weaker. The NHP dimensions covering ’Social Isolation’ and ’Mobility’ showed 
weaker relationships with the symptoms scores than the others. These were also the 
dimensions with the lowest mean scores which may suggest that they are less relevant 
as health problems - in this patient group - than the other dimensions.
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Table 5 .6 (a )  S ign ificance of re la tio n sh ip  between NHP scores and ind iv idual symptoms (n=149)
NHP dimiensions
Symptom Ener. Pain Emot
Reac
Sleep Soc
Isol
Mobi I Part
II
Comb.
1 Pain .0015 .0000 .0037 .0016 ns .0334 .0018 .0000
2 Flat. ns ns ns ns ns ns ns ns
3 Dist 
Abdo
.0005 .0000 .0000 .0041 .0261 .0039 .0110 .0000
4 Vomit .0117 .0017 .0001 ns ns .0498 .0011 .0014
5 Bowel ns .0139 .0208 .0290 ns ns ns .0295
6 Appétit .0209 .0432 .0094 ns ns .0547 .0113 .0225
7 Fatty F .0172 .0002 .0000 ns .0065 ns .0214 .0013
Uilcoxon Rank sum test, ns = p>.05
Table 5.6(b) shows highly significant links between the total symptom count and 
a consistent gradient of decreasing NHP scores as the patients summary of their 
health improves from ’Poor’ to Very good’. Similarly Table 5.6(c) shows that 
the better the patient feels the fewer symptoms they appear to report.
Table 5 .6  (b) Significance of association between select dimensions of NHP and symptom scores and 
summary health rating. Mean NHP scores by summary health rating (nFl53).
Energy Pain Emot
R
Sleep Soc
Isol
Mobi I Pt II Combi
ned
Symptoms p
.0011 .0000 .0000 .0007 .0651 .0163 .0001 .0000
Summary Health 
rating Sig.
.0000 .0000 .0000 .0006 .023 .0000 .0000 .0000
Means Poor 
Fair 
Good
Very Good
81.7
41.9
21.1
7.0
54.4
29.8
20.6
5.1
35.0
20.4
8.5
5.4
41.7 
35.4 
20.0
21.7
17.6
9.5
3.6 
5.2
28.1
10.0
9.0
5.0
45.7
28.3
17.8
14.3
43.1
25.8
13.8 
8.2
The significant relationships between the NHP, total symptom score and summary 
health status adds supporting evidence for the validity of all three measures. It 
also suggests that in order to identify the ’sicker’ patient at presentation , or the 
successful outcome of care, they may not all be necessary and that there is some 
redundancy in the data.
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Table 5 .6 (c )  Frequency of cases reporting  symptoms by sum ary  hea lth  s ta tu s  (npISS)
X
cases
Poor Fair Good V Good
X cases 13.5X 34.8X 35.4X 10.3X
Mean No. 
symptoms
p<.0000
- 5.10 3.41 2.93 2.13
Table 5.6(d) Mean changes in NHP scores in selected dimensions against mean changes in 
symptom score and smnary health status (n=153).
Change
Energy
Change
Pain
Change
Combined
Change -2 n=5 -15.2 -7.2 -12.9
in no. -1 n=14 11.5 8.7 9.6
Symptoms 0 n=22 11.3 9.1 5.1
1 n=31 8.5 19.3 10.2
2 n=32 18.2 15.9 8.7
3 n=18 27.2 24.4 15.1
4 n=22 22.6 32.9 16.1
5 n=8 33.4 35.3 23.2
Change Worse n=32 7.0 14.1 8.8
in Same n=58 13.2 13.7 8.1
summary
rating
Better n=63 21.3 24.5 12.7
As well as comparing these indicators in cross-section, it is also possible to 
examine the relationships between changes in indicators. In general when these 
changes are compared they broadly agree - though the correlations between 
movements in the three indicators are naturally not as strong. Table 5.6(d) shows 
the mean change in selected NHP dimensions (’Pain’, ’Energy’ and the combined 
score) against changes in total number of reported symptoms (admission minus 
follow-up) and changes in summary health status. For the few patients whose 
symptoms were worse or the same, the mean change in NHP scores were less 
than for those patients who improved on a number of symptoms. Thus it 
appeared that the magnitude of change in the total symptom score is related to the 
magnitude of change in these NHP dimensions. The relationships between 
changes in symptoms and changes in the other dimensions are not as strong.
Similarly the patients who are ’worse’ on the summary health status show a 
smaller change in mean NHP though these differences are not significant. This 
may indicate that the definitions of ’better’, ’same’ and ’worse’ used for the
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summary health status indicator are not sufficiently specific. If the definitions 
were altered such that ’better’ is defined as a change of two steps in the ordinal 
scale then clearer links were visible. Interestingly the mean change for these 
patients is still positive and not negative which is what would be expected if the 
two measures were in perfect agreement. That is patients who were ’worse’ on 
the summary health status would score higher on the NHP at follow-up than at 
admission.
Finally there were also significant differences between the change in the number 
of reported symptoms for those patients defined as ’better’ on the summary health 
status (average -2.1 symptoms per patients) against those defined as ’worse’ 
(average -0.97 symptoms per patient, p=.015).
These results therefore lend evidence for the validity of observed changes in the 
indicators - though the links between indicators are less strong than when they are 
compared in cross-section. Nevertheless there were the predicted relationships 
between improvements in the symptoms reported, improvements in the NHP and 
improvements in the summary health status.
The fact that the relationships between changes in the indicators are not as strong 
as the relationships between the indicators when compared in cross-section 
suggests that using these indicators it is easier to define a patient as ’sicker’ than 
to define a patient as ’better’. There are a number of reasons why the change in 
the indicators show more variability. The obvious one is that the degree of 
change requires two measures each of which will have inherent variability which 
when combined will tend to make the answers even more variable. A second 
difficulty with measures of change is that there may be problems with ’end- 
effects’ of the scales used, that is the NHP and symptom scores both tend to zero 
after the procedure. This may ’underestimate’ the relative improvement in 
patients with low initial scores. It may be that simple linear comparisons of 
changes in indicators are not appropriate. Finally it may be that assessment of 
changes in score is limited by the construction and weighting of the instruments
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which may not be appropriate to measure longitudinal change with sufficient 
specificity. Further analysis would be required to examine these alternatives and 
improve the association between one indicator and another.
Absolute changes in NHP and symptom scores and NHP were strongly related to the 
presenting score.
With the NHP there are clearly some ’end-effects’ when a very high proportion 
of patients do not score post-operatively. If the magnitude of change is taken as 
the indicator of outcome then the sicker the patient on admission the more chance 
there is of improvement.
The correlations between the initial NHP and subsequent change in each 
dimension were typically high ranging from .62 for ’Sleep’, to .75 for ’Pain’. 
Fig 5.2 shows as illustration the mean change in combined scores according to the 
initial score. In this case it can be seen that average change in score is very much 
lower when the initial score is low. The maximum possible change is shown for 
comparison. The same relationship was observed between the change in total 
number of reported symptoms/problems and the total symptoms/problems present 
at admission - the correlation coefficient being 0.60.
The importance of this observation is that using the change in these indicators as 
a measure of success, results will be extremely sensitive to the profile of 
admitting scores. This may be valid in clinical terms. The patient who presented 
with very severe health problems and had none at follow-up, obtained a greater 
benefit in outcome terms than the patient who was ’fairly healthy’ before the 
operation. For comparison between changes in scores for different populations 
of patients some standardisation may be necessary to exclude the variability in 
admitting score.
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Post-operative and peri-operative complications were significantly related to each other - 
but not to any o f the other indicators.
Table 5.7 shows the proportion of patients who experienced adverse events either 
during the hospital stay or afterwards. It can be seen that patients with ’peri­
operative complication* were also more likely to experience post-operative 
complications (p < .001). However these events in hospital were not directly 
related to the later events after discharge. One implication of this result is that 
events within the hospital may complicate cases but will not necessarily result in 
worse outcomes over a longer term. Earlier analysis of the assessments of risk 
made by the surgeons (for the relatively few patients where data were available) 
suggested that this was strongly linked to the incidence of peri-operative problems 
but not to longer term outcomes.
There were correlations between events after discharge such as visits to GP’s, A&E
departments and re-admissions.
The second part of Table 5.7 shows the proportion of cases who experience 
adverse events after discharge. The results suggest that these events tend to be 
related and that patients who are readmitted will be more likely to be those 
patients that have been to the GP or to Accident & Emergency departments.
The final section of Table 5.7 suggests that the responses to the statement'T feel 
no better than I did before" did not show any relationship to post-operative 
complications. Experience during validation interviews has suggested that there 
were some problems with the interpretation of this question and that the results 
are therefore not reliable. The other summary of transitions in health was the 
statement "I have health problems I did not have before" where positive 
responses to this question are associated with a higher incidence of visits to GPs 
and A&E - which is as predicted.
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Fig 5.2  The mean change in combined NHP score by acquitting score.
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Table 5 .7  Co incidence of events during s ta y  and to  f o l l o w - ( n F l 4 9 ) .
Percentage of patients reporting particular events/problems after operation.
Prevalence 
X  cases
Peri op Postop Readmit Go GP Go A&E No
better
Periop 
complies
17.8 -
Postop
complies
21.7 10.2"' -
Readmitted 5.1 0.6 1.3
Go GP 20.4 4.5 6.4 3.2" -
Go A&E 7.0 1.3 1.3 2.5 " 3.8" -
•No better' 28.0 4.5 6.4 2.5 6.4 1.3 .
'Health
problems'
5.7 1.3 1.3 1.3 3.8" 1.9* 2.5
p<.001 Chi-squared test
p<.01
p<.05
The relatively small proportion o f cases readmitted to hospital after three months showed 
significantly worse symptom scores, NHP scores and summary health status.
Table 5.8 records the mean follow-up NHP scores for each dimension and number 
of symptoms according to whether patients experienced one of the possible 
adverse events after discharge.
In general patients with peri-operative and post-operative problems showed no 
higher NHP or symptom scores than those without. This confirms the earlier 
observation that events during the hospital stay have not necessarily translated into 
longer term problems.
On the other hand patients who had been readmitted showed significantly higher 
NHP scores. This relationship is important if readmission is to be used as a 
proxy measure (Chambers & Clarke 1990). It appears that using these criteria 
readmitted patients are genuinely in worse health although the causal link to the 
earlier procedure still needs examination. Similar, though weaker relationships 
were also seen for the group of patients who reported visiting their GP.
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Table 5.8 The re la tio n sh ip s  of hea lth  events and hea lth  s ta tu s  (nFl49).
Mean NHP scores and maker of synptoaB by various post operative events.
Energy Pain Emot
Reacs
Sleep Social
Isol
MobiI. Pt II Comb Mean #
symps
Pen'op Yes 20.3 9.1 7.6 18.6 5.8 10.0 9.5 11.9 1.7
No 23.0 12.7 5.9 11.1 5.8 14.3 16.5 12.1 1.6
ns ns ns ns ns ns ns ns ns
Postop Yes 18.4 9.2 6.9 17.8 5.9 8.7 9.1 11.2 1.7
No 29.3 11.6 8.9 15.5 5.3 17.9 16.0 14.8 1.7
ns ns ns ns ns p=.050 ns ns ns
Read* Yes 18.6 7.8 6.3 15.8 4.8 9.8 8.7 10.5 1.6
mi t No 59.0 45.0 26.3 44.8 23.2 27.4 46.4 37.6 3.0
p<.001 p<.001 p<.001 p=.012 p<.001 p=.040 p=.001 p<.001 ns
Go GP Yes 18.2 7.5 6.9 14.8 5.3 10.5 8.6 10.6 1.5
No 30.4 17.3 9.0 27.1 7.9 11.3 18.8 17.2 2.5
p=.046 p=.026 ns p=.015 ns ns ns ns p=.001
Go A&E Yes 19.7 8.1 7.2 16.6 5.5 10.1 9.5 11.2 1.6
No 33.8 31.5 9.2 26.6 9.8 18.7 26.0 21.6 2.2
ns p=.001 ns ns ns ns ns ns ns
Better Yes 16.5 7.6 5.0 14.0 4.4 7.8 8.6 9.2 1.5
No 31.3 15.0 13.1 25.7 9.2 18.0 15.9 18.8 2.0
ns
H Prob Yes 19.8 8.8 6.8 17.4 5.5 10.3 10.1 11.4 1.6
No 36.3 24.8 15.6 15.3 9.7 17.7 20.6 19.9 3.6
Hann-Uhitney U test. ns=not significant (p>.05)
Effects of presenting characteristics.
The relationships between the various indicators and some basic presenting characteristics 
have been examined using simple bivariate analyses. A summary of the results are 
presented in this section. The importance of examining variation in outcome indicators 
by such presenting characteristics is that see if the indicators are unduly sensitive to 
changes in the mix of patients. If so then comparisons of indicators - between sites or 
over time - will require some form of standardisation for these patient characteristics. 
A second purpose was to consider whether relationships turned out as expected and if 
possible to reduce the size of the data set collected by eliminating variables which proved 
to be of less value.
The presenting characteristics used were:-
- Age
- Sex
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- Indications for surgery using the groupings of ’Acute’, ’History of acute’, 
’Chronic’, ’Others’.
- Acuity scale as described earlier (1 = Emergency, very acute; 2 = Acute with 
frequent biliary pain; 3= Biliary pain less than 4 times/year ; 4 = asymptomatic, no 
biliary pain).
- Co-morbidities - patients were classified according to the presence of active co- 
morbid conditions. Groups were for no co-morbidities, one condition, greater than 
one condition.
- Mean time since onset of symptoms - less than 6 months, 6-12 months or greater 
than 12 months.
- Obesity - defined as BMI>30 kgm’^  (Bray 1978).
- Smoking
There were no significant differences in the age profiles of the two sexes though the mean 
age of men (60.95 years) is slightly higher than women (58.89 years).
Symptoms/problems
Table 5.9 summarises the mean number of reported patient symptoms/problems according 
to a variety of presenting characteristics. Results are shown for pre-operation scores, 
follow-ups to 3 months and the change in score. There were significant differences 
between the sexes in the number of reported symptoms/problems on admission - and a 
lesser difference at follow-up. However the mean change in number of reported 
symptoms was not significantly different.
Most of the differences observed for the other variables were not significant - with the 
exception of the acuity scale which showed higher symptoms scores for the most acute 
patients on admission although at follow-up there was no clear pattern across the acuity 
scale. The result is that the greatest change in reported symptoms/problems is found 
amongst the acute patients who tended to have more symptoms pre-operatively - as one 
might expect. The fact that the pattern of results were different for the Acuity scale and 
the indications for surgery (as recorded on the forms) raises questions over the recording 
of the latter variable (as was discussed earlier).
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Table 5.9 Mean nunber of reported synptcms/probleas pre-operatively, at follow-up and change 
in between by presenting characteristics (n=149)
Mean No. reported 
symptoms/problems
Pre-op Follow
Up
Change
Female
Male
3.59
2.61
p=.0018
1.87
1.20
p=.025
1.72
1.41
ns
XAge<40 3.66 1.55 2.10
40-59 3.25 1.89 1.36
60-69 3.43 1.86 1.57
>=70 2.85 1.21 1.65
ns ns ns
% Acute 2.83 1.08 1.75
History 3.12 1.61 1.51
Chronic 3.64 1.96 1.68
Others 3.63 1.37 2.25
ns ns ns
Acuity =1 3.69 1.00 2.69
=2 3.67 2.00 1.67
=3 2.51 1.51 1.00
=4 2.68 2.00 0.67
p=.0003 p=.04 p=.0022
Comorbids.=0 3.39 1.58 1.82
=1 3.21 1.76 1.44
>1 3.26 1.71 1.55
ns ns ns
Mean Time <6m 3.00 1.73 1.27
since 6-12m 3.00 1.30 1.70
symptom >12m 3.73 1.87 1.86
onset ns ns ns
Obese No 
Yes
3.37
3.20
ns
1.68
1.47
ns
1.70
1.73
ns
Smokers No 
Yes
3.30
3.30 
ns
1.64
1.74
ns
1.66
1.56
ns
ns = not significant (p>.05)
Events in Hospital and Events after discharge
Table 5.10 summarises the proportion of cases associated with a particular adverse event 
after discharge according to patient characteristics. Once again the most significant 
variable appeared to be the acuity scale. The more acute cases had a greater number of 
peri-operative and post-operative complications. Fewer of the more acute cases tended 
to visit their GP after discharge.
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Table 5.10 Percentage of cases recording adverse event (during and after hospital stay) by 
various presenting characteristics (n=149).
X cases Adverse event
Periop 
complic
Post-op 
complic
Readmi t Visit GP Visit A&E No Better
Incidence(X) 16% 19.0% 5.6% 21.8% 7.7% 28.9
Female 16.2 21.9 3.8 20.5 11.4 29.5
Male 15.9 13.6 9.1 21.0 5.7 25.0
ns ns ns ns ns ns
Age: <40 10.5 23.7 7.9 34.2 7.9 18.4
41-60 14.3 17.9 3.6 21.4 7.1 28.6
61-70 14.3 9.5 0 16.7 4.8 31.0
>70 23.5 26.5 11.8 14.7 11.8 38.2
ns ns ns ns ns ns
Indications:
Acute 33.3 33.3 8.3 8.3 8.3 41.7
History Chronic 7.1 11.4 7.1 22.9 10.0 24.3
Other 23.2 25.0 3.6 25.0 5.4 28.6
25.0 25.0 0 0 0 37.5
ns ns ns ns ns ns
Acuity =1 30.8 23.1 3.8 3.8 3.8 38.5
=2 12.7 19.0 7.6 32.9 8.9 26.6
=3 15.4 15.4 2.6 10.3 7.7 28.2
=4 0 0 0 0 0 0
p=.0003 ns ns p=.001 ns ns
Co-morbidities
None 16.7 21.2 1.5 25.8 3.0 16.7
=1 15.4 17.3 7.7 15.4 11.5 28.8
>=2 16.1 19.4 9.7 19.4 9.7 51.6
ns ns ns ns ns p=.002
Time <6m 12.2 14.6 7.3 24.4 12.2 24.4
since <6-12m 6.1 15.2 9.1 12.1 6.1 24.2
onset >12m 23.8 27.0 3.2 23.8 4.8 34.9
Symptoms ns ns ns ns ns ns
Obese No 18.6 21.6 2.9 19.6 6.9 29.4
Yes 13.3 20.0 6.7 20.0 13.3 20.0
ns ns ns ns ns ns
Smokers No 19.8 19.8 5.7 17.9 9.3 26.4
Yes 7.0 18.6 4.7 27.9 2.3 32.6
p=.05 ns ns ns ns ns
Chi-squared, ns = not significant (p>.05)
In most cases the co-morbidities are not showing the type of relationship that one might 
expect. The exception to this is that patients with active co-morbid conditions are more 
likely to feel ’No Better’ after the operation. It is difficult to know if the lack of a 
relationship between co-morbid problems and these other events is due to the recording 
and classifying of the co-morbidities, or that the predicted relationship does not exist.
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Nottingham Health Profile
Table 5.11(a) summarises the mean NHP scores by age and sex category. There are 
some differences in the NHP scores by age and sex though the pattern is not consistent.
Table 5.11(a) Mean NHP scores by categories of age and sex.
SEX
F M
AGE AGE
<50 YRS 51-60YRS 61-70YRS >70YRS <50 YRS 51-60YRS 61-70YRS >70YRS
No. Cases 31 17 28 23 7 11 14 11
Energy
Pre-op 42.53 36.71 34.49 45.05 3.43 35.20 31.54 19.20
Post-op 28.36 27.91 14.37 25.63 14.62 16.17 13.45
Pain
Pre-op 33.92 19.35 30.91 25.99 17.32 40.45 12.98 29.26
Post-op 11.98 5.56 9.73 15.90 4.77 6.94 4.82 15.75
Emot.Reac
Pre-op 19.56 21.17 17.22 14.23 10.42 24.81 3.41 8.95
Post-op 9.84 8.20 7.42 3.84 1.01 5.12 7.55 4.82
Sleep
Pre-op 25.15 40.52 27.20 27.05 22.38 28.98 28.12 25.23
Post-op 15.97 29.54 19.35 18.27 7.20 3.18 16.38 17.10
Social I
Pre-op 5.41 13.69 8.93 12.30 3.22 4.05 1.45
Post-op 4.59 12.71 6.84 4.83 4.05 7.57 1.83
MobiIi ty**
Pre-op 9.72 7.46 15.29 29.57 8.32 17.68 5.72 15.57
Post-op 6.38 8.00 12.44 27.09 6.69 6.24 12.52
Part II
Pre-op 37.80 18.49 22.97 18.84 30.62 25.98 9.19 27.28
Post-op 16.13 15.13 4.76 16.78 10.39 5.10 6.50
Comb
Pre-op 22.72 23.15 22.34 25.70 10.85 25.20 13.63 16.61
Post-op 12.86 15.32 11.69 15.93 2.16 6.77 9.79 10.91
* *  significant correlation with age p<.001 } women only 
* significant correlation with age p<.01 >
It appears that women tend to score higher (ie ’worse health’) than men on most 
dimensions though this is most significant for ’Social Isolation’ and ’Energy’. These 
differences are observed for pre-op and follow-up scores - but there are no differences 
in the absolute change in score.
There is no consistent pattern with respect to age though mobility scores tend to be higher 
with older women than with elderly men. Table 5.11(b) shows the significance of the 
relationships between some other presenting characteristics and the NHP scores at 
admission, at 3 month follow-up as well as the change in NHP to 3 months. Table
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5.11(b) shows the observed statistical significance (using Kruskal Wallis test) between the 
NHP scores according to categories of sex, indications for surgery, the acuity scale, and 
the number of co-morbid conditions. The majority of tests revealed no association 
between the variables other than that expected by chance.
Table 5.11(b) NHP scores by presenting characteristics: Significance of relationships between NHP scores 
and presenting characteristics (n=149).
Presenting characteristic
NHP scores Sex Indic­ Acuity Co-morbid­
Pre-op ations scale ities
Energy .014 ns .042 ns
Pain ns ns .0000 ns
Emot R ns ns .005 ns
Sleep ns ns .086 .035
Soc Isol .008 ns ns ns
MobiIi ty ns .0002 .085 .0006
Part II ns ns .0017 ns
Combined ns .043 .0006 .031
Follow-up
Energy .007 ns ns .013
Pain ns ns ns ns
Emotional R ns ns ns ns
Sleep .030 ns ns ns
Soc Isol ns ns .033 ns
MobiIi ty .04 .0008 ns .001
Part II .03 ns ns ns
Combined .001 .023 ns .020
Change
Energy ns ns ns .024
Pain ns .0002 ns ns
Emotional R ns ns ns ns
Sleep ns .034 ns ns
Soc Isol .07 .049 ns ns
MobiIi ty ns ns ns ns
Part II ns .027 ns ns
Combined ns .006 ns ns
Kruskal Wallis analysis of variance.
Variation in the acuity scale showed the highest number of significant associations and 
seems the most important characteristic with respect to the admitting NHP scores. The 
pattern is that the more acute patients had significantly higher NHP scores on all 
dimensions (worse health) except ’Social Isolation’. There were no differences related 
to acuity at follow-up nor in the observed change in NHP. Given the earlier observations 
that higher pre-operative NHP scores tended to lead to higher changes in score, it is 
surprising that the higher NHP scores seen for the more acute cases did not also mean 
that higher changes in the overall score were observed. The fact that there were no 
significant differences in the change in NHP and the levels of the acuity scale may be an
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artefact of the data or an indication of the power of the statistical test.
The relationship between the NHP scores and the classification of indications for surgery 
was rather different. The largest changes were noted in the change in NHP rather than 
in the admission or follow-up scores. The observation that more acute cases, as judged 
by the indications for surgery, exhibit greater changes in mean NHP scores, differs from 
the acuity score which failed to show similar links. Further investigation of the 
behaviour of these two variables is needed.
The presence of co-morbidities seemed to be related to the sum of the NHP dimensions 
at admission (’Sleep’, ’Mobility’ and combined score) and follow-up (’Energy, 
’Mobility’ and combined score). However the change in NHP between admission and 
follow-up was affected only for the score on ’Energy’.
Finally , though not included in Table 5.11(b), obesity and smoking were not 
significantly related to any of these NHP scores. It should be noted that this analysis 
is only a simple exploration of the strongest links between variables and does not 
necessarily imply a direct causal link. It is quite possible that some of the observed 
relationships may be due to combinations of variables, for example it may be that NHP 
scores for ’Mobility’ are related to both age and the presence of co-morbidities - 
variables which tend to be associated anyway.
Though none of the variables examined show consistent relationships across NHP 
dimensions, it appears that sex and the balance of acute versus chronic patients are most 
important for making comparisons. In practice it has been found that the relative 
proportions of the sexes have been fairly constant during the course of the study. Thus 
comparisons of scores which have not been standardised for sex would be acceptable. 
However the proportion of acute cases has shown some fluctuations between quarters and 
may be the explanation of why poor outcomes are observed at certain time periods. The 
same cautions must also apply if NHP scores for cholecystectomies are to be compared 
between institutions.
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Main conclusions of the data analysis - Cholecystectomy.
1. Most indicators show a general improvement following cholecystectomy. An early 
concern of the study was whether the various instruments used would be able to detect 
change following the operation. But the NHP, the presence of symptoms and the overall 
health rating all showed significant change for the population of patients concerned. This 
results is especially important in that it has demonstrated the value of the NHP in this 
particular context.
2. There are significant inter-relationships between the various indicators and some 
duplication of data. By and large the indicators when viewed as cross-sectional 
descriptions of the patient’s health tend to support each other and give a validity to their 
use. These relationships are less clear when comparisons are made of movements in the 
indicators where they are clouded by variability in the instruments and more importantly 
’end-effects’ in using some of these scales.
3. There is sufficient variability in incoming patients to make the phenomenum of 
regression to the mean a problem especially when scores such as the NHP and symptoms 
scores tend toward zero in healthy patients. Thus, when considering the relative 
improvement in health associated with the procedure, a critical determinant is the 
admitting health status of the patient.
4. Despite the observed improvements in the population of patients there are clearly a 
number of patients who show little or no improvement and others where there are 
indications of health problems after the procedure. The proxy measures of réadmissions, 
and to a lesser extent GP visits, are related to poorer health - though this in turn may not 
be related to the cholecystectomy.
5. Though the presence or absence of individual symptoms was reported, they tended to 
be rather unpredictable as outcome measures when viewed individually and the behaviour 
of questions on bowel problems and loss of appetite was confusing. A simple index of 
the total number of reported symptoms/problems appeared to be a more reliable indicator
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of improvement.
6. Of the patient characteristics which appear to be related to the outcome indicators the 
most important was the acuity of the patients condition before surgery. Many of the 
other presenting variables showed some relationship to the indicators but there were few 
consistent and clear patterns in the results which necessarily suggest the need to 
standardise for these factors at admission. Larger sample sizes would give a clearer 
picture of the relevance of these factors and it is suggested that age, sex and the presence 
of co-morbidities (in some form) be retained in the dataset.
7. The major changes in outcome indicators occur within three months of the procedure 
and little change is seen thereafter to 12 months. Indeed events between 3 and 12 months 
may serve to confuse the picture as there is an increasing likelihood that deleterious 
changes in health are not related to the procedure. Interestingly problems during the 
hospital stay are not significantly associated with poorer outcomes at 3 and 12 months.
8. Further work could eliminate some of the variables collected in this study and operate 
on a reduced data set. The following is suggested
Outcome Indicators
Change in NHP or similar health status measure (baseline to follow-up). 
Survival
Réadmissions (and reasons)
Optionally:-
Change in number symptoms/problems reported 
Peri-operative and post-operative complications
Patient descriptors and other information
Administrative details - identifier, address, etc.
Age and sex
Acuity/Indication for surgery classifications 
Simple list of active co-morbid diseases 
Optionally:-
Clinicians assessment of patient risk.
Process data, pre & post-operative lengths of stay.
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D. Review Process
The results were fed-back to clinicians in the form of brief reports covering changes in 
the main outcome indicators, together with some more specific questions. As the results 
became available they were examined by quarters and reported back (see Appendix 5).
These reports were circulated to the consultant surgeons and then discussed at a 
subsequent meeting. As the recruiting of cases was slower than initially expected it was 
agreed that results should be reviewed every 3-4 months. In total four meetings have 
been held which all the consultant surgeons attended. As the consultant surgeons rarely 
all met together these meetings were specially organised, and there was clearly an interest 
in the approach and the results.
One attempt was made to introduce the study and interim results to the agenda of an 
existing meeting which included the whole surgical team. This was successful in 
disseminating the presence of the study though less productive in terms of discussing 
results. It was agreed that in future meetings with the four consultants would be the best 
forum.
Each meeting had an agenda and minutes were taken. The aims were to discuss both the 
process of data collection, the results to date and possible ways to improve the outcomes. 
A number of issues relating to data collection were raised and changes made as a result 
of these meetings. In particular the recording of the indications for surgery (the 
definition of which continues to be problematic) was examined, and the idea of the 
surgeons assessment of the risk of an adverse outcome introduced.
To summarise the reaction of the consultants:
a. The changes in symptoms scores were broadly as expected, though the high degree of 
residual bowel problems did raise some questions. Additional questions on diarrhoea or 
constipation were added to the forms but these have so far proved inconclusive.
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b. The changes in NHP were broadly in line with those expected - that is significant 
improvements in the scores for ’Energy* and ’Pain* with little change in ’Social Isolation’ 
or ’Mobility*. After some initial caution, the surgeons were happy to accept this 
instrument as a measure of general health status - indeed these results and their general 
acceptance are an important product of the cholecystectomy study.
c. A number of patients died, or had serious problems after surgery. Individual reports 
on these ’non-responding’ patients were prepared. Early review meetings discussed these 
individually though no general lessons emerged. In some cases the history and 
subsequent course of these patients was known and the issues had been discussed in other 
settings. At the most recent meeting the value of group discussions of these individual 
cases was raised.
d. The lengths of stay were longer than expected - though they have fallen steadily 
throughout the course of the study. This was one clear example of where it is possible 
to monitor the effects of a change in resource use directly on patient outcomes In this 
case there was no deleterious effect on outcomes observed as the length of stay decreased
e. The interpretation of the results was hampered by the lack of comparative data. This 
made the focus of the discussions more concerned with the processes and feasibility of 
data collection than with potential improvements in practice.
f. The results did serve to highlight the main area of concern with regard to outcomes 
from this procedure, namely the process of patient selection. Though no direct changes 
in practice appeared there was a growing consensus that the key to good outcomes lies 
in patient selection rather than the actual execution of care. It has been agreed that the 
issue of appropriateness of the procedure will be looked at using two examples of criteria 
drawn from the literature. By implication other aspects of care were judged to be 
satisfactory.
g. The data was linked to the case mix system and in particular to the DRG classification 
scheme (Bardsley, Coles & Jenkins 1987). This raised some important questions
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concerning the classification and the coding process. However it was felt that as the 
DRG classification was still in a state of flux (DRG definitions are currently being 
revised) and it was not worth investing too much effort to link these further.
h. The surgeons are keen to continue outcome studies of this form though the value of 
cholecystectomy as a relevant group for study was questioned. In particular it was 
expected that a major change in techniques will make the traditional procedure become 
obsolete. Indeed laparoscopic cholecystectomies have just started - the intention is to 
include these cases, suitably identified, in outcomes monitoring. Beyond this other 
proposed changes in the delivery of care such as the increase in day surgery have been 
suggested as opportunities for further work in outcomes monitoring.
j. The study has been seen by the surgeons as useful in exploring the relevant 
dimensions and techniques for outcome measurement and as one surgeon reported the 
study has been:
"Interesting as it showed elements o f the patient's response to treatment we 
would not normally have access to " (Appendix 4).
However the surgeons do not feel it has pointed to obvious ways in which their practice
could be improved. The study has helped the surgeons to identify the process of patient 
selection as critical to good outcomes and was seen to offer a tool for ensuring that future
changes in practice do not have deleterious effects on outcome.
In summary the cholecystectomy study has given some useful insights into the process 
of outcomes monitoring. There has been a clear commitment to the project from the 
clinical staff and a willingness to devote their time and resources to data collection and 
analysis. The surgeons concerned have expressed a wish to continue outcomes 
monitoring, possibly on other case types if the resources are available.
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Chapter 6 Diabetes
A. Introduction
Diabetes was the second condition chosen in the early stages of the project. As a 
chronic disease where most care is based in the outpatient (or GP) sector it represents a 
completely different model to that of the acute inpatient episode of the cholecystectomy. 
The Department of Diabetes Medicine at the Freeman Hospital has close links with the 
University and other teaching hospitals in the city and has an international reputation for 
research in diabetes medicine. The key medical and nursing staff have inpatient beds, 
run outpatient clinics and education programmes to cater for a population of 
approximately 1300 diabetic patients.
Diabetes Mellitus - background information
It is estimated that diabetes affects over 1 % of the general population and absorbs 4-5 % 
of health care spending (Laing & Williams 1989). The disease itself is caused by the 
body’s inability to produce sufficient amount of the hormone insulin which controls the 
metabolic balance of blood glucose. Whilst extreme imbalances in blood glucose can 
give rise to acute problems of hypo- and hyper-glycaemia, perhaps the major threat 
comes from the long term complications of the disease which affect many different organ 
systems. If untreated these complications can lead to very serious problems, blindness, 
amputations, kidney failure, heart attacks and strokes etc. These factors combine to give 
observed excess mortality in people with diabetes (Dorman et al 1984; Panzram 1987). 
The severity of some of these problems has been linked to the degree of blood glucose 
control in the preceding 10-20 years (Pirart 1978; Rand et al 1985). The aims of 
diabetes care are therefore to control blood glucose levels , to minimise immediate and 
long term risks, and treat (or oversee) complications as they arise. On this latter point 
it has been estimated that early detection of retinopathy followed by laser treatment can 
prevent blindness (Kohner & Barry 1984), and that intensive management of foot 
problems can reduce the amputation rate by 50% (Edmonds et al 1986).
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The control of blood glucose is achieved by a controlled diet, the use of certain tablets, 
or through injections of exogenous insulin. In addition patient education in how best to 
manage their condition is important. In general the least biologically disruptive regimes 
are preferred (ie diet to tablets to insulin).
Most diabetes patients fall into one of two categories; Type I or insulin dependent 
diabetes (IDDM) typically appears during adolescence and requires insulin treatment from 
the start and for the rest of the patient’s life. Type II or late onset diabetes occurs mainly 
over the age of 35 and is characterised by an increasing imbalance in blood glucose (the 
definition of when patients become diabetic is critical). The treatment typically starts 
with dietary control only (if possible) moving onto tablets and then insulin only when 
necessary. The largest single group are the non-insulin treated patients (NIDDMs) with 
type II diabetes.
During the past few years the preferred locus of care has been shifting away from 
hospitals towards more convenient and accessible community based clinics or with GPs 
(Day & Spathis 1988, Wood 1990). It is generally accepted that if the quality of care can 
be maintained then such forms of provision are preferable for the bulk of the basic care 
of patients with diabetes.
B. Data set and Data Collection 
Identifying outcome indicators
The diabetes study required the differentiation of the key patient types. Though the 
actual outcome indicators across these types are similar, the typical results that one might 
expect would be very different.
The key patient groups were defined as:
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Type I Diabetes - Newly diagnosed
- Historical caseload
Type n  Diabetes - Newly diagnosed
- Historical caseload
- Treatment by insulin
- Treatment by tablets
- Treatment by diet only
The pattern of outcomes expected from newly diagnosed patients is different from those 
who have been diagnosed for some time. The data collection and analysis for these 
patients was therefore different from that used to examine the long term changes in the 
returning clinical population ie the historical caseload.
The analyses in diabetes therefore split into two main groups.
1. Newly diagnosed/referred patients - required new data collection systems to monitor 
changes during the first year of treatment at the Freeman Hospital. The study specifically 
examined non-insulin treated diabetes. Most patients were newly diagnosed though others 
were referrals from elsewhere or patients whose contact with the Freeman (or other 
hospitals) had lapsed. It was agreed to include all these cases as representing a group 
about to start a new treatment regime at the Freeman. These were followed for the year 
after their first appointment.
2. Data on patients from the historical caseload were drawn from the system of annual 
reviews that was already in place at the Freeman Hospital. This scheme attempts to see 
all patients at least once a year for a battery of checks. Data on these visits has been 
collected on microcomputer since 1984. Patients in this part of the study included those 
with Type I diabetes as well as Type II cases treated by insulin, tablets or diet alone. 
The results for these separate patient groups are treated separately.
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The Outcome Indicators
Table 6.1 shows the outcome indicators and the agreed standards. The indicators fall into 
four groups described in detail below.
Indicators o f metabolic control
eg HbAl, blood lipids, body mass index, number of inpatient admissions for 
destabilisation.
These indicators are predictive of longer term health problems. They are relatively easy 
to measure and control in the short term. It is arguable whether some of these measures 
are process or outcome. In particular they may not necessarily reflect ill health from the 
patients perspective but are rather indicative of the long term problems (which are also 
included). At present the belief is that control of these factors is significantly related to 
long term health, although the proof may not be certain. However it is clear that they 
represent key objectives in the current treatment and control regimes in diabetes. It is 
for this reason that they have been included and in practice proved to be the most 
valuable indicators.
1. HbAl (glycosylated haemoglobin) assays have developed since the late 1970’s (Nathan 
et al 1984) as a way of assessing mean blood glucose concentration during the preceding 
6-8 weeks. It therefore proved a better measure of blood glucose control than the blood 
glucose levels which were subject to wide fluctuations. It has now become so widely 
adopted that "many physicians could not imagine treating diabetes without it" (Nathan 
1990). One recent study (Larsen,Horder & Morgensen 1990) has observed the effects of 
routine monitoring of HbAl itself and concluded that compared to a control group regular 
measurement leads to changes in diabetic treatment and improved metabolic control. As 
such its value is not only as a guide to treatment but also in predicting when long term 
complications may result from extended periods with high blood glucose (Klein et al 
1984). For example one recent study (McCance et al 1989) has shown that mean HbAl 
levels were correlated with an increasing risk of developing proliferative retinopathy in 
insulin dependant diabetes - independent of the time since diagnosis. Similarly a 
relationship has been shown between mean HbAl levels and the progression towards
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kidney failure (Feldt-Rasmussen et al 1986; Morgensen 1988).
Table 6.1 Examples of the Outcome Indicators at the Freeman
Outcome Indicator Standards Data collected
Metabolic control
HbAl >8.75% ="Unsatisfactory" 
>10.0% =''Poor”
At diagnosis, 3 months and 
subsequent annual reviews
Body Mass Index >27.5 kgm-^  = “Unsatisfactory" At diagnosis and 12 months, and 
annual review
HDL Cholesterol <0.9 mmol l’ =“Unsatisfactory“ At annual review
Cholesterol >6.5 mmol l’ «"Unsatisfactory" At diagnosis ( 3 months if high) 
and subsequent annual review
Complications of diabetes
Blood Pressure <160/90 or
95th percentiles for age <40
At diagnosis, three months and 
annual review
Circulatory problems Absent - Score as abnormal 
pulses, claudication, ulcer or 
amputation.
At annual review.
Eyes - Abnormal fundi 
Haculopathy 
Proliferative 
retinopathy
Absent At annual review
Neuropathy -Neuropathic 
symptoms 
-Biothesiometer
Absent - neuropathic symptoms 
Greater than 25 - both legs
At annual review
Kidney complications 
-Creatinine 
-Microalbumin
Absent - defined as present when 
>125 micromol l’
>10.0 mg mmol’
At annual review
Visual Acuity Better than 6/12 or 6/36 
(worst eye)
At annual review
Behaviour /Knowledge
Smoking None At annual review
Knowledge of diabetes Improvement on test score Simple questionnaire on diagnosis 
and after education programme
Well being
Health status Maintain/improve SIP score At diagnosis, 3 months and 12 
months
At the Freeman Hospital HbAl levels have been measured for many years and are 
considered perhaps the most important indicator of control. Assays are typically 
performed at diagnosis, annual reviews and often in-between. It was possible to agree 
beforehand categories of HbAl that could be deemed acceptable, unsatisfactory and poor. 
These values were based on international consensus values (Alberti & Cries 1988).
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2. Cholesterol Levels are important as a risk factor in cardiovascular disease. A number 
of related assays are used in assessing such patient risks. Thus high density lipoprotein 
(HDL) cholesterol and triglycerides are all measured although the total serum cholesterol 
was considered the most important indicator.
There is little doubt in the literature that elevated serum cholesterol (along with 
hypertension and smoking) is a major risk factor in ischaemic heart disease - a condition 
with an increased prevalence and risk with diabetes (Abbott et al 1988; Betteridge 1989). 
Control of cholesterol levels is possible with a combination of diet and drugs (Winocour 
& Laker 1990).
Although there has been some controversy over the value of screening for 
hypercholesterolaemia in the general population, screening in diabetes is generally 
accepted. At the Freeman measurements are routinely taken on diagnosis and at annual 
review. If high cholesterol levels are observed intermediate readings are also 
recommended.
3. Body Mass Index (BMI) was chosen as the simplest measure to relate weight to height 
- it is calculated as the weight in kilogrammes divided by height in metres squared (kg 
m'^). As such relative obesity can be assessed in a single statistic for patients of different 
height. Patients with values over 25 kg m'  ^ are usually considered ’overweight’ whilst 
a BMI over 30 kg m'  ^ indicates ’obesity’ (Bray 1978). In addition some data on 
absolute changes in weight have also been reported. The distribution of BMI values for 
non-insulin dependent diabetes is higher than in the general population. Changes in BMI 
from high to acceptable are an indication that diet regimes are being successful. Once 
again the standard values were taken from the literature (Alberti & Cries 1988).
4. Incidence o f hypo/hyperglycaemia is also considered as a monitor of the degree of 
control. The belief is that under the correct treatment regime patients should not 
experience periods when blood glucose levels are sufficiently high or low to cause major 
symptoms. In the case of insulin dependent diabetes an episode of severe hypoglycaemia 
and resulting ketoacidosis can be very serious and even fatal. However more frequent 
episodes of lesser severity are likely to occur, thus the definition in this case required
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some form of third party assistance or advice eg relative, GP help. As the study of new 
patients was based on non-insulin treated cases, the incidence of these episodes at follow- 
up was very low. As a result a valid analysis of the data could not be performed.
Indicators o f complications o f diabetes
These indicators cover the important health problems that exist within a diabetic 
population. They may only become manifest after a number of years of poor control and 
are not always amenable to immediate treatment. The incidence of these problems may 
reflect practice many years before. In many cases these complications can be inter-related 
and represent different manifestations of what is essentially the same underlying disease 
process. Nevertheless their treatment takes different forms concerning the relief of 
symptoms and patient problems.
These complications can be considered under a number of headings. With symptomatic 
health problems (eg the circulatory problems of claudication, ulcers and amputation, 
angina and neuropathic symptoms) goals are to minimise the effects of the disease on the 
patient. Risk Factors such as high blood pressure may reflect current health problems 
for the patients as well as increasing the risks of more serious problems later. Others are 
markers o f damage (eg absent pulses) which may become serious risks to immediate 
health (eg leg amputation).
Blood Pressure, when high, is considered undesirable both as a problem in itself with 
effects on patient’s health, and as a significant risk factor in other diabetic complications. 
(Diabetes Drafting Group 1985). In one study it was found that 40% of men and 53% 
of women in a newly presenting NIDDM population had hypertension by WHO criteria 
(Turner et al 1985). The measurement of blood pressure is subject to some unreliability; 
high blood pressure is confirmed only after at least two high measurements (Hope & 
Longmore 1984). Blood pressure measurements are routinely made at the outpatient 
appointments at the Freeman. For the purposes of outcome monitoring these were 
categorised according to WHO criteria or centile charts (Drury and Tam 1985). Any 
patients over 160/90 was considered ’high’, for the remainder the criteria were based on 
age specific 95% percentiles for a normal population. Concerted long term treatments
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are available to reduce blood pressure and should when applied result in a reduction in 
the proportion of patients with high values.
Neuropathy is recognised as one of the long term problems affecting around 20% of 
diabetes patients (Nabarro 1988). As well as loss of feeling in some limbs or pain and 
tenderness , it is associated with foot ulceration (The Lancet 1990). Definitions of 
neuropathy tend to be rather vague (Laing & Williams 1989). Two approaches were 
adopted for this analysis, one was based on the clinical assessment of the interviewing 
doctor about whether neuropathic symptoms were present. The other test was based on 
a quantitative assessment of vibration sensation using a biothesiometer.
Retinopathy in various forms represents one of the most significant, and avoidable, 
complications of diabetes. One study (Foulds et al 1983) estimated that 50% of a diabetic 
population would eventually need laser treatment for retinopathy. Rohan and colleagues 
(Rohan,Frost & Wald 1989) suggested that the incidence of diabetic retinopathy will 
produce blindness in 184 men and 276 women in England and Wales in one year. The 
treatment of retinopathy is effective if the condition is caught early enough (British 
Multicentre Study 1984). There is also evidence to suggest that screening programmes 
are cost-effective (Dasbach et al 1991).
Diabetic retinopathy evolves through a series of stages from background (early) 
retinopathy to proliferative retinopathy or maculopathy either of which can lead to 
blindness. Diabetes is also associated with a high incidence of cataracts. The assessment 
of impaired vision was split into a number of stages. In the first instance the standard 
Snellen charts (routine at diagnosis and annual review) were used to score for impaired 
visual acuity (corrected with glasses if necessary). In this case the worst eye was selected 
(thus reflecting the degree of disability) and scored into one of three basic categories as 
follows
Visual Acuity:
Ok = Better than 6/12.
Impaired = 6/12 to 6/36 
Seriously impaired = Worse than 6/36
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In addition a routine examination using an ophthalmoscope or special camera recorded 
any evidence of the development of retinopathy and certain other specific features. These 
were summarised into three categories categorised as follows:-
- Background retinopathy
- Proliferative retinopathy
- Maculopathy
Nephropathy is a complication of diabetes that mainly affects IDDM’s and is related to 
the duration of diabetes. It has been found to affect (in its earliest form) 6.8% of one 
sample of diabetes patients (Gattling, Mulle and Hill 1986) and in another study renal 
failure was found to be the largest single cause of death (45%) amongst IDDMs (Dorman 
et al 1984). It has also been observed that mortality from cardiovascular disease in 
diabetic patients is forty times higher in those patients who develop clinical nephropathy 
(Borch-Johnson & Kriener 1987).
The first sign of deteriorating kidney function is the presence of albumen in the urine 
which can be detected with the simple albustix test, or the more sensitive and 
sophisticated micro-albumin levels. In addition raised serum creatinine levels may be 
observed. These are all signs of impaired function and good reasons to hand over to a 
nephrologist for medical therapy. In this study micro-albumin levels were regarded as 
the preferred indicator of kidney malfunction predicting major problems 10-15 years in 
advance. However the assay is relatively new and is only just becoming routine, 
therefore the routine positive albustix and creatinine levels ( > 125 micromols 1*^) were 
used as indicating nephropathy.
Cardiovascular Disease can take a variety of forms and represents one of the most 
common complications in diabetes. Ischaemic heart disease is the most frequent cause of 
death in NIDDMs (Panzram 1987). In this study the presence of angina^ as noted by 
the interviewing physician, was used as an indicator of outcome. This is a potentially 
treatable complaint and one that can be controlled by medication, angioplasty or surgery. 
Within the diabetic population the incidence of cardiovascular disease should be improved 
with control of the relevant risk factors.
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In addition to coronary artery problems, peripheral vascular disease may become 
manifest. For the purposes of outcome measurement the development of circulatory 
problems in patients have been combined into an ordinal scale of increasing significance. 
This scale is based on a combination of clinical observations that are routine. At the 
lowest level is the absence of distal pulses (any limb) progressing to the presence of 
claudication, ulceration and then amputation. A patient will be classified according to 
the most severe problem present.
Indicators o f  general well-being
In addition to the clinical or medical considerations, the extent to which diabetes and 
associated problems affects (or hopefully does not affect) their daily life is important to 
patients. There has been relatively little work done on measures of general well-being 
amongst diabetic populations. Some studies have used existing instruments developed in 
psychiatry (Wilkinson et al 1988) to examine well-being amongst a diabetic population. 
Other studies have opted to look at specific symptoms/problems of the diabetic patient 
(Bulpitt et al 1976). The DCCT trial, looking at IDDMs, developed a composite 
questionnaire using instruments taken from the literature based on a number of 
dimensions of quality of life, satisfaction, impact, diabetes worry and social/vocational 
worry (DCCT Research Group 1988). Other than reporting satisfactory internal 
consistency and reliability for these tests there was little concluded about their validity. 
For NIDDMs, a series of scales to measure depression, anxiety, general well-being and 
treatment satisfaction have been developed (Lewis et al 1988; Lewis et al 1989; Bradley 
& Lewis 1990). These were purposely designed to divorce the somatic problems of 
diabetes (or its complications) from psychological status - as far as possible. The 
resulting measures are shown to be internally reliable and not to be correlated with 
somatic problems. The same group has also developed scales to examine health-beliefs 
amongst tablet-treated diabetics (Lewis et al 1990).
For our purposes the specific constructs of depression and anxiety were less important 
than an appreciation of overall well-being. It was also felt that interactions between a 
chosen scale and somatic problems of diabetes would be useful. Thus the desired scale
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could be validated by the extent to which they agree with some general notions of health - 
typically represented by their clinical manifestations. The measure would also have to 
be applicable to IDDMs and NIDDMs. The relative value of different types of scales 
has been examined in a cross sectional study as part of this project (see Appendix 6).
At the start of the study a decision was taken to use the Sickness Impact Profile (SIP) 
(Bergner, Bobbitt & Carter 1981). This was chosen because it was a well-documented 
and widely used instrument which seemed appropriate for this type of patient - although 
no actual studies had been performed. It was felt that other general health status 
measures ran the risk of being too insensitive for a population of patients that contained 
few disabling health problems. The full SIP consists of 136 statements grouped into 
twelve categories (which can themselves be grouped into dimensions covering physical 
function and psychosocial function). Each item has a weight and results can be expressed 
as the weighted sum of responses within each category or combined into a single score 
on the range 0 to 100%. The profile can be administered as a self-completed 
questionnaire.
It was felt that the whole questionnaire would be too long and too impractical to use. 
Therefore four independent categories of the Sickness Impact Profile (SIP) were selected 
based on a pilot study of 50 patients. The categories were selected because they were 
considered representative of the whole instrument (ie one physical,one psychosocial and 
two independent categories) and because they were found to elicit enough positive 
responses to make analysis possible. The sensitivity of this instrument to changes within 
the population under review was unknown at the start.
Indicators o f  education/behaviour/compliance 
eg Giving up smoking, improved knowledge of diabetes
There are a number of areas in which the knowledge and behaviour of the patient can 
help them in their daily lives and can help forestall future health problems. Enhanced 
knowledge of diabetes and limited changes in behaviour can be considered as legitimate 
goals of the health service. A number of measures were considered as possible 
candidates. In the end the indicators used were based on smoking and knowledge of
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diabetes. Work has been done at Charing Cross Hospital to develop knowledge 
questionnaires for Type I diabetes (Meadows et al 1988). This was used as the basis for 
the knowledge test in this present study.
Timing of observations
For newly diagnosed/referred patients the critical time periods were considered to be 
three months and one year after diagnosis (or first appointment). During this period one 
expects stabilisation of the patient and minimal complications to emerge. After a year 
the treatment regime will have been identified. Subsequent analysis is based on annual 
review of the patient thus looking at year on year changes. After one year newly 
diagnosed patients effectively join the larger group of patients representing the historical 
caseload of the clinic.
Other data items
In addition to the data required to examine outcome indicators some basic information 
was required to classify the patient. Most importantly age, sex, time of diagnosis (and 
hence age at diagnosis) and treatment regimes were collected. The dataset for the study 
of changes in the historical caseload of patients was based on a subset of data collected 
during the annual review process. The details of the micro-computer systems are shown 
in Appendix 6.
Data collection
The collection of data was divided into two main parts, with data for newly diagnosed 
cases requiring new collection systems while much of the historic data exploited existing 
information systems.
Newly diagnosed/referred patients
At the Freeman Hospital, all new patients are concentrated into one out-patient session 
which made identification of patients relatively easy. A quick scan of the list usually
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identified the few patients who were not eligible, say for example if they were already 
insulin-treated patients. The eligible patients were given questionnaires (by clinic staff, 
with project staff ’standing in’ when necessary) whilst waiting in outpatients. At the end 
of the clinic these forms were collected for data input. In addition the clinical features 
of the patient were taken from the notes and transcribed onto a basic pro-forma. This 
happened about 1-2 weeks after the outpatient session, allowing time for laboratory 
results to return. If the notes from one clinic were still together this process was fairly 
straightforward (approximately 3-4 minutes per patient). If the notes had been 
’dispersed’ the process took considerably longer. Throughout the project this 
transcription has been undertaken by a member of the clinical staff.
The three month follow-up was more problematic as the study patients were mixed into 
a larger clinic population (3-4 study patients in up to 90-100 total appointments per 
clinic). The process was further complicated as patients were quite likely to have been 
seen before the three month time period, or after. This meant that the follow-up had to 
fall within a window of between 2 to 4 months after diagnosis/first appointment. With 
a non-attendance rate of up to 15-20% this presented problems. The tracking of patients, 
knowing which clinic they were to re-appear in, was considerably eased by using the 
outpatient PAS (appointments) computer system which was recently introduced. Once 
the patient had been identified the forms were left in the clinic in a personally addressed 
envelope for the clinic staff to deliver and collect. Clinical details were again taken as 
before 1-2 weeks after the appointment. Given the resources required to carry out this 
interim follow-up the value of the information was being questioned. The 12 month 
follow-up of patients was far easier as they fell into the routine clinic system of the 
annual review process.
Historic Caseload (Annual Review Data)
Data collection for the historic caseload was based on the existing micro-computer 
information system which had been in place at the hospital for a number of years. All 
patients were given an annual review which checked a number of basic clinical and 
laboratory features. This process is recommended as good practice in the care of people 
with diabetes. The data was recorded on a simple pro-forma (see Appendix 6), some of
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which was completed by the doctor when seeing the patient, some completed by specialist 
nurses, and laboratory results added when they arrived. This data was input into the 
Metabase system, taking approximately 3 minutes per patients to input.
For this study most of the basic data required to plot the patient’s health was collected, 
but the analysis offered by the Metabase system was too limited. Therefore additional 
software was developed to extract the collected data and analyse and present the results 
in a suitable form. This extraction process is now being carried out relatively easily and 
at regular intervals.
Knowledge questionnaire
The knowledge questionnaires were given out at the first appointment for newly 
presenting patients. A subset of these patients attended and completed the education 
programmes organised by the diabetes specialist nurse. On completion the same test was 
repeated. The test has also been given to patients to complete at their first annual review 
appointment. The conditions for the completion of these forms was of necessity not ideal 
- whilst waiting for their appointment. It is possible that this added some variability to 
the results.
Validation
The bulk of the data collected was a duplicate of existing records. Software for analyzing 
the historical data base did enable checks to be made on the internal consistency of the 
data. A number of areas of inconsistency were identified:
- once a patient has an amputation, all subsequent reviews should record that fact. 
A handful of cases were found where past amputations had disappeared. These 
were traced to the failure to note ’not observed’, as distinct from ’not present’ at 
the time of data collection. These results were useful in encouraging staff to use 
the forms properly.
- in some cases the recording of ’not assessed’, which should have been 
represented by a nine was not consistent. For example missing HbAl values
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were sometime represented as blanks (which became equivalent to zero), 
sometimes as 99 or 99.9. To overcome this acceptable ranges were used as a 
screen to exclude extreme values from the analysis. Where possible the rates of 
not-recording are also reported. Changes in these values gave a useful indication 
of how thorough data collection had been over time.
- the data base contained a handful of typographical errors, HbAl of 8.5 entered 
as 85. Once again acceptable ranges eliminated these problems, if correction was 
not possible. Given the large amounts of data there were relatively few problems 
of this type.
- the calibration of certain tests and assays have changed over the years The 
outcome reports helped identify these problems. This will be discussed later in 
the data analysis section.
- for newly diagnosed patients, the tracking necessary for three month and twelve 
month follow-ups helped reduce the incidence of cases who ’fell out’ of the 
routine appointment system. For example it ensured that all patients who were 
due for an annual review were given an appointment etc.
Other studies in diabetes
In addition to these two main studies on newly presenting patients and the historical 
caseload, there have been a number of related issues which have been explored by 
Freeman staff during this period with either direct or indirect input from project staff.
GP survey,
A survey of diabetic care in a number of GP practices has been carried out 
(Tunbridge 1991). The data set for the evaluation of care amongst the GP’s was 
based on that agreed for the main hospital studies. Data was specifically 
collected retrospectively and prospectively on a range of mainly comparable 
indicators. Results to date were fed back to the GP’s concerned with a positive
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response. When compared to the hospital it appeared that control of diabetes by 
GPs was as good if not better than at the Freeman. However it is also clear that 
the nature of the patients varied between hospital and general practice.
A study o f  deaths amongst the clinic population
An issue of local concern has been the identification of when patients have died: 
the hospital did not always know of the fact of death or of the reason. A diabetic 
research nurse was therefore made responsible for identifying deaths and updating 
the Freeman database. Though an analysis of the reasons for deaths has not yet 
been possible the updated database is important in avoiding distressing and 
unnecessary annual review appointments being sent out.
A study o f non-attenders at annual reviews
Once again an issue of local concern has been patients who have not received an 
annual review appointment. Apart from improvements to the administrative 
mechanism for identifying when cases are not receiving annual reviews, it was 
also possible to examine, for a subset of patients, whether basic checks on their 
health had been conducted during the year and the degree of metabolic control. 
The results are included in the report shown in Appendix 6.
Cross-sectional study o f health status/treatment satisfaction measures,
A fairly large cross-sectional study of three different health status measures was 
undertaken. The results of this study formed part of the exploratory work 
undertaken in this area and so have not been presented in the data analysis 
section. Details are given in a draft paper for publication (Bardsley et al 1991).
Health changes in insulin starters
Towards the end of the study the question of whether transferring patients to 
insulin treatment yielded the expected benefits in well-being and control was 
raised. Clinical staff expressed genuine uncertainty over whether sufficient 
benefits were obtained and a study to examine the issue is being actively pursued.
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In-patient study
The diabetes department typically includes a number of inpatient admissions. A 
study to examine the short term outcome of these patients has begun though as 
yet the rate of recruitment is small and forms have barely reached re-appraisal 
after piloting (to date less than 20 patients in four categories have been included). 
The intention is to continue with this work and provide a mechanism for 
outcomes monitoring in this area of inpatient care.
C. Data Analysis
This section is divided into two parts - the first deals with the newly referred patients, 
the second with the historical caseload attending the annual review clinics.
For each section there are three basic questions:
1. Do the outcome indicators change as expected?
2. Are the outcome indicators independent or are they related to each other?
3. Are the outcome indicators sensitive to variations in the presenting characteristics 
of patients?
Finally a summary section brings together the observations from both patient populations.
Part I - Newly referred patients
Change in Indicators - Newly referred patients
Table 6.2 shows the numbers of cases accrued to August 1990 for which three month 
follow-up data should be available. Considering first the response rates to three months 
there is a fairly high proportion of missing cases. The reasons why cases are missing are 
varied but include:
- deaths
- patients transferred to GP care
- patients not diagnosed as diabetic
- patient not attending out-patients
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- patients moving out of the district
The follow-ups at twelve months suffer from similar problems. The relatively small 
number who have received an annual review is related to the time delays first in inputting 
data into the annual review system, and then transferring to software developed by tgis 
study. The results therefore cover only the first few months of patients recruited.
Table 6.2 Response Rates Newly diagnosed Non-insulin Treated diabetes.
No. New patients identified to Aug 1990 = 208
3 month follow-up = 146 (70.2%)
12 month follow-up = 62
Linked Annual Review Data = 35
Changes in metabolic indicators.
The three key indicators of control are shown in table 6.3. For HbAl, cholesterol and 
BMI there are significant reductions (using paired t-tests) between diagnosis and three 
months. Further details are given in Tables 6.4(a)-(c) which show the changing number 
of cases within pre-defined categories of these variables. With BMI and cholesterol 
levels there is a problem in that observations are not always taken - particularly at the 
three month follow-up. In the case of cholesterol the policy is that if the reading at 
diagnosis is normal (acceptable) then repeating the test at three months is not necessary. 
By and large this appears to be the case as can be seen in Table 6.4(b). This data can 
also provide a rough check on when tests were performed unnecessarily or not done when 
they should have been. There appear to be a substantial number of cases with high values 
at diagnosis yet no follow-up reading.
For HbAl, movement between categories is more common than in the other indicators. 
It is clear that quite large changes can be observed in certain patients for example 13 
patients have gone from one extreme (HbAl >10%) to the other (HbAl <7.5%) at 
three months. Improvements in HbAl are not restricted to those cases with high values 
at diagnosis though there is the natural tendency for higher values at the first appointment
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to show the greatest fall.
For cholesterol and BMI the results when viewed in these broad categories are less 
mobile. It is likely that many of the changes explaining the statistical significance in the 
mean values are occurring in patients initially in the highest category.
Table 6.3 Mean values of key indicators and categories of the Sickness Impact Profile from first 
appointment to three months and 12 months after first appointment (diagnosis). 
Figures in brackets are standard deviations where appropriate.
First appoint. to 3 months First appt. to 3 and 12 months
Indicator No. Mean Mean No. Mean Mean Mean
First +3mnths diag +3m +12m
Visit Sig vs
3 mnths
HbAl 123 10.5 8.7 26 10.9 9.6 8.8
(2.49) (1.81) (2.59) (2.27) (1.50)
ps.OOO pp.009 ns
Choi 68 7.0 6.7 14 6.3 6.3 6.4
(1.55) (1.48) (1.21) (1.37) (1.24)
P=.024 ns (ns)
BMI 123 29.4 28.7 23 29.8 29.6 29.3
(5.39) (4.96) (6.4) (6.03) (6.23)
ps.OOO ns ns
SIP Ambul 146 17.4 13.9 ps.OOl 62 17.5 16.6 17.6
Soc I soI 11.8 11.8 ns 11.2 14.5 15.9
RecrPa 19.0 16.9 ns 14.1 21.2 18.6
Hswork 20.2 18.3 ns 16.3 19.6 20.0
Combined 16.0 14.4 ^ .023 14.4 17.0 17.6
Significance test for changes from first visit in HbAl, BMI and cholesterol are based on t-test for SIP 
categories. Uilcoxon rank sums. (ns= p>.05)
Changes to 12 months
For the few patients who have data 12 months after diagnosis, there appeared to be no 
significant change in the indicators (for better or worse) after three months (Table 6.3). 
Though there was a change in the means of HbAl and BMI, in the right direction, these 
were not significant and the scale of change was less than that observed in the first three 
months.
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Table 6 .4  Changes in  in d ic a to rs  to  3 months by category
N/R=Not recorded
a  HbAl
After three months
First
Visit
Count
N/R
Good
<7.5
Acceptab
7.5-8.75
Le Poor 
8.75-10
V.Poor
>10
Row
Total
N/R 2 1 1 1 5
Good <7.5 4 12 3 4 1 24
Acceptable 7.5-8.75 6 7 6 1 1 21
Poor 8.75-10 6 7 4 3 20
V. Poor >10 6 13 13 20 23 75
Total
X
16
11.0
40
27.6
30
20.7
30
20.7
29
20.0
145
100.0
b.) Cholesterol
Count
N/R
Afte
Good
<5.25
r three tr 
Poor 
5.25-6.5
tooths 
V Poor 
>6.5
Row
Total
Visit N/R 5 2 1 7
Good <5.25 21 4 25
Poor 5.25-6.5 29 4 17 6 56
V Poor >6.5 19 1 8 28 56
Total
X
74
51.0
9
6.2
27
18.6
35
24.1
145
100.0
c.) Body Mass Index 
Count
N/R
Afte
Good
<25
r three m 
Ok
25-27.5
lonths
Poor
27.5-30
V Poor 
>30
Row
Total
Visit N/R 13 13
Good <25 3 20 2 25
Ok 25-27.5 1 3 18 3 25
Poor 27.5-30 1 8 17 2 28
V Poor >30 4 1 1 9 39 54
Total
X
22
15.2
24
16.6
29
20.0
29
20.0
41
28.3
145
100.0
Changes in Health Status
Fig 6.1 shows the distributions of the four categories of the Sickness Impact Profile at 
diagnosis together with a combined score. Each category is scored from 0 to 100% - the 
higher the score the ’sicker’ the patient. Summary statistics are shown in Table 6.3. The 
distributions of all the categories are highly skewed with a high proportion of cases 
scoring zero. Therefore non-parametric tests have been used to test for statistical
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significance. The score for ’Ambulation’ shows a significant improvement at three 
months for the main sample (though not for the subset who are included in the 12 month 
analysis). All the other categories score slightly lower at three months but these 
differences are small and not significant. Why the ’Ambulation’ category should change 
and not the others is a little puzzling and requires further exploration. The combined 
score also shows some differences to three months - though the relationship is not as 
strong.
This picture is typical of the one that has emerged during the course of the project. The 
key question is whether the absence of change represents genuine stability in the 
population - or merely reflects the insensitivity of the instrument. Further evidence on 
the behaviour of this scale is discussed later. As mentioned earlier a study was 
undertaken to compare the SIP with two other instruments and the results reported in 
Appendix 6.
Clinical Problems
Table 6.5 summarises the prevalence of clinical problems in patients at their first visit. 
The corresponding values for the cohort of patients who have been linked to annual 
review data is also shown.
It is clear that by the time of their referral these patients have a number of serious 
clinical problems. There are some problems with missing data - particularly for the visual 
acuity but by and large this group exhibits similar prevalence rates as those seen in the 
full population at annual review as discussed later.
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Ambulation
Fig 6.1 D istribu tions of SIP score categories (rr=208)
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Table 6.5 Clinical Problems of new patients. Percentage of cases with particular clinical problems at 
first visit for all cases and at first visit and first annual review for a sitset of these patients.
N/R=Not Recorded
X cases At Diagnosis Cohort Cohort
All cases At diagnosis at Annual Review
n=207 n=35 n=35
BP Ok 58.2 57.1 51.4
High Systol 21.6 28.6 17.1
Diastol 2.4 0 11.4
Both 12.0 8.6 20.0
N/R 5.8 8.6 0
Circulation Ok 69.2 51.4 68.6
Pulses 14.9 37.1 14.3
Claud 12.5 11.4 8.6
Ulcer 2.9 0 ' 5.7
Amput 0.5 0 0
Angina 12.0 8.6 14.3
Creatinine>125 8.7 5.7 8.6
Neuropathic Symp. 26.9 25.7 20.0
Background Ret. 14.9 14.3 25.7
Maculopathy 6.3 11.4 11.4
Prolif. Ret 1.4 2.9 8.6
Any 16.8
Vis Acuity Ok 63.0 34.3 97.1
6/12 to 6/36 7.7 5.7 2.9
Worse 6/36 3.8 0 0
N/R 25.5 60.0 0
Smoking 27.4 37.1 34.3
Impotence/Amen. 9.6 2.9 14.3
The small number of these new patients where annual review data became available later 
showed few differences from the overall population although with small numbers it is 
difficult to draw firm conclusions. The cohort at diagnosis reported rather a higher rate 
of circulatory problems and smoking, although there was less reported angina and 
impotence/amenorrhoea. By annual reveiw this cohort exhibits properties closer to the 
overall new patient population though the incidence of background retinopathy was higher 
and the rates of impotence/amenorrhoea had increased substantially.
Changes in Education Scores
The education test was given at three separate points, at diagnosis, after the education 
(programme for those patients who have taken part), and again at the annual review. 
This enabled the monitoring of changes resulting from the education programme and a 
comparison with those patients who had not attended the programme. The test is based
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on multiple choice questions with multiple correct answers (Meadows et al 1988). Scores 
are calculated as an adjusted percentage - the proportion of correct responses minus the 
proportion of incorrect responses. Random completion of the test should give an answer 
of zero, in some cases the scores were negative ie worse than chance.
Fig 6.2 Changes in education score before and after education programme (n=44)
Scores a re  exp ressed  as a d ju s te d  p e rce n ta g e s  (% c o r re c t  re sp o n ses - % in c o r re c t)
Score
A fte r  (%)
87.5-
75-
62.5-
50-
37.5
12.5
-12 0 12 24 36 48 60 72
Score B efore Programme (%)
Fig 6.2 plots the scores before and after the educational programme for those patients 
who have completed the programme. There appears to be a significant improvement in 
score after the programme though the differences are not large: the mean before was 
40.4% and afterwards 46.6% (p=.034). A handful of patients showed large increases 
in score (over 20%), though typically the increase was of the order of about 10%.
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Earlier results had indicated greater improvements amongst those patients who had low 
scores at the start, however this later analysis does not support this - if anything a 
number of patients who had low scores at the start appear to score slightly worse after 
the programme.
For the subsets of patients where data are available one year after their first visit it 
appears that whilst patients who have attended the education programme show an 
improvement in mean scores, those cases who did not attend show no improvement 
(Table 6.6). The differences in change in score between these two samples is statistically 
signficant.
Table 6.6 Effects of education programme on education score
Mean Score % No. Mean at Mean at
(Std Dev) start finish
Without education 17 35.5 34.0
programme (21.0) (17.5)
With education 25 38.9 41.6
jjrogramme (18.6) (20.9)
The education scores themselves have been compared to a number of other variables 
present at the first visit. In general there was little relationship between the clinical 
problems or levels of metabolic indicators and the education score. One exception to this 
was that the few cases of patients who have abnormal fundi score slightly better. The 
explanation for this is probably that these patients have been diagnosed for a longer time.
Overall it does appear the newly diagnosed patients scored worse than those patients who 
have been diagnosed a number of years earlier which one might expect. In fact the 
difference between the scores was quite large and significant with the newly diagnosed 
cases scoring 38.3% against 47.9% (p=.(X)6) for patients who had been diagnosed for 
at least one year. This gives an indication of the ranges of score that are likely using this 
test. It appears that based on this sample the differences between the mean score on this 
test will never be very large.
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Are indicators related to each other - New patients
Correlations between metabolic indicators - New patients
Table 6.7 shows the correlation between the three metabolic indicators and changes in 
those indicators at three months. It is clear that the only significant correlations are 
between the indicators and subsequent change in that indicator. These correlations are 
very strong and represent the ’regression to the mean* effect that is likely to occur. That 
is the larger the initial value the greater the amount of change. Beyond this there is little 
evidence that high values on one of these metabolic indicators are necessarily associated 
with high values on the others or that changes in one indicator are linked to changes in 
another. It should be noted that the numbers are relatively small but for this population 
of new patients it appears these three indicators represent quite distinct and independant 
changes in patients. A similar analysis (later) for annual review cases reported later in 
this chapter reveals a rather different picture.
Table 6.7 Pearson correlation coefficients for metabolic indicators at diagnosis 
and siÉxsequent changes in those indicators at three months later (n=68).
Change Change Chol­ Change
Correlations: HBAI HbAl BMI BMI esterol Choi.
HBA1 1.0000 .5678** -.1680 -.3124 .2262 .0828
Change HbAl .5678** 1.0000 -.0844 -.1127 .0783 .1242
BMI -.1680 -.0844 1.0000 .6284** .0913 -.0095
Change BMI -.3124 -.1127 .6284** 1.0000 -.0330 .0056
CHOL .2262 .0783 .0913 -.0330 1.0000 .4279**
Change Choi .0828 .1242 -.0095 .0056 .4279** 1.0000
1-tailed significance test. * = (p<.01) ** = (p<.001)
Links between metabolic indicators and clinical problems
The significance of relationships between the three metabolic indicators and clinical 
problems of presenting patients are later contrasted with results from annual review cases 
in Table 6.16(a). In the new patient population there appeared to be only one strong 
positive link - between BMI and high blood pressure, though there were a few other 
possible links especially between raised blood pressure and the metabolic indicators. 
Once again it would appear that in this population patients with high values on the 
metabolic indicators do not necessarily exhibit clinical problems as well. Although the 
metabolic indicators may be predictive of longer term problems in the future, they were
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not necessarily related to problems in the present.
Links between SIP scores and other indicators
Table 6.8 summarises the relationships between observed SIP scores and changes in total 
SIP (to three months) and the clinical indicators. The results from this sample can be 
contrasted with the separate study reported in Appendix 6 where a larger cross sectional 
sample gives slightly more conclusive results.
Table 6.8 Links between clinical indicators and SIP. Mean scores of SIP categories 
for patients with particular clincal problems (np208).
Kruskal-Wallis one way analysis of variance with ranks. Where p is not shown then p>.05.
Clin problem Ambulation Soc
Inter
Housewk Rec+Past Tot Change SIP
BP Ok 16.8 13.0 19.8 21.3 16.5 1.7
high Sys 16.2 12.6 20.9 16.1 15.8 3.0
Sys+Dias 20.5 11.6 18.9 18.1 16.4 2.4
Circul Ok 14.2 13.3 18.9 19.4 15.5 1.7
Pulses 22.9 11.7 23.0 22.3 18.5 0.1
Claud 23.3
p=.029
11.8 20.5 17.2 17.5 3.5
Retinop None 16.4 12.5 19.6 19.6 15.9 1.6
Any 17.9 13.1 20.4 18.6 16.6 1.8
Visual Ok 18.0 13.5 21.3 19.6 17.1 1.9
Acuity 6/12-6/36 14.7 6.8 23.2 18.8 13.9 2.8
Worse 6/36 25.0 11.8 19.4 18.8 18.0 4.6
Angina No 15.4 11.9 18.2 19.1 15.1 1.6
Yes 26.0
p=.006
17.3 30.6
p=.017
22.4 23.2
P=.022
1.6
Creatinine <125 16.0 12.1 18.7 19.1 15.4 1.8
>125 23.4 18.0 29.7
p=.071
22.0 22.4 0.9
Neurop. No 16.0 11.5 19.1 20.2 15.4 2.5
symptoms Yes 18.4 15.6 21.3 17.5 17.8 -0.7
The picture for new patients was that scores for ’Ambulation’ and the combined score 
showed up the types of relationship that one might expect.. The greater the clinical 
problems of the patient, the higher the SIP scores. Circulatory problems and angina were 
associated with higher scores. The same pattern of mean scores was also seen in patients 
with neuropathy, raised creatinine and abnormal fundi though the differences were small 
and not significant. There were no significant differences between the change in score 
(to 3 months) and any of these clinical problems.
It should be noted that a cross sectional study of patients showed a much clearer link
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between SIP scores and particular clinical problems (Bardsley et al 1991). The 
differences from this sample may be due to smaller numbers or to differences related to 
the population of newly presenting patients. Further analyses of these scores are being 
considered.
Effects of presenting characteristics - New patients.
The main differences in the presenting characteristics of patients that were examined were 
age, sex, time since original diagnosis and source of referral.
Age, Sex and time since diagnosis on SIP and metabolic indicators
Table 6.9 shows the mean scores of the SIP categories as well as HbAl, BMI and
cholesterol according to sex and age category and time since original diagnosis.
Table 6.9(a) Mean values for SIP categories, HbAl, BNI and Cholesterol according to age, sex and tii 
since original diagnosis in newly referred patients (n=208).
Significance for SIP is based on Kruskal-Wallis, for others ANOVAR.
Ambulation Soc
Isol
Housew
k
Rec+P
ast
Tot HbAl BMI Choi
Sex Male 
Female
14.2
19.8
p=.0012
13.0
12.1
ns
15.6
24.5
p=.004
17.6
21.3
ns
14.4
17.9
p=.041
10.1
10.7
ns
28.2
29.7
ns
6.1
6.9
p=.00
Age <40 11.6 13.4 22.6 20.9 15.8 8.8 33.0 6.2
50 10.9 11.8 14.0 18.0 12.8 9.7 29.7 6.4
60 21.5 14.6 23.7 18.2 18.9 11.0 29.6 6.9
70 21.3 12.1 23.1 20.1 18.0 10.1 28.0 6.4
>80 26.2 10.7 25.8 30.1 20.6 11.6 27.3 5.8
p=.0017 ns ns ns ns p=.005 ns ns
PrevDx >10yrs 17.4 12.5 22.6 19.5 16.8 10.1 6.1 28.1
<10yrs 17.1 15.2 19.3 21.0 17.3 9.8 6.4 29.7
New 16.8 12.3 20.1 19.4 16.0 10.5 6.6 28.8
ns ns ns ns ns ns ns ns
Table 6.9(b) Changes in HbAl and Cholesterol according to time since original diagnosis for 
newly referred patients.
Differences between HbAl are significant (p=.01), differences in cholesterol are not.
Number
cases
Change HbAl Change
Cholesterol
Diagnosed>10yrs 14 0.88 -.52
Diagnosed<10yrs 16 1.09 .27
Newly diagnosed 89 1.94 .39
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Considering first the SIP scores, ’Ambulation’, ’Housework & hobbies’ and the 
combined score showed significant differences between men and women, with women 
scoring significantly higher. The tendency for women to score higher has been observed 
in other health status measures and in other conditions. Only ’Ambulation’ showed a 
significant relationship with age. In this case it was expected that there would be 
stronger links between the SIP scores and age. The time since original diagnosis showed 
no consistent pattern with new patients scoring higher on some SIP categories and lower 
on others. It would therefore appear that the sex of the patient was the most important 
variable to consider when comparing absolute levels of these SIP scores. There were 
however no significant relationships between the changes in SIP score and any of these 
variables.
HbAl did show differences according to age categories. In particular the older patients 
tended to have higher initial HbAl values. There was also observed differences between 
the mean scores by sex. When aggregate scores for men and women were compared or 
scores within age categories (not shown), women tended to score higher than men 
though the differences were not signficant. A similar pattern of results was found in the 
larger annual review sample and has been reported in the literature (Stickland, Paton & 
Wales 1984). These results suggest that when age distributions or the balance between 
the sexes varies then some form of standardisation of HbAl scores may be necessary in 
order to make valid comparisons.
Considering the effect of time since diagnosis on HbAl, it appeared that there was no 
observed difference between the mean values of newly diagnosed cases (HbAl is 10.5% 
in Table 6.9(a) against those that have been diagnosed for some time (HbAl is 10.1% 
for those cases originally diagnosed over 10 years ago). However it is possible that 
differences in age between these populations may be masking some effect, those who 
have been diagnosed for a long time tended to be older.
When the change in HbAl to three months was compared there were marked differences 
between the newly diagnosed cases and those diagnosed over 10 years ago (Table 6.9(b)). 
It appeared that the fall in HbAl levels following first attendance at the new patient clinic
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was far greater in the cases who are newly diagnosed.
BMI showed no significant differences across age or sex categories though women had 
slightly higher values than men as did the younger patients.
Cholesterol levels showed quite large and significant differences between men and 
women - though no differences were related to age. The scale of this difference suggests 
that in developing comparable data sets some standardisation for sex may be necessary. 
The pattern of results for newly diagnosed versus previously diagnosed patients (Table 
6.9b) is similar to HbAl, though the differences in this small population were not 
significant, the mean improvement in cholesterol levels was largest in the newly 
diagnosed cases.
Effects o f Age, Sex and time since diagnosis on clinical problems
Table 6.10 looks for relationships between these presenting variables and the various 
clinical problems reported at the first visit. There were no significant differences 
between the sexes in the incidence with which these various problems were observed. 
However the age of the patients did appear to be significantly related - typically the 
average age of patients with a given clinical problem was higher than those without. 
These effects were strongest for raised systolic blood pressure, circulatory problems, 
angina, any retinopathy, and raised creatinine levels. This observation is hardly 
surprising - older patients will tend to have more clinical problems. It would be 
interesting to compare the observed increase in the incidence of clinical problems 
amongst these diabetic patients against a non-diabetic population in an attempt to see if 
the measures are sufficiently sensitive to show the excess morbidity in these cases that 
can be related to diabetes.
The comparisons of reported problems in the newly diagnosed patients against those 
previously diagnosed showed the opposite pattern to that seen for age. Newly diagnosed 
patients had a significantly lower incidence of retinopathy, neuropathy and impaired 
visual acuity. In the case of retinopathy the differences between these groups were quite
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large and an observed incidence of some form of retinal damage in 60% of those cases 
diagnosed over 10 years ago, yet new to the Freeman clinic is alarming.
Table 6.10 Clinical problems vs age, sex and time since first diagnosed (M=208)
Difference of age test by ANOVAR or t-test; of sex and previous diagnosis by Chi-squared, 
(ns = p>.05)
Clinical
Problem
XMale Mean Age Previous Diagnosis 
>10yrs <10yrs 
n=21 n=35
New
n=142
BP Ok 58% 61.7 63% 73% 60%
Sys 47% 66.1 18% 18% 24%
Sys+D 44% 60.6 6% 6% 13%
ns p=.029
(ns)
Circul Ok 56% 59.5 67% 66% 70%
Pulses 48% 65.3 10% 17% 15%
Calud 50% 66.6 20% 11% 13%
ns p=.022 (ns)
Abnormal Ok 55% 60.0 38% 83% 89%
fundi Any 43% 67.8 62% 17% 11%
p=.009 P=.000
Vis Acuity Ok 50% 60.5 93% 93% 83%
6/12 -6/36 50% 68.2 7% 8% 12%
>6/36 63% 60.6 p=.003
ns
Angina No 54% 60.0 81% 83% 90%
Yes 52% 69.5 19% 17% 10%
p=.003 ns
Creat <=125 54% 60.7 95% 88% 92%
>125 50% 70.5 5% 12% 8%
p=.0112 ns
Neurop No 54% 60.4 52% 57% 80%
symps Yes 52% 63.9 48% 43% 20%
ns ps.006
Differences by source o f referral
The various routes by which patients can arrive at the Freeman new patient clinics were 
classified into three groups. The two largest groups were direct referrals from GPs and 
referrals within the Freeman Hospitals. Particular specialties dominate internal referrals 
eg cardiology, urology. Within hospital referral may be because complications of 
diabetes have become manifest and treatment of these problems is underway in other 
specialties.
Alternatively it may be that routine screening of the patient has unearthed a suspicion of 
diabetes. Ideally these two ought to be separated. Finally there was a group of patients
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transferred from care in other hospitals - either because the Freeman was local or because 
of special requirements of the patient. This data has been examined during the course 
of the project. In this case the question was whether there were differences between 
patients referred from within the hospital to those sent by GPs. Table 6.11 shows that 
mean HbAl levels were higher in those patients who had come from GPs which suggests 
that the imbalance in blood glucose control is greater in these cases.
Table 6.11 Mean indicator values and proportion of clinical problems reported by Source of referral.
In Freeman 
n=79
GP
n=108
Other
n=21
Mean HbAl (Dx)p=.001 9.4 11.1 10.2
Change p=.024 1.1 2.4 1.6
Choi Dx (ns) 6.4 6.5 6.5
Change (ns) 0.38 0.42 -.37
BMI Dx (ns) 
Change
29.3 28.7 28.5
SIP Anbul 19.6 14.8 15.6 (ns)
Soc Inter 12.5 12.6 12.5 (ns)
Housework 23.0 18.5 13.7 (ns)
Rec+Past 21.1 18.5 18.2 (ns)
Total 17.7 15.2 14.3 (ns)
Change in total 0.0 2.5 2.8 (ns)
Sex X  Male (ns) 58.2% 47.2% 66.7%
Mean Age (ns) 60.6 61.6 63.2
Prev. Dx. >10 yrs 10.1% 9.3% 14.3%
(ns) <10 yrs 20.3% 12.0% 28.6%
New 67.1% 73.1% 47.6%
BP Ok (ns) 68.0% 57.0% 61.1%
Circul Ok 69.6% 72.2% 52.4%
(ns) Pulses 15.2% 14.8% 14.3%
Claud 11.4% 9.3% 33.3%
Ulcer 2.5% 3.7% -
Amput 1.3% - -
Eyes Fundi 16.5% 11.1% 28.6%
(ns) Maculop 3.8% 7.4% 9.5%
Prolif 2.5% 0.9% -
Any (ns) 19,0% 13.0% 28.6%
Angina (ns) 16.5% 9.3% 9.5%
Creatinine >125 (ns) 9.1% 10.0% 5.3%
Neurop Symps (ns) 29.1 22.2% 42.9%
Smoking (ns) 22.8% 30.1% 28.6%
Impotence (ns) 13.9% 5.6% 14.3%
The subsequent changes in HbAl over the next three months were also slightly better in
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the GP group, probably due to their initially higher values.
Otherwise there were no significant differences between the two groups with regard to 
all the other indicators. Perhaps the most worrying feature of the table was the high 
proportion of cases referred from GP’s with significant clinical problems. The higher 
rates of angina observed in referrals within the hospital was related to referrals from 
cardiology. It is interesting to note the slightly higher SIP scores from the in-hospital 
referrals which may be a reflection of the other problems in these patients.
Part n  - Annual Review Cases
Do the indicators change as expected - Annual review cases
As well as information on newly recruited patients, the diabetes project was also able to 
call upon the existing clinical data base of annual review information stretching back to 
1984. This data was analysed and presented in a number of ways that were not possible 
using the existing system. In this report the main interest is in the longitudinal changes 
that are observed between successive annual reviews - the time period chosen for this was 
the latest complete year ie 1988 to 1989. More recent data has been used in reports to 
clinicians including the first six months of the 1989-1990 cycle (Appendix 6). The data 
covers all four patient types and results for these are shown seperately. Later analyses 
tended to concentrate on the largest group of patients, those with Type II diabetes - and 
in some cases excluded insulin takers.
Changes in Laboratory Indicators
Tables 6.12(a) and (b) show the changes in patients between successive annual reviews. 
The tables are split into five subsections. Table 6.12(a) summarises all cases, while 
Table 6 .12(b) has four sections giving results for the individual treatment types.
Each table shows, for a range of indicators, the number of valid cases available for 
analysis followed by the number of cases classified as unsatisfactory (Hi) in the first year
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(1988) and then the second year (1989). The numbers who have changed between these 
years are then shown for each of the possible combinations. Beneath each figure is 
shown the percentage of cases. For example in Table 6 .12(a) a total of 483 cases came 
to both annual reviews in 1988 and 1989. 443 of these (92%) had two valid HbAl 
values. Of these 157 (35%) were ’unsatisfactory’ in 1988, whilst 213 (48%) were 
unsatisfactory in 1989. 195 were low at the start and stayed low, 122 were high and 
stayed high. 35 got ’better’ moving from high to low while 91 got ’worse’ moving from 
low to high.
Table 6.12(a) Changes In Lab indicators 1988-1989 
Total of all cases = 483
NB: 'Hi'= Unsatisfactory (not always high value)
No. unsatisf. Changes '88 to '89
Total '88 '89 LoLo Hilo LoHi HiHi
HbAl 443 157 213 195 35 91 122
92% 35% 48% 44% 8% 21% 28%
Choi HDL 360 138 142 107 35 31 187
75% 38% 39% 52% 9% 10% 30%
Body Has 461 175 190 252 19 34 156
95% 38% 41% 55% 4% 7% 34%
Choieste 441 148 129 256 56 37 92
91% 34% 29% 58% 13% 8% 21%
Creatini 425 39 50 364 11 22 28
88% 9% 12% 86% 3% 5% 7%
Triglyce 435 184 164 216 55 35 129
90% 42% 38% 50% 13% 8% 30%
Nicroalb 60 1 12 47 1 12 0
12% 2% 20% 78% 2% 20% 0%
The range of indicators used here is larger than for the newly presenting patients and 
includes triglycerides, high density lipoprotein (HDL) cholesterol. Though these latter 
indicators have been presented, they have not formed an important part of discussions and 
considered as a secondary indicator. The following analyses therefore concentrate on the 
three main metabolic indicators - HbAl, BMI, and cholesterol. Creatinine is included 
in this section yet it should more appropriately be grouped with the later indicators of 
clinical complications.
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Table 6.12 (b) Changes in  lab in d ica to rs  1988-1989
Insulin treated (Age at diagnosis >35 years) Total cases = 69 
NB: 'Hi* = Unsatisfactory (not always high value)
No. unsatisf. Changes '88 to '89
Total '88 '89 LoLo HiLo LoHi HiHi
HbAl 65 32 40 20 5 13 27
94% 49% 62% 31% 8% 20% 42%
Choi HDL 45 15 14 12 2 3 28
65% 33% 31% 62% 7% 4% 27%
Body Mas 66 20 26 38 2 8 18
96% 30% 39% 58% 3% 12% 27%
Choieste 62 23 19 35 8 4 15
90% 37% 31% 56% 13% 6% 24%
Creatini 63 7 8 52 3 4 4
91% 11% 13% 83% 5% 6% 6%
Triglyce 60 27 20 29 11 4 16
87% 45% 33% 48% 18% 7% 27%
Nicroalb 9 0 2 7 0 2 0
13% 0% 22% 78% 0% 22% 0%
Insulin treated (Age at diagnosis <55 years) Total cases = 92
NB: 'Hi' = Unsatisfactory (not always 
No. unsatisf. Changes '88
high value) 
to '89
Total '88 •89 LoLo HiLo LoHi HiHi
HbAl 85 44 55 23 7 18 37
92% 52% 65% 27% 8% 21% 44%
Choi HDL 71 12 11 5 6 7 53
77% 17% 15% 75% 10% 8% 7%
Body Has 91 16 16 72 3 3 13
99% 18% 18% 79% 3% 3% 14%
Choleste 84 16 13 64 7 4 9
91% 19% 15% 76% 8% 5% 11%
Creatini 80 3 5 73 2 4 1
87% 4% 6% 91% 3% 5% 1%
Triglyce 83 8 8 69 6 6 2
90% 10% 10% 83% 7% 7% 2%
Nicroalb 12 0 1 11 0 1 0
13% 0% 8% 92% 0% 8% 0%
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Table 6 .12(b) continued
Treated by tablet Total cases = 171
NB. 'Hi' = Unsatisfactory (not always high value)
No. unsatisf. Changes '88 to '89
Total '88 '89 LoLo HiLo LoHi HiHi
HbAl 158 60 77 65 16 33 44
92% 38% 49% 41% 10% 21% 28%
Choi HDL 131 63 66 52 14 11 54
7 7 % 48% 50% 41% 8% 11% 40%
Body Mas 159 71 71 80 8 8 63
93% 45% 45% 50% 5% 5% 40%
Choleste 156 59 60 77 19 20 40
91% 38% 38% 49% 12% 13% 26%
Creatini 150 16 25 124 1 10 15
88% 11% 17% 83% 1% 7% 10%
Triglyce 153 89 80 52 21 12 68
89% 58% 52% 34% 14% 8% 44%
Nicroalb 20 1 4 15 1 4 0
12% 5% 20% 75% 5% 20% 0%
Treated by diet only Total cases=151
NB: 'Hi' = Unsatisfactory (not always high value)
No. unsatisf. Changes '88 to '89
Total '88 '89 LoLo HiLo LoHi HiHi
HbAl 135 21 41 87 7 27 14
89% 16% 30% 64% 5% 20% 10%
Choi HDL 113 48 51 38 13 10 52
75% 42% 45% 46% 9% 12% 34%
Body Has 145 68 77 62 6 15 62
96% 47% 53% 43% 4% 10% 43%
Choleste 139 50 37 80 22 9 28
92% 36% 27% 58% 16% 6% 20%
Creatini 132 13 12 115 5 4 8
87% 10% 9% 87% 4% 3% 6%
Triglyce 139 60 56 66 17 13 43
92% 43% 40% 47% 12% 9% 31%
Nicroalb 19 0 5 14 0 5 0
13% 0% 26% 74% 0% 26% 0%
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HbAl
The results observed for 1988 to 1989 were rather different from earlier years. Table 
6.12(a) illustrates a significant increase in the proportion of patients with HbAl levels 
which have been classified as ’unacceptable’ ie >8.75. The goals of care are to maintain 
low levels in those cases low at the start and to reduce levels for patients who were 
previously high. These figures suggest a net shift for the worse during the year. The 
shift is observed across all patient types.
When these figures were presented, they surprised the clinicians and caused some concern 
- and raised questions over whether the assay had remained constant. Further 
investigation revealed (Home et al 1991) that though laboratory quality controls had been 
adhered to there had been problems with the calibration of the assay and that an increase 
of 1% had been observed across all cases in three hospitals served by the same 
laboratory. It is unlikely that this discovery would have been made otherwise and could 
have potentially affected the treatment of many cases in the area - ie patients could have 
been given more aggressive treatments. The assay is currently being changed.
Results from earlier years had presented a more realistic picture. Typically the pattern 
of HbAl levels revealed large differences between the various treatment groups as would
Table 6.13 Changes in mean HbAl. Year on year change from 1985 to 1988 as means or percentage 
classified as Lo (<=8.75X) or Hi (>8.75%)
(ns = p>.05)
1985-86 1986-87 1987-88
Number 107 170 222
Mean HbAl Start 8.52 8.44 8.44
Finish 8.68 8.50 8.20
ns ns p<.05
X Lo to Lo 44 53 52
Lo to Hi 22 13 12
Hi to Lo 11 14 15
Hi to Hi 23 20 22
be expected. Table 6.13 shows that the year on year changes in mean values were 
typically small and no large changes in the proportion of cases classified as ’acceptable’ 
or ’unacceptable’. Perhaps the most important feature of these earlier results had been 
the overall stability in this population even in those cases with high HbAl levels. This
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had been a subject for discussion amongst the clinical staff.
Body Mass Index (BMI)
The picture with regard to BMI was of even greater stability between years in these 
patients. Thus in total only 4% of cases moved from above 27.5 kg m'^  to below whilst 
7% moved in the opposite direction. In total 34% were classified as high in both years. 
Once again there were large differences between the patient types - high BMI values 
being much more of a problem in non-insulin treated cases.
Cholesterol
Total serum cholesterol (as opposed to HDL - high density lipoprotein) showed fewer 
patients overall in the ’unsatisfactory’ category and there was a net improvement - more 
patients going from high to low than vice versa - particularly in diet treated patients 
where the net change is almost 10%. Type I patients (Insulin treated and dx < 35 yrs old) 
showed lower levels than the other groups - as was expected.
Changes in clinical problems
Table 6.14 reports on the observed incidence of clinical problems in 1989 and the 
changes from 1988. It was originally hoped that it might be possible to determine the 
rate at which particular problems are likely to emerge during the year. For such rates 
to be calculated a reasonable number of emerging problems relative to the uncertainties 
of the measurement and recording system would be needed.
Non-recording o f data
The proportion of cases with no observation is noted as has been the case throughout the 
study. It is recognised that there can be a problem either when basic checks that should 
be made at annual reviw are not made or, more commonly, if the check has been made 
it is not reported correctly. The actual level of non-recording in 1989 data was better 
than that observed in previous years. The exception to this was the biothesiometer 
measurements where the machine was not available for some time during the year.
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Changes in calibration o f tests
The observed changes in the proportion of patients recording high biothesiometer readings 
or positive albustix are far greater than would be expected either by chance or by disease 
progression amongst the population. In fact both these measurements ran into problems 
of calibration changes. The effect on observed incidence of clinical problems is quite 
dramatic and such changes can be expected to present problems in longer term 
longtitudinal studies such as this. It is interesting to observe that though the unreliability
Table 6.14 Incidence of clinical complications 1988-1989
X incidence in 1989; [X change 1988 to 1989, -ve figures show fall]
Variable 
Number cases =
Total
483
Ins Dx<35 
98
Ins Dx>35 
83
Tablet
177
BP ok 67X 3] 85X 11 66% 81 64% 01 57% [ 71
BP Sys 17X -1] 8X -51 19% -111 18% 41 19% [ 11 -
BP Dias 5X 0] 3X 31 4X 51 5X 01 9X C -51 -
BP Both 10X -2] IX 31 11% -51 10% -31 14% [ -41 -
BP NotRec IX 1] 3X -21 OX 21 OX 1] IX [ 11
V Acuity ok 88X 4] 96% -11 87% 21 84% 71 86% [ 81
6/12 to 6/36 9X -5] 3% -11 11% -61 9% -31 11% [ -91 -
Worse 6/36 2X -1] OX 11 IX -11 4X -21 2X C -21 -
Not Rec IX 2] IX 11 IX 51 IX 11 IX [ 21
Circul Ok 70X 4] 92X 01 70% 21 63% 11 60% [ 111
Pulses 15X -5] 7X -31 11% -21 19% -31 17% [ -91 -
Claudic 11X 0] OX 21 12% -21 12% 21 18% [ -21 -
Ulcer IX 0] OX 11 IX 21 IX 01 2X [ -21 -
Amputation 3X 0] IX 01 6X 01 3X 01 3X [ 21 -
Not Rec OX 0] OX 01 OX 01 OX 01 OX [ 01
Fundi Ok 74X -1] 62X 51 75% -71 72% -21 84% [ 01
Abnormal 26X 11 38X -51 25% 71 26% 21 16% [ 01 -
Not rec OX 0] OX 01 OX 01 OX 01 OX [ 01
Haculopathy No 92X 1] 94X 21 89% 41 88% -11 96% [ 11
Yes 8X -1] 6X -21 11% -41 10% 11 4X [ -11 -
Not Rec OX 0] OX 01 OX 01 OX 01 OX [ 01
Prolif Ret inop No 94X -11 95X -51 94% 01 91% -1] 96% [ 21
Yes 6X 11 5X 51 6X 0] 7X 11 4X [ -21 -
Not Rec OX 01 OX 01 OX 01 OX 0] OX [ 01
Angina No BOX 51 98X 01 80% 51 75% 81 73% [ 41
Yes 20X -51 2X 01 20% -51 23% -8] 27% [ -41 -
Not Rec OX 0] OX 01 OX 01 OX 01 OX [ 01
Neur Symps No 76X 71 88X 21 66% 71 74% 61 74% [ 121
Yes 24X -71 12X -21 34% -81 23% -61 26% [■121 -
Not Rec OX 0] OX 01 OX 11 IX 0] OX [ 11
Biothesiom <25 26X 271 6X 101 33% 271 31% 571 29% [ 351
>25 45X -81 68% 41 37% -81 38% 71 39% [■121 -
Not Rec 30X -191 26% -141 30% -181 29% -121 33% [-231
Albustix -ve 93X -81 94% -121 95% -171 90% -61 93% [ -11
+ve 6X 71 4X 111 5X 121 7% 61 7X [ 01 -
Not Rec OX 21 IX 21 OX 51 OX 11 OX [ 11
Smoking No 83X -21 77% -31 86% -61 83% -31 84% [ 21
Yes 17X 21 23% 31 14% 61 15% 31 16% [ -21 -
Not Rec OX 01 OX 01 OX 01 OX 01 OX [ 01
Diet
129
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in biothesiometer readings was suspected beforehand, the change in albustix was not. 
This may potentially lead to different treatments being offered for some patients with 
important implications for their health and also for resource utilisation.
Significance o f changes
Table 6.15 shows the significance of the year on year changes for a selection of 
indicators. In all cases, for the cohort of patients where two readings were available 
there was a higher proportion of reported problems at the end of the year. However in 
all cases there was also a proportion of patients where the problems had ’disappeared*. 
The scale of observed change during the year (ie the percentage of cases where problems 
’appeared’ or ’disappeared’) when compared to the overall percentage reporting the 
problem gives some idea of the consistency with which a problem may be present.
Table 6.15 Significance of changes in the prevalence of clinical problems 
between successive annual review - Non insulin treated patients
(1988-89; n = 391)
Prevalence
Yearl
Prevalence
Year2
Change 
- to+
Change 
+ to -
Signif.test
McNemar
Chi-sq
Circulation Ok 69.1 64.7 p=.02
Pulses 11.5 16.6 7.4 3.1
Claud 13.8 13.6 7.2 6.9
Ulcer 1.6 1.5 1.1 1.4
Amput 4.1 3.6 - - - 1.4
BPressure High 32.3 36.2 16.7 12.8 ns
Eyes Background 25.8 23.3 6.9 9.5 ns
Haculop 7.7 8.4 4.6 3.8 ns
Prolif 6.1 5.9 3.3 3.6 ns
Angina 17.6 23.8 9.2 3.1 .0009
Creatinine 9.9 12.8 5.2 2.3 .0776
Neuropthaic Symps 18.1 26.1 15.5 7.5 .002
Visual Acuity 5.1 12.0 9.3 2.4 .0002
In the cases of angina, neuropathic symptoms and impaired visual acuity there were 
significant changes for the worse. Changes in the incidence of retinopathy were not large 
and it appeared that one year may be too short a time scale to see an effect with this 
volume of cases. There were relatively large changes in the proportion of cases with 
high blood pressure yet no net shift for better or worse. It is not possible to tell from 
the data whether these results reflect genuine changes in the patients or are merely due
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to the unreliability of blood pressure measurements.
Are indicators related to each other - Annual Review Cases
Correlations amongst metabolic indicators and changes in indicators 
Table 6 .16(a) shows the correlation between the metabolic indicators and changes in those 
indicators between successive annual reviews. The strongest relationships were between 
change in score and the original scores for cholesterol and HbAl a feature in common 
with that seen earlier in the newly diagnosed patients (Table 6.7). Thus those patients 
with high values in the first year tended to show the greatest change by the subsequent 
year. This regression to the mean effect is to be expected and it is perhaps surprising 
that in this case the same effects were not observed for BMI.
Table 6.16(a) Links between metabolic indicators. Pearson correlation coefficients for metabolic 
indicators and changes in metabolic indicators.
Non-insulin treated cases only, both sexes, n = 302
Correlations: HBA1 BMI CHOL Change Change Change
HbAl CHOL BMI
HbAl 1.0000 .0903 .1360* .3932** .0632 .1248
BMI .0903 1.0000 .1150 .0129 .0198 .1052
CHOL .1360* .1150 1.0000 .0163 .5174** .0505
Change HbAl .3932** .0129 .0163 1.0000 .1049 .0725
Change CHOL .0632 .0198 .5174** .1049 1.0000 .1111
Change BMI .1248 .1052 .0505 .0725 .1111 1.0000
1-tailed significance test. * = p<.01, * *  -  p<.001
Links between metabolic indicators and clinical problems
Table 6.16(b) shows any links there may be between the clinical problems the patient 
faced and the absolute values of the metabolic indicators. The clinical rationale behind 
control of the metabolic indicators is that they will predict future complications. The 
table shows the significance of the relationship drawn from analysis of variance. Only 
one link held true for both new patients and annual review cases - that being the positive 
relationship between high blood pressure and BMI where the correlations were highly 
significant.
Apart from this there appeared little pattern to the results and little consistency between 
the two samples. For the annual review sample higher cholesterol levels seem to be
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associated with a number of other problems (circulatory, angina, retinopathy).
Table 6.16(b) Significance of links between clinical indicators and laboratory indicators
New = newly recruited patients (n=208); AR = Type II patients in annual review clinic (n=391)
HbAl Choi BMI
New AR New AR New AR
Circulation ns ns ns .0505 ns ns
Blood Pressure .039 ns .043 ns .000 .0002
Angina ns ns ns .0093 ns .0051
Back Retinop ns .04 ns ns ns ns
Haculop ns ns ns ns ns ns
Prolif ns ns ns .0037 ns ns
Vis Ac ns ns ns .0525 ns ns
Creat>125 .009 ns ns ns ns ns
Neurop symps ns ns ns ns ns .0291
The BMI values were also associated with the presence of angina and neuropathic 
symptoms. However there was no association between the levels of HbAl and any of 
the clinical problems.
There was little evidence of any strong relationships between changes in the clinical 
indicators and the absolute levels or changes in the metabolic indicators as seen in Table 
6.16(c). The only relationships with a probability less than five percent were between 
patients who develop circulatory problems or high blood pressure during the year having 
slightly higher average cholesterol levels. Otherwise the evidence suggests a deteriorating 
clinical condition was largely independent of these metabolic indicators. Or the other 
way round that short term changes in the metabolic indicators were not linked to the 
appearance of the various clinical problems.
The absence of relationships between these sets of indicators does not lead to the 
conclusion that short-term metabolic indicators are not useful predictors of complications 
in the longer term. The speed at which the various complications develop suggest that 
complications arise due to poor control 10-15 years earlier and so there is a substantial 
time lag between high metabolic indicators and the development of these clinical
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problems.
Table 6.16(c) Relationships between changes in indicators between annual reviews (n=391).
%  cases Mean
HbAl
Mean
change
HbAl
Mean
Chole
Mean
change
Chole
Mean
BMI
Mean
change
BMI
Circulation Same 82.8% 8.1 -.60 6.0 .07 27.3 - .44
Worse 17.1% 8.3 .52 6.4 .13 27.3 -.07
ns ns P=.03 ns ns
BP Same 83.4% 7.9 -.79 6.0 .09 26.4 -.45
Worse 16.6% 7.9 -.57 6.4 .27 27.2 -.53
ns ns p=.04 ns ns ns
Eyes Same 84.8% 8.0 -.75 6.2 .15 27.3 -.29
Worse 15.2% 8.5 -.39 6.1 .18 27.6 -.29
ns ns ns ns ns ns
Angina Same 88.5% 8.1 -.65 6.1 .17 26.9 -.25
Worse 11.5% 8.3 -.52 6.5 .25 28.5 -.44
ns ns ns p=.09 ns
Neuropathy Same 82.1% 8.1 -.63 6.2 .13 27.1 -.30
Worse 17.9% 8.0 -.49 6.1 .12 28.2 -.36
ns ns ns ns ns ns
Creatinine Same 94.3% 8.1 - .66 6.1 .10 27.1 -.37
Worse 5.7% 7.5 -.79 6.5 .26 28.9 + .40
p=.09 ns ns ns ns ns
Vis Acuity Same 90.3% 8.1 -.65 6.1 .10 27.2 -.36
Worse 9.7% 8.2 .37 6.5 .20 28.5 -.05
ns ns ns ns ns ns
Links between clinical problems
Table 6.17 shows the proportion of cases that attended 1989 annual review with two 
different clinical problems and the significance of the association between these problems 
(using Chi-sqaured test). There appeared to be a number of significant pairings of 
complications where the reported frequency of both problems being present exceeds that 
expected by chance. Thus for example circulatory problems were associated with 
angina, background retinopathy, impaired visual acuity, neuropathic symptoms and raised 
creatinine levels.
The table suggests that there was a tendency for clinical problems to cluster in patients 
rather than being completely independent. This is generally the picture one might expect 
in any population. It is also possible that another variable could be explaining these 
observed correlations, the most likely being age or that they are indicative of a common 
underlying disease process? Further analysis is needed to address these questions fully.
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Table 6 .17  S ign ificance of a s so c ia tio n  between p a irs  o f c l in ic a l  problems (n=391)
BP High Angina Backgr 
retino 
P
Maculo
P
Prolif 
retinop
Visual
Acuity
Neurop.
symps
Greatin. 
>125
Prevalence 30.3% 21.7% 22.6% 6.2% 5.2% 6.5% 25.6% 11.3%
Circulation P 15.4% 5.3 4.4 5.0 1.5 1.0 1.6 4.5 3.7
C 14.1% 4.7 5.8 3.5 0.6 1.5 1.4 6.4 2.0
U 1.4% 0.6 0 1.0 0.2 0.2 0.4 0.4 0
A 2.9% 1.2 1.0 1.0 0.4 0.2 0.4 1.0 0.4
(ns) p=.000 p=.001 ns ns p=.005 ps.OOO pp.002
Blood Pressure m m 6.8 6.6 2.0 2.1 2.2 10.0 3.9
ns ns ns ns ns pe.012 ns
Angina B m 5.2 1.0 1.7 1.4 9.9 4.3
ns ns ns ns p=.000 pp.004
Back Retinop m m * — m m 6.2 5.2 1.8 7.0 3.5
ns ns ns
Maculop — — •  m . . 1.4 0.6 1.9 1.8
p=.0001 ns ns pp.003
Prolif m » m —. 0.6 2.1 1.2
ns ns ns
Visual Acuity 2.4 1.7
ns pp.022
Effects of presenting characteristics - Annual review cases 
Effects o f age and sex on BMI, HbAl, Cholesterol
Table 6.18 summarises the relationships between the three metabolic indicators and age, 
sex and time since diagnosis. In addition to showing the mean values on these indicators 
by age and sex categories, the table also shows correlation coefficients between mean 
variables and the age, the time since diagnosis and the age at diagnosis.
For HbAl there was a very strong difference between the sexes yet with little effect due 
to age. Analysis of variance using age as a covariate suggested that there were highly 
significant (F=16.2, p=.000) differences between mean HbAl levels across the sexes 
and no significant relationship due to age. Women typically scored higher than men.
With regard to BMI levels, there appeared to be no direct relationship between mean 
BMI and either age or sex or the age at diagnosis. There was an observed negative 
correlation between time since diagnosis and BMI in men, ie men who have been
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diagnosed for a long time tended to have slightly lower average BMI. The mean 
cholesterol levels for women tended to be slightly higher than for men and there appeared 
to be no consistent relationship with age. or time since diagnosis. However the age at 
diagnosis was postively correlated with cholesterol levels in women.
These results suggest that sex is probably the most important variable to adjust for when 
making comparisons of these metabolic indicators and appears more influential than age, 
the time since diagnosis or the age at diagnosis. Though it is recognised that age is not 
necessarily linearly related to these indicators the lack of large observed differences 
between age groups is a little surprising.
Table 6.18 Effects of age and sex on metabolic indicators (Non-insulin treated patients only) and 
Pearson correlation coefficients against age and time since diagnosis.
Age Group Mean
BMI
Mean
Cholesterol
Mean HbAl
Male Female Male Female Male Female
41-50 27.1 27.1 5.9 5.9 7.8 9.5
51-60 27.4 26.5 6.0 6.7 7.6 8.4
61-70 26.2 29.0 5.8 6.4 8.2 8.5
71-80 26.5 28.2 6.3 6.7 7.2 8.4
>80 27.1 26.6 5.3 6.8 7.1 8.5
Correlation coefficient: 
vs age
vs time since diagnosis 
vs age at diagnosis
-.001 
-.211 ** 
-.11
.110
-.137
.046
.067
.009
.047
.193
.035
.199*
.009 
.273 ** 
-.028
- .04 
.074 
-.233**
* = p<.01, ** = p<.001
Effects o f age, sex and time since diagnosis on clinical problems.
Table 6.19 shows the relationships between the clinical complications of diabetes and age, 
sex and time since diagnosis. With regard to sex, it appeared that the proportion of 
women with proliferative retinopathy, impaired visual acuity and raised creatinine levels 
is greater than men.
A more consistent picture emerged with respect to age where patients with clinical 
problems who tend to be older than those without them. These differences are highly
160
Table 6.19 C lin ica l problems vs age,sex and tim e s in ce  f i r s t  diagnosed (n=482)
Differences in age tested by ANOVAR or t-test; in sex and previous diagnosis by Chi-square.
Clinical
Problem
XMale Mean Age Mean
Dx
Time
BP Ok 61% 61.5 7.9
Sys 56% 64.2 7.2
Sys+D ns p=.04 ns
Circul Ok 59% 59.9 yrs 7.1
Pulses 50% 69.9 9.6
Claud 69% 65.7 7.6
Ulcer 43% 59.9 6.0
Amput 60% 62.1 9.1
ns p=.000 p=.009
Back Ab No 58% 61.9 7.3
Yes 63% 64.0 8.8
ns ns p=.014
Macul 58% 62.2 7.6
75% 64.6 8.6
ns ns ns
Prolif 59% 62.5 7.6
56% 60.4 8.0
p=.017 ns
Vis Acuity Ok 60% 61.5 7.6
6/12 -6/36 39% 75.9 7.5
>6/36 p=.005 p=.000 ns
Angina No 59% 61.5 7.7
Yes 57% 65.2 7.5
ns P=.012 ns
Creat <=125 59% 61.8 7.6
>125 58% 66.8 8.6
p=.0004 p=.012 ns
Neurop No 58% 61.8 7.6
symps Yes 62% 63.7 7.8
ns ns
significant for circulatory problems, visual acuity, angina, raised creatinine levels and 
blood pressure. The increased incidence of these problems with increasing age suggests 
that some form of standardisation of these indicators would be essential for comparisons.
Similarly the related effects of time since diagnosis showed significant associations with 
the presence of circulatory problems and background retinopathy. The correlation 
between time since diagnosis and age was not as strong as one might expect and it is 
clear in Table 6.19 that time since diagnosis did not behave in the same way as age. For 
example the mean age of patients with impaired visual acuity was much greater than 
patients with satisfactory vision, yet there was no differences between the mean time 
since diagnosis. It may be that impairment in vision was not related to the diabetes.
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Table 6.20 examines these relationships in more detail by showing the observed 
proportion of cases with a particular problem by age category and time since diagnosis 
category. Though the numbers in the various cells in this table are uneven - for example 
very few patients are under 40 (or over 80) and diagnosed over 15 years the patterns are 
interesting. The table illustrates the dramatically increased prevalence of these clinical 
complications in the older age groups. These gradients are seen particularly clearly in 
the largest sample of cases who have been diagnosed less than five years where for 
example circulatory problems rise from 3.4% in the under 40 age band to 73% in the 
over 80 age band. These age related effects were far greater than the range in prevalance 
associated with time since diagnosis ie 34% for those diagnosed for under 5 years to 46% 
in those diagnosed over 15 years ago. The prevalence of high creatinine levels showed 
a similar pattern with a steeper gradient with respect to age than with increasing time 
since diagnosis.
For impaired visual acuity, neuropathic symptoms and angina, age appeared to be an 
important factor but the time since diagnosis less relevant. This may be because the care 
provided is minimising the incidence of complications from the time of diagnosis. 
Alternatively it may be related to the relative survival rates of patients with and without 
clinical problems.
When changes in the under 40 age band were examined there appeared to be slightly 
steeper increases in the reported prevalence of the various clinical problems over time 
since diagnosis. For most indicators the reported incidence of problems in those 
diagnosed within five years is less than that for those diagnosed over five years ago. 
This can be contrasted with the 50-60 and 60-70 year age bands where the opposite tends 
to be true, namely that the observed incidence of clinical problems was lower in those 
patients who have been diagnosed over 5 years than in the newly diagnosed cases. It is 
possible that in these age groups this differential is a reflection of the effects of the 
services offered after diagnosis.
162
Table 6.20 Proportion of cases with observed clinical problems by category of age and tii 
diagnosis (n=482).
Chi-squared, (ns = p>.05)
since
Time since diagnosis
< 5 years 
n=216
5 - 1 0  years 
n=181
10 - 15 years 
n=37
> 15 years 
n=48
BP
Age <40 n=56 17.2 18.8 0 0
50-60 n=118 29.3 14.3 42.9 18.2
60-70 n=158 38.5 34.9 15.4 17.6
70-80 n=122 35.8 32.0 14.3 50.0
> 80 n=28 63.6 50.0 0 25.0
Sig. (Chi-Sq) p=.057 p=.069 ns ns
All ages 33.8% 28.7% 16.2% 25.0%
Circul
Age <40 n=56 3.4 18.8 28.6 0
50-60 n=118 22.4 19.0 14.3 27.3
60-70 n=158 32.3 27.0 23.1 35.3
70-80 n=122 50.8 48.0 42.9 75.0
> 80 n=28 72.7 70.0 66.7 100
Sig. (Chi-Sq) p=.000 p=.0015 ns pe.006
All ages 32.4% 32.6% 29.7% 45.8%
Eyes
Age <40 n=56 6.9 25.0 28.6 0
50-60 n=118 24.1 16.7 0 18.2
60-70 n=158 21.5 15.9 23.1 41.2
70-80 n=122 22.6 24.0 57.1 58.3
> 80 n=28 18.2 30.0 33.3 0
Sig. (Chi-Sq) ns ns ns pp.062
All ages 20.4% 19.9% 27.0% 33.3%
Vis Acuity
Age <40 n=56 0 0 0 0
50-60 n=118 0 0 0 0
60-70 n=158 4.6 1.6 0 5.9
70-80 n=122 17.0 8.0 14.3 16.7
> 80 n=28 45.5 10.0 33.3 25.0
Sig. (Chi-Sq) pc.OOOO ns ns ns
All ages 7.9% 3.3% 5.4% 8.3%
Angina
Age <40 n=56 0 12.5 42.9 0
50-60 n=118 19.0 23.8 0 18.2
60-70 n=158 26.2 20.6 23.1 17.6
70-80 n=122 30.2 38.0 0 25.0
> 80 n=28 27.3 10.0 0 0
Sig. (Chi-Sq) p=.022 ns ns ns
All ages 21.8% 24.9% 16.2% 16.7%
Neurop. Symps
Age <40 n=56 6.9 25.0 28.6 25.0
50-60 n=118 20.7 23.8 0 27.3
60-70 n=158 38.5 25.4 30.8 35.3
70-80 n=122 28.8 24.0 42.9 16.7
> 80 n=28 0 0 66.7 25.0
Sig. (Chi-Sq) p=.003 ns ns ns
All ages 25.1% 23.2% 29.7% 27.1%
Creatinine>125
Age <40 n=56 3.6 0 0 0
50-60 n=118 1.9 12.5 20.0 18.2
60-70 n=158 5.0 10.7 15.4 6.3
70-80 n=122 19.2 23.4 14.3 33.3
> 80 n=28 18.2 0 0 0
Sig. (Chi-Sq) p=.007 p=.071 ns ns
All ages 8.3% 13.0% 11.4% 14.9%
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Summary - Data Analysis 
The choice of outcome indicators
The analysis of outcomes in diabetes has involved a greater number of different indicators 
than in other specialties. Indeed the volumes of data are so great that some indicators 
have received only a cursory examination or have been dropped from the analysis either 
because:-
- they replicated other indicators,
- recording was unreliable,
- the observed incidence was too low, or
- they had less clinical significance.
These indicators included the observed frequency of smoking, impotence or amenorrhoea, 
lipid measures of triglycerides and HDL cholesterol, frequency of hypoglycaemia and 
inpatient admissions among newly referred type II patients.
Two other indicators, albustix protein and biothesiometer measures have proved too 
unreliable in this setting as the calibration of these tests has changed over time and 
between suppliers of the test - alternatives are therefore used. While not central to this 
study the questions raised over the reliability of some common diagnostic tests could have 
very important implications particularly when decisions about treatment critically depend 
on such results. It is also a waste of resources to collect data which is of no value or 
unreliable.
The preferred indicators therefore fell into the following categories (as noted in Table 
6. 1):-
1. Indicators of metabolic control
a. HbAl
b. Body Mass Index
c. Serum cholesterol
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2. Indicators of complications of diabetes or risk factors
a. Raised blood pressure
b. Impaired visual acuity
c. Retinopthy - background, proliferative or maculopathy
d. Circulatory problems, worst of;
- absent pulses
- claudication
- ulcers
- amputation
e. Angina
f. Marker of kidney disease - raised creatinine levels (though
micro-albumin would be preferred if available)
g. Marker of neuropathy - symptoms
3. Improvement/maintenance of general health status
4. Improvement in knowledge of diabetes
All these categories have been applied to examine changes in newly referred patients - 
and in some form they are all applicable for all diabetes cases.
It is these indicators that form the basis of the following review. Returning to the 
original questions at the start of the data analysis section therefore:
1. Do the indicators change as expected?
2. Are the indicators related to each other?
3. Are the indicators sensitive to patient characteristics?
1. Metabolic indicators - HbAl, BMI, Cholesterol
Newly referred patients
HbAl, BMI and serum cholesterol showed marked and significant changes in mean
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values in the three months after the first visit to the new patient clinic. Though some 
change for the better is also observed to a year it is of a lesser scale. The effect of the 
early stages of treatment can be clearly seen in these indicators at three months and one 
year. Despite this improvement in the population, not all patients fall into the 
’satisfactory’ category at follow-up.
It appears that the absolute levels of these three indicators are independant of each other 
and that a patient classified as ’unsatisfactory’ on one will not necessarily be 
’unsatisfactory’ on the others. The observed changes over the first three months in any 
one indicator are related to the initial value of the indicators - higher initial readings are 
associated with greater subsequent change. However the scale of such changes are not 
related between indicators.
The values of these variables are largely independent of indicators of complications and 
knowledge of general health status. The exception to this was the significant link 
between high BMI and raised blood pressure.
Though the relationships are not strong, the values of these indicators may be influenced 
by the age and sex distributions of the new patient population - sex seems more important 
as a standardising variable if comparisons are to be made to other data sets.
Similarly the scale of change in HbAl and cholesterol is greater for patients who are 
newly diagnosed when compared to those cases who have been diagnosed for some time. 
Once again for comparative analyses this variable may be important.
Annual Review Patients
In contrast to the newly referred patients these indicators show little change in mean 
values between annual reviews (with the exception of spurious changes in the assay). 
Though there is little net change a proportion of patients (of the order of 10-20%) will 
move between the classification of ’satisfactory’ and ’unsatisfactory’ and vice versa. 
Though the apparent stability of these indicators is seen as disappointing, it has been 
generally accepted that this reflects practice in the clinic and is not a reflection of the
166
measures being too insensitive.
As with the newly referred population the indicators are largely independent, though a 
weak correlation between high HbAl and high cholesterol is observed. The scale of 
change between annual reviews is related to the initial values.
With the exception of the BMI-Blood pressure link, the values of these indicators is 
independent of the clinical complications of diabetes.
Similarly there are intermittent relationships between the values of these indicators and 
the sex of the patient and the time since diagnosis. Women typically score higher than 
men, and higher values are found in those who have been diagnosed longer.
Finally there are the expected large differences between the different categories of 
patients -especially between type I and type II diabetes.
2. Indicators of complications of diabetes or risk factors
The recording of the variety of clinical complications can be beset by a number of 
problems including
missing data
problems with the reliability of measures eg blood pressure 
changes in the calibration of tests
changes/differences in the way problems are defined (for example a large 
rise in the incidence of retinopathy followed the introduction of a new 
camera)
problems of small numbers of affected patients
When used as cross sectional descriptions of a population - even newly referred cases, 
most of the clinical problems are present in at least five percent of the sample. The 
exceptions being amputations, ulceration and proliferative retinopathy. The small 
numbers of these complications make interpretation even more difficult.
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In the newly referred population, there were insufficient cases with two data points to 
draw any firm conclusions about change in the first year following referral. However 
in the annual review population the numbers are larger and change can be seen between 
successive years. The largest changes are seen in the increasing incidence of impaired 
visual acuity, neuropathic symptoms and angina, with lesser changes noted in the 
circulatory problems and raised creatinine levels. No significant change is observed for 
blood pressure and retinopathy. It is clear that not all of the apparent change between 
years is for the worse.
It was hoped that it would be possible to identify an expected annual increase in the 
incidence of particular complications. Analysis to date has suggested that the changes in 
successive years are not predictable with this data and further analysis over longer time 
periods is required.
The indicators when used to describe a population in cross section appeared to behave 
largely as expected. They tended to be related to age and to general health status. There 
was also some relationship between the different indicators (possibly linked via age) 
which would suggest that their appearance in the population was not wholly independent.
3. Improvement/maintenance of general health status
The Sickness Impact Profile has been used to monitor longitudinal change in newly 
referred patients though the results have been generally disappointing. The distributions 
of scores were highly skewed, as was feared at the outset, with a high proportion of 
patients scoring zero. It was therefore not surprising that it was difficult to observe any 
change in the score. The change that did occur was in the category dealing with 
’Ambulation’.
The SIP score was found to be linked to certain clinical problems and in a larger cross 
sectional study to behave largely as expected with older people and women scoring 
higher. In practice the measure seemed to work better when identifying the minority of
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patients who had severe health problems rather than the day to day effects of diabetes. 
As such it was more akin to a summary measure dealing with the variety of complications 
of diabetes and could be expected to change along similar time-scales.
4. Improvement in knowledge of diabetes
The knowledge test has shown itself to be useful in monitoring the subset of patients who 
attend and complete the educational programme. Though the improvement in scores was 
not large there was a significant increase in score after the education programme. 
Moreover there was also a greater increase in scores observed in these patients than in 
those who did not attend the course.
Scores on the simple test were largely independant of other outcome indicators but they 
were related to the time since diagnosis as one would hope. Patients who have been 
diagnosed for a long time score signficantly higher than those who have just been 
diagnosed. The difference in scores is of the order of 10%. Knowledge scores were not 
significantly related to age and sex.
D. Review Process
The review of data in diabetes has taken two distinct cycles. At one level, meetings 
were held with medical colleagues invited from other hospitals as well as a local GP to 
examine the results. Appendix 6 includes the report circulated to the latter of these 
meetings.
In addition meetings were held approximately every two months within the Freeman 
Hospital to discuss progress and the results of the project. The membership of this group 
included consultants, senior registrars and nurse specialists. The study of patient 
outcomes itself has proved useful in a number of respects.
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1. Data collection/recording
As a result of the study and the ability to actually look at results longitudinally, data that 
had been collected for some time is now being analysed and used. This made problems 
in data collection easier to identify and gave a greater incentive to improve data collection 
and inputting. The envisaged review system in which the annual review data base would 
be examined every 6 month is now in place. In addition the data helped reinforce some 
of the basic checks that should be carried out, for example cholesterol levels on patients 
whose last reading was unacceptably high.
2. Identify patients/booking appointments
The effort put into looking at the exisitng information systems and following patients has 
led to improvement in the identification of patients and the follow-up of non-attenders. 
In particular it has been found that during 1989 a high proportion of patients did not 
receive an annual review. The changes in some key outcome indicators for these patients 
have been specifically collected and analysed. Similarly problems were found in 
identifying when patients had died and a specific search was needed to bring the basic 
data-base up to date. The identification of patients who have died has now become more 
rigorous.
3. Application o f guidelines for junior doctors.
The results from the annual review clinic were worse than expected - the pattern of little 
change among poorly controlled patients was particularly alarming. As a result an 
attempt was made to help junior doctors by introducing a system of clinic guidelines.
4. Specific checks for hypercholesterolaemia
The high cholesterol rates observed among patients also caused concern and have led to 
greater efforts to monitor and control cholesterol levels in at risk patients. As yet no 
beneficial effects of this policy have been observed - hopefully the next year will show 
some improvement in the general cholesterol levels observed in the clinic population.
5. Refinement o f the education programme
The study of patient knowledge of diabetes revealed a number of areas where
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improvements to the education programme could be made. In particular an analysis of 
the responses that patients were making to individual questions, those they got right and 
those they got wrong proved useful in examining the content of the course. For example 
the ability to differentiate between hyper and hypoglycaemia was deemed to be poor and 
the course was changed accordingly.
6. Examination o f non-responding patients
The data raised some important issues concerning the nature of patients who had 
relatively poorly controlled blood glucose. For example these patients included a higher 
proportion of women, and a high proportion of patients that had been diagnosed for some 
time.
In fact the general picture of blood glucose control against time since diagnosis revealed 
a depressing though realistic picture of what should be expected from the clinic. Some 
analyses examined specific treatments for poorly controlled cases. Though it is difficult 
to generalise in such cases there were some questions raised over the appropriate choice 
of therapy for some cases.
7. Changing the assay for HbAl.
The changes in mean HbAl levels observed during 1988-1989 showed an increase in all 
patient groups - and at face value were considered alarming. This raised the question 
of whether the laboratory assay had changed. It appears that though no formal change 
has occurred in the assay the laboratory reports this increase across all its samples 
covering two other hospitals (the general lesson is reported in Appendix 6 and in a 
presentation at a BDA meeting Home et al 1991). A decision has been made to change 
the techniques used.
Without the ability to review longitudinal change provided by this study this problem may 
not have been detected. It was felt that this may explain the otherwise unprecedented 
recent increase in referrals to the clinic.
8. Changes in calibration o f biothesiometer and albustix
Longitudinal analyses of the albustix test for alubuminuria and the biothesiometer tests
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for neuropathy also identified problems in calibration which may otherwise have gone 
unnoticed. Comparing successive years it became clear that in both cases the number of 
reported positive results had increased dramatically and far more than could be explained 
in clinical terms.
Changes such as these could have widespread effects on the diagnosis (and treatment 
rates) for clinical complications of diabetes. The analysis of results across a population 
of patients, as in the outcomes study, enabled these problems to be identified.
9. Development o f parallel studies
A number of additional related studies of patient outcome have been undertaken or are 
emerging and the department now has considerably more expertise in the tools required 
to monitor outcomes. In general there has been a shift towards looking towards better 
outcome measures rather than traditional measures of process. Perhaps the best example 
is currently underway and that is a specific examination of the changes when patients are 
put on to insulin treatment. This simple study is using retrospective and prospective data 
to address the fundamental question of whether moving patients on to insulin is achieving 
real results in terms of both blood glucose control and treatment satisfaction. The results 
could potentially change the criteria that are used in making this decision.
Perhaps the most important consequences of this study lie in the ability of the department 
to examine its performance in a new way and incorporate patient outcomes as a critical 
part of that assessment. Thus the value of the project was expressed by one clinician 
(Appendix 3) as:-
"We are now clear that the data can be collected, examined against standards 
and that the result can be presented in a useful form. All those that have seen the
analysis have found it useful Given a large boost to our general audit activities
and expanded our views o f what it might achieve”
In summary the study of outcomes in diabetes, despite the difficulties posed by a chronic 
disease, has been successful in agreeing the concepts of outcomes monitoring. It has also
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led to the recognition that the data can be useful in identifying and implementing 
improvements to clinical practice. Clinical staff are keen to continue this work.
173
Chapter 7. Angioplasty (PTCA)
A. Introduction
The Freeman Hospital includes one of the most prestigious centres for cardiothoracic 
surgery and medicine in the country. The cardiology department includes 4 full time 
NHS consultants, 2 part time academic posts and 3 part-time consultants (shared with 
neighbouring hospitals). Two consultants have led the use of PTCA within the Freeman 
for the treatment of angina. The procedure has been in use at the Freeman since 1981, 
and the skills required to perform the procedure are being passed on to other consultants. 
As a regional specialty patients can come from different parts of the country - though 
most are from the Northern region.
Angioplasties were selected for the study mainly because it was a relatively new area of 
medicine which was expanding rapidly. Given the relative novelty of the procedure there 
existed considerable uncertainty over when this treatment is to be preferred to others.
Indications and natural history
Coronary heart disease (CHD) is one of the most common chronic diseases in the UK. 
The disease is caused by impaired blood flow in the critical vessels supplying the heart. 
When sufficiently severe, this results in anginal chest pain of varying degrees of severity, 
and with a high risk of myocardial infarction and death.
The technique of Percutaneous Transluminal Coronary Angioplasty (PTCA), was first 
used in 1977 (Gruntzig 1977), and uses a small balloon on the end of a catheter to dilate 
narrowed vessels. Within the relatively few years since then, PTCA has come to be an 
established treatment for coronary heart disease. As such the procedure sits between the 
medical management of angina through a variety of drugs and the more invasive surgical 
procedure of by-pass grafting (CABG). The use of this procedure has certainly grown
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quickly due both to the fact that it is less invasive than surgery and that it is claimed to 
be less expensive (Treasure 1990). In the US it is reported that PTCA had by 1987 
become more common than bypass surgery as a method of revascularisation (Baim & 
Ignantious 1988).
In its early years the use of PTCA was limited to relatively low risk patients with 
straightforward single vessel disease (Detre et al 1988) and stable angina. However as 
techniques ’improved’ and equipment became more sophisticated, PTCA came to be used 
on a wider variety of patients including those with multi-vessel disease (Holmes,Reeder 
and Vliestra 1988) or in other specialised situations (Sprigings et al 1988).
Despite the rapid growth, "uncontrolled" according to one commentator (Treasure 1990), 
there is still considerable uncertainty over its long term efficacy. Although PTCA is 
considered as a cost-effective method of revascularisation for patients with single vessel 
disease and stable angina its cost-effectiveness over surgical revascularisation is in some 
doubt. In stable angina and multi-vessel disease the initial complication rate is higher 
with PTCA than with CABG. The selection of patients for these different 
revascularisation techniques varies throughout the world indicating there is as yet no 
consensus (Chassin et al 1987; Brook et al 1988; Naylor et al 1990; Gray et al 1990).
There are a number of long term prospective randomised trails underway including RITA 
(Randomised Intervention Treatment of Angina) a British funded trial seeking to recruit 
patients in 15 centres (though not at the Freeman Hospital). Results from these various
trials should become available in the next 2 to 5 years.
In the United States, a National Heart, Lung and Blood Institute registry of PTCA’s 
performed has been established (Detre et al 1988). Comparisons between the early years 
(1977-1981) and later years (1985-86) suggest that there were changes in both the nature 
of patients treated, that is they were older with more complex disease and treatment
histories, yet outcomes observed in hospital were better.
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B. Data set and Data Collection 
Identifying outcome indicators
The key patient types considered were those with stable and unstable angina. Though the 
range of outcome indicators for both these groups were similar the observed results were 
expected to be different for the two groups. All reports therefore showed the results 
separately for these two groups.
a. Successful procedure
The actual PTCA procedure does not always result in the dilatation of the required 
vessels, therefore the first consideration was whether dilatation had been achieved - 
success usually being defined as when the residual narrowing is less than 50% on all 
vessels attempted and with no adverse events occurring. This is one of the standard 
measures of angiographic success with rates of the order of 85-88% quoted in the 
literature (Henderson et al 1989; Glazer et al 1990; Rupprecht et al 1990). There were 
some early problems in the Freeman study in distinguishing an attempted angioplasty 
from an investigative angiography (exploration with catheters) - the decision to perform 
the procedure not always being taken in advance. An attempted angioplasty was 
therefore defined as one where ’the guide wire was passed into the vessel in order to 
cross the lesion’. Subsequent failure to dilate the vessel was deemed a ’failed 
angioplasty’.
b. Death
With coronary disease there will always be a significant mortality rate, in hospital and 
to follow-up, especially among cases with unstable angina. A number of studies have 
examined survival after PTCA and observed a mortality rate of up to 2% (higher if 
PTCA was unsuccessful) after 5 years. (Henderson et al 1989; Detre et al 1988). In 
general the majority of deaths will be from cardiac causes.
c. CABG - elective or emergency
In patients with stable angina, PTCA should preclude the need for subsequent early
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surgery. In some cases when the PTCA is unsuccessful the patient is transferred 
immediately for an emergency CABG. In other cases elective surgery for stable angina 
patients may follow at a later date due to either the failure of the PTCA, the recurrence 
of the dilated lesion or the progression of coronary artery disease. The proportion of 
cases undergoing CABG is yet another of the standard measures used to gauge PTCA 
success rates. The anticipated rates range from 5% within the first year to 10% after 5 
years. For patients with unstable angina the initial aim is to stabilise the patient and later 
CABG may be appropriate.
In this study the distinction was made between emergency and elective surgery when 
collecting data. However in the analysis these groups were pooled.
d. Repeat PTCA
In most cases the procedure should only be necessary once (at least within 5 years), thus 
the rate at which patients received repeat PTCA’s in the same vessel was regarded as a 
poor outcome. The procedure may be repeated because the first attempt was unsuccessful 
in dilatation or because of the patient symptoms or a process of re-stenosis of vessels. 
(Holmes,Reeder & Vliestra 1988; Leimgruber et al 1986; Serruys et al 1988). Repeat 
PTCAs are said to carry greater risks (Sugrue et al 1987).
e. In-hospital events - post-procedure
As with surgical procedures there are a number of problems that may be manifest before 
discharge from hospital. These included myocardial infarction, recurrence of angina, and 
local vascular complications. Detre et al observed an in-hospital non-fatal MI rate of 
4.3% and it was expected that such events would happen with a measurable frequency. 
The goals of treatment are that such problems, though inevitable to some degree in this 
population of patients, should be as rare as possible.
f .  Decreased Anginal Pain
One of the prime indications of success is a reduction in the severity of chest pain felt 
by the patient. The assessment of anginal pain was based on the standard classification
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of the Canadian Cardiovascular Society (CCS)(Cambeau 1976) which distinguishes four 
classes of pain:
I "Ordinary physical activity does not cause, .. angina ", such as walking and
climbing stairs. Angina with strenuous or rapid or prolonged exertion at 
work or recreation.
II "Slight limitation o f ordinary activity". Walking or climbing stairs
rapidly, walking up-hill, walking or stair climbing ajier meals, or in cold, 
or in wind, or under emotional stress, or only during the few  hours after 
awakening. Walking more than two blocks on the level and climbing more 
than one flight o f ordinary stairs at a normal pace and in normal 
conditions.
III "Marked limitations o f ordinary physical activity. " Walking one to two 
blocks on the level and climbing one flight o f stairs in normal conditions 
and at a normal pace.
IV "Inability to carry on any physical activity without discomfort - anginal
syndrome may be present at rest. "
Though such schemes are part of the basic vocabulary in cardiology, there were problems 
in the extent to which clinical staff used the same criteria to assess patients (in particular 
there can be confusion between the CCS scheme and the New York Heart Association 
definitions). Therefore changes in pain were based on series of questions asked of the 
patient, the angina class could be estimated from the patient’s response to five key 
questions on the degree of pain they suffered. These questions were adopted so as to 
be similar to a study, then current, of CABG patients that was being undertaken. In 
addition to the classification obtained from the patient, the angina score recorded in the 
notes (albeit sometimes implicitly) was also recorded for validation.
There is relatively less known about the clinical success of PTCA in terms of changes in 
anginal pain though one study (Henderson et al 1989) has reported that, after 5 years, 
70-80% of patients remained free of angina and a further 6-12% had improved at least 
2 angina grades (CCS scale). Rupprecht et al found that after 3 years, 59% of stable and 
84% of unstable angina patients had experienced an improvement of at least one class in 
the CCS classification (Rupprecht et al 1990).
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g. Increased walking distance
A standard method of assessment of the severity of angina is based on how far the patient 
can walk before pain starts. After the procedure the patient should be more active and 
able to walk further before pain commences. This was gauged simply by asking the 
patient before and after the procedure. More sophisticated methods are available and 
often used, for example exercise testing, however this was ruled out because though it 
was common it was not routine on all patients especially at follow-up. It would also 
require data to be collected by clinical staff which would be more restricting in terms of 
data collection ie require an out-patient visit for the follow-up.
h. Improved well-being
A number of different measures have been used to monitor quality of life in 
cardiovascular disease and coronary surgery (Fletcher, Hunt & Bulpitt 1987; Mayou & 
Bryant 1987). The Nottingham Health Profile (Hunt, McEwen & McKenna 1986) was 
chosen as a suitable instrument for assessing patient well being. This had the advantage 
that other studies of heart diseases had used the scale successfully (Wallwork & Caine 
1985; O’Brien, Buxton & Ferguson 1987; Buxton et al 1985; O’Brien et al 1988).
Where possible patients were given forms before the PTCA. In the case of emergencies 
this was not possible, so only follow-up data was available. In some cases the patient 
may not have had any serious symptoms prior to admission, for example following 
emergency admission for a first myocardial infarction. In these cases the expected pre­
admission (pre-morbid) scores would be approximately zero.
/. Other health events after discharge
In addition to major health events during the hospital stay, it was also necessary to 
consider some events that the patients might experience after discharge as indicators of 
poor outcomes. The patient was asked at follow-up whether they had been readmitted 
to hospital , or visited A&E departments or their GP and if so the reasons why. There 
were some problems found in interpreting the reasons given by patients and their exact 
clinical significance in relation to the PTCA.
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], Decreased Potency o f Medication
At least one other study has examined medication after PTCA, in that case as a proxy for 
quality of life (Rupprecht et al 1990). This reported that 45% of stable angina patients 
were receiving no anti-anginal therapy at three years. There was some debate in this 
study as to whether decreased medication - essentially a process measure - should be 
included in our dataset. In the end it was decided that the information may be useful and 
so was included. The potency of medication was based on a simple six point 
classification, the aim being to see a drop down the scale at follow-up. Pre-PTCA 
information on medication came from the notes, at follow-up information came from the 
patients themselves. Though the latter did cause some concern about its reliability , the 
validation suggested that the patients were well aware of the nature of the drugs they 
were taking.
Medication Scale:
1 One drug taken for cardiac problems eg aspirin, diuretic, antiarhythmic
2 One drug for cardiac problems plus one other
3 Two drugs for angina from the following classes - beta-blocker or calcium 
antagonist or long acting nitrate
4 Two drugs for angina (as 3) plus another drug for cardiac problem (eg aspirin, 
diuretic, ACE-inhibitor, antiarhythmic)
5 Triple therapy - angina drugs including a beta-blocker and a calcium antagonist
and a long-acting nitrate
6 Triple therapy plus another.
Timing of observations
It was agreed that as well as obtaining baseline data before the procedure and brief details 
on discharge from hospital, follow-up information should be at three months and twelve 
months in the first instance. As not all the patients returned to the Freeman (some go to 
local doctors in distant parts of the region) the follow-ups could not be tied to hospital 
outpatients appointments after discharge.
One of the complicating factors in this study was that a number of patients received a 
repeat PTCA. The practice for these patients was to consider the first analysis ended at
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this point (an endpoint had been reached) and start again on the second PTCA. If the 
necessary data for the pre-procedure assessment was already available from recent earlier 
follow-ups, eg if the patient had complete an NHP 2 weeks earlier, this was used rather 
than repeating data collection.
Other data items
In order to help the analysis of the database additional information was collected
a. The severity of the disease and the affected vessels was recorded.
This included whether the patients had single, double or triple vessel disease 
(taken from CASS 1983a). The degree of stenosis and the particular vessels 
affected was noted - based on evidence from cardiac catheterisation. An indicator 
of ventricular function was also used with categories of either poor, moderate or 
good. If no comment was made and no evidence of dyskinesia was found 
ventricular function was assumed to be good. In addition a list of basic risk 
factors and information about previous problems was collected.
b. The details of the procedure undertaken, the vessels attempted and dilated and any 
problems that emerged during the procedure.
c. The cardiologist’s assessment of risk was added some way into the study. This 
was based on a simple three point classification of the risk of an adverse outcome 
for that patient.
Data collection
The model for data collection on angioplasty was almost identical to that used for 
cholecystectomy. Once again a local research nurse was available to undertake the co­
ordination of data collection.
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1. Patient Identification
Most eligible patients were admitted to one ward and identified by the local research 
nurse through contacts with ward sisters. In some cases it was not known beforehand if 
a patient was to receive a PTCA - rather than exploratory catheterisation. If in doubt 
these were initially included in the study and excluded later. Some patients were 
emergency cases or too ill to complete forms and data could only be collected 
retrospectively and at follow-up.
2. Pre^procedure questionnaire and background information
Patients joining the study were given a letter of introduction and asked to complete a 
NHP and questionnaire checking details of the severity of symptoms (see Appendix 7). 
On completion these were handed back to the research nurse. The basic clinical details 
were collected from the medical notes, typically after discharge when the notes were 
more complete. There were a number of areas where a good working knowledge of 
cardiology was required to elicit information that could be hidden in test results in the 
notes or in laboratory reports.
3. Discharge information - complications
Brief details of events during the hospital stay were completed by the nurse after the 
patient had been discharged. A simple pro-forma listing the main possibilities was used 
with a category to deal with other conditions.
4 Follow-up information
The follow-ups at three and twelve months were carried out via postal questionnaires to 
patients. These reproduced the pre-PTCA questions on symptoms and the NHP. In 
addition there were questions concerning medication, re-admissions and visits to A&E 
departments or to their GP. If patients failed to respond to their first follow-up within 
one month they were automatically sent another questionnaire. If no response was 
forthcoming after the second questionnaire, the local GP was checked to see that the 
patient was still alive.
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5 Data inputting
All data was input through locally developed software into a series of databases. 
Analysis and reporting was also through local software.
Validation
A number of approaches to validation were adopted for different items in the data set.
1. Patient Interview
A semi-structured interview was used to validate some of the general details of the 
patients experience. The interviews were carried out shortly after follow-up 
questionnaires had been returned, though these were not seen by the interviewer 
beforehand.
Time since anginal pain began:- There was general agreement on the time since 
anginal pain started between information given at interview and the result of the 
questionnaire. Discrepancies were noted in only one case which was not clinically 
significant (ie 2 years versus three years).
Previous medical history:- In most cases the interview and questionnaire revealed 
the same details though in two cases it appeared the questionnaires missed 
important prior events, one being a myocardial infarction, the other a previous 
PTCA.
Walking distance:- There were some problems observed in estimating the 
’walking distance’ before the PTCA. In some cases at interview it was confused 
with the state before the angina. This made comparisons difficult. The two 
methods did agree on the two extremes of the spectrum ie cases who walked over 
2 miles with no problems or cases where walking was very limited. Assessments 
of walking distance at follow-up closer to the actual times of interview showed 
greater agreement with only one case showing a difference (less than half a mile
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at interview but 2 miles on the questionnaire).
2. Comparison o f angina scores
The duplication of angina scores, one obtained from the notes and the other from the 
patient allowed a comparison between the two methods. There was a significant 
association between the two scores (p< .05) though there was an exact agreement in only 
36% of cases, with 31% of cases higher on the patient’s score, and the remaining 33% 
higher in the notes. The patient completed score showed a significantly lower proportion 
of patients recorded as class III angina. The pattern of responses required to fall into this 
class demanded correctly interpreting the question about whether pain was observed only 
during certain conditions - a more complex question than the others. It is likely that in 
some cases patients have ticked the boxes incorrectly and this has resulted in an 
assignment of class II rather than class III angina. In total more patients reported having 
the most severe class (38%) than did the notes (26%). It was noted during the course 
of the study that there were some differences in the definition of class IV angina (the 
New York Heart Association scale differs from the Canadian one used here). This may 
explain the discrepancy (Cambeau 1976).
It should be noted therefore that in order to be consistent between pre-PTCA and follow- 
up, the angina classes quoted in the data analysis section may not correspond exactly to 
those defined by the clinicians but are drawn from the responses given by the patient. 
The outcome indicator therefore relates to changes in pain based on the pattern of 
responses given by the patient.
3. Internal consistency
A number of checks were made for internal consistency between data items and these are 
reported in the data analysis section. In particular the NHP ’Pain’ score was found to 
be significantly associated with the class of angina (see Data Analysis section).
4. Check against another database
The cardiologist primarily responsible for developing PTCA at the Freeman kept a
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separate list of all the patients on whom he had performed a PTCA. The list was updated 
with major events that may have happened. The CASPE database was periodically 
checked against this list. In general the two matched up. The biggest problem occurred 
when cases were included in the CASPE study following exploratory catheterisation and 
PTCA was not attempted. This led to tightening the definitions of attempted PTCA. 
The classification of patients as either stable or unstable angina was taken from this 
database.
C. Data Analysis
The analysis of the data concerned three main questions.
1. Do the indicators show significant changes following PTCA?
2. Are the indicators related to each other?
3. Are the results influenced by the presenting characteristics of patients?
Response rates
As with cholecystectomy, the response rates were extremely good. From 202 patients 
(to November 1990) only 10 cases had no 3 month follow-up (95.0% response rate).
One problem was incomplete baseline data for emergency admissions due either to the 
patient being admitted too quickly or too ill to complete the forms. This is unavoidable 
but means that for unstable angina patients baseline data was only available in 53% of 
cases which form the sample used in the longitudinal analyses.
Changes to 3 months (Table 7.1)
Table 7.1 summarises the main events of patients to three months. The results have been 
split into two groups, stable and unstable angina. The population is further divided into
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patients who had a successful angioplasty against those where the procedure failed. Some 
additional data on events within hospital after PTCA were collected (for example, return 
of angina on the ward, post-procedure complications) however the data has not been used 
in the analysis as it tends to overlap with other information.
Failed PTCA
In total 22 of the 202 patients (10.9%) had PTCAs that were unsuccessful - with a higher 
incidence amongst the unstable than stable angina cases. This fîgure roughly correspond 
to the ’failure’ rate that is expected and compares with values of 5-15% quoted in the 
literature.
Events to three months
In total four patients died, three in hospital and one after discharge. Of these 2 had severe 
disease and had been considered unsuitable for surgery. One patient died as a result of 
renal failure and another after a heart transplant. None of these was a straightforward 
case and these results were not surprising at the time.
The most common event up to 3 months after the procedure was patients going for either 
elective or emergency surgery - in total 17 cases. This group included as expected a 
large proportion (though not all) of the failed PTCA cases and a high proportion of cases 
with unstable angina. Only one case had a subsequent myocardial infarction with no 
other procedure. Table 7.1 clearly shows that unstable angina patients were much more 
likely to have another event after the PTCA. Perhaps more surprising is that the stable 
angina category with successful PTCA included a number of repeat PTCAs to the same 
vessel. Some of these would have been planned beforehand as part of the treatment 
strategy for that patient.
The réadmissions were a large category and included a variety of reasons other than 
repeat PTCA’s, CABG or investigatory angiograms. The reasons quoted (from all cases) 
included :-
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Table 7.1 Sumary of events to three months by patient type 
to 1/11/90 n=202 (10 Cases have no 3 month follow-up)
Angina Type
Stable Angina Unstable Angina
Successful PTCA? Successful PTCA?
Yes No Yes No
OUTCOME
Died in hospital 1 2
CABG in hospital 1 3 1 5
MI in hospital 1
Died after discharge 1
CABG after discharge 3 3 1
Repeat PTCA 5 3
Readmitted 7 3 1
None of the above 98 6 45 2
Table 7.2 Changes in key indictors to three months by patient type
Stable Unstable CABG Fail nec Readmitted
Ok Ok
No. cases 98 45 17 8 11
(with pre+post data) (80) (24) (12) (5) (11)
Anginal Pain X Better 52.6" 46.7 62.5' 25.0 50.0
X Same 42.1 33.3 25.0 50.0 33.3
X Worse 5.3 20.0 12.5 25.0 16.7
X Class IV Start->3m 31->14X 44 ->20X 40 ->13X 25 ->25X 44 ->17X
Walking Dist. X Better 51.4' 50.0 58.3 50.0 45.5
X Same 40.0 35.0 25.0 25.0 36.4
X Worse 8.6 15.0 16.7 25.0 18.2
Medication X Better 36.3" 16.7 58.3 20.0 9.1
X Same 42.5 45.8 25.0 80.0 81.8
X Worse 21.3 37.5 16.7 - 9.1
X Triple Therapy Start > 3m 56 ->48X 20 ->53X 41 ->33X 63->100X 55->64X
NHP mean admission Energy 46.4 45.9 49.9 34.4 40.6
Pain 25.8 26.1 25.8 26.0 20.2
Emot Reac 24.0 24.2 27.4 14.5 33.1
Sleep 34.8 25.3 30.5 17.1 46.7
Soc I soI 10.9 12.7 18.8 12.1 11.3
MobiIi ty 16.2 19.9 24.8 21.2 20.5
Part II 51.9 48.8 53.6 54.3 57.2
Combined 26.8 25.7 29.5 20.7 28.7
NHP Follow-up Energy 29.0 25.2 22.7 34.4 41.7
Pain 10.7 13.1 12.1 12.6 15.8
Emot. Reac 14.8 19.6 15.3 15.1 22.0
Sleep 28.5 20.6 33.7 17.1 44.0
Soc Isol 5.5 5.5 1.7 8.3 13.4
MobiIi ty 10.6 13.1 17.1 22.0 16.0
Part II 27.2 35.7 33.3 57.2 40.3
Combined 16.5 16.2 17.1 18.2 25.5
Change in NHP Energy 17.5'" 20.6" 27.2' 0 -1.2
Pain 15.1'" 13.0' 13.5' 13.5 4.4
Emot. Reac 11.6'" 4.6 12.1 -.5 11.1
Sleep 6.3 4.7 -3.2 0 2.7Soc IsoI 5.4' 7.2 17.1' 3.9 -2.0
MobiIi ty 5 6 6.8 7.8 -1.9 4^5 .Part II 
Combined 23.9"
10.2'"
13.1
9.5' fd "
-2.9
2.5
16.9
3.3
p<.001, " p<.01 p<.05 Changes to 3 months Uilcoxon Rank sum test.
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F ’Chest pains, pains in neck & jaw’
F ’Blood clots above and below angioplasty’
F ’Severe chest pain’
F ’Chest pains’
O ’Virus chest infection’
O ’Many times chest pain ’
O ’Gastroscopy’
F ’Chest pain’
O ’Pains in both arms and up neck’
F ’Gastric reflux’
F ’Kidney transplant’
F ’Clot in femoral artery. Due to angioplasty’
(Cases marked with F were admitted to Freeman, O to Other hospitals). It became clear 
that the reasons for re-admission may not necessarily be related to the PTCA (the same 
also applies to visits to A&E departments) and that cases in this category needed careful 
interpretation.
Table 7.1 makes clear that it is difficult to isolate the one event of PTCA in these patients 
when there are a considerable number of other events and interventions happening in this 
chronic disease. Thus examining the outcomes of PTCA becomes more complex as the 
patient population fragments into different groups as different treatment options are used.
Subsequent analyses grouped patients into five categories as defined below:
a. Stable angina no events. (Stable Ok)
b. Unstable angina no events (Unstable Ok).
c. Patients who have had CABG (CABG).
d. Patients whose PTCA was unsuccessful (not elsewhere classified) (Failed nec)
e. Patients who have been readmitted other than for CABG or PTCA (Readmit).
Some patients do not fall into any of these groups, including repeat PTCA patients and 
patients who have had only a myocardial infarction. For patients with a repeat PTCA 
at the Freeman Hospital, it was the practice to stop data collection from the first 
procedure and start on the second, effectively recognising that for assessing the outcome
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of the first PTCA an appropriate end-point had been reached.
Changes in anginal pain (Table 7.2)
The analysis of anginal pain was based on the patients response to the questionnaire and 
not on clinical assessments of their angina category. The caveats about whether the 
resulting score represents the same value as that made by a clinician must be borne in 
mind - however the main interest is in longitudinal change. Results show the proportion 
of patients who had improved by at least one class, stayed the same or got worse. In 
addition the proportion of patients with the most severe class of angina (IV) before and 
after the procedure are shown.
The results indicated a general improvement for most groups with around 50% of patients 
recording an improvement of at least one class.
Considering first the stable angina group, about half showed some improvement whilst 
only 5% appear worse. After the procedure only 14% of these patients had Class IV 
angina compared with 32% at the start. Thus this group showed a net improvement and 
one that was statistically significant. It is possible that there were beneficial changes in 
the patients who stayed in the same angina category but that the instrument was not 
sufficiently sensitive to the scale of change.
The unstable angina group also showed a net improvement though in this case a higher 
proportion of patients appeared worse. This was presumably a reflection of the 
’instability’ of the angina. The results cannot show what proportion of patients would 
have got worse without treatment (or with other treatments). The changes in CABG 
patients and those readmitted are similar to these two groups.
The worst results are shown for the ’Failed PTCA nec’ group where as many patients got 
worse as got better and the proportion of cases with Class IV angina stayed the same. 
This is as one would expect for this group of patients. The lack of any change is an 
encouraging sign of the validity of the measure and suggests that the improvements seen
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in the other patient groups can be attributed to the successful PTCA rather than other 
factors.
Change in walking distance
The walking distance for patients was classified into 4 groups.
1. ’Never leaves the house’ or ’Drives everywhere’
2. ’Walks less than 1/4 of a mile’
3. ’Walks 1/4 to 1/2 mile’
4. ’Walks more than 1/2 a mile’
As with the anginal pain, cases were classified as better, the same or worse on this 
ordinal scale corresponding to the patient’s progress to three months. All patient groups 
showed increased walking distance in about half of the cases. All groups also showed 
a noticeable proportion of cases where the walking distance is less at follow-up than at 
admission, the worst being the ’Failed nec’ and ’Readmitted ’ categories. The groups 
of ’Stable Ok’ patients seem to fare best. As with the pain scores the change in walking 
distance reveals a considerable proportion of patients who are the same or worse - a fact 
which raises questions over the sensitivity of the score.
Changes in medication
The six point medication scale described earlier was used, the less potent the medication 
the ’better’. The last two categories of this scale cover triple therapy. The pattern of 
changes in medication were different across patient groups. ’CABG’ patients showed 
the best improvements. The ’Stable Ok’ group showed a slight reduction in medication 
whilst the ’Unstable Ok’ cases appeared worse. Similarly the proportion of cases on 
triple therapy showed little reduction from before PTCA to follow-up. This overall lack 
of change in medication has been raised by clinical staff as a surprising result. It was 
suspected that any review of medication following PTCA was occurring after three 
months. In all cases there still remained a high proportion of cases on triple therapy after 
the procedure.
190
Changes in health status
The mean NHP scores at admission and changes in score to follow-up are shown in Fig 
7.1 and detailed figures given in Table 7.2. The NHP scores on admission were largely 
similar for all patient groups. Higher scores were observed for ’Energy’, ’Sleep’ and 
Part II of the profile. The latter perhaps showing how the disease itself appeared to have 
a fairly large impact on everyday living amongst these patients.
At follow up the scores for most groups were significantly lower yet the relative scores 
between dimensions stay largely the same. Thus for example ’Energy’ and ’Sleep’ which 
were high scoring dimensions before PTCA were also the highest at follow-up. The scale 
of improvements amongst the stable, unstable and CABG groups are roughly comparable 
and the changes in the higher scoring dimensions tend to be significant for all these 
groups.
The exceptions to this general pattern of improvement in NHP are the group of failed 
PTCA and readmitted cases where the observed improvements are noticeably less. On 
the latter group the high scores at follow-up reinforce the idea that there is something 
different about these patients that has led to their readmission. It is interesting to 
observe that the ’Failed PTCA’ patients show little change on most NHP dimensions - 
which is what one would hope to see if the instrument is working correctly.
Changes to twelve months (Table 7.3)
Table 7.3 summarises the main events in those patients who have reached the stage of 
a twelve month follow-up. It is clear comparing this table to the events at three months 
(Table 7.1) that there were a substantial number of changes between 3 and 12 months. 
In particular, patients were still liable to go for CABG or be readmitted for a repeat 
PTCA. Once again activity amongst the unstable group is higher than for stable patients. 
No additional patients died during this period.
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Fig 7.1 Mean NHP scores on admission and change in  NHP
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Twelve months after the PTCA only 49% of stable patients and 29% of unstable patients 
had had a successful PTCA and had not had another intervention, an MI or been 
readmitted to hospital. Very few of the patients have died (3%) or had an MI (2%), but 
from our original sample roughly 17% have had a CABG, 14% a repeat PTCA and 21% 
had been readmitted for some other reason.
Table 7.3 Events after PTCA to 12 months
n=95 2 cases not respond at 12m
Angina Type
Stable Angina Unstable Angina
Successful PTCA? Successful PTCA?
Yes No Yes No
OUTCOME
Died 1 2
CABG 4 6 4 2
MI 1 1
Repeat PTCA 8 5
Readmitted 10 1 9
None of the above 30 10 1
Table 7.4(a) summarises the changes in indicators between three months and twelve 
months. The general picture is of relative little change beyond the improvements seen 
to three months for those patients who are not readmitted. It appears that the beneficial 
effects of the PTCA are manifested within the first three months. Beyond three months 
other events may occur in a large number of cases and tend to reduce the overall success 
rate of the procedure.
The number of cases in each category is relatively small so it is difficult to be confident 
about the results at this stage. However results for patients who have been readmitted 
appear generally worse than the other groups, once again reinforcing the idea that the fact 
of readmission and a worse health status are linked. Once again there are a variety of 
reasons for these réadmissions apart from CABG, PTCA and angiograms. As with 
cholecystectomy there are more unrelated admissions between 3 and 12 months than 
before the 3 month follow-up.
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Table 7 .4 (a )  Changes in  key in d ica to rs  to  12 months by p a tie n t type
Stable
Ok
Unstable
Ok
CABG Fail nec Readmi t
No. cases
with pre+post data
25 10 14 - 18
Anginal Pain % Better 67 50 64 39
X Same 29 50 27 31
X Worse 5 0 9 31
X Class IV Before ->12m 29->5 50->25 55->18 46">46
Walking Dist. X Better 53 80 44 60
X Same 33 20 28 15
X Worse 13 - 28 25
Medication X Better 64 25 43 36
X Same 18 50 29 29
X Worse 18 25 29 36
X Triple Therapy Before->12m 50->23 75 >75 43 >57 57-49
NHP mean admission Energy 47.5 31.0 42.7 56.2
Pain 18.9 11.0 27.8 42.7
Emot. Reac 19.8 2.6 22.2 30.1
Sleep 22.4 13.5 35.4 50.2
Soc IsoI 6.5 0 10.3 14.0
MobiIi ty 15.0 8.5 14.2 17.5
Part II 47.4 46.4 50.0 63.3
Combined 21.8 11.1 25.4 36.8
NHP combined score at 3 mnths 13.1 7.2 19.4 24.1
NHP 12 mnth Energy 23.7 0 40.9 44.7
Follow up Pain 9.6 0 13.8 21.8
Emot. Reac 14.5 0 20.7 20.7
Sleep 22.9 16.6 36.2 31.5
Soc IsoI 2.4 0 5.5 10.3
MobiIi ty 12.7 0 11.5 24.6
Part II 23.4 21.4 43.9 33.7
Combined 15.1 2.8 21.4 25.6
Table 7.4(b) Changes in key indicators from three months to 12 months by patient type
Stable
Ok
Unstable
Ok
CABG Fail nec Readmi t
No. cases
with pre+post data
25 10 14 1 18
Anginal Pain X Better 17.4 12.5 36.4 16.7
3m-12m X Same 56.5 75.0 36.4 - 38.9
X Worse 26.1 12.5 27.3 44.0
X Class IV 3m-12m 4 ->4 13 ->13 9 ->18 39->11
Walking Dist. X Better 10.0 10.0 38.9 20.0
X Same 
X Worse
83.3
6.7
90.0 44.4
16.7
55.0
25.0
Medication X Better 44.0 30.0 35.7 33.3
X Same 24.0 50.0 28.6 44.4
X Worse 32.0 20.0 35.7 22.2
X Triple Therapy 3m->12m 52->24 60->40 50->29 50->50
NHP Admission 21.7 11.1 25.4 36.8
Combined score 3 months 13.1 7.2 19.4 24.1
mean 12 months 15.1 2.8 21.4 25.6
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The reasons for readmission after three months included
O ’Chest and viral infection’
F ’Vascular op and blood clots’
F ’Infect in leg’
F ’?Pericarditis and test as CABG did not work’ 
O ’Hysterectomy’
O ’D&C - for slight bleeding’
O ’Colitis’
O ’Fitting Tenckoff catheter, NGH-chemo’
O ’Severe anaemia’
F ’Repeat camera tracings around heart’
F ’Chest pain + repeat angiogram’
O ’Angina attack’
Table 7.4(b) shows the changes from before PTCA to the twelve month follow-up. This 
table therefore covers the improvements seen to three months and possible deteriorations 
beyond that. The stable angina patients show clear net improvements in walking 
distance, anginal pain, and NHP scores. For this group it also appears that there has 
been some change in medication presumably in the months after first follow-up.
However there remains a substantial proportion of patients on the most potent medication 
- triple therapy - one year after PTCA. The unstable patients (of which there are 
relatively few who have not been re-admitted within a year) showed changes in anginal 
pain and walking distance and extremely good NHP scores after one year. For this small 
group the outcomes looked very good - not only has the PTCA worked to prevent an MI, 
but there appears to have been a net improvement in the general health status which was 
not really expected. More numbers are needed to confirm this pattern.
The outcomes of the group of CABG patients appeared to show a net improvement up 
to one year after the PTCA - though the degree of change was not as marked. Analysis 
of this group could be confused by the fact that the time since the CABG and the follow- 
up could vary between 1 day to one year. Nevertheless improvements in anginal pain 
and walking distance were observed. Similarly improvements were seen in some 
dimensions of the NHP but the scale of the change was less than for the previously 
mentioned categories.
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The group of patients who have been readmitted did not show clear improvements. 
Walking distances were slightly better but the anginal pain and medication appeared 
largely the same. The NHP scores tended to be higher at admission and at follow-up for 
this group.
Links between outcome measures
The various indicators were compared on admission and at follow-up. In addition the 
observed changes in indicators between admission and follow-up were compared. In 
summary the results of these comparisons suggest that there appears to be some overlap 
between the pain scores, the NHP scores and the walking distance when viewed at 
admission or at follow-up. Though the indicators do not reveal identical results the 
general messages were comparable. The following section gives some examples of these 
links.
Table 7.5(a) shows the relationship between the pain score at admission and the mean 
NHP scores on selected dimensions. As discussed earlier the NHP ’Pain’ score was 
significantly related to anginal pain class, as were the ’Mobility’ and combined scores in 
the direction predicted. The higher the pain scores the higher the mean NHP scores, a 
relationship that appeared particularly strong for class IV angina cases.
Table 7.5(a) Relationship between selected dimensions of NHP and admitting pain score (nFl79)
Pain MobiIi ty Combined X Triple 
Therapy
Pain score=0 12.7 8.7 26.2 50%
=1 20.6 16.7 24.6 67%
=2 20.4 14.2 22.1 58%
3 21.2 9.6 23.5 45%
=4 38.7 26.1 34.8 60%
Significance p=.0002 p=.0007 p=.005 ns
Table 7.5(b) examines NHP scores and other indicators against walking distance. 
Excluding the group "Drives every where, never leave house", the relationship was as
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expected. The greater the claimed walking distance the lower the NHP scores, the 
gradient applying across all dimensions. Similarly the proportion of patients with class 
rv  angina reduced across these categories showing the link to pain scores. Thus there
Table 7.5(b) Mean NHP scores, XClass IV angina and Xtriple therapy by walking distance
Dist=1
Home/drives
Dist=2 
<1/4 m
Dist=3 
1/4-1/2m
Dist=4
>1/2m
Energy 42.2 64.7 48.1 25.6
Pain 25.4 39.4 25.6 16.9
Emotional R 22.2 33.1 26.2 19.8
Sleep 31.4 43.7 33.6 25.4
Soc IsoI 10.9 19.7 11.2 5.8
Mobi I 17.4 24.2 20.0 8.5
Part II 50.7 60.9 55.5 36.0
Combined
(p=.005)
24.9 37.5 27.4 17.0
X  Class IV 49% 61% 29% 27%
X  Triple 
Therapy
62% 65% 62% 50%
appeared a consistent picture that patients who were more active tended to have lower 
pain scores and lower NHP scores. This relationship was also observed when follow-up 
scores are compared.
The exception was for category 1 ("Drives everywhere" or "Never leaves home") which 
did not fit this pattern. It appeared that patients falling into this category may not have 
been giving a genuine reflection of their overall health though they may well have been 
answering the question truthfully. It is suggested that because of this these cases should 
therefore be excluded from the ordinal scale.
The links between these indicators and the medication category were more complex and 
difficult to interpret. There was no consistent pattern whereby the patients on more 
potent medication appeared less active or healthy as is shown in Table 7.5(c).
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Table 7 .5 (c )  Mean ccebined NHP scores fay m edication category .
Medication Category No.
NHP Combined 
Mean Std. Dev
Single 2 13 27.4 12.03
Double 3 9 21.6 15.82
4 35 27.6 18.45
Triple 5 17 30.0 16.99
6 77 25.3 21.08
Total - 154 26.2 19.00
Comparing changes indicators.
Table 7.6 shows the correlations between the dimensions of the NHP at admission , 
follow-up and the changes between admission and follow-up. There was a high degree 
of correlation between the scores of individual dimensions of the NHP - most correlations 
were significant to the 0.1 % level. The most important aspect of the table is that the 
fact that changes in score were related to the initial score. That is the higher the 
admission the higher was the change in score. All the NHP scores showed skewed 
distributions with a high proportion of cases scoring zero - particularly at follow-up. 
It is possible that there are some ’end-effects’ caused by using a scale where 
improvement in score will tend towards zero.
Table 7.7 summarises the relationship between changes in certain indicators from 
admission to three months and shows average change in the combined NHP score for 
patients who appear better or worse on three indicators. The relationships were not the 
simple pattern one might expect given the correlation observed earlier when the indicators 
are compared in cross-section. Whilst it appeared that patients who were ’better’ on the 
pain score and in terms of walking distance showed larger average improvements in 
NHP, the differences between patients who were the ’same’ or ’worse’ was not as one 
might expect. Patients who had the ’same’ anginal pain had lower improvement in NHP 
than those who got ’worse’- which was not as expected.
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Table 7 .6  C orrela tions between adm itting WHP, follow-up NHP and changes in  NHP (np132).
Correlations: Energy Pain Emot. Reac Sleep Soc Isol Mobi I Part II Comb.
Admission
Energy 1 0000** .4799** .4727** .3875** .4136** .4974** .4630** .7997**
Pain .4799** 1.0000** .4601** .3905** .4251** .6289** .4461** .7534**
Emot Reac .4727** .4601** 1.0000** .4942** .6572** .3933** .4699** .7832**
Sleep .3875** .3905** .4942** 1.0000** .1276 .3204** .3039** .6601**
Soc IsoI .4136** .4251** .6572** .1276 1.0000** .3261** .3820** .6343**
MobiIi ty .4974** .6289** .3933** .3204** .3261** 1.0000** .4833** .6962**
Part II .4630** .4461** .4699** .3039** .3820** .4833** 1.0000** .5801**
Combined .7997** .7534** .7832** .6601** .6343** .6962** .5801** 1.0000**
Follow -up (3mnth)
Energy .4849** .3069** .2200* .2661** .2187* .3500** .1438 .4437**
Pain .3163** .3136** .1712 .1573 .1687 .2754** .1297 .3271**
Emot Reac .3158** .2576* .4189** .1044 .3583** .3014** .1368 .3922**
Sleep .3108** .3297** .2967** .5238** .2062* .2437* .1414 .4537**
Soc Isol .1739 .1312 .3818** .1093 .3411** .1859 .0415 .2886**
MobiIity .4001** .4086** .2007* .1931 .2399* .4863** .1209 .4396**
Part II .3577** .3691** .2458* .0647 .2049* .3997** .3488** .3716**
Combined .4666** .3942** .3678** .3366** .3287** .4076** .1667 .5351**
Change in NHP
Energy .5624** .1998* .2746** .1439 .2155* .1768 .3367** .3969**
Pain .2061* .6920** .2980** .2437* .2673** .3758** .3165** .4524**
Emot Reac .1774 .2167* .5956** .3851** .3180** .1134 .3330** .4098**
Sleep .0801 .0639 .2041* .4913** -.0798 .0799 .1675 .2139*
Soc Isol .2623** .3060** .3361** .0384 .6949** .1695 .3333** .3855**
MobiIity .1489 .2779** .2243* .1555 .1183 .5925** .3916** .3194**
Part II .0908 .0659 .1950 .2089* .1541 .0716 .5681** .1809
Combined .3913** .4139** .4722** .3714** .3516** .3392** .4552** .5375**
** p<.001 *p<.01
For the medication, patients moving on to less potent drug regimes (better) show a 
worsening NHP score, whilst those where the drugs are more potent show an 
improvement. This may be because a reduction in medication makes people feel worse 
though further investigation of this point is needed.
Table 7.7 Comparing changes in indicators. Mean combined NHP scores according to changes in 
pain, walking distance and medication.
Better Same Worse
Pain 30.6 7.4 14.2
Medication -5.4 10.6 13.8
Walking Distance 14.1 12.1 3.3
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Effects of presenting variables
Presenting variables within patient groups
Table 7.8 summarises the prevalence of certain features of the patients on admission for 
each of the five main patient groups discussed earlier. In brief there were few significant 
differences between the presenting characteristics of the various patient groups.
There was little difference in the mean age of the groups ranging from 49 to 54 years. 
The proportion of women was slightly higher in the ’Unstable* angina group (36%) and 
lower in the ’Failed PTC A’ group (13%) with on average 25% of patients being women.
The percentage of patients who had had a previous procedure (either PTCA or CABG) 
varied around the average of 15%, being lower in the ’Unstable’ angina group and the 
CABG patients. Of the ’Failed PTCA’ cases, 25% had had some previous procedure. 
The proportion of patients with a previous MI was more constant at around 32% and was 
highest in the CABG group (41%).
The complications (including hypertension, diabetes, smoking etc) showed few variations, 
with around 40% of cases having none of these additional problems or risk factors. The 
percentage of such ’non-complicated’ cases appears slightly lower in the ’Unstable’ 
angina group and the ’Failed PTCA’ group.
The proportion of cases with disease of a single vessel (as opposed to two or three 
vessels) was lower in the ’Failed PTCA’ cases. Together with the slightly higher 
’stenosis score’ it appears that the pathology of the disease in the ’Failed’ cases was 
greater than for the successful cases. This observation had been made during the course 
of the project and was broadly in line with the view accepted by the clinicians.
Ventricular function was re-classified into either ’Moderate or poor’ and the rest (very 
few cases were recorded as having poor ventricular function and most were ’good’). 
There appeared to be no large differences between the patient groups.
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Table 7 .8  C h a ra c te r is tic s  of p a tie n ts  on admission fo r main p a tie n t groups
Total Stable
Ok
Unstable
Ok
CABG Failed 
nec
Readni t All
failed
No. 179 98 45 17 8 11 22
Mean Age (yrs) 53.1 53.4 53.7 50.9 53.9 49.7 52.3
X Male 74.5X 77.6X 64.4X 76.5X 87.5X 81.8X 81.8X
Female 25.5X 22.4X 35.6X 23.5X 12.5X 18.2X 18.2X
X Prev op 14.6X 19.4X 8.9X 5.9X 25. OX 0 13.6X
X Prev MI 31.ax 30.6X 31.IX 41.2X 25. OX 36.4X 36.4X
Compile* =None 42.7 48.0 33.3 47.1 25.0 45.5 40.9
étions =1 47.9 44.9 51.1 47.1 75.0 54.5 59.1
>1 9.4 7.1 15.6 5.9
X Single Vessel 59.9 63.3 60.0 58.8 37.5 63.6 40.9
X Vent.function 
Moderate/poor
14.6 19.4 8.9 11.8 - 18.2 9.1
Mean Stenosis 
Score
2.85 2.58 3.16 3.06 3.63 2.90 3.54
In general this limited analysis shows that there were not enormous differences between 
the presenting characteristics of these groups. The exception to this was the relationship 
between the more severe pathology of cardiac disease in the failed PTCA cases. Though 
there were relatively few cases where the PTCA was unsuccessful the group did appear 
to have had a greater degree of vessel involvement, more serious stenosis of vessels and 
a slightly higher rate of complications or risk factors. These factors add up to more 
clinically severe disease in these cases. Thus it appears that the simple rate of failed 
PTCA’s will be especially sensitive to the severity of presenting disease and this factor 
must be examined in comparative studies.
For the other groups the approach used here suggests that these factors are not strongly 
predictive of these immediate outcomes and that outcomes expressed in terms of these 
groups will not be unduly sensitive to changes in the mix of patients treated.
Presenting variables by NHP scores
Table 7.9 summarises the relationships between the presenting variables and the NHP 
scores (using the combined score) for the group of stable angina patients with no other 
intervention to 3 months.
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Table 7.9 NHP scores (mean combined scores) by presenting characteristics (m=132) 
Significance tests by Kruskal-Wallis analysis of variance with ranks.
Mean NHP scores (Combined)
Pre Post Change
Age Band
<40 26.4 18.8 7.6
41-50 24.4 13.8 10.7
51-60 30.5 18.5 11.9
>60 23.3 16.4 6.9
ns ns ns
Sex
Male 24.3 15.2 9.1
Female 34.6 20.7 13.9
ns ns ns
Previous Surgery?
No 26.5 15.4 11.1
Yes 27.9 21.3 6.6
ns ns ns
Previous MI?
No 23.6 13.1 10.5
Yes 33.5 23.7 9.7
p=.046 p=.037 ns
Complications
0 23.7 11.2 12.5
1 29.1 20.3 8.8
2 31.3 26.2 5.1
ns ns ns
Number vessels
Single 26.4 17.4 8.9
Double 26.0 13.8 12.2
Triple 34.9 20.4 14.5
ns ns ns
Stenosis score
1 22.8 2.0 20.8
2 28.6 22.8 5.8
3 27.0 16.7 10.2
4 17.1 6.1 11.0
5 25.6 12.7 13.0
7 48.0 43.1 4.9
ns ns ns
Ventricular Function
Good 25.7 16.1 9.6
Poor/Mod 30.2 17.9 12.3
ns ns ns
There appeared to be differences between the average NHP scores on admission 
according to sex though these are not all significant using non-parametric tests. In 
particular women tended to score higher on most dimensions and thus on the combined 
score. Interestingly the higher scores for women were typically observed on both 
admission, follow-up and change in NHP. Perhaps surprisingly there were no clear 
patterns in NHP scores with respect to age and certainly no statistically significant ones. 
It might be expected that older patients would tend to show higher NHP scores but this 
is not evident. However it should be noted that the age range in this group of patients
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was generally lower than in other studies at the Freeman and there were few very elderly 
patients receiving PTCA.
When regarding the various presenting features of patients which will suggest clinically 
more difficult patients there was a generally consistent relationship. Patients who have 
had a previous operation, have had a myocardial infarction, poor ventricular function, 
greater vessel involvement and more co-morbid conditions or complications tend to have 
higher initial NHP scores (though using non-parametric tests none of these relationships 
in isolation is statistically significant at the 5% level). For all these variables it appears 
that the NHP scores at follow-up tend to be higher as well though all cases show a 
general improvement in NHP scores.
Differences in the scale of the change in the NHP scores were not consistent for the 
various presenting characteristics. Clinical complexity was associated with less change 
in NHP when considering previous surgery, previous myocardial infarction and the 
presence of comorbid complications. With all these variables the more complex cases 
showed a smaller net change in NHP and so one can infer derived slightly less benefit 
from the PTCA.
The opposite picture was observed for patients with poor ventricular function and 
multiple vessel disease where the clinically more difficult patients showed a larger change 
in NHP and so one infers a greater benefit. The score of the degree of stenosis in 
cardiac vessels showed no consistent relationships to any of the NHP scores.
These results do show some of the relationships one might expect between the various 
clinical problems and the health status as measured by the various dimensions of the 
NHP. However there is no consistent and statistically significant relationship to the 
change in NHP observed between admission and follow-up at three months. If this latter 
value is used as the indicator of successful outcome then it would appear that, for the 
purposes of comparative studies, the results suggest that standardisation for these clinical 
factors may not be necessary. A larger number of cases would provide more confidence 
in such a conclusion.
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Presenting Variables by Other Outcome Indicators
Table 7.10 shows the relationships between changes in walking distance, medication and 
anginal pain, according to the presenting characteristics of patients. The values in the 
table represent the proportion of patients with a given characteristic who are observed to 
be better, the same or worse on each of the indicators. For example of the patients aged 
over 60 and using walking Distance as the outcome indicators, 58% of the over 60’s are 
better, 36% the same and 12% have lower reported walking distances.
There appeared to be few consistent relationships which hold across all indicators. Thus 
considering the age categories, the older age band appeared to fare slightly better in terms 
of walking distance or anginal pain in that fewer cases appeared to be ’worse’ at follow- 
up than admission when compared to younger age bands. However the older age group 
showed less change in the medication.
Sex did not appear to be strongly related to changes in any of the indicators, the pattern 
for men and women being largely the same. The biggest difference being the slightly 
higher proportion of women who are ’worse’ with respect to walking distance at follow- 
up (21% for women versus 12% for men). Patients who had had previous surgery 
seemed to fare better with respect to walking distance and medication yet worse with 
respect to anginal pain (36% ’better’ against 57% of those with no prior surgery). 
Similar results were seen comparing improvements in walking distance and anginal pain 
against previous myocardial infarction. The patients who had had an MI appeared 
slightly better with respect to walking distance (65% ’better’ versus 48% of those 
without prior MI) however they appear to do worse in terms of anginal pain (30% better 
versus 63% without MI).
Patients with more complications/co-morbidities showed less change with respect to 
medication though a greater percentage showed improvements in anginal pain. 
Comparing improvements in patients with single vessel disease against those with two 
affected vessels, it appeared walking distance and pain indicators agree that greater
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Table 7.10 Relationship between presenting characteristics and sttsequent changes in walking distance, 
medication and anginal pain. Percentage of cases 'Better', 'Same' or 'Worse' at three months after 
PTCA (n=132).
Walking Distance 
Better Same Worse
Medication 
Better Saw Worse
Anginal Pain 
Better Same Worse
Age Band
<40 0 100 0 50 50 50 50 0
40-50 52 36 12 44 28 28 53 42 5
50-60 56 24 21 38 50 12 50 42 8
>60 58 37 5 21 53 26 58 42 -
Sex
Male 53 36 12 36 43 21 55 39 7
Female 58 21 21 37 42 21 46 54 -
Previous Surgery? 
No 54 34 12 34 46 20 57 39 4
Yes 54 27 20 47 27 27 36 55 9
Previous MI?
No 48 33 19 43 41 17 63 30 8
Yes 65 31 4 23 46 31 30 71 -
Complications
=0 51 27 22 41 32 27 61 30 9
=1 57 35 8 35 51 14 40 60 -
2 50 50 - 17 50 33 50 50 -
NimÉier Vessels 
Single 49 35 16 37 41 22 44 47 8
Double 67 21 13 29 46 25 59 41 -
Triple 40 60 - 60 40 - 100 - -
Ventricular Function 
Good 56 30 15 39 36 25 54 39 7
Poor/mod 47 42 11 26 63 11 50 50 -
Stenosis
=1 - 100 - 33 67 - 100 - -
2 52 35 13 39 35 26 40 53 7
=3 50 31 20 39 42 19 50 43 7
=4 63 25 13 25 50 25 80 20 -
>4 60 40 40 60 40 60
improvements in both indicators are seen in patients with two vessel rather than single 
vessel disease. There are no clear patterns with regard to the effects of either ventricular 
function or the stenosis score on the indicators.
As with the NHP scores the general pattern is largely as one might expect yet using this 
crude analysis there are few relationships which appear to be statistically significant or 
send consistently strong messages across all the outcome indicators.
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Conclusions on data analysis.
1. The analysis of results was complicated by the complexity of different treatment 
patterns that emerge in patients after a PTCA. The picture is different from that seen in 
cholecystectomy where there tends to be an isolated event in hospital the consequences 
of which are fairly easy to follow. CHD is of course a chronic disease and it is clear that 
PTCA does not make the problems disappear completely. The fact that patients are likely 
to receive additional interventions after the PTCA makes the analysis of the data 
considerably more complex by requiring the population of patients to be split into a 
variety of groups. The numbers of cases in each group tend to be small and conclusions 
about the behaviour of the group correspondingly less reliable.
2. The pattern of change in stable angina patients is different from that in unstable angina 
patients. These groups have been examined separately throughout this study and it is 
clear that though similar measures can be used for these two groups the expected 
outcomes will differ. Thus for example only a minority of patients (30%) with unstable 
angina will not have been readmitted for some other intervention a year after the initial 
PTCA.
3. The analysis of outcomes in terms of the major events following PTCA eg success, 
death, CABG etc. shows results more or less as expected and roughly in line with those 
quoted in the literature. The frequency with which these events occur in the study 
population is sufficient to make reporting of such events reliable and these simple 
descriptions of process can become a useful proxy outcome indicator.
4. The more direct measures of patient health ie NHP, angina scores, walking distance, 
do show significant improvements to three months following successful dilatation. For 
angina scores and walking distance the categorisations based on the patient’s response to 
a simple questionnaire were crude but still sufficiently sensitive to show a net 
improvement. However it is clear that there are substantial proportions of patients who 
do not show any improvement with these indicators and a few who appear worse at
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follow-up. The results suggest that one can expect about half the patients to show an 
improvement to three months on the two indicators. Though the NHP scores are highly 
skewed they do show significant improvements in the most important dimensions using 
non-parametric tests of significance. For the few cases whose PTCA failed, there are no 
major changes in these three indicators - a fact which supports the conclusion that 
changes are related to the PTCA rather than either random variation or some other effect.
5. The benefits of the PTCA - as measured in relation to patient health - are manifested 
at three months with no great changes for the better to 12 months. However the negative 
aspects of further events do appear up to 12 months and probably beyond and therefore 
follow-up to a year at least is recommended. The proportion of patients who receive no 
other intervention falls to about 50% of stable angina patients by 12 months.
6. Though in general different measures of patient health are related - when compared 
in cross section - there also appears to be considerable degrees of variability in any one 
measure. Thus higher scores of anginal pain will tend to be associated with higher NHP 
scores in the population of patients, but the relationship does not hold true for all 
patients. Nevertheless statistically satisfactory relationships can be seen between NHP 
scores, reported walking distances and pain scores and suggest these indicators are 
demonstrating some degree of convergent validity. The relationships between 
longitudinal changes in these indicators tend to be much weaker.
7. There is no consistent link between the potency of medication and the other health 
indicators. This is probably because health status and medication are in some form of 
equilibrium, as pain increases so the medication should increase to counteract this and 
so lead to lower pain. The problem in this case is that the potency of medication is really 
a process measure and not particularly useful as a proxy for health. The results have 
suggested that medication has not changed to the degree expected at three months though 
changes at 12 months are observed for some patient types. This is as expected given the 
current policy at the Freeman Hospital.
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8. The relationships between presenting characteristics and eventual outcome appear 
rather weak. The most significant observation is the relationship between more disease 
pathology, complicating conditions (risk factors) and failure of the PTCA procedure. 
Some differences between NHP score and sex have been observed.
D. Review Process
Though a number of meetings were held with the main cardiologist concerned only two 
wider meetings were held to discuss the results. The review process has been 
handicapped by the lower then expected rate of PTCAs which increased the time taken 
for sufficient numbers of cases to emerge. This has been coupled with the necessity to 
analyse distinct groups of patients separately, so reducing the numbers in any one group.
Nevertheless the clinical staff concerned have expressed an interest in the results and are 
keen to continue with data collection if possible. Some of the main areas of interest have 
been:
1. Discussions have been made of the relative value of the usual outcomes or endpoints 
for clinical trials - mainly process measures and deaths - versus the more patient centred 
measures - pain relief, health status etc. Though the NHP has performed well it has been 
less well accepted than in cholecystectomy. In terms of the relative impact of the 
information the traditional process measures were considered more useful and easier to 
understand.
2. The reactions to the results were mixed and though two of the indicators, deaths and 
failed PTCAs, were known in advance - there was a genuine uncertainty over what 
outcomes to actually expect. In particular, limited comparisons to the literature have 
been used to place the results in some context - though this is not available for the more 
sophisticated measures. There has been interest in comparing the results to a similar 
study of CABG patients that has been carried out recently at the Freeman Hospital. In 
fact some of the data have been designed to be compatible.
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3. The lack of change in the medication was greeted with some surprise and it was 
suggested that perhaps clinicians were being a little conservative in their use of drugs 
following PTCA. The cardiologists are considering reducing the potency of drug regimes 
at an earlier stage than at present. This is one area where a possible clinical change may 
result.
4. There were some doubts expressed over the value of using the patients’ perception as 
a way to measure outcome in this group. More specifically there is felt to be a wide 
variation in how patients cope with their condition which may not be in proportion to the 
severity of their disease. This question concerns not just the process of assessing health 
status by asking the patient but also the variability between patients in the way that they 
react to what in one sense can be considered essentially similar health states. Opinions 
were divided on the question of whether the selection criteria for patients (PTCA or 
other treatments) include some assessment of those who were felt to be ’psychologically’ 
more likely to benefit from the procedure?
5. One of the key areas of debate was the process whereby patients were selected for 
PTCA and this was felt to be the most important determinant of the outcomes. There 
was correspondingly relatively little debate over the specific process of care adopted for 
patients. Thus, as with the cholecystectomy study, the data has served to focus attention 
on one key issue which is felt to be the most important in improving outcomes of this 
particular procedure.
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Chapter 8 Other Specialties 
Orthopaedics, Rheumatology, Urology
In addition to the main specialties the study has undertaken some work in other 
specialties. In orthopaedics a study of knee replacements has been underway for some 
time and the work has developed along the lines of that seen in cholecystectomy and 
angioplasty. In rheumatology there have been discussions about the dataset and a number 
of ad-hoc studies designed to help the rheumatologists with their audit process. In urology 
the work has been limited to a discussion of the outcome data set for an examination of 
prostatectomy.
This chapter gives a brief overview of the work in these specialties and a limited analysis 
of the results to date. They have been included because they have provided useful 
insights into the main project and how its findings are applicable to other specialties and 
contribute to the results of the study as a whole.
A. Orthopaedics - Knee replacements.
Work in orthopaedics originally began because the area was of keen local interest and 
because of the proposed development of a local clinical information system. It was 
recognised from the start that the commitment of the study team would have to be 
limited. The case type chosen was knee replacements - with the likelihood that hip 
replacements would be examined later. Though there are a number of consultant 
orthopaedic surgeons at the Freeman Hospital, only two carry out knee replacements and 
these have been involved in the development of the outcome indicators and the review 
of the results.
Outcome indicators
1. Knee Junction
There is a standard method of assessing knee function before and after knee replacement
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that has been used for some time and has formed the basis for studies of the relative 
effectiveness of different prostheses (Insall et al 1976). The assessment made by the 
doctor is based on the doctor-patient interview and includes basic questions on the degree 
of pain and patient function, as well as measures of the degree of damage to the affected 
joint. The scoring system is rather arbitrary with a maximum score of 100 , the higher 
the score the better the knee function. Both surgeons used this structure in assessments 
of the patients therefore a standard pro-forma was adopted which included the items of 
the knee score for completion during the patient interview.
2. Improvement in health status.
It was agreed that in addition to improving knee function, there was also the objective 
to improve health from a wider perspective. Early on in the study the intention was to 
identify datasets that would be compatible between rheumatology and orthopaedics. The 
two specialties work very closely together at the Freeman sharing resources and patients. 
Given this commonality the Erst choice of a general health status measure was the health 
assessment questionnaire (HAQ) which has come to be something of a standard in 
rheumatology (Fries 1983; Kirwan & Reeback 1986; Leighton-Read et al 1987). 
However it was realised fairly early on that this questionnaire did not cover the main 
problems experienced by the knee patients. In particular it included a variety of 
questions concerned with the upper body and did not include more general psychological 
or social functioning. It was therefore decided to try the Nottingham Health Profile 
which had been proving satisfactory in the other specialties. This has been the instrument 
of choice for the rest of the study.
3. Peri-operative complications
As with other surgical studies, a simple form was used to check for problems during the 
procedure or anaesthetic. Free text was used in this case rather than pre-specified 
responses.
4. Post-operative complications
With any surgical procedure there are a number of problems that may arise post- 
operatively. A list of potential problems was agreed and included:
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- Wound infection
- Post-operative bleeding
- DVT/ Pulmonary embolus
- Respiratory infection /complications
- Cardiovascular complications
- CNS complications
- Urinary complication (eg retention, infection)
- Septicemia
- Renal failure
- Other (specify)
5. Joint loosening - X  ray evidence
One of the problems that can occur following knee replacement is that the prosthesis 
becomes loosened. The assessment of this is based on a very simple scoring of the 
evidence of translucent zones revealed by post-operative X-ray. The scale and position 
of any translucent zones was noted before the operation and at subsequent follow-ups. 
The recording is based on simple diagrams of the joint used by Goldberg and colleagues 
(Goldberg et al 1988). A serious increase in these zones is an indication that the joint 
is loosening.
Other data items
The intention that the orthopaedic study would eventually contribute to the development 
of a local clinical database meant that the scale of additional information collected was 
larger than needed purely for outcomes measurement. In particular a number of details 
concerning the patient before the operation are collected. It is intended that the 
relationships between these factors and eventual observed outcomes are explored in some 
depth.
Key items recorded include:
Administrative - Hospital number, name, address etc.
Indications for surgery 
Extent of arthritis 
Previous surgery 
Concurrent conditions 
Type of prosthesis
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Knee detail - Lachman’s Test, pain.
Pre-operative X-ray - Pathology of knee disease etc. 
Post-operative X-ray
Timing of observations
The timing of observations for knee replacements is rather different from that in other 
specialties with longer time scales being considered more appropriate. This stems from 
the evidence on various joint replacement procedures that the prosthesis itself will 
eventually have to be replaced, typically the time scale for hips being 10-15 years. 
Goldberg and colleagues (Goldberg et al 1988) followed 82 patients who had had a 
condylar knee prosthesis for an average of nine years and found that ten had had a 
revision for various reasons. Thus the Freeman surgeons were interested in knowing how 
long their joints would stay in place as well as the immediate benefits of the procedure.
For the purposes of continuous monitoring of outcomes prospective studies over 10-20 
years are unlikely to have much managerial impact. Therefore benefit over shorter time 
scales were measures using three months (or nearest out-patient visit) and twelve months 
after the procedure.
Data Analysis
This data analysis section records only brief descriptions of some of the results rather 
than a comprehensive examination of all the relevant variables. The selection of issues 
in this report is based on those that have developed during the course of the study and 
discussions with the orthopaedic surgeons.
1. Changes in Knee and NHP scores.
Table 8.1 shows the changes in the knee score and NHP scores to 3 months, and to
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twelve months for the smaller subset of patients who have reached that stage.
These results show the changes for patients who have received a single operation only 
and give a clear idea about the sensitivity of the measure to changes in patients health.
Table 8.1 Changes in Knee Score and NHP scores to 3 months and 12 months
Mean scores to 3 months n=137 Mean scores to 12 months n=43
Before +3mnths Si 9 Before +3
months
+12
months
Si g
Knee Score 
(sd)
44.7
(13.6)
72.9
(17.4)
.000 46.4
(13.1)
75.7
(12.4)
79.7
(14.6) ns
Energy 41.5 29.1 .000 45.7 24.6 19.8 ns
Pain 64.1 33.4 .000 71.1 35.2 30.5 ns
Emot.Reacs 22.5 11.7 .000 20.7 10.5 11.5 ns
Sleep 48.1 35.4 .000 63.2 47.4 42.1 ns
Soc Isol 14.6 7.1 .000 14.8 3.3 5.1 ns
MobiIity 46.1 31.8 .000 47.7 29.6 31.4 ns
Part II 42.7 29.0 .000 37.4 23.6 23.6 ns
Combined 39.5 24.7 .000 43.9 25.1 23.4 ns
The knee scores show significant improvements after the procedure typically moving 
from an average of about 45 before the operation to 70-80 afterwards. These changes are 
roughly in line with those observed by Insall et al (Insall et al 1976). For the subset of 
cases who have reached the twelve month follow-up (without revision) there is only a 
small change in knee score beyond three months.
Similarly the NHP scores on all dimensions show significant improvements. Fig 8.1 
shows the distributions of the six dimensions of the NHP before the procedure. The 
highest scoring dimension is ’Pain’, followed by ’Mobility’, ’Energy’ and ’Sleep’. 
’Social Isolation’ and ’Emotional reaction’ score lower, with highly skewed distributions, 
though the mean values are still above zero. Three months after the procedure the scores 
are all significantly lower. The residual scores at three months however are still above 
zero particularly for ’Pain’, ’Energy’, ’Mobility’ and ’Sleep’. These results suggest that 
there is a marked improvements related to the procedure but that the patients still have 
quite significant health problems afterwards. The scores on the NHP are fairly high both
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before and after the procedure - when compared to other specialties.
2. Correlations between knee score and NHP
Table 8.3 shows the correlations between the knee scores and the dimensions of the 
NHP. Interestingly only pain and mobility (and the combined score) are significantly 
related to the knee score for the pre-operative assessment. At follow-up only energy and 
mobility (and combined) score are correlated. There are no significant correlations 
between the change in NHP and the changes in knee score.
Given the earlier similarities between the way in which the two sets of scores behave 
after the procedure this lack of strong links between the two is a little surprising. 
However it is clear from the content of the two scales that they are often measuring 
different things. In terms of content the pain element in the knee score is quite large and 
some correlation with the NHP is therefore observed for this element (though the 
weightings used in calculating the knee scores are rather arbitrary). However apart from 
this the score does focus on the pathology of the knee itself - a rather narrow view of the 
patient. The NHP on the other hand incorporates the far broader picture of general 
health.
Table 8.2 Correlation (rank) between NHP scores and 
Knee scores (n=123)
Knee Scores
Correlations: Initial Follow up Change
Score Score Score
Initial NHP
Energy .2047 -.2586* -.0816
Pain .3399** -.1945 .0509
Emot.Reac .1856 -.0800 .0486
Sleep .1534 -.1628 -.0365
Soclsol .1305 -.1490 -.0395
Mobi I .2708* -.2486* -.0337
Parti I .0966 -.1738 -.0796
Combined .3200** -.2792** -.0283
Change to 3m
Energy .0112 .0497 .0327
Pain .0565 .1190 .1286
Emot.Reac .0407 -.0226 -.0425
Sleep .0282 .0332 .0434
Soclsol .0479 -.1406 -.1405
Mobi I .0444 .1274 .1278
Part II .0920 -.0493 -.0946
Combined .0123 .0536 .0500
1-tailed Signif: * - .01 ** - .001
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Fig 8.1 D istribu tions of NHP scores before acfenission for knee replacement (n=184)
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3. Effects of age and type of arthritis.
Table 8.3 shows the observed changes in both NHP by age band and for osteoarthritis 
and rheumatoid arthritis separately. With regard to the age, the results suggest that the 
younger age band, under 60 years of age do not do as well as the older age groups when 
the NHP is examined. The observed scores for the younger age band before the 
operation are not greatly different from the older groups. There are no differences across 
age groups in terms of the change in knee score. A number of explanations for this have 
been offered during the study and none have been found to be wholly satisfactory. It is 
clearly due to some form of interaction between overall health perceptions, and possibly 
expectations, being different with age. Burton et al have suggested that patient 
expectations from hip replacements are an important part of the assessment of outcomes 
and may not necessarily correlate with the technical success of the procedure (Burton, 
Wright & Richards 1979). The results are being investigated further while the issue of 
whether differences in expectations can (and should) be met from within existing 
technologies and resources needs to be addressed.
Finally, Table 8.3 also shows that the benefits of surgery, both in terms of the knee score 
and overall health status, are not significantly different for patients with osteoarthritis and 
those with rheumatoid arthritis. This differed from the expected results that rheumatoid
Table 8.3 Initial and change in Knee score and average change in NHP for patients according to age
group and type of arthritis. ns=not significant p>.05
Differences by age Difference by arthritis
Age<60
n=45
60-70
n=51
>70
n=68
OA
n=104
RA
n=55
Initial Knee 44.9 41.2 45.6 ns 44.4 44.2
Change Knee 27.3 31.3 24.7 ns 28.8 27.1
Energy -1.4 13.6 21.2 .049 10.7 16.8
Pain 23.0 40.1 41.1 .017 37.9 33.2
Emot. Reacs 8.5 13.4 19.5 ns 14.3 14.9
Sleep 15.8 16.1 26.4 ns 21.7 17.3
Soc Isol 7.1 7.3 14.4 p=.050 9.9 7.1
Mobi I 11.0 11.1 26.9 p=.027 19.4 14.3
Part II 17.3 25.2 18.4 ns 21.7 12.5
Combined 6.9 16.3 18.6 p=.039 14.4 15.1
patients will not benefit as much since they would have more serious longer term
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problems which may overshadow the benefits gained in a single joint.
Using the information
Data on outcomes has been presented to the relevant clinicians in the form of simple 
reports as in the other specialties. These reports have been discussed in meetings as in 
other specialties. Discussion have included :
- issues of data collection
- results to data
- validity of the various measures used
- effects of presenting characteristics
- individual case review of ’non-responding patients’
The two consultants concerned, and their senior registrar when relevant have shown a 
commitment to the project and in fact have been responsible for most of the basic data 
collection. The research team has been responsible for co-ordinating the data collection 
and chasing up when necessary but the input in terms of resource has been considerably 
less than in other specialties. Nevertheless the clinicians have shown interest in the 
results and analysis and found them useful and their comments n teh evaluation form 
included (Appendix 3):
"As yet in orthopaedics still not at our one year objective which will be o f value. 
We have certainly learnt the value o f measurement but require further analysis to 
assess our conclusions "
"Enables detailed review after a busy clinic with highlighting o f problems'
Though the NHP was at first regarded with some suspicion, it has proved itself to be an 
important part of the assessment of patient outcomes and has come to be accepted by the 
clinicians themselves. Once again the validity of the instrument in monitoring changes 
in this type of surgery is an important finding of the study. It is now accepted that the
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wider view of health offered by such measures is critical in the assessment of outcome.
There has been some conflict between the demand for basic information over long time 
scales and in particular the expected life of prostheses, which was of particular interest 
to the clinicians, and the shorter term reviews necessary to complete an audit cycle as 
advocated by the research team. Thus the results to date are only seen as addressing 
outcomes in the short term.
The clinicians were already familiar with the knee score and its interpretation raised 
fewer problems in the early stages. Thus both surgeons were aware of the expected 
range of scores to be seen before the operation. However the scale of observed change 
to follow-up was not known locally. The improvement has been reassuring and conforms 
to figures quoted in the literature. Moreover simple diagrams showing the change in 
score made it easy to identify those patients where improvements had not been for the 
better. These patients were reviewed individually using all the available data.
Similarly, patients who had poor outcomes either in terms of the NHP or post-operative 
problems were reviewed individually. Though discussion of these individual patients was 
interesting there were few general lessons about how practice could be improved in 
future. A variety of explanations were offered but the two most common reasons were:-
- that patients had severe disease in a number of joints (or other health problems) 
which were limiting the scale of improvement.
- that, though the operation was ’technically’ successful, patients were not willing 
to either exercise or test the knee, or change their life-styles. It was suggested that 
some form of screening to identify these patients in advance be undertaken if one 
wished to secure the maximum benefit from the procedure.
The review of data in orthopaedics cannot point to any specific changes in practice that 
have yet resulted. However clinicians have expressed their greater awareness of a 
number of issues. Thus the observed, and as yet unexplained, relatively poor
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improvement in the younger age band is causing some concern, as is the question of 
selecting those patients who are most likely to benefit. The observation of the relative 
improvement in the rheumatoids has also brought comment and in effect confirmed their 
current practice.
Conclusions
The study of outcomes in orthopaedics has shown that, with commitment from the clinical 
staff, it is possible to link in data collection for outcome measurement with existing 
processes of data collection. The scale of involvement for the research team in this study 
is limited to the co-ordination and analysis of data. The results have been encouraging 
both in terms of the changes in outcome indicators that are observed after surgery and 
the behaviour of the instruments chosen. It appeared that though both the traditional 
Knee scoring system and the NHP show improvements after the operation, they are 
describing different types of health benefit that the patients received.
B. Rheumatology - Rheumatoid arthritis
The work undertaken in collaboration with the rheumatologists, is another example of 
where the clinicians shared an interest and enthusiasm for research into outcome 
measurement. The study has become involved in a number of pieces of work with the 
clinicians which have explored possible outcome measures in rheumatology. The work 
has been rather opportunistic and has been limited by the resources that the research team 
could devote. Nevertheless some interesting results have been revealed and useful issues 
addressed.
There are five consultant rheumatologists shared between the Freeman Hospital and the 
Royal Victoria Infirmary. In addition to out-patient sessions, which is the focus for most 
work in rheumatology, they have some beds at the Freeman and also work closely with 
orthopaedic surgeons.
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Outcome measurement in rheumatoid arthritis
In the early stages discussions were held with the clinicians to agree a basic data set for 
outcome measurement in rheumatology. The patient group selected was rheumatoid 
arthritis which comprises the bulk of the specialty workload.
Rheumatoid arthritis is a chronic disease that presents some specific problems for 
outcome measurement. The longer term outcomes of treatment of rheumatoid arthritis are 
not especially promising and results after 20 years have shown a general deterioration in 
patient function (Scott et al 1987). Though slightly higher mortality rates are observed 
in rheumatoids (Symmons 1988) the main effects of the disease are pain and a 
progressive loss of function. The measurement of outcomes in rheumatoid arthritis is 
complicated by a number of factors:-
i. The disease progresses over fairly long time scales and loss of function can be slow 
and so the measurement of improvement or maintenance of function is 
correspondingly more difficult.
ii The disease typically exhibits periods of short-term improvement or deterioration.
iii The causes of the disease are largely unknown, and the links between short-term 
clinical measures and longer term health outcomes difficult to trace (McKenna 1988)
iv Rheumatoid arthritis itself can take a variety of forms , and is related to a number of 
other similar inflammatory disease, it may be that the term covers a whole family of 
more specific case types (Woolf 1988).
Despite, or possibly because of, these problems, a considerable amount of work has been 
done in rheumatology to explore outcome measurement (Fries 1983; Thompson 1988). 
In particular, the study of the effects of the disease on everyday function and quality of 
life is well established (Deyo 1988). A simple four point classification to describe the 
degree of functional impairment has been in use since 1949 (Steinbrocker, Trager & 
Batterman 1949).
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The Health Assessment Questionnaire (HAQ), developed by Fries and colleagues (Fries 
et al 1980) and later tested in the UK (Kirwan & Reeback 1986) is a simple scale for 
measuring disability in arthritis and has come to be something of a standard in the Held. 
Other measures have also been widely used including the arthritis specific ’Arthritis 
Impact Measurement’ (ATMs) (Meenan, Gertman & Mason 1980) and the general 
Sickness Impact Profile (Bergner at al 1981). There are also examples of the use of such 
scales in clinical trials (Meenan et al 1984; Bombardier et al 1986; Speigel et al 1986). 
Comparative studies have previously suggested that in this group of patients different 
measures are highly correlated and though favourites can be chosen they behave in 
similar ways (Liaing et al 1985; Fitzpatrick et al 1989).
There is therefore a well-established field of work in measuring these issues with respect 
to rheumatoid patients. There is in addition a number of clinical and laboratory measures 
which are accepted as standard assessment tools. These include:-
i Laboratory measures include haemoglobin levels, rheumatoid factor and erythrocyte 
sedimentation rates (ESR) - the latter being voted in one study 'the most reliable 
single indicator o f disease severity* (Bull et al 1989). However there was little 
evidence of the link between this score and patient health outcomes and such process 
measures have been described as having no inherent value to the patients or society 
(Fries 1983).
ii Measures of specific function eg grip strength, walking time, morning stiffness are 
widely used and tend to be specific to certain joints and subject to some unreliability 
in measurement.
iii Measures of the number and severity of painful,tender and swollen joints often exist 
in the form of an index, for example the Ritchie index (Ritchie et al 1968)
iv Radiographic evidence is sometimes used, for example with scoring systems. However 
these can be very labour intensive.
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Combinations of these measures have been used to classify patients according to the 
severity of disease (Dawes et al 1989) or to measure specific disease activity (Mallya & 
Mace 1981).
Discussion of these various measures were held with the clinicians and a basic data set 
drawn up. One of the basic problems was the gap between the short term measures of 
disease activity which tend to be couched in terms of laboratory and clinical measures and 
longer term measures of outcomes which reflect patient’s function and health. For a full 
evaluation of outcome both types of measure were felt to be important. However the 
collection of data on disease activity is time-consuming to collect. It was recognised that 
additional resources would be required if this data set were to be used as in the other 
specialties.
Cross-sectional comparisons of health status measures
Though the HAQ has come to be something of a standard measure in rheumatology, it 
still has some problems. One is the fact that the results may be affected by disease of 
the upper limb more than the lower limb. A second problem was that if aids were given 
to patients, the scores automatically went up (using one scoring system) even if patient 
function was the same. In addition a concern was expressed over the relative lack of 
sensitivity of the score to changes in very severely ill patients. It was possible that some 
of the alternative general health status measures would prove more useful. Therefore a 
study was undertaken, as a pilot project to examine the use of three measures (the HAQ, 
the SIP and the NHP) in an outpatient population of rheumatoid patients.
More specifically the aims of the study were to :
i. Test whether the instruments could be administered to an outpatient population.
ii. Compare the distributions of scores obtained and in particular examine the ranges of 
scores obtained on the SIP and NHP scales for patients with high values on the HAQ.
Questionnaires were distributed via the outpatient clinic to 100 consecutive patients and
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returned by post in pre-paid envelopes. In total 80 sets of forms were returned (there 
was no chasing of non-responders).
Briefly, the results confirmed that such questionnaires could be given out by staff and 
would be returned by patients with satisfactory response rates. For one-off cross 
sectional studies the methods were satisfactory. It was clear from the scores returned that 
all three measures were sufficiently sensitive to detect health problems in these patient 
groups and that the mean scores on most dimensions were well above those expected in 
a ’healthy* population (results of the NHP are discussed with those obtained from other 
specialties in Chapter 9).
All three scales show generally high correlations with each other. These relationships 
were strongest between the HAQ and those dimensions of the NHP and SIP which 
measured basic function (Table 8.4(a)). In particular ’Pain’ and ’Mobility’ in the NHP 
and ’Ambulation’ and ’Self-care’ in the SIP. Thus with respect to the basic 
physical/functional dimensions of health the measures were in broad agreement.
It was also clear that patients were scoring high on dimensions of the SIP and NHP that 
were concerned with social and psychological problems, dimensions of health that are not 
covered by the HAQ. Table 8.4(b) shows the high internal correlations between the SIP 
categories of ’Social interaction’, ’Alertness’ and ’Emotional Behaviour’ and the NHP 
categories of ’Social Isolation’ and ’Emotional Reactions’. The correlations between 
these dimension and the HAQ are noticeably poorer. Thus it appears the HAQ is failing 
to pick up significant problems that these patients had in these respects.
There was little evidence to suggest that the NHP or SIP dimensions were more sensitive, 
and more capable of showing improvement, for patients with high HAQ scores. In 
particular it was felt that at the high end the HAQ scale the score was insensitive to 
improvements in patients health therefore the variability in NHP and SIP scores were 
compared for patients with low HAQ scores against those with high scores.
The analysis of the distribution of the HAQ and SIP scores for patients with high HAQ 
showed no greater range of values than for patients with a low HAQ score. Thus there
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was no evidence to suggest that, in this population, the NHP or SIP would be capable 
of detecting any more improvements in severely disabled patients than the HAQ.
Table 8.4(a) Correlation coefficients between HAQ and selected dimensions of NHP and 
SIP dealing with basic physical function (nf=80).
NHP dimensions: Pain, Mobility (Hobi)
SIP categories: Self care & movement (S.Care), Ambulation (Ambl)
 NHP- SIP-
Pain Mobi I Total S.Care Ambl Mobi I
HAQ .47 .66 .59 .69 .57 .59
NHP Pain . .60 .63 .54 .49 .44
NHP Mobil - - .67 .66 .60 .58
SIP Total - - .84 .71 .83
SIP S.Care - - - .69 .69
Sip Ambl - - - - .64
Table 8.4(b) Correlation coefficients between HAQ and selected dimensions of NHP and 
SIP dealing with social and psychological function (n=80).
NHP dimensions: Emotional Reactions (EmR) and Social Isolation (Sods)
SIP categories: Social Interaction (Socint), Alertness (Alert),
Emotional Behaviour (Emob), Communication (Comm)
 NHP- SIP-
EmR Sods Total Socint Alert Emob Comm
HAQ .22 .21 .59 .27 .05 .36 .16
NHP EmR - .73 .56 .53 .46 .52 .56
NHP Soc Is - - .49 .38 .36 .35 .58
SIP Tot - - - .76 .56 .69 .55
SIP Socint - - - - .60 .62 .33
SIP Alert - - - - - .51 .34
SIP Emob - - - - - - .50
One explanation for this may be that the outpatient population is, relatively speaking, at 
the less disabled end of the spectrum of rheumatoid patients. Later studies were therefore 
undertaken to address, among other things, whether the same results were obtained with 
an inpatient population.
In-patient follow-up study.
At about the same time this study started, the rheumatologists themselves were examining 
possible audit procedures for the specialty. They developed a fairly sophisticated system 
of identifying goals for individual patients and recording whether these goals were met 
at discharge. The data, along with a comprehensive description of the patients diagnosis, 
was collected on a locally developed computer database.
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It was agreed that the research team would undertake a follow-up of these patients 
approximately one year after discharge. This would be based on a simple questionnaire 
sent to patients that would include the HAQ. The clinical team used the opportunity to 
ask patients about the stay to explore some issue of patients’ satisfaction with care and 
their view of the value of the in-patient stay. The aims of this study were to:-
i Test whether improvements in hospital were matched by improved function at follow- 
up.
ii Validate changes in the HAQ by comparison to other questions on changes in health 
and any problems post-discharge.
iii Survey patients’ satisfaction with the inpatient admission
iv Examine the changes in HAQ after discharge against the goals achieved in hospital.
The questionnaire (Appendix 9) therefore included an additional page with the following 
series of questions:
- Do you feel your stay in hospital improved the state of your health in general?
- Do you feel your stay in hospital improved your arthritis?
- How well controlled do you feel your arthritis is now?
- How often have you felt the level of pain you experience has been unacceptably 
high?
- How well do you feel you understand your arthritis now?
- What do you see as your main problems due to your arthritis?
- Do you have any health problems, other than those due to your arthritis?
- Which social services do you receive?
Patients were contacted using the addresses supplied by the clinical database.
Results
The results of this exercise have yet to be studied in full and the following paragraphs 
only describes those issues discussed to date.
Survival
There were a greater number of patients who had died since admission than expected.
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The exercise revealed a number of administrative problems in identifying when 
patients had died and local information systems were unaware of the fact.
The observed death rates were far higher than regional age and sex related mortality 
rates for the general population would suggest and were a great surprise to the clinical 
staff. Though life expectancy with RA is slightly reduced (Symmons 1988) this 
would not explain the observed incidence. This simple observation of how many 
patients had died within a year of discharge prompted a more specific process of case 
review on the individuals concerned. This was discussed at a rheumatology audit 
meeting. As a result of that review it was recognised that there was a need to 
examine the care of cervical myelopathy in the district and a review is underway. 
This is one example of where a simple piece of information on what happens to 
patients after they leave hospital has been used to examine the quality of care and 
promote practical changes as a result.
Changes in HAQ Score
The results showed that during the inpatient stay the average HAQ score does not 
show any significant change between the initial value of (1.75) and the final value of 
(1.72). Though the average of the scores remained the same approximately 36% of 
cases showed better scores and 27% worse scores from admission to discharge.
When the follow-up scores were examined there was a significant worsening of HAQ 
scores from 1.65 to 1.85 (p=.003). In this group 31% of patients are better and 
51 % worse at follow-up. Fig 8.2 shows the distribution of initial and follow-up HAQ 
scores, and the changes in-between.
General Questions
Patients were asked a series of general questions about the hospital stay and the 
problems they faced. A majority (65%) felt that the hospital stay had improved their 
health, whilst slightly fewer (52%) felt the stay had improved their arthritis. Though 
the answers to these questions are related there were a proportion who felt that the 
stay improved their general health but not their arthritis. When the changes in HAQ
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are examined against these responses the findings broadly agree in that patients who felt 
the stay had not improved their health or arthritis showed greater average increases in 
HAQ score. Patients were also asked to grade (on a scale of 0 to 6) whether they felt 
their arthritis was better controlled, whether they understood their condition better, and 
whether their pain was better. The replies to all three questions showed a broad 
distribution of scores involving both extremes of the scale. The patients views on 
whether their health was any better largely mirror the changes observed in the HAQ, a 
large proportion replied that they were much worse with respect to control of their 
arthritis and pain (Fig 8.3). However the responses did show that patients tended to have 
a better understanding of their condition at follow-up. The responses to the questions on 
pain and understanding of arthritis were related, patients who felt they understood the 
disease scored lower for pain.
The perception of control of arthritis was found to be related to the change in HAQ 
score. Patients who felt the disease was better controlled showing, on average, an 
improvement in HAQ whilst those who felt worse controlled showed larger reductions 
in HAQ (Fig 8.4)
Comparison of health status measures on in-patient population.
The study of health status measurement on in-patients was prompted by the clinical staff 
for three reasons:-
1. The earlier study of outpatients had failed to show the expected lack of sensitivity at 
the extremes of the HAQ. The comparison of inpatients would address a similar 
question for a more severely disabled patient group.
2. Comparison of NHP scores derived from the rheumatology outpatient study with 
NHP scores for other conditions had shown relatively high scores for RA patients. 
This prompted questions over how inpatients would score on the NHP and whether 
changes in health status could be observed.
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3. Nurses on the orthopaedic ward had expressed an interest in the evaluations provided 
by the NHP and suggested they were useful in gaining an overall picture of the 
impact of the disease on the patient’s everyday life. It was thought possible that 
nurses in Rheumatology may also find the instrument useful in this respect.
Therefore a limited study of consecutive RA patients was undertaken using both the HAQ 
and NHP (the SIP was rejected on the grounds that it was too long and produces results 
very similar to the NHP in the earlier study). The ward clerk was responsible for 
identifying the relevant patients and handing out and collecting the questionnaires. 
Completed questionnaires were located centrally in the ward. Some concerns had been 
expressed about the patients views on the confidentiality of the information. Therefore 
an initial pilot study of ten patients was undertaken with the research team interviewing 
patients after completion of the questionnaire. There were no cases when patients 
expressed concern for the confidentiality of the data and they were all happy for the data 
to be collected and stored centrally.
In addition to the questionnaire clinical details of the patients were drawn from the local 
computer data bases to examine the effects of diagnosis, age and sex on the observed 
scores.
Recruitment of patients was stopped after ICX) cases. A follow-up questionnaire was sent 
to patients 3 months after discharge, and this data is now being returned. The results 
have not as yet been discussed with clinical staff.
Early Results
With regard to the use of the NHP by nursing staff, it appears that, unlike in 
orthopaedics, there is little if any use made of the questionnaires.
The distributions of the NHP scores are shown in Fig 8.5. It is noticeable that these 
distributions were not skewed for four of the six dimensions - with the exceptions of 
’Emotional Reactions’ and ’Social Isolation’. The early results showed high correlations
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between the HAQ scores and the NHP dimensions when comparisons were made between 
the initial scores, the follow-up scores and the changes in scores. The largest correlations 
were seen for the NHP dimension of ’Mobility* at admission and follow-up where 
correlation coefficients over 0.7 were observed and the scores for ’Energy’ where 
correlations are greater than 0.4. The weakest correlation are for ’Social Isolation’ and 
’Emotional Reactions’ as observed in the outpatient study. Though correlation coefficient 
between NHP and HAQ scores are lower when the changes in score are compared they 
are still highly significant and suggest that changes in one score are matched, by and 
large, by changes in the other.
Table 8.5 Correlations between NHP, HAQ and changes between admission and three months. 
Significance levels shown uvlemeath correlation coefficients (n=92).
Initial NHP Follow-If NHP Change in NHP
vs initial HAQ vs follow-up HAQ vs change in 1
Energy .4192 .4224 .3526
p= .000 p= .000 p= .000
Pain .2785 .4802 .3206
p= .004 p= .000 p= .001
Emot.Reacs .2693 .2371 .3898
p= .005 p= .011 p= .000
Sleep .2563 .3359 .1736
p= .007 p= .001 p= .049
Soclsol .3078 .2034 .2604
p= .001 p= .026 p= .006
Mobil .7477 .7651 .3551
p= .000 p= .000 p= .000
Partll .1124 .4152 .3468
p= .143 p= .000 p= .000
Combined .5015 .5493 .4546
p= .000 p= .000 p= .000
Both scores show the same picture with regard to the average change between admission 
and the three month follow-up, namely that there is no overall change in the population 
means. Further analysis of this data is being undertaken.
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Fig 8.5 Distributions of NHP scores for In-patient Rheumatoid Arthritis. n = 9 2  
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Conclusions - Rheumatology
The various pieces of work undertaken in Rheumatology have been largely explorative. 
The clinical team have a well established pattern of audit and this work has tried to help 
that in a number of ways. The studies of alternative health status measures have 
broadened the view of outcomes available to the team. Results with the NHP and SIP 
have shown dimensions where rheumatoid patients are scoring highly (indicating poorer 
health) yet are not covered in the functionally based measure of the HAQ. Comparisons 
of RA patients to other case types have also been of interest and have shown the high 
levels of disability among this patient group.
Finally the study has also demonstrated that in the right circumstances, the simplest piece 
of information from a patients follow-up, ie survival, can prompt a productive 
investigation into the quality and effectiveness of care provided.
C. Urology - Prostatectomies
Work with the urologists was once again prompted by their interest in the area of 
outcome measurement. From the start it was made clear that resources were very limited 
and a full scale investigation of outcomes would have to be resourced from elsewhere.
However two pieces of work were completed. One was an exploration of the type of 
dataset required to monitor outcomes of prostatectomies, and the second was a simple 
study of ways to monitor symptomatic improvement in patients.
Outcomes indicators for prostatectomy
Prostatectomy was chosen as the most suitable group for outcome monitoring in urology. 
It formed the most common patient group and represented a fairly standard treatment 
procedure. A number of other studies of outcome of prostatectomy have been undertaken
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yet uncertainty still exists over the benefit that may be expected (Fowler et al 1988, Roos 
et al 1989). The available evidence suggests that the operation is successful in terms of 
symptom relief in 70-80% of cases (Neal et al 1989), though changes in the quality of 
life are less certain (Fowler et al 1988). Recently, outcomes of prostatectomy have been 
the subject of international collaborative studies (WHO 1988) and in the UK a large inter­
regional study has just been completed. The discussion of outcome measures sought to 
exploit this earlier work.
In order to cope with large numbers of patients it was agreed that the data set should be 
kept as simple as possible. The outcome indicators would be based on:-
Symptomatic improvement - using a simple scale developed by Frimodt-Moller (Frimodt- 
Moller et al 1984) which assesses irritative and obstructive symptoms. A patient 
completed version of this scale was devised and tested.
Complications o f procedure - a checklist of basic post-operative problems was developed 
(as in other studies) to be completed by the clinical staff at discharge.
Improvements in health status- The Nottingham Health Profile was selected as an 
appropriate instrument based on evidence of the other outcome studies on elective 
surgical cases in the Freeman Hospital, and from the N. W.Thames/Oxford region studies.
Major events after discharge - it was agreed to include questions covering adverse events 
after discharge including repeat operations and re-admissions in the review of patients at 
follow-up.
In addition key features of the patient on admission and of the process of care were 
considered important and added to the list of necessary data items. These included:
Age
Co-morbid conditions - by organ system
Indications for surgery - Acute/chronic retention, symptomatic, malignant prostate or 
other.
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Procedure type - Trans-urethral, open, or bladder neck incision.
Though the routine collection of data for this outcome study was not undertaken by the 
research team the work was used as part of a successful bid for regional funds to audit 
prostatectomy outcomes in a number of sites. This work is now being undertaken by 
the Urologists. Plans to develop a multi-region audit of prostatectomy are also being 
developed in collaboration with the Royal College of Surgeons.
Assessing symptom status
One of the potential problems in the assessment of outcomes in urology was the 
requirement of clinical staff to score patient symptoms with a scale that was not part of 
the routine practice. Moreover repeating the score at follow-up would require an 
interview by the clinician. It was agreed that it would much simpler, and possibly more 
reliable or accurate, if patients could complete the scale themselves.
A simple patient questionnaire was therefore developed based on the Frimodt-Moller 
scoring system. The questions were worded so as to be as unambiguous as possible 
while retaining the ability to translate back to the original scoring structure. The new 
questionnaire was tested on fifty patients by being given before the operation and six 
months after and then comparing the scores derived from patients with the clinicians 
assessments. Full details are presented in an article submitted for publication (Bardsley 
et al 1991b).
The results suggest that this method produced scores that correlated sufficiently well with 
the clinician based assessment. The scales show significant improvement following the 
operation in the way that was predicted. The patient completed score also showed a 
better correlation with the the patients perception of the success of the operation, than the 
clinical scoring. It is suggested that the use of such a patient completed scale provided 
a much more practical way for developing symptomatic assessments of patient outcomes.
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D. Conclusions - Other Specialties
The studies that have been undertaken in orthopaedics, rheumatology and urology have 
only been reported briefly in this report. Though the data that had emerged from these 
studies is interesting perhaps the main messages from this work concern the possibilities 
for outcomes monitoring in different settings and the interest of the clinicians involved.
These studies have been important in testing both the theoretical and practical work done 
in the main specialties. The resources devoted to data collection in these specialties has 
been less than for the main specialties yet useful results have been observed. The main 
input has been in the process of developing sets of outcome indicators and in the analysis 
of results. In one sense the research team was acting as a resource available to the 
hospital to help various clinical groups develop outcome measurement within their own 
specialties. It was therefore possible to draw on expertise in both the theory and 
practice of outcome measurement that developed during the course of the project. This 
type of role for an ’outcomes office’ which can advise and assist specialties in their own 
development of outcomes would seem to be a useful organisational model for promoting 
such measures.
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Chapter 9 An overview of the results
The previous chapters show the detailed results in the individual specialties and cover the 
choice of outcome indicators, the results obtained and brief descriptions of the ways these 
results were interpreted and used by clinicians.
In contrast this chapter brings together the results from a general perspective and with 
an emphasis on the lessons that might apply to other specialties and other hospitals 
wishing to undertake similar work. The results are presented in three parts. The first 
deals with general observations on the processes of Data Collection and its associated 
costs. The second section gives an overview of the similarities and differences in the 
Outcome Indicators selected and used across the different conditions. Finally the 
chapter summarises some general findings with regard to Using Outcome Information.
A. Data Collection Methods.
Work with seven different specialties during the course of this project has inevitably 
involved a wide variety of data collection methods. Before considering some of the 
detailed issues of which methods worked in which circumstances it is important to note 
some key findings. The first key point is that in all cases some form of outcome 
assessment proved possible. The resources devoted to various projects varied, as did the 
breadth of outcome measures developed but in all cases data were collected which 
enabled longitudinal comparisons in patients’ health to be made in much more 
sophisticated ways than had been previously possible.
A second key point is that outcome assessments can include patients’ assessments of 
their own health. In fact data collection for these instruments proved less of a problem 
than for some of the traditional clinically based measures. There are very few examples 
of situations where such measures have been used in routine monitoring of hospital 
caseload. The results of this study suggest enormous potential for the future.
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A third point is that the scale of data collection depends on the purpose of outcome 
measurement and the resources available. There is no simple answer to the questions 
how should we measure outcomes and what data do we need to collect? The answers to 
these questions depend on why you want to measure outcomes and how much you are 
prepared to pay for the information. The type of data required in a routine monitoring 
system covering a whole hospital will be different from those required to judge the 
efficacy of two alternative treatments.
1. General Models of data collection
Though there were a variety of data collection methods used they did fall into two general 
models (outlined in Figs 9.1 and 9.2) one for specific hospital based intervention 
(typically acute care), the other for monitoring of chronic disease over longer time scales. 
These patterns are related.
Hospital Treatment Model (Fig 9.1)
The health benefits of a particular intervention can be expected to emerge within 
a fairly well defined time period. Thus data collection required a pre-treatment 
baseline assessment of the patient - preferably involving the patient themselves, 
with this basic data being supplemented by detail at discharge and most 
importantly at follow-up after an agreed time period, say three months and twelve 
months. Success was measured by the changes from baseline to follow-up. The 
data were collected from a combination of sources including patient completed 
questionnaires, medical notes or pro-forma from clinicians. Ideally data can be 
extracted from existing computer systems such as the PAS or case mix computer.
Patients who receive the same treatment twice - for example a repeat PTCA cause 
logistical problems for data storage. A repeat procedure will require the first 
episode to be stopped and a new one begun. This effectively means that the 
analysis of results compares interventions performed rather than patients receiving 
the treatment. For those few patients who do receive the intervention twice - the
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fact is recorded as a presenting characteristic for the second episode.
Long term chronic disease (Fig 9.2)
With a chronic disease there may be no clear endpoints, the outcomes are 
therefore typically concerned with maintaining health and preventing deterioration 
and are expressed as marginal changes from one point to the next. The clearest 
example is the annual review process in diabetes where all clinic patients should 
be seen at the Freeman hospital at least once a year. The details of the patient's 
health are captured at each visit and outcomes expressed as longitudinal change 
between them. Determining the link between process and outcome can be 
especially problematic in the treatment of chronic diseases when the disease 
develops over long timescales. It may be that measurement at each point of 
contact (eg out-patient appointment) is not necessary and that comparison over 
defined time periods are necessary. It may be that a subset of an individual 
patient’s visits may have to be selected as the appropriate observation points for 
outcome monitoring. The exploitation of local clinical micro-computer data bases 
is important in this respect. They can fulfil the role of maintaining the register 
of patients, recording some of the basic information (which may be integral to 
most consultations) and then enable longitudinal comparisons across groups of 
patients. In both diabetes and rheumatology there was some earlier experience in 
developing just such data bases.
In many cases patients with chronic disease will experience a stay in hospital. 
These should be regarded as events within the longer term course of treatment. 
It may be that the specific goals of the in-patient episode are studied separately - 
as for example in diabetes in-patient studies. Thus the hospital treatment model 
is more appropriate to examine such changes in the short term.
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Fig 9.1 General Hospital Treatment (In -p a tien t)  data co llec tio n  model
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b. Specific Methods
The various data collection methods used in each specialty were described in detail in 
previous chapters. Table 9.1 summarises some of the tasks required for data collection. 
The methods of data collection were under constant review throughout the course of the 
project and it is difficult to generalise about which methods will be most reliable and least 
labour intensive in any one area. The choice of method clearly depends on the working 
patterns within one area, the personnel involved and the cost/resource commitment that 
can be made.
Throughout, the study has tried wherever possible to use hospital staff to perform the 
data collection - provided this did not disrupt their normal work patterns. As such it was 
reasonably successful in achieving this but it has become clear that outcomes 
measurement of this form will not come about without some resourcing specifically 
devoted to development of that aim. In particular the development of data collection 
systems for outcome monitoring required a process of co-ordination of the various data 
elements as well as the collection of data which was not part of previous assessments - 
for example health status measures from patients. The scale of costs of data collection are 
discussed later.
In addition to this general observation some more specific points about the processes of 
data collection that emerged from this study are:-
* Postal follow-ups of patients showed high response rates and were easy to 
administer even with fairly long questionnaires.
* Patient questionnaires presented fewer problems (in terms of their timely 
completion) than some of the forms completed by clinical staff. The major gaps 
in information coverage tended to be in the clinical information that should have 
been supplied by the doctors. Outcomes assessment based solely on information 
drawn from patients would be far easier in terms of data collection.
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* Retrospective collection of data from case notes is practical if staff are available 
and providing the relevant information was actually in the notes. Straightforward 
items such as brief details of medical history and concurrent problems were 
recorded in some detail. More sophisticated issues - such as the indications for 
cholecystectomy or the severity of a patient’s angina may not be present. 
Substantial amounts of time were spent searching for notes to All in gaps in the 
information. If notes were used then the more recent they were (preferably while 
still on the ward/in the clinic) the less effort involved. There were obvious 
economies of scale in this area, it being far easier to abstract the relevant data from 
one pile of notes than chase notes around the hospital.
The process of collecting data for outcomes monitoring overlapped with other areas 
of information collection. Problems in the current information systems tended to 
produce problems for the outcome review.
Time sensitive information - typically capturing a patient’s views before a 
procedure created problems and requires a relatively high labour input. The 
difficulty was that if patients were not to be missed, admissions to wards had to be 
checked fairly regularly. Attempts at contacting elective admissions before coming 
to the hospital were not successful -though for some hospitals and some case types 
they may well be. Our solution was to have a local contact in the department who 
could monitor all the admissions to the relevant wards and who would be on hand 
to see patients if necessary.
The existing computer systems already contained some important aspects of the 
information required. In diabetes a substantial proportion of the information was 
already being collected on a micro-computer. In orthopaedics the proposed local 
clinical computer system aimed to collect much of the basic outcome dataset. The 
Patient Administration System (PAS) was essential for tracking patients as 
réadmissions or through outpatient appointments. Finally basic information on 
diagnosis and demography was available from the resource management systems
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(though collected independently), although further work would be needed to make 
this routine. It was shown that it was possible to link this data to the outcomes 
database. There are considerable potential benefits from this integration of local 
clinical data bases with the main hospital systems. Among the advantages are an 
improvement in the quality of data to the main systems; the reduction of the 
unnecessary re-inputting of data; and a consistency in data elements across systems. 
More sophisticated systems should also be capable of checking for re-admissions 
(and deaths) of patients treated in a particular specialty.
In a number of cases, the outcomes study required clearer definitions on data items 
that were already being collected. For example in orthopaedics a pro-forma was 
used to formalise and document the assessments made by clinicians.
The identification of whether patients had died between contacts caused problem
in all specialties - as has been noted by others (Walters 1990). In some cases
forms were sent out to patients who had died and this caused unnecessary distress 
to friends or relatives. Therefore a variety of methods were used to check on 
patients survival at follow-up:
- Hospital PAS systems were checked. However it was realised that these 
were not always up to date. In fact project staff have been helping hospital 
information staff by notifying them of any deaths they discover.
- All local health authorities were requested to circulate their notifications 
of deaths to the project office. The intention was to add this information
to a special database in our office. The volume of cases, and the backlog
however has meant that we were only able to deal with Newcastle residents. 
There would seem to considerable scope for improving the co-ordination, 
storage and dissemination of this information, probably at a regional level.
- The name and telephone number of a patient’s General Practitioner is now 
recorded. Where there is a likelihood that the patient may have died these 
were contacted before sending out questionnaires.
- In cases of uncertainty the relevant clinical staff were asked if they had
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any knowledge of particular patients.
These types of steps will be required in many outcome studies.
3. Costs of data collection
It is difficult to answer the question about what the costs of data collected for outcome 
studies will be since they are dependant on a number of factors.
Table 9.2 illustrates the typical expected time spent on data collection in each of the 
specialties. It is clear from this table that the costs vary quite considerably across 
systems. The key factors governing the cost appear to be:
The extent to which data collection is additional to current practice or whether it 
exploits existing staff or procedures. For example the use of a standard pro-forma 
in the diabetes annual review clinic and orthopaedic knee assessments means that 
information collection is part of the standard clinical assessment that would go on 
anyway.
The process of data collection can demonstrate considerable economies of scale. 
The more patients seen the less time per patient.
The physical location and timing of data collection can affect the costs. Comparing 
cholecystectomy with angioplasty, the basic task of checking for patients in the 
cholecystectomy study was more complicated as operations were spread over a 
number of days and possibly wards. All the angioplasties were done on the same 
day and ward block.
The most expensive items were those connected with identifying patients and 
chasing and abstracting information from notes. The rheumatology study was a 
simple comparison of health status measures in which the patients provide most of 
the information.
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Table 9.1 Data C o llec tion  Tasks
Task Possible Staff
Identify patients Check admission to relevant ward or ward block, 
or Check out-patient appointment list.
R Nurse 
Ward staff 
Clinic staff
Give forms to patient and collect Either hand forms+letter to patient directly or 
leave in out-patient department
Research Nurse 
Ward staff 
Clinic staff
Complete clinical pro-forma Collect clinical details direct from patient Clinician
Extract data from notes Transcribe details from notes/lab results to pro­
forma
Research Nurse
Chase forms (and completers) Ensure all relevant forms have been completed and 
chase those that haven't.
Research Nurse
Chase notes Ensure completeness of information from notes Research Nurse
Data input Entry to software Secretary
Check details for postal follow up Check hospital numbers addresses, deaths etc. Research Nurse
Send out follow up Print labels envelopes etc. Research Nurse
Check Returns Ensure all postal forms returned - re-send to non­
responders
Research Nurse
Check database integrity Ensure various entries on data base consistent and 
complete, (occasional validations)
Research Nurse
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Data inputting was not been a great problem. Efforts could have been made to 
improve the speed of inputting software but this did not prove to be necessary 
despite some large data-sets.
The identification of patients in the hospital and making contact with them was 
expensive if the data was to be collected at a certain time during the stay (eg 
shortly before an operation) and for all patients.
Estimates for the inpatient projects with the largest datasets such as the angioplasty and 
cholecystectomy models (collecting pre-operative baseline data, process details and two 
follow-ups) are that with reasonable co-operation from other hospital staff data collection 
time per patient averaged out at around one hour. This hour would include contacting 
the patient and collecting pre-procedure data (25% of time), abstracting additional data 
from notes and co-ordinating forms (25%), inputting the data and doing two follow-ups 
at 3 and 12 months.
A team of one whole time equivalent researcher (say nurse) plus a half time input clerk 
could expect to cope with around 50 patients per week (2500 patients per year). The 
additional costs of just the marginal data collection for this most intensive of the 
approaches would therefore be up to £20,000 per year for roughly 2500 patients (around 
10% of the hospital throughput). In addition some time for analysis of the data would 
be required as well as the initial set-up costs for software and computers. Though 
extrapolating from this limited base is a risky exercise and assuming economies of scale 
balance the overhead costs, it would appear that this most intensive form of data 
collection on all in-patients would cost up to £200,000 per year which for this hospital 
is less than 0.5% of annual recurrent expenditure.
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Table 9 .2  Typical resources required  fo r  da ta  c o lle c tio n .
Task Angio Chole Ortho Geriats Diab
new
Diab
AR
Rheumatol
IP
Typical
Hrs/pat
Max monthly
throughput (No. of patients)
20 20 40 80 20 20 20
Approximate Hours/month
Identify patients 
Give forms to patient 
Complete clinical pro-forma
6
[1]
4
[1]
2
[2]
(10)
[6] Nurses 
[24]Doctors
4
[6]
(5)
{5} 4 .25
Extract data from notes 
Chase forms (and completers) 
Chase notes
10 8 8 - 8 - - .25
Data input 4 4 12 8 6 2 2 .25
Check details for FU 
Send out FU 
Check returns 
Check database integrity
6 6 12 16 8 - 6 .25
Total additional hrs/month 26 26 34 24 26 2 12
Hours/patient 1.3 1.3 0.85 0.30 1.3 0.1 0.6 1.0
[ ] - Non-project staff tasks additional to normal 
{ ) - Non-project staff - pre-existing tasks - not included in totals
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Table 9.3 What information at what cost for what purpose? 
be included from a fixed resource of one and a half wte.
Suggested hierarchy of information sources and rough estimates of the numbers of patients that could
Information No. patients (cumulative 
information) [Extra tasks]
Comments
1. Postal follow-up to patient 
for réadmissions, death
300/week Crudest assessment, less than 10% of cases will show problems, of 
these maybe 1% will be 'interesting*.
Tend to report as individual cases (exceptions)
2. Follow-up health status Q. 200/week
[Extra data input from 1.]
With only follow-up need comparative data to see if scores good/bad 
etc. Will give finer grading of post-op health than 1. though 
interpretation may be the problem.
3. Basic presenting characteristics 
Age, sex, indications 
co-morbid conditions
150/week
[Download from computers?] 
[Note chasing and 
abstraction?]
Important when aggregating results across patients. The indications 
for surgery are critical, other variables less so, but leaving them 
out seems unnecessarily risky.
4. Presenting health status 
(base line for follow up)
100/week
[Trapping patients on admit]
Enables questions like - how many patients are 'better' and how many 
'worse'? In 2. assumed all pre-op scores are the same. 
Interpretation more complex. Need to trap patients before the 
operation- may not get emergency admissions. Strongly correlates to 
clinically more complex cases.
5. Specific symptoms/problems at 
follow-up
100/week
[Extra data input]
Opportunity to check on specific questions at follow-up eg abdo pain, 
vomiting etc. Best as simple yes/no with a clear idea about what the 
answer should be. Save costs by not having a baseline.
6. Post-op complications 
Use checklist.
eg wound infections etc. yes/no
100 /week
[Additional abstraction on 
discharge]
Fairly easy to collect retrospectively (assume major problems in 
notes). We found not too illuminating , a number of transient 
problems are seen which have gone by follow-up.
7. Process data
Pre & Post-op LOS
Theatre time, specific tests etc.
50 /week
[Additional detail abstracted 
from notes]
Not outcomes, but good for discussions.
Address specific questions of variation in resource use vs outcomes
8.Peri-operative complications 50 /week
[Clinician completed form]
Opportunity for surgeons to report things going wrong in theatres 
(predictive of immediate post-op problems). May also want surgeons 
assessment of risk.
9. Specific symptoms/problems on 
admission
50 /week
[Minor addition to patient 
questionnaire]
Baseline values for 5. may not be needed if the items chosen are 
fairly clear cut,. In our studies though we have found it dangerous 
to assume patients will have certain problems on admission
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These costs could be dramatically reduced (or the volume of cases increased) by reducing 
the size of the data set, using more pro-forma completed by the clinicians as they see the 
patient, or more reliance on patient based data. A study using just follow-up data would 
be considerably cheaper. Table 9.3 gives rough estimates for the numbers of patients that 
could be included using different parts of the data collection process and gives some brief 
comments on how the analysis and type of question addressed will vary with the scale of 
data collection. At one extreme are simple follow-up studies using little or no baseline 
data. These would be feasible for large volumes of patients and enable some comparative 
analyses but the interpretation would be difficult. At the other extreme is the fiill data 
set used in this type of study.
B. The Outcome Measures
The study worked in parallel in a number of specialties and sought to develop outcome 
indicators that would be suitable for particular conditions and which might provide 
generalisable lessons about outcomes monitoring across specialties. There need not 
necessarily have been any common outcome measures across specialties yet certain 
common themes emerged.
Tables 9.4(a) and 9.4(b) put most of the measures into a common framework. There are 
many examples of common measures across specialties. The indicators have been 
classified into the following categories:-
- Deaths
- General Health Status
- Major adverse event (réadmissions)
- Symptoms/problems relief
- Treatment complications
- Treatment Success
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1. Commonality/specificity of data items
The study did not aim to develop measures which would be applicable across all disease 
types thus it is not surprising that the data-sets collected in each specialty show some 
differences. In a comprehensive analysis of outcomes such differentiation is inevitable 
and probably desirable (Patrick & Deyo 1989). There will always be the need for some 
measures to describe specific outcomes associated with specific patient types and possibly 
even processes of care.
Nevertheless some common data elements did emerge, for example:- 
Basic administrative, demographic information
Age,sex,date of admission, hospital identifier, address etc.
Recording of co-morbid conditions for acute interventions
Recording peri-operative and post operative complications for surgical procedures
Deaths - during or after treatment but before follow-up
Major adverse events after discharge before follow-up - re-admissions
General Health Status measures
2. Comparisons of health status scores across conditions
A number of different instruments were used to assess health status during the course of 
this study. Different tools were used in the belief that they would be more specific and 
more sensitive to particular conditions. However by the end of the study it became clear 
that there was a considerable interest in using the same instrument across conditions and 
data became available for the use of one instrument (NHP) in almost all case types 
studied (the exception being care of the elderly where administration of the questionnaire 
proved a problem). There are distinct advantages in having one instrument for a range 
of conditions. In practical terms standard methods of administration, scoring and 
interpretation make the collection and analysis of data easier. There is also the ability 
to compare between case types and treatments in a common context - though the analysis 
is potentially difficult.
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Table 9.4(a) Summary of Key Outcome Indicators For Three procedures.
Cholecystectomy PTCA Knee Replacements
Successful care or 
treatment
Surgeon pro-forma
Symptom/problem
General Well Being.
Réadmissions
Death
Other indicators:
Cardiologist pro-forma 
Specifically for vessels 
dilated
Surgeon pro-forma
Treatment complication Pro-forma on discharge
[ Commonly include.. DVT,
Pro-forma on discharge Proforma on discharge (in hospital)
wound infection, urine retention, MI, etc ]
Patient completed questions 
before and at follow up on 
pain,vomiting, bowel function, 
flatulence, abdom. distension. 
Postal follow-up.
Improvement in Nottingham 
Health Profile
Patient questionnaire and 
hospital computer system.
DHA notification, hospital 
computer, postal.
No visits to A&E
Patient completed questions 
on pain, walking distance. 
Angina score from notes. 
Postal follow up.
Improvement in Nottingham 
Health Profile
Patient questionnaire,hospital 
and clinical computers 
Specifically repeat PTCA’s.
DHA notification, hospital 
and clinical computer, post.
Reduce medication
Knee scoring system follow up (3 & 12 mnths) 
Out-patient follow-up.
Improvement in Nottingham 
Heath Profile
DHA notification, hospital 
computer.
No loosening prosthesis
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Table 9.4(b) Summary of Key Outcome Indicators For Diabetes and Care of the Elderly
Diabetes Geriatrics
Successful care 
treatment
Metabolic control via HbAl, 
Body Mass Index, Cholesterol 
etc.
Short-term complications, Angina, 
Blood Pressure.
Alleviation of acute 
medical condition
Treatment complications No admissions for
hypo/hyper-glycaemia
Symptom/problems
General Well Being.
No admissions
Death
Other indicators
Minimal long term complications Improvement in functional 
from consultation pro-forma/ Barthel score against 
existing database eg retinopathy, 
ulcers, nephropathy.
Improvements SIP completed by 
patient in clinic.
individual patient target 
Improved mental test score
Patient asked in clinic and 
hospital computer system.
Patient education/compliance 
tested before/after education
program.
Important discriminatory Age, sex, diabetes type
DHA notification, hospital 
and clinical computer
Minimise burden on informal 
carers (strain scale)
Maintain independence at home.
Medical condition, admission
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Figs 9.3(a) to 9.3(f) present NHP results across the variety of case types we have 
examined. These graphs show the average values on the six dimensions of the NHP. The 
higher values on the scale indicate poorer states of health. Such comparisons within the 
hospital - or to values from the literature were received with great interest by the various 
clinicians concerned. Similar comparisons have been made using a different instrument 
by the medical outcomes study (Tarlov et al 1989).
By and large these results confirm the expected picture and help to re-assure us of those 
dimensions of health measured. In cholecystectomy the dimensions covering energy, 
’Pain* and ’Sleep’ were highest (ie indicating poorer states of health) before the operation 
and show the greatest change. This can be compared to knee replacements where 
’Pain’, ’Sleep’ and ’Mobility’ showed the greatest changes to 3 months. Both the initial 
scores and the residual scores at three months were greater in the knee replacement 
patients as one might expect for patients with chronic problems.
In Figure 9.3(d) the presenting NHP profiles are compared (using mean values) for 
cholecystectomy, knee replacements and angioplasties. Patients about to receive a knee 
replacement showed markedly higher scores on ’Pain’, ’Sleep’ and ’Mobility’ with PTCA 
patients being slightly worse on ’Energy’. ’Social isolation’ consistently scored as the 
lowest of all dimensions.
Figs 9.3(e) and 9.3(f) contrast the NHP profiles for types with lowest and highest average 
NHP scores from the cases studied. In one the high scores of rheumatoid patients were 
clear - with inpatients only slightly higher than out-patients. In contrast the mean scores 
in diabetes (in this case the distributions are very skewed, many score 0) are markedly 
lower. Nevertheless the scores of Type II patients (who are typically older with more 
diabetes complications) showed up higher than those of the sample of patients with type 
I diabetes. A closer examination of these NHP distributions in a population of patients 
with diabetes showed that the scores are very skewed with a high proportion of cases 
scoring zero, it has been found that the scale is able to differentiate between patients with 
and without specific clinical problems (Bardsley et al 1991a).
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NHP for Cholecystectomy
Pre-op and at 3 months
NHP Score
50 - 
60 -
70  1 1 1 1 1 1---
ENERGY PAIN B d T  SLEEP SOCIAL MOBIL
HI 3 months Improvement
Figure 9.3(a) Mean NHP scores and change in NHP score to 3 months 
after cholecystectomy.
NHP for Knee rep Iacments
Pre-op and at 3 months
NHP Score
70
ENERGY PAIN BJKDT.
3 months
SLEEP SOCIAL
 1---
MOBIL
Improvement
Figure 9.3(b) Mean NHP scores and change in NHP score to 3 month a 
fter knee replacement
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NHP for PTCA - Stable Angina
Pre-op and at 3 months
NHP Score
50 -■
60 - ■
70
ENERGY
 1—
PAIN
 1--
EMOT.
3 months
SLEEP
Improvement
 1 1------
SOCIAL MOBIL
Fig 9.3(c) Mean NHP score and change in NHP score to 3 months after 
PTCA (stable angina patients)
nitial NHP for different case types
NKP Score
I  Knee RopI VZA
Figure 9.3(d) Mean NHP scores on admission to hospital for three 
procedures, Cholecystectomy, Knee Replacment and PTCA (Stable angina 
cases)
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Mean NHP scores
Rheumatoid arthr its
NHP Score
70
ENERGY PAIN BvOT.
Rheum IP
SLEEP
Rheum OP
SOCIAL MOBIL
Figure 9.3(e) Mean NHP scores for patients with Rheumatoid arthritis 
(Inpatient and Outpatients)
NHP means
Three different types of diabetes
NHP Score mm.
40 - 
50 - 
60 -
70
ENERGY
 1--
PAI N BvDT. SLEEP SOCIAL
 1---
MOBIL
Type I Type I I Insu I In Type II Diet or Tabs
Figure 9.3(f) Mean NHP scores for patients attending diabetes outpatient 
clinic.
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Thus for example the patients receiving knee replacements probably scored highest across 
all dimensions but in particular on ’Pain’ and ’Mobility’. In fact they scored just slightly 
higher than an out-patient sample of cases with rheumatoid arthritis (suggest more severe 
patients are receiving the knee replacements). The knee replacements continued to score 
highly after the procedure (though there is a significant improvement) which is as one 
would expect from a population with severe chronic disease.
3. Timing of measurements
Ideally, relative outcome measurement should be a cumulative function of health over 
time. However continuous measurement over time is not practical and the assessment of 
outcome has to be based on changes observed between two points in time. The choice 
of appropriate time periods for assessing outcomes can be as important as the choice of 
outcome measures for valid assessments. Results in this study have suggested that the 
best times for measurement vary by condition. Assessing the best time for measurement 
requires balancing when the effects (if any) of the intervention are manifested (beneficial 
and harmful) against changes in health that may occur that are not related to the 
intervention. The longer one waits to assess the effects of the intervention, the more 
uncertainty is created by unrelated events. To answer the question fully requires an 
assessment of the relative sensitivity and specificity of different time periods such as by 
the use of receiver-operator characteristic (ROC) curves (Deyo & Centor 1986). In this 
study the use of 2-3 different time periods does give us some ideas about what may be 
the best time periods for different conditions.
In cholecystectomy the greatest benefit seemed to be observed by three months after 
discharge. Though it was not tested, surgeons felt that observations earlier than this 
would see patients still suffering from minor self-limiting problems following the 
operation. By twelve months some patients will show the effects of health problems 
which are largely unrelated to the operation thus serving to make the measures less 
specific.
In angioplasty, where the patient has long-term chronic disease, though most of the
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benefits were shown at three months, during the following nine months a number of 
adverse events, connected with the condition, rose and substantially altered the picture 
of success. It is possible that such events will continue beyond a year.
In geriatrics, most of the benefit in terms of improvement in functional status occurred 
during the inpatient stay. Significant improvements were observed in patients during this 
time and no significant change in function (for better or worse) was seen after discharge. 
Though this is probably not an appropriate interval for all the outcome indicators - for 
functional status it may be the best way to monitor performance.
Finally in diabetes it was clear that there was a period of beneficial changes in newly 
diagnosed patients which could be monitored either at three months or a year. However 
after this early phase, established cases showed only slow overall changes over 
subsequent years. In this case the minimum of one observation per year after the initial 
diagnostic period seems appropriate to ensure that health status was being maintained.
4. Multi-dimensionality, clinical and patient perspectives
One common thread across work in all specialties was the multi-dimensional view of 
outcomes. Thus success was not measured against a single score but against a variety 
of measures. In this type of study such a multi-dimensional view of outcome is 
recommended. Different outcome measures can have different value and properties when 
it comes to interpreting results and relating outcome to the processes of care (Lohr 1989).
During the course of this study, outcome indicators could be categorised with respect to 
three key properties. Any one indicator can be mapped somewhere onto all three axes:-
1. From clinical perspective to the patient’s perspective
2. Process/proxy measures or direct descriptions of health
3. Vaguely linked to processes of care to strongly linked to care
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The ideal indicator was one that represented the patients’ perspective (that is utility 
expressed by the patient rather than the clinical perception of that utility), was a direct 
description of the patient’s health rather than a proxy measure, and could be closely 
linked to the process of care. No one measure satisfied all these criteria completely and 
different indicators tended to have different combinations of these properties.
Patient vs doctors*perspective.
As discussed earlier, the chosen indicators included different perspectives on outcome - 
most importantly a mixture of the clinical view and the patient’s view. Though the 
incorporation of some type of assessment of how the patients feel was rather novel the 
principle was accepted in all specialties and in time the instruments used were accepted 
as valid.
It might be argued that the only perspective that matters is the patient’s. However this 
would deny the value of a variety of clinical measures which either can be assumed to 
correspond to the patients perception (for example the judgement that amputations or pain 
is undesirable), or that were accepted as legitimate predictors of longer term health 
problems. In these circumstances it may not be possible for the patients to assess the 
relative value of different health benefits, or for the perceived benefits to be measured.
Process/proxy measures vs direct measures o f health:
Similarly during the course of the project the distinction between process measures and 
outcome measures became blurred. At the start considerable efforts were made to 
concentrate on outcomes which were direct descriptions of patient health. A variety of 
strictly process measures eg length of stay were offered and rejected. However in many 
cases measures which were descriptions of process were accepted as proxy outcome 
measures in the belief that they were linked to real patient problems and so the 
benefits/disbenefits of treatment. For example re-admission following surgery, or HbAl 
levels in diabetes. These measures tended to be easier to define and collect and perhaps 
most importantly easier to interpret. In some cases the process measures were claimed
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to best define the goals of a particular service. They were administered in the belief that 
the process would lead to better patient health yet the evidence may have been flimsy. 
Thus for example in diabetes, HbAl levels do not directly affect the patients every day 
life -yet they were very often the focus for determining the types of treatment offered.
Vaguely linked to treatment vs strongly linked to treatment.
The problems of determining the causal links between process and outcome inherent in 
Donabedian’s definition were a common thread across specialties. Though a particular 
pattern of outcome was observed - explaining why it had occurred and how it could be 
improved was not necessarily easy. The causal links between certain processes and 
outcomes may be relatively unknown - which makes the identification of how to improve 
care difficult if not impossible. Thus the general health status measures were accepted 
as legitimate ways of describing a patient’s health - but if a patient failed to improve they 
gave few clues as to the reasons why or how it could be avoided in future. For example 
in cholecystectomy poor performance on the NHP could be due to specific problems 
related to the surgery or other general health problems such as rheumatism or even in one 
case a road traffic accident. On the other hand the clinical measures tended to be more 
useful in this respect. For example a wound infection following surgery gives some 
indication of which areas of clinical practice need to be examined and hopefully 
improved. These differences between measures are important when the question of how 
to use the data is considered.
5. Availability of data
An early goal of the project was to exploit as much of the existing information as 
possible with the important addition of measures from the patient’s perspective. The idea 
was that if the information was important as a clinical description of the patient then it 
would have been collected in some form somewhere. The ideal is when the data is 
already collected on a computer database. Local data from the case mix computer and
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clinical micro-computers was used and such systems hold considerable potential value for 
outcomes information work.
In other cases data was extracted from clinical notes where it has to be admitted the level 
of recording was variable. In some cases the project required data in a standard format 
which was possibly a development and improvement on existing methods. For example 
in orthopaedics a standard assessment of knee function has been used for some time - the 
project merely required the information to be re-organised into a standard format.
C. Using the Outcome Information
This study has sought to examine how outcome information can be used in practice. It 
should be noted that the timescales required for collection and analysis have been very 
short - indeed some of the more complex analyses have only just been performed and are 
now being shared with the clinicians. It is therefore perhaps not surprising that the uses 
to which the information has been put are limited and the results rather mixed. Some 
of the important issues drawn from experiences at the Freeman Hospital are discussed 
below.
1. Clinical support
The results of the questionnaire sent to clinicians (Appendix 3) confirms the view 
developed by the project team that there has been a surprising commitment by clinical 
staff to the project and a desire to see the work continued. All responses suggested that 
the objectives of agreeing and collecting outcome measures have been met and clinicians 
would like, if possible, to continue the study in some form.
The commitment is manifested in resources devoted to the project either through the use 
of their own research staff for collecting and co-ordinating data to involvement in 
meetings to discuss and disseminate results. The conclusion is that in this particular
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setting the clinicians are genuinely interested in assessing the outcomes of their care 
either at the level of individual patients or as groups of patients. Moreover they have 
proved willing to consider relatively sophisticated measurement instruments (though they 
may well be unused to them) as appropriate to measuring outcomes and have found them 
satisfactory. The interest shown by the clinicians in the results are fairly clearly shown 
in their responses to our questionnaire (Appendix 3) which included:
"We are now clear that the data can be collected^ examined against standards and 
that the results can be presented in a usefitl form. All those who have seen the 
analysis found it useful"
"Interesting as it showed elements o f the patient *s responses to treatment we would 
not normally have access to ".
"Enables detailed review after a busy clinic with highlighting o f problems"
At the start of the project the research team were aware of the potential sensitivity of the 
information and were correspondingly circumspect in drawing any conclusions. Though 
it is true that most of the results are generally positive, there were no problems when 
negative results have been presented and discussed. Similarly clinicians were willing to 
share their data to colleagues, managers and in some cases with clinicians from 
neighbouring hospitals.
There were some problems in this area - the most notable being a failure to complete the 
right forms at the right times but these have not proved insurmountable barriers.
On the question of whether clinicians would like to continue to monitor outcomes the 
responses were generally positive the reservations being about the costs of data 
collection
"Yes" (3 times)
"Yes - difficult to know whether it should be seen as a ^project* type approach or 
'routine ' at this stage. Ultimately must be routine but the best measures arid logistics 
(without extra resources) need to be sorted out"
"We are doing. We are also extending the ideas to the Northern Region, and 
nationally and to GPs. "
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"As fa r as is practicable but we do not have the resources in staff/record keeping to 
make a fu ll continuing study practical"
2. Changes in information gathering
In most specialties the project has had some, hopefully beneficial, effects on the way 
information is gathered. The requirements for outcome measurement were for a greater 
degree of standardisation than existed before as well as the collection of some additional 
data which was agreed to be of value to practising clinicians. Examples include the 
recording of main care givers and addresses on discharge in geriatrics and the system of 
standardised knee scores in orthopaedics. In diabetes the ability to examine data 
longitudinally has identified some issues over the calibration of certain tests which would 
otherwise have probably gone unnoticed (Home et al 1991).
3. Changes in practice.
Despite the limited time available there are some examples of changes in practice that 
have resulted from this project.
In diabetes, the change in outcome indicators between successive annual reviews revealed 
results that were worse than expected and changes have been made as a result. The 
initial presentation of their own department’s results came as something of a 
disappointment and there was a feeling that they were failing to meet their own standards. 
The study has changed the clinicians’ perception of the benefit which they give to patients 
and they have identified areas of care in particular need of attention.
It is too early to assess the consequences of these changes but they include:
- new protocols of care for clinic staff
- introduction of formal targeting for individual patients
- increased emphasis on ensuring that clinic staff adhere to the basic recording 
practices
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- replacement of a laboratory assay
- changes in the content of the educational programme
Perhaps more importantly there appears to be an acceptance that it is important to include 
the patients’ perceptions in assessing care. For example the question of whether 
transferring patients to insulin yields the expected benefits in well-being, has been raised. 
This issue is about to be explored further by specifically studying changes in both blood 
glucose control and treatment satisfaction in patients as they are transferred to insulin 
treatment. The department is now committed to continuing a review of its outcomes in 
the widest sense.
In geriatrics there has been an increased attention given to the problems of informal 
carers and attempts to develop a support group. The care giver strain scale (discussed 
in Chapter 4) is being used as a simple screening tool for the nurses to highlight potential 
problem areas.
In orthopaedics, the results have changed the clinicians’ views on the benefits of surgery 
for different groups. For example, the use of knee replacement is shown to provide 
almost as much benefit to rheumatoid patients as it does to those with osteoarthritis. The 
results have also suggested that younger patients appear to fare less well - the reason for 
this is not known and is being investigated further. Anecdotally there is the suggestion 
that some patients have higher expectation of outcome - an area that has not been 
explored but which may need addressing.
In cardiology there have been no significant changes in practice but one issue -the 
decision when to reduce medication is being considered. In rheumatology the use of 
audit data has helped to identify concerns within a particular patient group ie the rate of 
deaths from cervical myelopathy. Steps are underway to develop a more integrated 
approach to care of this particular problems. The value of all the measures in helping 
to shape the practice is also generally accepted.
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In surgery, on the other hand no major changes have resulted. A number of important 
questions relating to the care have been raised but there are no clear indications about 
how to actually improve practice. There would seem to be a number of factors 
contributing to why this should be the case.
It is clear that different specialties have reacted in very different ways. Why? The 
remainder of this chapter attempts to outline some of the factors that in our experience 
are responsible for this variation and which might serve to help or handicap the 
exploitation of outcome information.
a. Interpretation and standard setting
As the indicators were developed so attempts were made to identify standards that would 
describe when observed results fell below the expected standards. In practice it was very 
difficult to identify explicit standards in anything but general terms as the expected 
outcomes of care were often unknown. Thus for example many of the agreed aims were 
couched in terms of improving the patients’ condition from the baseline or having 
minimal adverse events. Of course in practice what emerged was that some patients did 
not improve and that adverse events were observed in a small but significant proportion 
of cases. In diabetes where explicit values were used - drawn from the literature - it 
became clear that expecting all patients to achieve these goals was too optimistic. A 
more realistic standard would be to say that x% of cases will achieve a given goal.
Comparisons to values in the literature were fraught with possible problems of differences 
in case types, context or process. Though they were used, they could not be considered 
as hard and fast bench-marks. Having studied outcomes for 1-2 years it now becomes 
possible to identify more appropriate norms.
The development of realistic standards therefore required a period of preliminary data 
collection and analysis - effectively one turn of the audit cycle. The novelty of the 
measures means that other projects in outcomes monitoring will experience similar 
problems. This has implications for studies where the goal is not continuous monitoring
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but a snapshot of the outcomes achieved since a realistic assessment of whether the 
results are ’good’ or ’bad’ will be that much more difficult to make. The outcomes 
information seemed most effective when there was a surprise value - typically when 
results were far worse than expected. In this cases there was clearly some kind of 
implicit, or explicit, benchmark being used to assess results.
The availability of comparative data within and across hospitals can ease these problems - 
especially if sufficiently large variations in outcomes are is observed. By the end of the 
project it was clear that any comparable data would have been welcomed and could have 
helped identify areas where practice could be improved.
b. The value o f different indicators - causality and information
The previous section discussed how different indicators have different merits with regard 
to their ability to reflect directly patient’s health, the patient’s perspective of their well­
being and be associated with a process of care. Considering the discussions across all 
specialties it is clear that in order to prompt questions and suggestions about how 
improvements to care are to be made, then the issue of causality is important. Whilst 
the general principle that health status measurement reflects the care provided is accepted, 
these measures proved among the most difficult to interpret in terms of how clinical 
practice affects the results and there tended to more interest in indicators which were 
under closer control. For example short term levels of blood glucose control in patients 
with diabetes are felt to be easier to control than the long-term complications of diabetes.
Some of this may be due to the novelty of the tools used. Considerable efforts have been 
made to examine the relationships between the clinical measures and the more general 
health status measures and confidence in the latter has undoubtedly grown during the 
course of the study. We also have to admit to some initial scepticism about these tools. 
But it is now clear, for example, that if you wanted to measure anginal pain, a more 
reliable indication is obtained from a dimension of the NHP than the standard clinically 
accepted angina classification.
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The least useful part of the outcome indicators tended to be those sections of health status 
measures dealing with psychological or social problems (though it is fair to say that 
generally these scores were lower). This may be just a reflection of the case types used 
in this study.
One of the consequences of using such general health status measures in patients with 
chronic or concurrent diseases was that the scores may reflect the effects of a disease 
process that is unrelated to the treatment process. For example a patient with arthritis 
might be expected to score highly (ie indicating ’poor health*) after a cholecystectomy 
irrespective of the relative success of the surgery as their arthritis will remain a 
significant health problem. The positive side of this is that it potentially enables one to 
assess the effect of the intervention in the context of all the health problems that the 
patient faces. Patients undergoing knee replacements showed a marked improvement in 
NHP scores - but they also have high residual scores as a result of their arthritis. The 
negative side is that this may mask the beneficial effects of the treatment and clinicians 
may feel that the effect of these other disease processes are beyond their control.
On a number of occasions during the project discussions centred on the psychological 
profile of the patients and the subsequent benefit. One problem discussed in orthopaedics 
was the patient whose knee was working adequately yet they were unwilling to exercise 
it and improve their lifestyle. Similar discussions in cardiology concerned patients who 
were unnecessarily cautious about their condition and let it limit their lives far too much. 
The problems were seen to be in identifying such cases in advance and the ethics of 
possibly targeting care to those patients who would benefit most.
c. The search fo r truths
The limitations on the conclusions that can be drawn from this type of outcomes study 
were discussed in the first chapter. Throughout the project it has been clear that non­
controlled studies which cannot assess ’what would have happened anyway’ cannot 
identify the most effective model of treatment. What they can do is to identify where
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goals are not being met or that variable x is associated with worse results, or to permit 
the comparison of two processes through post-hoc analysis. Such statements can act as 
the starting point for more definitive research or analysis or as a way of refuting 
currently held but misguided beliefs (eg that rheumatoids do not beneAt from knee 
replacements; reducing length of stay affects patient outcome).
One of the implicit benefits of monitoring outcomes has been not just the identification 
of particularly poor outcomes that require improvement - but also the recognition of when 
a particular area of care is not felt to be a problem. In cholecystectomy the rates of post­
operative complications were felt to be in line with those expected. Though some wound 
infections were observed it was not felt to require remedial action. One would hope that 
the effect with then be that, for example, future discussions on installing new laminar 
flow systems in theatres etc. will bear these results in mind. There are many areas in 
which a better knowledge of outcomes might support the status quo and be inferred as 
a positive result for this project.
A note of caution was required in many instances where it was felt that because we were 
looking at outcomes of care, we would necessarily identify the best treatment process. 
As mentioned earlier, a routine monitoring system may not enable such comparisons 
though if desired it is possible to formulate specific research questions with more specific 
methodologies - within the basic framework of outcomes monitoring. This would 
probably have helped in the analysis of results. In particular there seems scope to 
employ outcome measures in comparative studies over time to evaluate particular service 
changes that may be taking place.
d. Role o f audit and management
It became increasingly clear that to make best use of the results there was a need for the 
sort of critical questioning environment that is to be found in good medical audit (Shaw
1989). There is the danger that outcomes information merely becomes ’interesting’ 
without necessarily guiding improvements in the service. Similarly for the outcomes
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information to be used as part of the management process, at the level of consultant firms 
or specialties, a link is needed between the local priorities and management issues being 
considered.
e. Uncertainty o f efficacy or uncertainty o f technique.
One general observation on the potential effectiveness of the outcome information was 
that it appeared more useful where there was recognised uncertainty over the value of a 
particular intervention or the choice between techniques.
It has been argued that clinicians will only be interested in outcomes measures if they 
look good. We would not support this view. Though it is undoubtedly easier to defend 
the NHP if it changes some of the results in the right direction, even negative results 
have been accepted.
f .  Links between access, appropriateness and treatment
A recurrent theme in many of the outcomes review meetings was the importance of the 
patient’s condition before the treatment began. In cholecystectomy, angioplasty and knee 
replacements, the key issues as perceived by the clinicians was about choosing which 
patients were to have the procedure rather than the technique used. In order to maximise 
outcomes it was recognised that the selection of patients was critical. The issues involved 
for each of these conditions are all slightly different. For cholecystectomy the decisions 
were about the additional dangers of surgery when judged against medical management 
of the symptoms in certain high risk patient groups ie elderly and those with complicating 
conditions. In orthopaedics the choice was who would benefit most from being taken off 
the waiting list to use a scarce resource. In angioplasty questions were whether the 
patient would benefit more from a PTCA, than from surgery or medical management.
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g. Alternative methods o f presentation - individuals vj groups vs exceptions
A number of different methods of presenting the information were possible. Specifically 
outcomes could be reported as :
- Individual patients.
Data can be presented by individual patient either as a summary listing or as 
additional information in the clinical notes. Though this was used in some 
circumstances it was not done generally for all patients. However there is 
considerable potential if the approach could become part of the clinical information 
available say in the notes. There are a number of ways in which those could be made 
possible, though the resources to do it were beyond the scope of this study. It should 
however be noted that there are considerable similarities between local clinical 
databases and the outcome data used here and that in an ideal world a single system 
would feed both approaches.
- Changes in groups of patients
Most of the results were presented as changes in groups of patients - subdivided by 
relevant key variables where necessary. Throughout the study there has been a need 
to reconcile the clinicians* tendency to think of individual patients, with the results for 
groups of patients. The groupings used for analysis are critical and considerable 
efforts have been put into exploring the relationships between the presenting 
characteristics of the patient - effectively the grouping criteria - and the observed 
outcomes. This is particularly important in developing indicators that are comparable 
across time and across sites. In general the relationships between these presenting 
characteristics and outcomes were not as strong as originally thought. In many cases 
variables that one might expect to have predicted worse outcomes - for example the 
level of co-morbidities - did not have a strong effect on the population of patients as 
a whole.
271
- Exception reports of patients with ’poor’ outcomes.
In some specialties patient-specific reports were collected on patients who had ’poor’ 
outcomes and these were discussed individually. This exercise was useful in that it 
helped the understanding of the group results by having individual case histories. 
However it was not effective as a means of identifying generalisable conclusions either 
about those patients or about the way care was delivered. Explanations tended to be 
of the form that - ’that was a difficult or unusual patient anyway and there was little 
else we could do’.
h. Analysing the data
One of the reasons that this study extended beyond its original brief was that there was 
a genuine interest in exploiting the resources that the project had available. Apart from 
the growing experience in agreeing and collecting outcome indicators there were also 
some additional basic skills such as in computing and analysis and interpretation of data 
available.
In concluding this chapter, it should be noted that the timescales for developing the 
outcome indicator, collecting the necessary data and reporting back the results have been 
rather short (under three years). The necessity to develop a confidence in the behaviour 
of the outcome indicators requires both satisfactory sample sizes and some basic 
understanding of the natural variability of the measures. The study has shown a variety 
of methods of data collection and given some valuable lessons in how others might 
proceed towards outcome measurement if they wish. The ability to translate observed 
results, in terms of outcome, into practical steps to improve performance is clearly not 
simple yet an understanding of the issues is important if outcome information is 
ultimately to prove of value. Despite the limited timescales this project has provided 
some useful pointers and generated a genuine interest amongst the clinicians in applying 
outcome measures. The next chapter discusses some issues concerning the wider 
application of these results.
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Chapter 10 Conclusions
This study has shown that through working closely with clinical staff in a variety of 
specialties it is possible to develop sets of outcome measures which are accepted as 
legitimate indicators of performance. Moreover data for the monitoring of these 
indicators has been collected and the results usefully discussed with clinicians and, to a 
lesser extent, managers. The project has also shown that in some circumstances the 
presence of the outcome information has prompted changes in the way care is delivered 
and the quality of the service assessed. In the longer term there is considerable potential 
for exploiting outcome information at a local level in helping with a variety of issues in 
both clinical practice and in the operational and strategic management of health services. 
Though there are a number of practical and theoretical problems in the effective use of 
outcome information but they do not constitute insurmountable barriers.
The outcome indicators used at the Freeman Hospital are relatively sophisticated and 
contain a certain amount of redundancy of information. More streamlined data sets can 
be envisaged as a result of this developmental work. Specific issues will require subsets 
of the indicators used in this study. The purpose of outcome measurement and the 
resources available for measurement will largely determine the indicators chosen.
A. Relevant dimensions of outcome in secondary care
It is possible that the outcome indicators developed at the Freeman Hospital may not be 
accepted by clinicians in the same specialty elsewhere. However, experience to date 
suggest that others would produce broadly similar indicators. One example of a wider 
consensus approach is that being adopted by the Royal College of Physicians working
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party on functional assessments in the elderly which is in the process of identifying 
outcome indicators which will hopefully be acceptable to the profession as a whole. The 
problems this group faced were similar to the ones experienced in Newcastle, and the 
conclusions largely the same. They agree on the use of the Barthel test, the abbreviated 
mental test and some measures of accommodation status. The issue of a general quality 
of life measure, appropriate for this group of patients, has yet to be resolved.
Similarly the basic indicators in diabetes seem to be largely accepted in a number of 
different settings. Work in Newcastle has shown how they can be applied to GP care 
of people with diabetes. In this study the basic indicators of metabolic control and 
clinical complications are largely the same as those used with the Freeman Hospital 
outpatient population.
One further example of agreement on approaches to outcome measurement, is the issue 
of the use of generic health status measures. Here again the consensus seems to be that 
if possible these measures should be included. The most popular general tool in the UK 
still seems to be the Nottingham Health Profile - despite the debates over its derivation 
and weighting. In the US a similar instrument, the SF-36, is gaining widespread support 
and is being applied in a variety of settings. In fact there exists an organisation to 
promote the use of such outcome tools and to encourage the sharing of data (Inter-study
1990).
Though this project has purposely not used measures of patient satisfaction, it is being 
increasingly accepted that some measure of patient satisfaction is appropriate for a 
comprehensive evaluation of quality (Maxwell 1984; Cleary & McNeil 1988; 
Kerruish,Wickings & Tarrant 1988). The rationale behind this is that the objectives of 
care should include the aim of maximising patient satisfaction - independently from the 
health outcomes or technical quality of care offered. Beyond this lie the largely 
uncharted territory of issues concerning the relationships between the technical outcomes, 
patient expectations and patient satisfaction.
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Fries (Fries 1983) described outcomes in terms of the five D’s -death, disability, distress, 
drug side effects, and dollars. The classification that has emerged from this project is 
not surprisingly similar but its focus on the effects of interventions in a hospital give it 
a more specific flavour. (Dollars are not relevant in the UK context as for the most part 
patients do not incur direct financial loss as a result of care).
Most of the range of outcome measures used in this study can be classified under the 
following headings:
- Deaths and survival
Though the observed rate at which patients die varies enormously across 
conditions, in most settings survival is a critical outcome measure.
- General Health Status
The benefits of care should result in a marginal improvement in health status as 
perceived by the patient. The improvement may be expressed relative to a baseline 
value before the intervention or to the expected change that would occur without 
intervention. In some cases good outcomes may be about maintaining health status 
in the face of a chronic disease process.
- Major adverse events after discharge
Following treatment there are a number of possibly serious health related events 
- typically indicators of worsening patient health - which can be used as realistic 
proxies of outcome. The obvious example is re-admissions (which as this study 
has confirmed is associated with worse health) Others may include visits to 
accident and emergency suites, other treatments, for example CABG surgery 
following angioplasty in stable angina patients.
- Symptoms/problems relief
Some outcomes may be expressed in terms of the relief of specific patient 
symptoms or problems, for example anginal pain following PTC A, flatulence 
following cholecystectomy.
- Treatment complications
Treatment may produce adverse consequences over a short time period. The lower 
the incidence of these problems the better the outcome. For example wound
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infections following surgery, drug reactions etc.
- Treatment/technical Success
In some circumstances the successful administration of the treatment itself can be 
considered an outcome - though it is also a process measure. The best example 
from this study is dilation of vessels during angioplasty.
These categories overlap slightly but they are a useful framework for considering the 
variety of outcome measures in the different specialties.
B. Possible roles for outcome measurement
Chapter 1 discussed some of the different applications of outcome measurement within 
the health service. The relevance of this work and extensions to it can be considered in 
a variety of contexts. The following sections consider these different approaches 
including the use of outcomes measurement in terms of the care of individual patients, 
in audit, in resource management, hospital management and in the contracting process.
1. Outcomes in management of individual patients
Clinical measures
The study has tried to build on a variety of measures that are currently used to assess 
patients in everyday medical practice. As such it could be said that some aspects of 
outcome measurement is already part of the way medicine is practised. However it is 
clear that a formal recognition of these indicators and their measurement may enhance 
the assessment of patients on an individual basis. One example form this study is the 
identifications targets for HbAl in diabetes, the behaviour of measures across the clinic 
population and value of showing longitudinal changes in the individual. One of the 
potential improvements to the diabetes project is to reinforce this aspect of the study by 
presenting the collected information on individual patients perhap as a summary patient
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history in a simple form which is presented to the doctor when confronted with a 
returning patient in a clinic. Such developments require local clinical databases to handle 
and format the necessary information longitudinally and will require a consistency in the 
way data is recorded.
For acute interventions, the potential value of the additional information collected in this 
study is to act as a monitoring screen on patients. In some cases follow-ups beyond the 
normal outpatient visit can help identify when a particular patient problem requires more 
attention. This is not to suggest that patients should never be discharged from a hospital 
consultants’ care, but rather that outcome monitoring could potentially act as a way of 
screening for post-treatment problems, and in some circumstances one could speculate 
that this could be an acceptable alternative to an outpatient visit to hospital.
Using General Health Status Measures
The use of individual health status instruments as part of medical assessments of patients 
has been recommended in some quarters (McEwen 1988) though there is limited practical 
experience.
One study has developed a series of charts designed to assess the health status of the 
patient whilst present in the physician’s office (Nelson et al 1990). One particularly 
ingenious approach to data collection has been to use a version of the questionnaire 
which can be completed by the patient whilst waiting, read by an optical mark reader 
machine and results given to the patient and clinician, and stored for longitudinal analysis 
(the technology is being tested in Boston by Ware and colleagues - pers. comm).
The appeal of such measures of general health status is that they can widen the clinician’s 
appreciation of what will constitute a real benefit for the patients and avoid the danger 
that short term clinical success is sought at the expense of long-term patient benefit (the 
problem of ’the operation was a success but the patient died’). Thus a standardised 
instrument is supplementing the subtle assessments that clinicians already make (or should 
make), or acting as a screening tool to highlight potential problems. Some have suggested
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it possible that such measures become part of the process whereby patients themselves 
learn to assess the likely risks and benefits of treatment and take a more active part in 
evaluating proposed treatment plans (Wennberg 1990).
The use of standardised scales can also provide a more objective and reliable assessment 
than informal methods. The use of standard measures of patient function has been 
advocated in care of the elderly (Dickinson & Young 1989) and in this study there was 
a period when the use of such a scale was felt to be helping focus inter-disciplinary 
discussions in geriatrics.
Similarly the use of the Nottingham Health Profile of individual patients in orthopaedics 
generated interest amongst the nurses who found the questionnaire a useful way to assess 
the effects of the disease on the patient. Other than these examples the project has not 
explicitly sought to present changes in health status measures on individual patients - most 
analyses have been of groups of patients. When individual scores have been presented 
they have tended to be part of the summaries of patients whose outcomes were poor (in 
which role they were generally consonant with other data items).
There are considerable uncertainties about how far these types of measures should 
become part of everyday clinical practice. It may be that they are no better than the 
assessments already made by experienced doctors as Hopkins has suggested
"Experienced physicians predict with fa ir accuracy which patients will do well and 
which will do badly. The head-shaking that goes on over the coffee in sister*s 
room presumably reflects the unconscious assessment o f comparatively simple 
clinical variables and their relation to probable outcome that are more formally 
dissected in scales o f functional status"
(Hopkins 1990 p51)
Our experience would make us less confident on this point especially for acute 
interventions - if only because the progress of patients beyond their follow-up 
appointments are largely unknown.
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2. Outcomes in clinical audit - local and national
The findings of this study have great relevance in the area of the development of 
outcomes monitoring in clinical audit. Audit processes typically require similar 
conditions as outcome measurement, namely a local commitment of resources and local 
skills in storing and analysing information, and therefore lends itself to the development 
of outcome measurement. Indeed we would suggest that the addition of outcome 
measures can increase enthusiasm for the audit process itself and add considerable 
interest. It is also likely that a combination of process and outcome measures will 
provide the most fertile environment for improvements in the service. Both the Royal 
Colleges of Physicians and of Surgeons are encouraging audit and welcome the addition 
of outcome measures at local or national level (Hopkins & Costain 1990). This does not 
mean that just because a particular local audit process includes outcome measures it will 
necessarily be successful, it will still require the type of supportive environment outlined 
by Shaw & Costain (Shaw & Costain 1989).
The limitations on analysing uncontrolled comparisons of outcome must be borne in 
mind. Outcome evaluation at one site cannot determine what is the best treatment or 
what would have happened without treatment. The value of the information critically 
depends on the extent to which observed outcomes can be related to the desired standards 
of care and whether the information can be interpreted in such a way as to identify 
current problems in the service or potential for improvement.
3. Outcomes in resource/local management
Moving away from the purely clinical area, what prospects are there for the relatively 
sophisticated outcomes measures used in this study becoming an important part of local 
health service management? Such moves are seen as being generally desirable but not 
without problems.
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A good relationship between the clinicians and other managers will be even more vital 
in the future NHS. Given the uncertainties over the choice of outcome measures and 
skills needed in their interpretation, there is an important role for the clinicians in 
helping to establish the local validity of any results. Our experience has been that they 
can contribute considerable enthusiasm to the process. A top-down imposition of the 
criteria for outcome assessment is likely to meet strong opposition from the clinicians or 
at least apathetic disinterest. The history of performance indicators, which include some 
outcome measures, points to important problems in this respect (CASPE 1988) in the 
uneven use of information within the service and the perceived value of that information.
An extension of the approach to outcome measurement that was developed during this 
project would seem to have much potential. Thus outcome indicators would grow by 
agreeing local indicators within specialties, formalising these within the resource/local 
management structure and using the indicators in concert with other information on costs 
to address issues broadly relating to the best use of resources.
It is possible to envisage a monitoring role for outcome measures in this context. In 
particular they could be used to examine the relationships between patient outcomes and 
changes in the organisation of the service. This can be in the form of ensuring that 
resource or organisational changes do not have negative consequences , as well as 
checking that changes deliver the health benefit that was envisaged. The availability of 
the technology for outcome measurement should permit more sophisticated evaluations 
of different options to be undertaken. For example the growth of day surgery may be 
accompanied by a program of outcomes monitoring to ensure that care is to the standard 
required as throughput increases. Similarly the effects of reducing lengths of stay could 
be monitored in the same way.
As with much other management information it may not be possible to identify hard and 
fast truths about the best way to deliver care but it should enable the quality of evidence 
presented and debated to be improved. In the theoretical sense it may also be that
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outcome information can help clinicians and managers to identify common priorities and 
objectives between what are often disparate and competing factions within the service.
4. Hospital management
Beyond the local management of resources at the level of the specialty or clinical team, 
there is a broader aspect to outcome management that can be considered across the whole 
hospital. Is it possible to envisage outcomes management being used to address issues 
at the hospital level?
a. Monitoring individual services/specialties
It is possible to envisage an extension of outcome monitoring at the level of individual 
service or departments to a system that considers information at a more aggregate level 
across the whole hospital. The role of the hospital management in this respect would be 
to support the individual departments in operating at the standards of outcome they have 
determined for themselves.
Using the degree of detail employed in this study would not be feasible (too much data 
and probably too expensive) and there would have to be agreed mechanisms for 
summarising outcome indicators or presenting tracer indicators for tracer conditions. 
Systems might be based on high-level indicators with a wide coverage of case types 
collected all the time, leaving detailed information to be used in specific circumstances.
b. You can’t have all o f the data all o f the time
It may be that different levels of information become available to different levels of 
management within the service. Comprehensive monitoring of all the indicators is likely 
to be too impractical and expensive. However a combination of general indicators 
applied across the whole hospital and more specific indicators for selected conditions 
could prove valuable. There are a variety of ways of selecting the areas for in-depth
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analyses:
1. Specific indicator conditions or tracers could be used as examples within one 
specialty.
2. Poor outcomes , as seen from the general figures, could prompt investigations in 
specific areas.
3. Issues could be selected which were relevant and of major importance to resourcing 
decisions eg scale of risk, scale of costs.
4. Areas could be selected on the basis that there was a lack of knowledge of their 
outcomes.
5. Specialties could be part of a planned programme for particular scrutiny - maybe 
as part of a hospital wide plan to cover all the major case-types every few years.
c. Differential Resource Allocation.
The ethics and practicalities of differential resource allocation to specialties or particular 
programmes of care on the basis of their outcomes achieved raises difficult questions. 
Could and should hospital management decide to spend money on angioplasties because 
they yielded a greater net benefit than knee replacements? Such questions encompass the 
issues of the balance between the breadth of services offered as well as the marginal 
utility of investment in particular programmes of care.
Questions on the relative efficiency of health investments are dear to the heart of 
economists who have developed the concept of comparative costs per QALY to guide 
such decisions (Williams 1985, Gudex 1986).
The assessments used in this study have been multi-dimensional and have purposely not 
sought to distil the different indicators of outcome into a single unitary measure. Leaving 
aside the technical (Rosser 1990) and moral (Smith 1987) arguments over the QALY 
(including the question of whether benefit to the health service is directly equivalent to 
the linear sum of individual patient utilities) there are problems simply trading off 
outcomes for one condition against those of another. Where there are different indicators
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in different specialties, comparing the relative improvements in a functional knee score 
after knee replacement with the rate of coronary artery bypass surgery after angioplasty 
tells little about the relative value of the two procedures. Some common measurements 
have been used, including the marginal change in health status. In some cases it may be 
inappropriate to consider the benefits of treatment solely in terms of an immediate 
improvement in health status - as for example in angioplasty where the avoidance of 
myocardial infarction in unstable angina patients is considered relevant.
One problem arises in assessing changes operating at the margin of current practice. 
Observing that one elective procedure yields greater benefit than another (on the same 
yard-stick such as the NHP) only reflects current practice in terms of the nature of the 
treated patients and the techniques used. It does not necessarily mean that a marginal 
increase in volume will necessarily deliver the same benefits. For example increasing 
the volume of angioplasties would change the nature of the presenting population of 
patients - possibly the procedure will be carried out on less severely ill patients. Will the 
average benefit per patient be the same with the new case mix receiving treatment - not 
if the general observation that the sicker you are at the start the more your ’benefit’ holds 
true.
Perhaps more importantly it will not say whether reducing the rate at which an 
intervention is given will proportionately reduce the benefit or avoid disbenefits. To take 
an extreme example, stopping cholecystectomies would potentially lead to fatalities 
amongst patients who were not treated. Outcomes monitoring of the form used at the 
Freeman says nothing about what would happen to patients if the intervention is not 
given.
A second problem concerns debates around the weighting and scaling of health status 
measures that is contentious. Most of these scales were devised as cross sectional tools 
which weighted different health states according to patient preferences (by some method). 
This does not necessarily mean that a change in health status would be valued in the same 
way by others or by the population overall, nor that the relationships are linear across the
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scale such that say an improvement in pain of 20% is twice as good as one of 10%.
These factors, and others, will certainly serve to blur simple comparisons of relative 
utility between treatments. In practice these types of questions are unlikely to be 
answered mechanistically in isolation from the myriad of other local economic and 
political issues which influence practice. Nevertheless it is likely that outcome measures 
can contribute in some way as part of the evidence that guide decisions about the relative 
benefits of types of care or treatment.
5. Contracting and marketing
In recent months there has been considerable speculation about the possible role of 
outcome measures in the new contracting process. The White Paper placed a greater 
emphasis on developing the quality of care and certainly poses difficult problems about 
how this is to be measured and achieved. District and regional health authorities are 
making plans and proposals are emerging. Not surprisingly the most likely candidates 
at the moment are those indicators based on data that is already collected on a large scale 
(Charlton,Bauer & Lakhani 1984; Middleton 1987).
Is there a potential role for the outcome measures developed in this study here to become 
part of the purchaser-provider contract? It is unlikely that all the indicators used would 
be practicable for this purpose but a subset could be envisaged. The types of outcome 
indicators used in this study might suggest a health authority specify clauses in a contract 
for a type of elective surgery such as:-
- less than 2% deaths within a year
- 95 % of patients to show improvement in health status of x points
- no related re-admissions within 3 months?
Interestingly the Freeman Hospital, which has been given trust status, recognises that 
outcome measurement can be important in its quality assurance programme and in
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attracting potential customers. From the providers point of view outcome measurement 
can be used in internal quality assurance and management as discussed earlier and also 
in attracting providers to place care there.
For hospitals who are the first to develop local outcome measures there is an advantage 
in information terms in that they will be able to say something about the outcomes they 
achieve. This will provide a marketing advantage in assuring purchasers that they take 
quality assurance seriously, and even if the outcomes are less then perfect there will be 
little or no comparable information from other sites. Beyond this stage, it seems possible 
that outcomes information may come to act as rather sophisticated, and potentially quite 
effective marketing tool.
For purchasers there is considerable potential in using some of the outcome measures to 
bring about improvements in quality, though once again problems exist in analysis and 
in interpretation cannot be underestimated. Purchasers face the difficult problems of 
specifying and defining outcomes in a form that can be monitored. At present, even 
using crude measures what constitutes ’desirable outcomes’ are largely unknown. For 
example deaths following elective surgery are undesirable, yet they will inevitably exist 
in some small proportion through no fault of the quality of care given by providers. The 
resolution of what can be considered acceptable would be as problematic as it is in the 
hospital. In such circumstances the ability to compare information between competing 
providers would seem critical.
One of the most difficult problems will be relating the process of needs assessment to the 
resulting outcomes. It was observed earlier that for the acute interventions in particular 
the presenting characteristics can be critical in determining the outcomes achieved. In 
secondary care the admitting health status represents need but the problem for the 
purchaser is in determining the need in its resident population and then relating this to 
the outcomes of treatment that should be expected. This implies the purchaser having 
knowledge about situations where care is not being provided and might require providers 
to monitor additional features of patients attending for care.
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c. Future research agenda
Outcomes measurement in the future faces two conflicting pressures. On the one hand 
is the surge in interest in outcomes measures and the requirements of the organisational 
change in the service. On the other hand are the uncertainties of which measurement to 
use and how to interpret observed outcomes. Roberts has recently produced an action 
plan for the development of outcomes in the UK (Roberts 1990) which is comprehensive 
in its coverage of the issues and provides a useful framework for discussions.
From the perspective of this study the most important issues would be seen as:
Agreement on the dimensions and boundaries o f outcome measures
This project identified appropriate ranges of outcome measures in hospital. Do 
these apply elsewhere? Will different specialties generate indicators of a different 
nature? This study adopted one approach with a high level of local clinical 
participation, gained a high level of support but might be thought to have suffered 
from an over-rich demand for data. Other more top-down approaches would be 
possible but would certainly induce different responses and requirements.
Methodological issues
Despite the widespread agreement on the use of general health status measures 
which represent the patient’s perspective, there is still relatively little experience 
of applying these measures in practice. The operating characteristics of these tools 
are unknown and considerable work needs to be done on their evaluation in a 
theoretical and practical sense. The scales used in this study may not be the best - 
but they have by and large done the job expected of them in the clinical case types 
examined. Would they prove as useful in the rest of secondary and primary care? 
The results from the Freeman Hospital are only a starting point in the assessment 
of how outcome indicators can be derived that will enable fair comparisons 
between centres. There is considerable scope for examining the applicability of 
these measures in other settings and such work if conducted properly could form
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the basis for nationally agreed indicators.
Operationalising outcome measurement and management
This project was organised as an external research team operating within a 
consenting hospital. For the future there are questions about how outcomes 
measurement might fit into the organisation of health services. For example within 
a hospital, there would be advantages in having a central outcomes ofGce to advise 
specialties and co-ordinate data collection and liaise between managers and clinical 
staff. Similarly the questions of how outcome information can be used in hospital- 
wide or purchaser quality assurance mechanisms need to be tackled.
Enabling change in clinical practice
The timescales for examining the effects of outcome information on clinical 
practice were necessarily limited in this study though some changes have been 
observed. This work could be enhanced and further research structured to address 
the important issues of how to turn information into action to improve services .
This research project has exploited techniques from a variety of disciplines - clinical 
medicine, public health, epidemiology, sociology, information science, statistics, health 
service management - in order to explore potential improvements to health service 
management and organisation. It is one of the few projects in the world that has 
attempted to develop outcome measurement within a real hospital setting across a range 
of conditions. As a pilot study it has yielded results which point to considerable potential 
to exploit these measures further within the British health service.
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Appendix 2(a) SICKNESS IMPACT PROFILE - SIP (Subset of complete instrument)
DESCRIBES YOU AT THE MOMENT AND IS RELATED TO YOUR STATE OF
HEALTH.
This set of statements describes walking and use of stairs. Yes
I walk shorter distances or often stop for a rest. [ ]
I do not walk up or down hills. [ ]
I only use stairs with a physical aid - for example, a [ ]
handrail, stick or crutches.
I only go up and down stairs with assistance from someone [ ]
else.
I get about in a wheelchair. [ ]
I do not walk at all. [ ]
I walk by myself but with some difficulty - for example. [ ]
I limp, wobble, stumble or I have a stiff leg.
I do not use stairs at all. [ ]
I get about only by using a walking frame, crutches. [ ]
stick, walls, or hold onto furniture.
I walk more slowly. [ ]
The following statements describe the activities vou usually do in vour snare time -
for relaxation, entertainment, or iust to pass the time.
I spend shorter periods of time on my hobbies and recreation. [ ]
I go out to enjoy myself less often. [ ]
I am cutting down on SOME of my usual inactive pastimes -
for example, I watch less TV, play cards less or read less. [ ]
I am not doing ANY of my usual inactive pastimes -
for example, I do not watch TV, play cards or read. [ ]
I am doing more inactive pastimes instead of my other [ ]
usual activities.
I take part in fewer community activities. [ ]
I am cutting down on some of my usual physical recreation
or more active pastimes. [ ]
I am not doing ANY of my usual physical recreation or
more active pastimes. [ ]
Please Turn Over
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The following statements describe vour contact with vour family and friends.
YES
I go out to visit people less often.
I do not go out to visit people at all.
I show less interest in other people’s problems - for example,
I don’t listen when they tell me about their problems,
I don’t offer help.
I show less affection.
I take part in fewer social activities than I used to - for 
example, I go to fewer parties or social events.
I am cutting down the length of visits with friends.
I avoid having visitors.
My sexual activity is decreased.
I often express concern over what might be happening to 
my health.
I talk less with other people.
I make many demands on other people - for example, I insist 
that they do things for me or tell them how to do things.
I stay alone much of the time.
I am disagreeable with my family - for example, I act stubbornly 
or spitefully.
I frequently get angry with my family - for example, I hit 
them, scream or throw things at them.
I isolate myself as much as I can from the rest of my family 
I pay less attention to the children.
I refuse contact with my family - for example, I turn away 
from them.
I do not look after my children or family as well as I 
usually do.
I do not joke with members of my family as much as I 
usually do
Please Turn Over
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This group of statements covers work that vou do on a regular basis.
YES
I am retired. [ ]
My work has not been affected by my health. [ ]
I do not work at all because of my health. [ ]
I only do housework or work around the house for short periods 
of time or I rest often. [ ]
I do less of the daily household chores than I would usually do. [ ] 
I do not do any of the daily household chores that I would 
usually do. [ ]
I do not do any of the maintenance or repair work that I would
usually do in my home or garden. [ ]
I do not do any of the shopping that I would usually do. [ ]
I do not do any of the cleaning that I would usually do. [ ]
I have difficulty using my hands - for example, turning taps, 
using kitchen gadgets, sewing or doing repairs. [ ]
I do not do any of the clothes washing that I would normally do [ ] 
I do not do heavy work around the house. [ ]
I have given up taking care of personal or household business 
affairs - for example, paying bills, banking and doing household 
accounts. [ ]
Are there any comments you would like to make?
Thank you for your help.
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Appendix 2(b)
NOTTINGHAM HEALTH PROFILE
Listed below are some problems people may have in their daily life. Look down the list 
and put a tick in the box under YES for any problem you have at the moment. Tick the 
box under NO for any problem you do not have.
Please answer every question. If you are not sure whether to say Yes or No, tick 
whichever answer you think is more true at the moment.
YES NO
I’m tired all the time 
I have pain at night 
Things are getting me down
I have unbearable pain 
I take tablets to help me sleep 
I’ve forgotten what it’s like 
to enjoy myself
I’m feeling on edge 
I find it painful to change position 
I feel lonely
I can only walk about indoors 
I find it hard to bend 
Everything is an effort
I’m waking up in the early hours of the 
morning.
I’m unable to walk at all
I’m finding it hard to make contact with
people
The days seem to drag 
I have trouble getting up & down 
stairs or steps
I find it hard to reach for things [ 1 [ ]
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Remember, if you are not sure whether to answer yes or no to a problem, tick whichever 
you think is more true at the moment.
YES NO
I’m in pain when I walk 
I lose my temper easily these days 
I feel there is nobody I am close to
I lie awake for most of the night 
I feel as if I’m losing control 
I ’m in pain when I’m standing
I find it hard to dress myself 
I soon run out of energy 
I find it hard to stand for long 
(eg.at the kitchen sink, bus queue)
I’m in constant pain
It takes me a long time to get to sleep
I feel I am a burden to people
Worry is keeping me awake at night 
I feel that life is not worth living 
I sleep badly at night
I ’m finding it hard to get on 
with people
I need help to walk about outside 
(eg.a walking aid,someone to support) 
I ’m in pain when going up & down 
stairs or steps
I wake up feeling depressed 
I ’m in pain when I’m sitting
Now please go back to the beginning and make sure you have answered every question.
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P A R T E
Now we would like you to think about the activities in your life which may be affected 
by health problems. In the list below, tick YES for each activity in your life which is 
being affected by the state of your health. Tick NO for each activity which is not being 
affected, or which does not apply to you.
Is your present state of health causing problems with your....
YES NO
Job of work [ ] [ ]
(That is, paid employment)
Looking after the house [ ] [ ]
(eg.cleaning & cooking, repairs 
& odd jobs around the house)
Social life [ ] [ ]
(eg. going out, seeing friends, 
going to the pub)
Home life [ ] [ ]
(That is: relationships with 
other people in your home)
Sex life [ ] [ ]
Interests and hobbies [ ] [ ]
(eg.sports,crafts & arts)
Holidays [ ] [ ]
(eg.summer/winter holidays, 
weekends away)
Thank you for your help.
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Appendix 2(c) HEALTH ASSESSMENT QUESTlONNAmE
WE ARE INTERESTED IN LEARNING HOW YOUR ILLNESS AFFECTS YOUR ABILITY TO FUNCTION IN 
DAILY LIFE. PLEASE FEEL FREE TO ADD ANY COMMENTS AT THE END OF THIS FORM.
PLEASE TICK THE ONE RESPONSE WHICH BEST DESCRIBES YOUR USUAL ABILITIES
Without ANY With SOME With MUCH Unable 
difficulty difficulty difficulty to do
1.DRESSING AND GROOMING 
Arc you able to:
- Dress yourself, including 
tying shoelaces and 
doing buttons?
- Shampoo you hair?
2.RISING
Are you able to:
- Stand up from an armless 
straight chair?
- Get in and out of bed?
3.EATING
Are you able to:
- Cut your meat?
- Lift a full cup or glass 
to your mouth?
- Open a new carton of milk 
(or soap powder)?
4.WALKING 
Are you able to:
- Walk outdoors on flat ground?
- Climb up five steps?
PLEASE TICK ANY AIDS OR DEVICES THAT YOU USUALLY USE FOR ANY OF THESE ACTIVITIES:
 Cane  Devices used for dressing(button hook,
 Walking frame zipper pull, long handled shoe horn etc)
 Crutches  Built-up or special utensils
 Wheelchair  Special built-up chair
Otherfspecify).................................................
PLEASE TICK ANY CATEGORIES FOR WHICH YOU USUALLY NEED HELP FROM ANOTHER PERSON:
 Dressing and  Eating
Grooming
 Rising  Walking PLEASE TURN OVER
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PLEASE TICK THE ONE RESPONSE WHICH BEST DESCRIBES YOUR USUAL ABILITIES OVER THE PAST 
WEEK
Without ANY With SOME With MUCH Unable 
difficulty difficulty difficulty to do
5.HYGIENE 
Are you able to:
- Wash and dry your entire 
body?
- Take a bath?
- Get on and off the toilet?
6.REACH
Arc you able to:
- Reach and get down a Sib object 
(eg. a bag of potatoes) from just 
above your head?
- Bend down to pick up clothing 
from the floor?
7.GRIP
Are you able to:
- Open car doors?
- Open jars which have been 
previously opened?
- Turn taps on and off?
8.ACTIVITIES 
Are you able to:
- Run errands and shop?
- Get in and out of a car?
- Do chores such as vacuuming, 
housework or light gardening?
PLEASE TICK ANY AIDS OR DEVICES THAT YOU USUALLY USE FOR ANY OF THESE ACTIVITIES:
 Raised toilet seat  Bath rail
 Bath seat  Long handled appliances for reach
 Jar openerf for jars previously opened)
Otherfspecify).
PLEASE TICK ANY CATEGORIES FOR WHICH YOU USUALLY NEED HELP FROM ANOTHER PERSON:
 Hygiene ......... Gripping and opening things
 Reach................................. Errands and housework
Thank You
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Appendix 2(d) VALIDATION PROFORMA FOR ANGIOPLASTY PATIENTS
Ncune: JG.NW
Date:
BEFORE ANGIOPLASTY
How long have you suffered from anginal pain?
HISTORY OF ?:
MI [ ) CCF [ ]
prev. CABG ( ] PEP ( J
prev. PTCA [ j Smoker ( j
chron.resp.dis. ( ] Hyper.lip. ( ]
How far could you walk each day before operation?
What limited exercise? angina [ ] sob [ ] fatigue [ ] other [
1
What activities brought on your angina?
Unusual strenuous activity.
Walking...... how far.....
Stress,cold or windy, meals.
Climbing stairs (one flight)
Washing,dressing.
»
AFTER ANGIOPLASTY
Since Operation:
Have you been seen at A/E?
Have you been readmitted to hospital?
What medication?
How far can you now walk each day?
What limits your exercise? Angina [ ] SOB [ ] Fatigue [ ] Other
[ ]
Are you more or less active than when you first suffered from angina?
More [ ] Less [ ]
Still suffer yes [ ] no [ ]
If yes -
What activities bring on angina? YES NO
Unusual strenuous activity [ ] [ ]
Walking ( j [ j
How far
Emotion, cold, windy, meals [ ) [ ]
One flight stairs ( ] { ]
Dressing, washing etc. ( ] [ ]
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Appendix 2(e) VALIDATION PROFORMA FOR CHOLECYSTECTOMY 
PATIENTS
Name: J6 JW
Date:
- Introduce yourself....
- What the project is....
- Purpose of visit: - to check people understand questions,
- to see if anything has been missed,
- to find ways to improve project.
- Interview takes approx. 30 mins.
1 /BEFORE THE OPERATION
- When did the symptoms first appear?
- When was gall bladder problem first diagnosed?
- What symptoms were there?
(pain,flat.,dist.,vomit,appet.,fatty,bowels*)
* Probe bowels if reported as a problem.
- How would you rate your overall health?
poor[ ) fair[ ] good[ ] v.good[ ]
2/AT PRESENT
- Did all the symptoms disappear after the operation?
- If not .... - which are still present? *
* Probe bowels if reported as a problem.
- How would you rate your overall health?
poor[ ] fair[ ] good( ] v.good[ ]
3/NEW PROBLEMS
- Have you seen your GP with a complication?
- Have you been readmitted to hospital/seen at A+E since your 
operation?
- Do you have any health problems that you did not have before?
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Appendix 2(f) VALIDATION PROFORMA FOR ORTHOPAEDIC PATIENTS
NAME:
DATE :
Introduction ....
What the project is ......
Purpose of visit:- to check people understand questions.
to see if anything has been missed, 
to find way to improve project
Interview takes approximately 30 minutes.
BEFORE THE OPERATION
What kind of surgery did you have?
new repacement
revision
bilateral
Have you had any other replacement surgery?
What was the extent of your symptons (arthritis) before the operation?
(How many joints affected)
Did you suffer from any other problems?
How would you rate your overall health?
poor [ ] 
KNEE SCORES
fair ( ] good ( ) V good [ ]
BEFORE AFTER BETTER SAME WORSE
Walking pain
Rest pain
Climb stairs
Transfer
Walk/Stand
Assisted by
AT PRESENT
Any problems after the operation?
(how many follow-ups)
Any other health problems?
How would you rate your overall health?
poor ( ] fair [ ] good [ ] v good [ ]
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Appendix 2(g) VALIDATION PROFORMA FOR RHEUMATOLOGY PATIENTS
NAME:
HOSPITAL NUMBER:
DATE:
Introduction:
Explain purpose of study:
Explain purpose of interview:
To identify any problems with questionnaires 
To check people understand the questions 
To find way to improve it, if necessary
Interview will take about 15 - 20 mins.
SECTION ONE - general
1. Do you remember completing the forms?
2. When was it given?
Who by?
3. Do you know where forms are kept on completion?
4. Did this in any way affect your replies?
5. The form had your name on it, did this affect your replies at all?
6. Were there any questions you did not feel happy about 
answering?
7. Did you have any problems completing the forms?
( + NHP eg. DIMENSION 1 - 7 )
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Appendix 2(h) PROFORMA FOR VALIDATION OF NHP IN:
- Cholecystectomy
- angioplasty
- orthopaedics
There are 6 dimensions and a general health section in the NHP. Each 
dimension should be assessed individually, on a continuum of: "none" to 
"high" depending on the degree to which the individual is affected.
Use the prompts to structure the interview, if necessary.
Dimension 1 - PAIN
Prompt - Do you suffer from pain?
none[ ] low[ ] medium[ ] high[ ]
Comments:
Dimension 2 - MOBILITY
Prompt - Is your mobility restricted in any way?
none[ ] low[ ] medium[ ] high[ ]
Comments:
Dimension 3 - ENERGY
Prompt - Do you often feel tired?
none[ ] low[ ] medium( ] high[ ]
Comments:
Dimension 4 - SLEEP
Prompt - Do you have any problems with sleeping?
none( ] low[ ] medium[ ] high[ ]
Comments:
Dimension 5 - EMOTION
Prompt - How have you been feeling lately (eg happy, depressed)?
none[ ] low[ ] medium( ) high[ ]
Comments:
Dimension 6 - SOCIAL ISOLATION
Prompt - Do you ever feel lonely/isolated?
none[ ) low( ] medium[ ] high[ ]
Comments:
GENERAL HEALTH
Prompt - Are there any aspects of your life that you feel are affected by 
your health?
QUESTIONS ABOUT THE FORMS
Do you remember completing the forms?
Did you have any problems completing the forms?
Do you have any other comments about the forms/interview?
Thank you for your time and cooperation.
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Appendix 3 - Response to questionnaire circulated to clinicians
Freeman Outcome study - Questions for clinicians.
The study has been concerned with examining the feasibility of outcome measures and 
the usefulness of that information in informaing practice at all levels of the service.
1. Did you feel that the project achieved these objectives?
Yes. We are now clear that the data can be collected, examined against 
standards, and that the result can be presera in usejul form. All those who 
have seen the analysis have found it useful.
2. Did you find the outcome information and/or interesting? In what way?
1. We have a much greater idea o f the degree to which we were failing to 
meet targets.
2. We have identified areas o f care in need o f particular atteraion (eg. BP/lipids).
3. We have identified a major problem in one o f the most important biochemical 
tests.
3. a) Has the information influenced the way you see the service or provide care?
b) Have there been any changes as a result of this study?
If so, in what way?
If not, why not?
a. We have devised and implemeraed new protocols o f care as a result.
b. We have iraroduced formal targetting.
c. There is clearly a need for more attention to agreed protocols o f care 
by clinic staff.
d. We are to replace the present glycosylated haemoglobin assay.
4. In what ways could the study have been improved?
We could have used more time in diabetes alone - eg for inpatients, new
insulin starters. These projects have only just got going.
5. Do you intend to continue outcomes monitoring in your speciality?
We are doing. We are also extending the ideas to the Northern Region 
and nationally and to GP*s.
6. Has the study helped you in any other ways?
Given a large boost to our general audit activities and expanded our views o f 
what it might achieve.
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Freeman Outcome study - Questions for clinicians.
The study has been concerned with examining the feasibility of outcome measures and 
the usefulness of that information in informaing practice at all levels of the service.
1. Did you feel that the project achieved these objectives?
Yes - mthin the time scale.
2. Did you find the outcome information useful and/or interesting? In what way?
Interesting as it showed elements o f the patientas response to treatment he 
would not normally have access to.
3. a) Has the information influenced the way you see the service or provide care?
No
b) Have there been any changes as a result of this study?
If so, in what way?
If not, why not?
No
I would not expect this to occur with the time scale or without a 
comparative group to assess our results against.
4.In what ways could the study have been improved?
By a "comparative " study using a similar format.
5. Do you intend to continue outcomes monitoring in your specialty?
As far as is practicable but we do not have the resources in staff/record 
keeping to make a full continuing study practical.
6. Has the study helped you in any other ways?
Useful in identifying what is happening and surprising in the apparent value o f the 
Nottingham Health Profile.
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Freeman Outcome study - Questions for clinicians.
The study has been concerned with examining the feasibility of outcome measures and 
the usefulness of that information in informaing practice at all levels of the service.
1. Did you feel that the project achieved these objectives?
Yes
2. Did you find the outcome information useful and/or interesting? In what way?
Yes.
Enables detailed review after a busy clinic with high lighting o f problems.
3. a) Has the information influenced the way you see the service or provide care?
Yes
b) Have there been any changes as a result of this study?
If so, in what way?
If not, why not?
Marked reluctance to operate on younger patients.
4. In what ways could the study have been improved?
Screening predecisions as suitable for surveying the psychological profile
5. Do you intend to continue outcomes monitoring in your specialty?
Yes
6. Has the study helped you in any other ways?
Collated the results without as much involvement.
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Freeman Outcome study - Questions for clinicians.
The study has been concerned with examining the feasibility of outcome measures and 
the usefulness of that information in informaing practice at all levels of the service.
1. Did you feel that the project achieved these objectives?
As o f yet in Orthopaedics still not at our one year objective which will be 
o f value. We have certainly learnt the value o f measurement but require 
fiirther analysis to assess our conclusions.
2. Did you find the outcome information useful and/or interesting?
In what way?
Useful yes furthers the analysis o f result o f knee replacement.
Interesting yes. In our project we have had excellent feedback and initial 
results appear to isolate a subgroup o f patients which deserve further study 
and analysis.
3. a) Has the information influenced the way you see the service or provide care?
b) Have there been any changes as a result of this study?
If so, in what way?
If not, why not?
Yes. See above.
The group identified require further study the determine which particular features 
are common to this group o f young patients having TKR.
4. In what ways could the study have been improved?
Within the restrictions appeared to be reasonably designed as a 
preliminary project. I  think improvements can be made now following our 
initial project.
5. Do you intend to continue outcomes monitoring in your specialty?
Yes
6. Has the study helped you in any other ways?
Improved our understanding o f outcomes study and value.
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Freeman Outcome study - Questions for clinicians.
The study has been concerned with examining the feasibility of outcome measures and 
the usefulness of that information in informaing practice at all levels of the service.
1. Did you feel that the project achieved these objectives?
Yes. Rheumatology project not yet completed but data available has 
prompted re-evaluation o f service.
2. Did you find the outcome information useful and/or interesting? In what way?
Yes. (a) sets diseases in context i f  a * general* health status (eg.NNP) is used.
(b) demonstrates deficiencies in treatment measures for the severely disabled
(c) will allow some rationalisation o f use o f resources.
3. a) Has the information influenced the way you see the service or provide care?
b) Have there been any changes as a result of this study?
If so, in what way?
If not, why not?
(a) Yes.
(b) developing a more integrated service for cervical myopathy (commonest single 
cause o f death)
4. In what ways could the study have been improved?
Given the constraints on time (and resources) available, difficult to see 
another approach that could have been more profitable.
No shortage o f ideas for further studies!
5. Do you intend to continue outcomes monitoring in your specialty?
Yes - difficult to know whether it should be seen as a ’'project" type 
approach or "routine " at this stage. Ultimately, must be routine but 
best measures and logistics (without extra resource) need to be 
sorted out.
6. Has the study helped you in any other ways?
Invaluable contribution from an external group (CASPE) in formulating 
design and analysis o f outcome data.
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Freeman Outcome study - Questions for clinicians.
The study has been concerned with examining the feasibility of outcome measures and 
the usefulness of that information in informaing practice at all levels of the service.
1. Did you feel that the project achieved these objectives?
Yes.
2. Did you find the outcome information useful and/or interesting? In what way?
Useful and interesting.
30% o f patients die from the day o f admission to 3/12 after discharge. I  
should have guessed a lower percentage (as doctors tend to do) but I  am 
not very surprised at the finding as it reflects the multi-system impairment 
and the frailty and age o f many o f our patients.
3. a) Has the information influenced the way you see the service or provide care?
b) Have there been any changes as a result of this study?
If so, in what way?
If not, why not?
Not so far.
a. It will no doubt influence our management, eg. re-admissions to 3/12 
seems very high but again may reflect the frailty and the additional reason 
fo r the last admission. The findings will make us look more closely at the 
reasons for re-admission, and attempt to improve them.
The apparent difference in pattern o f care seems to reflect degree o f  
disability/illness on admission, and perhaps there is a difference in age.
4. In what ways could the study have been improved?
7 am disappointed by the low numbers and incomplete assessment o f care­
givers obtain. We need to improve our information on this aspect o f 
discharge and maintenance.
5. Do you intend to continue outcomes monitoring in your specialty?
Yes
6. Has the study helped you in any other ways?
It has focussed our attemion on what we are doing and will help us to 
think about it more, as audit our work more often and more carefully.
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Freeman Outcome study - Questions for clinicians.
The study has been concerned with examining the feasibility of outcome measures and 
the usefulness of that information in informaing practice at all levels of the service.
1. Did you feel that the project achieved these objectives?
Yes, There has been some ^discomfort’ in the use o f the ’softer* 
outcome measures in such a chronic ongoing disease such as CAD.
2. Did you find the outcome information useful and/or interesting? In what way?
Both useful and interesting - to have a more complete follow up in 
cases who have had PTCA.
3. a) Has the information influenced the way you see the service or provide care?
Yes.
b) Have there been any changes as a result of this study?
If so, in what way?
If not, why not?
The major change will be withdrawal o f antianginal drugs.
4.In what ways could the study have been improved?
1. The outcomes aims are probably slightly different in unstable angina 
and stable angina and maybe this should have been incorporated into the 
design eg. Thus in UAP the usual aim is to stabilise patient so that can 
leave hospital without AMI. Subsequent management could easily be 
CABG at some point and one would expect CABG rate to be higher. In 
stable angina relief o f symptoms.
2. Classification o f angina should have been by cardiologist, not 
retrospectively from notes/reports.
5. Do you intend to continue outcomes monitoring in your specialty?
Yes
6. Has the study helped you in any other ways?
It has highlighted something we were always aware o f - the difficulties 
in monitoring outcomes in a chronic condition which is so heterogeneous 
(Thus sometimes angioplasty is done to allow another procedure, eg. 
renal transplant, to be done more safely - sometimes to stabilise 
symptoms, sometimes to relief symptoms, sometimes to hopefully 
’protect’ myocardium) as is the patients’ response to their illness.
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Appendix 4(a) Data Collection Proforma - Care of the Elderly (In-patients) 
QUESTIONNAIRE 1
Page 1
ADMISSION ASSESSMENT;
Name:
Address:
Hospital no.:
Age:
Date admitted: 
Date assessed:
Date discharge: 
Date death: 
Consultant: OJ RC
Marital status:
Main Care - Giver: 
(relationship)
Spouse 
Child 
Sibling 
Informal 
Other relation
Family Relationships: 
(Are there any 
significant problems?)
Admitted from home [ ]
Transferred from ward [ ]
Transferred from another 
hospital [ ]
Attention required 
[ ]
Not relevant 
[ ]
Abbreviated Mental Test (AMT):
(Each question scores one mark)
Adm. Dis.
1. Age [ ] [ ]
2. Time (to nearest hour) [ ] [ ]
3.
4.
5.
6.
7.
8 .
9.
10.
Address for recall at end of 
test - this should be repeated to 
patient to ensure it has been heard 
correctly: 42 West St.
Year
Name of institution 
Recognition of 2 persons 
DOB (day & month sufficient) 
Year 2nd world war 
Name of present monarch 
Count backwards 2 0 - 1
Mental Test Score 
Rating (S,M or N ) 
Cognitive Score Rating: [0-3]
Severe
4-6]
Moderate
7-10]
Normal
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Page 2
This relates to disease relevant to this admission to hospital.
Significant Medical Conditions:
ACTIVE INACTIVE Specify
Cardiovascular [ ] [ ] ..................
Respiratory [ ] [ ] ...................
Gastro-intestinal [ ] [ ] ...............
Musculo-skeletal [ ] [ ] ...............
Renal [ ] [ ] ...............
Genito-urinary [ ] [ ] ...............
Metabolic [ ] [ ] ...............
Nervous system [ ] [ ] ...............
Psychiatric [ ] I ] ...............
Skin [ ] I ] ...............
Social [ ] [ ] ...............
DISCHARGE ASSESSMENT
Better Same 
General Status: [ ] [ ] [
Worse 1 
] [ ]
Died
Family Relationships: 
(Have aspects of 
care-givers strain been 
attended to?)
Medical Condition: 
(In relation to active 
problems at admission)
Mental Test Score:
[ ] [ ] [ ]
[ ] [ ] [ ]
Admission
Discharge
[ ] 
[ ]
Have goals been achieved overall? 
Yes[ ] No[ ] 
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Uncertain[ ]
QUESTIONNAIRE 2
PATIENT NAME:
BARTHEL ADL INDEX
Bowels Incontinent
Occasional accident 
Continent
Bladder Incont. / catheterised
Occasional accident 
Continent(for over 7days)
Grooming Needs help
Independent, face/hair,etc
Toilet use Dependent
Needs some help 
Independent
Feeding Unable
Needs help,eg-cutting 
Independent
Dressing Dependent
Needs help(1/2 unaided) 
Independent
Bathing Dependent
Independent
Mobility Immobile
Walks-help of l(verb/phys) 
Wheelchair indep. 
Independent
Transfer Unable
Major help(l-4 people) 
Minor help(verb/phys) 
Independent
Stairs Unable
Needs help(verb/phys) 
Independent up & down
Home environment
Home alone
Home with soc.services 
Home with nursing prof. 
Home with other 
Sheltered accom. 
Residential care L.A.
Priv.
Nursing care H.A. Rehab.
" " Long-T
" " Private
HOSPITAL NO.: 
Adm. Goal Dis
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QUESTIONNAIRE 3 
Patient name:
QUESTIONNAIRE FOR CARERS 
Hosp. No: Date:
Here is a list of things which other people have found difficult when caring for a relative
/friend /neighbour. Can you say whether any of these apply to you? 
just as a guide). Please tick either YES qt NO for every item.
YES NO
I.Sleep is disturbed, (eg.because he/ 
she is in & out of bed at night)
2.It is inconvement. (eg.because helping 
takes too much time/or his/her house 
is a long way away)
3.It is a physical strain, (eg.because 
he/she is hard to lift)
4.1t is restricting, (eg.helping means 
no free time/can’t go out much)
5.There have been family disruptions.
(eg.there is no privacy/usual routine is disrupted)
6.There have been changes in personal 
plans (eg.holiday,had to turn down a job
7.There have been other demands on my 
time (eg.from the rest of my family)
8.There have been emotional adjustments.
(eg.arguments,etc.)
9.Some behaviour is upsetting.
(eg. incontinence, forgetfulness)
10. It is upsetting that he/she has changed 
so much. (eg.seems a different person since stroke).
I I .There have been work adjustments.
(eg.keep having to take time off work)
12.It is a financial strain.
13.1 feel completely overwhelmed, 
(eg.worry of how you will cope).
]
]
Thank you for your help.
]
examples are given
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Appendix 4(b) Report on Outcomes - Care of The Elderly Feb 1991 
1 /PRESENTIN G  CHARACTERISTICS
a/Sample; - 420 patients
- 241 Professor James' caseload ( O c t 89-December '90)- OJ.
- 179 Dr. Cooper's caseload (Jan.'90-December '90) -RC.
b/Sex distributiont c/Aoe distribution: d/Admitted from;
male female
OJ 93 148
RC 56 123
35.5% 64.5%
Range: 61 - 98 years.
Mean: 81.9 years.
There were no significant 
age differences between the 
two consultants' caseloads.
home ward hosp. total
OJ 66 132 8 206*
RC 75 95 8 178*
Table 1.1
*Not all patients have this recorded.
e/Patient tvoe:
- The patients were classified as:
- Terminal ( 17 patients )
- Investigation ( 17 patients )
- Rehabilitation (382 patients )
These categories of patients have different expected outcome criteria and 
it was decided to analyse the rehabilitation group results only.
f/Mental Test Scores:
The shortened MTS has been done at admission on the majority of patients 
(62%):
Severe Moderate Normal
0-3 4-6 7-10
OJ 18 40 95
RC 16 31 61
%Total 8% 17% 37% Table 1.3
q/Lenoth of stav:
30 
27 
24 
21 
% 18
15
12
9
6
3
0 nnnn
f g h
a = < 1 week
b = 1 - 2 weeks
c = 2 - 3 weeks
d = 3 - 4 weeks
e = 4 - 5 weeks
f = 5 — 6 weeks
9 = 6 - 7 weeks
h = 7 - 8 weeks
i = 71-100 days
j >100 days
Figure 1.1
- 76% of patients stayed < 28 days.
- 5.5% of patients stayed > 56 days.
- 5 patients stayed > 100 days ( 2 OJ; 3 RC ).
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h/Presentino medical characteristics:
There is a high incidence of co-morbidities within this group. The 
presenting medical problems were classified as either active or inactive 
and these are presented in table-1.4
No. pats.=420 (382 rehab., 17 terminal, 17 invest. )
Medical
problem
Rehab.- 
active
Terminal - 
active
Invest. - 
active
Inactive - 
total
Neurological 177 10 1 47
Psychiatric 151 5 5 16
Cardiovascular 131 5 3 87
Gastro-intest. 121 5 12 48
Musculo-skel. 104 2 2 47
Metabolic 101 5 6 37
Respiratory 95 5 2 26
Genito-urin. 91 8 0 24
Skin 38 0 0 8
Renal 21 2 0 8
The most common active problems of patients who are admitted for 
investigations, belong to the gastro-intestinal tract e.g. bleeding 
in the GIT, causing anaemia.
The most common active problems of patients who are admitted for 
terminal care are neurological in origin e.g.CVAs. Genito-urinary 
problems are also recorded as prevalent in this group, urinary 
incontinence accounting for the majority 
For the study group of patients ( i.e. those admitted for 
rehabilitation), the range of active medical problems is listed
in order of prevalence in table-1.4.
i/Home environment on admission;
home/alone 
home/soc.s. 
home/prof. 
home/other 
sheltered 
res.care(LA) 
res.care (?) 
rehab/nurs. 
L-T nur/careij - i  r / - — !
pri. nur/care--r-l
10 15 20 25 40 % Figure 1.2
78% of patients are living in the community, either alone, or with 
support in their homes, on admission.
i/Care-Qivers' strain;
The care-givers' strain scale is scored from 0 to 13, with 0 being 
equivalent to no stress reported and 13 being equivalent to the highest 
level of stress reported. Despite problems with response ( only about half 
of those sent a form have replied) a picture of which aspects of care are
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found most stressful to carers is emerging from the data.
- 38% of the carers reported a low level of stress(<5).
42% reported a moderate level of stress(5-9).
- 20% reported a high level of stress(10-13).
The aspects of caring that are most frequently reported as stressful by the 
carers are:
%tage respond +ve
- upsetting behaviour 71%
- physical strain 60%
- restrictions on self 57%
- upsetting as changed 56%
- feeling of overwhelm 51%
- sleep disturbance 47%
- emotional adjustments 46%
- changes in personal plans 45%
- inconvenience 44%
- family disruptions 40%
- demands on time 40%
Work adjustments and financial worries are reported as stressful in only 
about 25% of carers ( this could be largely due to the fact that the carers 
tend to be older and largely female).
2 /OUTCOMES;
Outcomes to 3/12 for rehabilitation group ( for those who were discharged 
before December 1990 & therefore followed up to 3/12 ): - Table 2.1
1 2 4 6 0 Tot
OJ 37 26 84 28 41 216
RC 32 19 70 18 27 166
Tot 69 45 112 46 68 382
Outcome codes: 1 = died in hosp.
2 = died to 3/12 
4 = OK to 3/12
6 = readmitted to 3/12 
0 = no follow-up
The outcomes can be summarised:
- 30% of patients die altogether (no difference between 
consultants).
- 19% of RC's patients die in hospital.
- 17% of OJ's patients die in hospital.
- a further 12% of OJ & 11.4% of RC die before 3/12 follow-up.
- 13% of OJ & 11% of RC patients are readmitted to Ward 14 by 3/12
follow-up (17% & 16% of those surviving to 3/12 follow-up 
respectively).
- 81% OJ patients are followed-up to 3/12.
- 84% RC patients are followed-up to 3/12.
- of those reaching 12/12 follow-up,46% of OJ patients & 38% of RC 
patients die. 31% of patients are readmitted to 12/12( However, the 
numbers are very small to date).
a/Readmissions:
The number of réadmissions recorded refers to those patients who are 
readmitted to Ward 14 and not other wards, or hospitals. Of 46 réadmissions 
to 3/12, 5 patients died during the hospital stay and 5 patients died in
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the subsequent 3/12. The difference in functional capacity (Barthel score) 
between the first discharge and the readmission tends to be large and 
negative eg. for those who die in hospital on a readmission, the difference 
in Barthel scores is at least -7.
Some individuals are readmitted more than once - these include 2 patients 
who have been readmitted three times and 8 patients who have been 
readmitted twice. The presenting medical characteristics at subsequent 
réadmissions tend to be related to those at the original admission. Five 
of these in-patient episodes are due to patients being referred to another 
specialty for treatment and then being re-transferred back to Ward 14 
afterwards.
b/Barthel Scores:
The functional ability of the patients has been measured at admission(B1), 
at discharge(B3), at 3/12 follow-up(B21) and at 12/12 follow-up(B31). The 
expected outcome at discharge (ie. the goal) has been set at admission(B2).
The mean scores for the group of rehabilitation patients are seen in 
table 2.2:
CONS. BARTHEL1 BARTHEL2 BARTHEL3 B3-B1 BARTHEL21
OJ 13 16 15 2 14
RC 10 14 14 4 12
BOTH 10 14 12 2 13
Table 2.2
The distributions of scores at both admission and discharge show a high 
proportion of scores over 17 - indicating relatively less disability. A 
ceiling effect occurs with these patients whereby their potential for 
improving scores is considerably reduced if the initial score is high.
From admission to discharge: Better Scune Worse
Improvements are significant OJ 60% 34% 6%
( p<.001 using Wilcoxon ) RC 70% 21% 8%
Discharge vs. goal set: Better Same Worse
OJ 17% 56% 27%
RC 19% 44% 36%
From discharge to 3/12: Better Same Worse
OJ 28% 21% 51%
RC 27% 15% 58%
From admission to 3/12: Better Same Worse
The follow-up scores are sig. OJ 46% 11% 43%
better than at admission. RC 66% 3% 31%
p=.0061.
The admitting pattern of the consultants appears to be different - 
RC tends to admit patients with a lower Barthel who subsequently 
show a better improvement than those patients admitted by OJ. The 
difference in the change in Barthel scores is statistically 
significant { p=.036 ).
When the individual items of the Barthel are examined between 
admission and discharge, only 15-20% of patients are worse at
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discharge. The majority are the same, with a varying number who are 
better at discharge. The best improvements are seen in mobility, 
dressing ability, transfer ability and grooming - the improvements 
being highly significant.
- However, as can be seen above, the overall Barthel scores are 
largely better at discharge than at admission - these improvements 
are statistically significant
- A larger proportion of OJ patients achieved their set goals than did
RC patients.
- The best performances against goals are seen for items covering
control of bowels and bladder and for bathing.
- The majority of patients' functional ability declined at 3/12
follow-up, compared to discharge. 15-20% maintain their discharge 
level.However there are a handful of quite disabled patients on 
discharge who have subsequently improved to 3/12 - the majority are 
in some other care facility.
- When admission Barthel scores are compared to 3/12 scores, there is
a significant improvement to 3/12 & a marked difference between the 
consultants. 66% of RC patients who reach 3/12 follow-up improved
their functional ability from admission, compared to 46% of OJ 
patients.
12/12 follow-uDi
Only 11 of the rehabilitation group of patients have had a follow-up to
12/12. Of these:
Better Same Worse 
From 3/12 to 12/12: 5 2 4
From admission to 12/12: 8 0 3
Therefore overall, there appears to be an improvement in functional ability
over time. However, this is as yet a very small sample.
c/Care-oivers strain scale:
- Only 27 of the carers who successfully completed a strain scale 
during their dependants' admission have been followed up to 3/12. Of 
these, 10 report less stress than admission, 7 report the same 
degree of stress and 9 report a higher level of stress.
- The most frequently reported aspects of caring that are reported as
stressful are similar to those at initial contact.
- Of those who report a lower level of stress at follow-up than at
initial contact, two carers show a reduction of at least 7 points. 
Four out of the nine who report increased stress show an increase of
5 or more points.
Only one carer has been followed up to 12 months. This is a young
lady who cares for her grandmother and has reported a low level of
stress (1) on each occasion.
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d/Home environment I
home alone 
horn/soc.serv. 
hom/nurs. 
home with oth. 
sheltered 
LA res/care 
priv/res 
further rehab 
L/T nur/care 
priv/nur/care
10 17 "Jo" 25 ~35 “ I—  40 Figure 2.1%
The proportion of the sample living independently (either supported or not) 
in the community has decreased from the time of presentation to hospital. 
There is a larger proportion of patients in hospital, either for further 
rehabilitation, or for long-term care. The proportion of patients in 
residential care is about the same.
12/12 follow-up:
Of the 11 patients that have been followed up to 12/12:
- 2 patients are at home alone
- 2 patients are at home with social services support
- 3 patients are at home with another person
- 2 patients are in res.care
- 2 patients are in private res.care
8 of these patients are in the same home environment as at admission 
12/12 previously.
None of them improve, that is , become more independent.
However, there is little or no deterioration in independence over 
the 12/12 period for this small number of patients.
e/General ratings:
At discharge clinical staff were asked to assess whether goals had been 
achieved for each patient and whether medical problems had been resolved. 
They were also asked to assess whether or not the patient was generally 
better. For the majority of cases ( around 80% ) the answers to these
questions were positive. Although it was felt originally that this was 
infact due to over confidence in the outcomes a more detailed analysis 
of the assessments, in conjunction with the accommodation on admission and 
discharge ( as an indicator of degree of dependence ) has revealed that 
these improvements are perhaps genuine -see table 2.3:
Accommodât ion same Accommodation worse
General: better 82% p=.001 19%
same 63% 38%
worse 20% 80%
Medical: better 80% p=.004 20%
Scime 66% 34%
worse 2.9% 71%
Goals: better 81% p=.000 20%
same 74% 26%
worse 36% 65%
All relationships are highly significant ( Chi-squared p=.0000 ) 
Table 2.3
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3 /D IS C U S S IO N !
There are strong and statistically significant links between the admitting 
Barthel scores and the accommodation status of patients. This is as one 
would expect - patients who have come from other institutions score on the 
whole lower than those who have been living at home.
These relationships are consistent in the discharge Barthel scores:
Accommodât i on
admit
- on admission 
discharge change admit
- on discharge 
discharge change
Home 12.2 15.1 3.0 13.1 16.4 3.4
Residential care 8.0 10.1 2.6 9.9 13.6 3.7
Rehabilitation 7.5 9.0 1.5 8.7 10.5 1.9
LT care 6.2 8.4 2.2 8.5 7.2 -.61
Barthel scores against home environment. 
All relationships are highly significant
Table 3.1
There is a weak link between overall admitting Barthel scores and 
mental ability at admission. The patients with lower MTS show a 
lower functional ability than those with higher MTS. This 
relationship is to be expected, as patients with confusion will most 
probably be more more dependent.
The functional abilities at admission, of those patients who die in 
hospital are lower than for the survivors - this relationship is 
highly significant (p=.0000).
Patients under 70 years tend to do better in terms of survival, 
changes in functional status and changes in home environment 
compared to patients over 70 years. This may reflect a proportion of 
patients where the acute illness is more significant than chronic, 
longer term problems.
The length of stay is over 4 weeks in 24% of cases and 3% patients 
stay over 10 weeks. Of those remaining in hospital over 4 weeks, 23% 
are discharged to residential care, who have been in the community 
previously. Is this an indication of a delay in arranging 
accommodation at discharge, or are these patients just slow to
respond to rehabilitation? A further 47% of those whose LOS was 
over 4 weeks and who were previously living in the community, have 
been discharged to another hospital, either for further 
rehabilitation or for long-term care.
Does this indicate a set of patients who are slow to respond, or a 
delay in arranging the transfers?
Of those patients who die in hospital, but are not classified as 
terminal", 64% are transferred to Ward 14 from other wards within 
the hospital. Also, 30% of those who die, do so within 2 weeks of 
admission to the ward. Does this fit the expected pattern of 
admission to the ward?
When the goals set for functional improvement are compared to the 
actual level attained at discharge (B2 and B3) a large proportion of 
patients do not attain their set goals ( 27% for OJ & 36% for RC 
patients ). Why is this? Are the goals being set realistically? Or 
is there a problem with the rehabilitation of this group of 
patients? Would it be useful to know which patients have not
achieved their set goals?
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General commentst
The measurement of outcomes in this type of Elderly Care setting 
have proved to be largely dependent on survival, réadmissions and 
functional ability ( as measured with the Barthel index). Although 
the numbers over this period are fairly large (420) there have been 
difficulties with collection of data at follow-up. About 20% of 
these patients have not been followed up to 3 months - the 
difficulty arising when they do not attend for an Out-patient 
appointment at around this period and they are not living in some 
kind of care facility where they are easily accessible.
There are only a small number of this group of patients who are due 
to have a 12 month follow-up, but as numbers grow, the problem of 
successfully locating the patients will become more of a problem. It 
may necessitate a change in the strategy of data collection, with 
attempts being made to check survival, réadmissions and home 
environment only, as opposed to collecting functional assessments on 
a routine basis.
Julie Goodfellow 
Martin Bardsley
Feb 1991.
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Appendix 5(a) Data collection forms - Cholecystectomy
Admission Date [ / / 1
Discharge Date [ / / ]
Op Date ( / / ]
Freeman Hospital Cholecystectomy Study 
PRE-OPERATIVE ASSESSMENT 
(Obtained from the patient notes)
Consultant; CV PW 
NJ JC
Hospital No.: [..................... ]
NAME: .. 
ADDRESS:
The indication for surgery is:
History of acute cholecystitis [ ]
Acute cholecystitis on 
admission [ ]
Asymptomatic gallstone ( ]
Empyema ( )
Chronic cholecystitis 
Common bile duct stone 
Obstructive jaundice 
Hucocoele 
Cholangitis
Other, please specify
Significant current/chronic disease:
Please Specify Taking
Medication
Cardiovascular 
Nervous system 
Respiratory 
Musculoskeletal 
Gastrointestinal 
Metabolic
Renal/genito-urinary 
Other problems
Other Details
Weight : ( ] Height :
Smoker : [ ] Non-smoker: [
Heavy drinker: (Men >21 units;
[ ]
] Ex-smoker : [ 
Women > 14 units ) [
Previous abdominal surgery [ 1
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QUESTIONNAIRE 2 Date [ / / 1
Freeman Hospital Cholecystectomy Study
Surname :.....[.............................. ]
First name : [.............................. ]
Hospital No: [.............................. ]
Patient Pre-operative Self-administered Questionnaire
We would like to ask you some questions about your health and in particular 
about the problems related to your gall bladder.
Please tick the appropriate box.
Have you had any abdominal pain? Yes No
[ ] [ ]
If yes......
How many times in the last year have you had 
abdominal pain?
Once Twice Three times Four times or more
[ ] ( ] [ ]
When did your gall bladder symptoms 
first appear?
Please give an approximate date.
When were you first diagnosed 
(by your G.P. or hospital surgeon) 
as having gall bladder disease?
[ ] 
MONTH
MONTH
YEAR
YEAR
Please tick 'Yes' if the following statements applv to vou, 
otherwise tick 'No'.
I take tablets/drugs for my 
abdominal pain
I suffer from flatulence a lot 
(belching/wind)
I suffer from abdominal distention 
(bloating)
I feel sick and/or vomit 
My appetite is normal?
Eating fatty food bothers me 
My bowel function is normal 
I have constipation 
I have diarrhoea
Yes No
Overall how would you rate your health at present?
Poor [ ] Fair [ ] Good ( ] Very Good [ ]
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QUESTIONNAIRE 3.
PRE-OPERATIVE FORM
PATIENT IDENTIFICATION: DATE:( / / ]
Name... 
Address.
Hospital No;
Operating Surgeon or Consultant [........................... ]
1. Indications for surgery:
History of acute cholecystitis [ ] Chronic cholecystitis
Acute cholecystitis on Common bile duct stone
admission [ ] Obstructive jaundice
Asymptomatic gallstone [ ] Hucocoele
Empyema [ j Cholangitis
Other, please specify.
2. How do you rate the risk to the patient of significant 
post-operative morbidity?
Low High
Risk]--------------------------------------------- 1 Risk
3. Are there complicating factors in this patient?
4. Operation type: Elective [ ]
Urgent [ ]
Emergency [ ]
Date of operation: [.................... ]
Were there any significant «complications during the 
operation?
If yes were they:
Surgical 
Please specify
Anaesthetic 
Please specify
* Significant = a condition that....
- prolongs the length of stay
- requires extra clinical resources
eg. nursing diagnostic tests, extra time 
in theatre.
Completed by.......................... Date: [
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QUESTIONNAIRE 4 
PATIENT IDENTIFICATION:
Name.................
Address..............
Hospital No..........
Date:[ / / ]
Post-operative complications
Were there any significant post-operative complications?
YES
- Wound infection.................. ............
- Intra-abdominal infection....................
- Post-op bleeding............................
- D.V.T./Pulmonary embolis.....................
- Respiratory infection/complication...........
- Cardiovascular complication (eg. M.I.)........
- CNS complication (eg. stroke)................
- Urinary complication (eg. retention/infection).
- Septicaemia.................................
- Renal failure...............................
- Other, please specify
NO
Significant = a condition that...
- prolongs the length of stay
- requires extra clinical resources
eg. nursing, diagnostic tests, extra 
time in theatre.
Completed by............................  Date: [
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QUESTIONNAIRE 5 Post-operative patient questionnaire 
Three month/one year follow upt
Hospital No: [............... ]
Some people continue to have problems for several months after their 
operation. Some people have no problems at all. We would like you to say 
whether you agree with the following statements.
Please tick 'Yes' if the following statements applv to vou, 
otherwise tick 'No'.
SINCE THE OPERATION. Yes No
I take tablets/drugs for my abdominal pain 
I suffer from flatulence a lot 
(belching/wind)
I suffer from abdominal distention 
(bloating)
I feel sick and/or vomit 
My appetite is normal 
Eating fatty food bothers me 
My bowel function is normal 
I have constipation 
I have diarrhoea
I have visited the GP with a complication 
related to the operation
I have health problems I did not have before 
I feel no better than I did before
If so please specify
Overall, how would you rate your health at present:
Poor [ ] Fair [ ] Good [ ] Very good ( ]
Please tick the correct box Yes No
Have you been seen at Accident 5 Emergency (A & E) [ ] [ ]
since your operation?
Have you been re-admitted to hospital since your [ ] [ ]
operation?
If yes which hospital?
Freeman [ ]
Royal Victoria Infirmary (RVI) [ j
Newcastle General (Westgate Road) [ ]
Other [ )
Please specify
If yes, what were you admitted for?
Repeat Nottingham Health Profile
Thank vou for vour help. Please return these forms in the stamped addressed 
envelope provided.
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Appendix 5(b) Caspe/Freeman Outcome Study Report Aug 1990
Cholecystectomy Outcomes by Quarter.
Q1=J-F-M 1989 
Q2=A-M-J 1989
Q3=J-A-S 1989 
Q4=0-N-D 1989
Q5=J-F-M 1990 
Q6=A-M-J 1990
1. Patient characteristics and events in hospital.
Follow-ups Age distribution
Q. Tot. 3mnth 12mnth %Male1 Mean <60 60-70 >70
1 27 85% 81 41% 65.5yrs 28% 28% 44%
2 22 100% 77 27% 57.9yrs 53% 32% 16%
3 27 100% 0 26% 59.8yrs 42% 31% 27%
4 16 94% 0 38% 56.7yrs 44% 44% 13%
5 38 89% 0 34% 59.0yrs 53% 17% 31%
6 14 43% 0 21% 56.3yrs 40% 40% 20%
Total 144 88% 27 32% 59.8yrs 44% 29% 2
Indications for surgery:
%Emergency %Asymp. %Chronic %History %Acute %Other
1 JFM 19% 19% 11% 52% 4% 15%
2 AMJ 0% 14% 27% 41% 0% 18%
3 JAS 22% 19% 19% 33% 11% 19%
4 OND 13% 6% 31% 50% 6% 6%
5 JFM 26% 21% 26% 18% 18% 16%
6 AMJ 0% 29% 0% 36% 0% 36%
Total 16% 18% 20% 36% 8% 17%
Mean length of stay
Nos. Preop Post All <lwk l-2wks >2wks
1 JFM 25 2.3 6.5 9.8 20% 52% 28%
2 AMJ 18 1.8 4.8 10.5 6% 83% 11%
3 JAS 22 1.5 6.9 9.0 18% 73% 9%
4 OND 16 2.4 6.5 9.6 6% 88% 6%
5 JFM 24 1.7 5.9 9.7 21% 71% 8%
6 AMJ 6 2.2 3.5 8.0 17% 83% 0%
Total 111 2.0 6.0 9.6 15% 72% 13%
2. Post-■op complications and events after discharge
Copmplications To 3 months To 12 months
Peri-op. Postop Readmit AE GP Readmit AE GP
1 JFM 19% 26% 9% 9% 13% 18% 18% 18%
2 AMJ 27% 32% 5% 9% 32% 12% 24% 47%
3 JAS 7% 19% 7% 0% 19% - - -
4 OND 13% 13% 7% 13% 33% - - -
5 JFM 24% 26% 6% 12% 24% - - -
6 AMJ 7% 0% 0% 0% 0% — — —
Total 17% 22% 6% 8% 22% 15% 21% 31%
Post-op complications:
Urine retention 9 cases
Reap. Infection 2 cases
Cardiovasc. comp 2 cases
Abdom complic 1 case
Bleeding 1 case
DVT 1 case
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Readmissions %
After three months: (patient ID's removed)
-"Replace blocked arteries stomach' 
-"Infection in wound"
-"Pain and sore around wound" 
-"Scar tissue turned septic"
-"Pain and vomiting"
-"Pain and coughing up blood" 
-"Heart attack"
-"Road traffic accident"
-"To convalescence"
From 3 to 12 months:
-"Cyst in throat"
-"Broken collar bone"
-"Heart attack"
Patients died:
4 patients have died (up to 12 months), 
a -
b
c —
d
We know at least one other patient has died but not yet reached 
their 12 mnth f/u point.
3. Changes in Symptoms to three months
Before: % reported problems
SYMPTOMS Tablet Flat. Dist Ab Vomit Bowel Appétit F.Food
1 J-F-M 26% 59% 52% 44% 22% 33% 63%
2 A-M-J 41% 59% 59% 68% 18% 32% 68%
3 J-A-S 48% 52% 52% 70% 37% 37% 74%
4 O-N-D 44% 81% 44% 56% 44% 31% 75%
5 J-F-M 37% 61% 53% 53% 45% 26% 71%
6 A—M—J 29% 43% 36% 57% 14% 21% 71%
Total 38% 59% 51% 58% 32% 31% 70%
After - % reported problems
SYMPTOMS Tablet Flat. Dist A Vomit Bowel Appétit F.Food
1 J-F-M 7% 30% 30% 11% 30% 33% 22%
2 A—M—J 18% 36% 23% 5% 45% 23% 36%
3 J-A-S 26% 30% 30% 19% 26% 19% 30%
4 O-N-D 25% 56% 38% 38% 31% 31% 56%
5 J-F-M 11% 13% 18% 8% 37% 32% 16%
6 A—M—J 0% 14% 7% 0% 64% 64% 0%
Total 15% 28% 24% 13% 37% 31% 26%
*Basic pattern is as before the greatest changes are in vomiting, tolerance 
of fatty foods, distended abdomen and flatulence. Little improvements is 
seen in 'bowel* problems.
^Additional questions on the nature of bowel problems were added to the 
forms.
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4. Changes in the NHP
Mean scores before: 
NHP
1 J-F-M
2 A-M-J
3 J-A-S
4 O-N-D
5 J-F-M
6 A-M-J
Energy Pain Sleep Emot Sod Mobil PtII
27 36.9 24.2 17.0 27.9 8.8 15.6 21.2
22 40.4 29.1 16.6 27.8 5.8 11.7 28.6
27 42.0 28.2 17.6 27.6 13.4 17.4 25.9
16 40.7 23.9 14.6 27.1 5.5 9.0 27.7
36 31.0 34.8 20.3 31.9 6.4 18.2 28.6
12 42.4 23.4 19.3 34.3 10.9 20.3 28.6
Total 140 37.8 28.3 17.8 29.3 8.4 15.7 26.5
Mean Scores after :
NHP +3mnths Energy Pain Sleep Emot Sod Mobil PtII
1 J-F-M 27 22.5 11.3 7.5 13.9 5.7 13.4 8.5
2 A-M-J 22 24.9 16.3 6.0 16.8 2.9 14.0 14.3
3 J-A-S 27 20.1 6.8 10.3 22.6 6.0 12.9 14.3
4 O-N-D 16 29.8 15.4 9.2 25.7 15.5 10.5 16.1
5 J-F-M 35 11.0 4.5 2.3 6.2 3.1 7.6 7.8
6 A-M-J 5 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Total 132 19.4 9.5 6.4 15.0 5.6 11.0 11.0
% patients showing improvements in NHP:
NHP Energy Pain Sleep Emot Sod Mobil PtII
1 J-F-M 44% 63% 59% 67% 19% 30% 48%
2 A-M-J 50% 59% 55% 55% 9% 32% 59%
3 J-A-S 56% 63% 41% 41% 33% 30% 41%
4 O-N-D 31% 44% 44% 38% 6% 13% 38%
5 J-F-M 43% 71% 71% 71% 17% 43% 54%
6 A-M-J 80% 40% 80% 20% 40% 40% 80%
Total 47% 61% 57% 55% 19% 32% 50%
5. Changes to 12 months
The general picture of patients 12 months after the operation is similar 
to that at three months - NHP scores stay much the same from 3 to 12 months
Mean NHP scores:
Pre-op +3mnths +12mnths
Energy 38.8 24.9 23.5
Pain 26.2 14.0 10.0
Emot Reac 14.9 6.8 6.9
Sleep 25.6 16.3 20.0
Soc. Isol 5.6 4.5 6.3
Mobil 14.4 14.3 15.0
Pt II 21.6 11.0 11.4
* Symptom scores are roughly similar (possibly slightly worse). 
Symptoms - No. patients reporting problems:
Pre-op +3mnths +12mnths
Tablets 11 4 6
Flatulence 24 14 12
Dist Abdomen 22 10 3
Vomit 23 4 3
Bowel 7 15 11
Appet 14 11 11
F.Food 27 12 17
At the moment the results 
add much to the picture.
would suggest that the 12
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Examples of exception reports
The follwing summaries refer to a selection of patients who apppear not to 
have done well after the operation - either as reflected in their NHP or 
réadmissions. It is interesting to oberserve that in most cases the NHP, 
the list of symptoms and the facts of readmission tend to agree.
Do these patients hold any useful lessons?
Patient Summary 
Indications 
Co-morbidities 
Previous ops.
Abdominal pain 
Symptoms since 
Problems 
3mth. later 
12 roth. later 
Op. complications 
Post-op. complications:
A Patient idllllllll (4) dd/mm/yy 
Chronic cholecystitis
Hysterectomy, tonsillectomy
>4 times last year
6/87 Diagnosed 1/89
tablets,abdo.dist.,appet.,fatty food
flat.,abdo.dist.,bowels
tablets,abdo.dist.,fatty foods
NHP scores Pre-op +3mth. +12mth.
1. Energy 100.00 60.80 63.20
2. Pain 72.96 30.17 35.27
3. Emotional reaction 19.78 10.47 0.00
4. Sleep 34.27 0.00 12.57
5. Social isolation 0.00 0.00 0.00
6. Physical mobility 33.19 31.07 41.86
7. Partll responses 42.87 70.00 42.87
Readmitted? no no
GP? yes yes
A+E? no no
Feel no better? no no
Other problems? no no
Comments: 3/12 - infection in wound. 
12/12 - no reported problems
Patient Summary 
Indications 
Co-morbidities 
Previous ops. 
Abdominal pain 
Symptoms since
A patient id222222 dd/mm/yy (2)
Chronic cholecystitis 
Angio Dec.88 re chest pains 
Tubal tie, eye op.
>4 times last year 
1/87 Diagnosed: 10/88
Problems: tabs,flat.,abdo.dist.,vom.,bowels,appet.,fatty 3mth. 3 mnth
later: no change
Op. complications :
Post-op. complications:
+12mth.NHP scores pre-op +3mth.
1. Energy 100.00 63.20
2 . Pain 73.31 100.00
3. Emotional reaction 69.84 55.85
4. Sleep 77.63 77.63
5. Social isolation 64.67 42.14
6. Physical mobility 31.07 31.07
7. Partll responses 42.87 56.00
Readmitted?
GP?
A+E?
Feel no better? 
Other problems? 
Comments: Pain - 
chest pain.
yes
yes
yes
no
yes
constant(r.side) and coughing up blood. Still getting
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APPENDIX 5 (c) Notes on Links to Case Mix - DRGs August 1990
T h e  p a t i e n t s  o n  t h e  c h o l e c y s t e c t o m y  o u t c o m e s  s t u d y  d a t a  b a s e  
h a v e  b e e n  l i n k e d  i n  t o  d e t a i l s  f r o m  t h e  h o s p i t a l  c a s e  m i x  
s y s t e m .  T h e  d a t a  c o v e r e d  a l l  e p i s o d e s  f r o m  J a n u a r y  1 9 8 9  t o  
M a y  1 9 9 0 .  T h e  f o l l o w i n g  n o t e s  c o v e r  s o m e  o b s e r v a t i o n s / i s s u e s  
r e s u l t i n g .
l . I n  s o m e  c a s e s  o u r  p a t i e n t s  w e r e  r e g i s t e r e d  w i t h  a n  
e x p e r i m e n t a l  n u m b e r  r a t h e r  t h a n  a  h o s p i t a l  n u m b e r  s o  l i n k a g e  
w a s  n o t  p o s s i b l e .  I n  s o m e  c a s e s  a  l i n k  w a s  m a d e  -  b u t  t h e  
i n p a t i e n t  e p i s o d e  w a s  t h e  w r o n g  o n e  ( t y p i c a l l y  w r o n g  D R G  a n d  
t o o  s h o r t ) .  T h i s  m a y  b e  d u e  t o  m y  s o f t w a r e ,  t h e  d o w n l o a d  o r  
t h e  a b s e n c e  o f  t h e  r i g h t ( s u b s e q u e n t )  c o n s u l t a n t  e p i s o d e  o n  
c a s e  m i x .  I  w i l l  i n v e s t i g a t e  f u r t h e r .
2 . T h e r e  a p p e a r e d  t o  b e  e x a m p l e s  w h e r e  t h e  c o d i n g  w a s  n o t  
c o m p l e t e  o r  n o t  a c c u r a t e .  I n  m y  o p i n i o n  t h e  D R G  i s  a  g o o d  
w a y  o f  q u i c k l y  i d e n t i f y i n g  a n y  g r o s s  a n o m a l i e s .  T h e  m o s t  
c o m m o n  p r o b l e m s  a r e  e i t h e r  w h e n  t h e  c o d i n g  h a s  n o t  b e e n  
d o n e ,  o r  w h e n  a  p r o c e d u r e  c o d e  a p p e a r s  t o  b e  m i s s i n g  
( p r o b a b l y  t h e  D R G s  2 0 7 , 2 0 8 ) .
3 . T h e  k e y  e p i s o d e s  ( i e  t h e  s t a y  d u r i n g  w h i c h  t h e  
c h o l e c y s t e c t o m y  w a s  c a r r i e d  o u t )  m a i n l y  f a l l s  i n t o  f o u r  D R G s
1 9 7  " T o t a l  c h o l e c y s t e c t o m y  w / o  c o m m o n  d u c t  e x p l o r e  w / o  c c "
1 9 8  " T o t a l  c h o l e c y s t e c t o m y  w / o  C . D . E .  w i t h  c c "
1 9 3  " B i l i a r y  t r a c t  p r o c e d u r e  e x c l u d i n g  t o t a l  c h o l e c y s t e c t o m y
w i t h  c c "
1 9 4  " B i l i a r y  t r a c t  p r o c e d u r e  e x c l u d i n g  t o t a l  c h o l e c y s t e c t o m y
w i t h o u t  c c "
T h e s e  t w o  p a i r s  a r e  d i s t i n g u i s h e d  b y  t h e  p r o c e d u r e  c o d e s ,
J 1 8 . 3  ( T o t a l  c h o l e c y s t e c t o m y  o n l y )  l e a d i n g  t o  D R G s  1 9 7  a n d  
1 9 8 ,  J 1 8 . 2  ( c h o l e  +  C B D  e x p l o r e )  l e a d i n g  t o  1 9 3  a n d  1 9 4 .
T h e  c o m p l i c a t i o n s / c o - m o r b i d i t i e s  a r e  a  f a i r l y  m i x e d  a n d  
i n c l u d e  c o d e s  f o r . ,  a n g i n a ,  M S ,  p n e u m o c o n i o s i s ,  c h o l a n g i t i s  
e t c .
A  f e w  p a t i e n t s  h a d  o t h e r  p r o c e d u r e s  w h i c h  m a y  l e a d  t h e m  t o  
o t h e r  D R G S  -  w h i c h  i s  a s  i t  s h o u l d  b e .
4 . T h e r e  a r e  s o m e  n o t a b l e  p a t t e r n s  i n  t h e  w a y  m a n y  p a t i e n t s  
h a d  a n  e a r l i e r  a d m i s s i o n  ( i n  a n o t h e r  D R G ) .  S i m i l a r l y  s o m e  
p a t i e n t s  s h o w  r é a d m i s s i o n s  t h o u g h  t h e  D R G s  t e n d  t o  b e  
v a r i e d .  T h i s  i d e a  o f  a  b u n d l e  o f  i n - p a t i e n t  e p i s o d e s  -  e v e n  
f o r  e l e c t i v e  s u r g e r y  -  s e e m s  t o  h a v e  i m p l i c a t i o n s  f o r  
c o n t r a c t i n g  e t c .  I f  y o u  b a s e d  y o u r  c h a r g e s  o n  j u s t  t h e  c h o l e  
e p i s o d e  y o u  c o u l d  l o s e  i f  y o u  a r e  a l s o  d o i n g  t h e  d i a g n o s t i c  
w o r k - u p s  o n  2 0 %  o f  t h e  p a t i e n t s .
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T h e  f o l l o w i n g  f i g u r e s  a r e  t a k e n  f r o m  9 6  c a s e s  a d m i t t e d  f o r  
c h o l e c y s t e c t o m y  f r o m  M a r c h  1 9 8 9  t o  M a r c h  1 9 9 0
M a i n  E p i s o d e
D R G  1 9 7  9  c a s e s  T o t a l  c h o l e c y s t e c t .  w / o  C D E  w i t h  c c
D R G  1 9 8  4 4  c a s e s  T o t a l  c h o l e c y s t e c t .  w / o  C D E  w / o  c c
D R G  1 9 3  1 0  c a s e s  B i l i a r y  t r a c t  p r o c .  e x c  t o t  c h o l e  + c c
D R G  1 9 4  9  c a s e s  B i l i a r y  t r a c t  p r o c .  e x c  t o t  c h o l e  w / o  c c
N o  L i n k :  1 0  c a s e s
W r o n g  L i n k :  5  c a s e s
D R G  2 0 7  3  c a s e s  D i s o r d e r s  b i l i a r y  t r a c t  w i t h  c c
D R G  2 0 8  2  c a s e s  D i s o r d e r  b i l i a r y  t r a c t  w / o  c c
D R G  1 4 8  1  c a s e  M a j  s m a l l  & l a r g e  b o w e l  p r o c
B l a n k  1  N o t  y e t  c o d e d
D R G  2 0 0  1  c a s e  H e p a t o b i l  d x  p r o c  f o r  n o n - m a l i g
D R G  1 9 2  1  c a s e  M i n o r  p a n c r e a s , l i v e r , s h u n t  p r o c
T y p i c a l  e p i s o d e s  b e f o r e  c h o l e c y s t e c t o m y :
D R G  1 8 3  
D R G  2 0 7 / 2 0 8
9  c a s e s  
1 0  c a s e s
M a i n l y  e n d o s c o p i c  e x a m i n a t i o n  
B i l i a r y  t r a c t  d x  b u t  n o  p r o c e d u r e
O t h e r s  i n c l u d e :
2 0 4  D i s .  p a n c r e a s
1 4 3  C h e s t  p a i n
1 2 5  C i r c .  d i s o r d e r s  e x  A M I
2 0 6  D i s e a s e  l i v e r
4 4 9  P e p t i c  u l c e r
4 1 6  S e p t i c a e m i a  
8 8  C h r o n .  O b s t r .  P .  D i s  
1 6 5  A p p e n d i c e c t o m y  
8 7  P u l m  o e d e m a  
4 4 9  P o i s e n i n g
T y p i c a l  e p i s o d e s  a f t e r  c h o l e c y s t e c t o m y :
3 9 4  O t h e r  O R  p r o c  b l o o d  f o r m i n g  o r g a n s  
1 1 1  M a j o r  r e c o n s t r u c t i v e  v a s e ,  p r o c  
1 8 3  O e s a p h a g i t i s  e t c .
1 0 0  O t h e r  d i g e s t i v e  s y s t e m  d i a g n o s i s  
1 0 9  C a r d i o t h o r a c i c  p r o c e d i r e
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Appendix 5(d) Minutes of CASPE/General Surgery Meeting 20/11/90.
P r e s e n t ;
M a r t i n  B a r d s l e y .  M r .  P .  W r i g h t .
J u l i e  G o o d f e l l o w .  M r .  C .  V e n a b l e s .
A l i s o n  M c C a l l u m .  M r .  N .  J o n e s .
J o a n  W a t s o n .  M r .  J .  C h a m b e r l a i n .
G i l l  S a n d e r s .
1 . A d d i t i o n a l  A n a l y s e s
M B  p r e s e n t e d  s o m e  a d d i t i o n a l  a n a l y s e s  h e  h a d  d o n e  o n  t h e  
r e s u l t s  p r e s e n t e d  i n  t h e  m a i n  r e p o r t .  T h e s e  i n c l u d e d :
a) R i s k  A s s e s s m e n t
T h e  n u m b e r s  o f  c a s e s  w i t h  a  p r e - o p e r a t i v e ' r i s k '  
a s s e s s m e n t  w a s  o f t e n  n o t  c o m p l e t e d  o n  t h e  p r e ­
o p e r a t i v e  f o r m .
T h o s e  t h a t  h a v e  b e e n  c o m p l e t e d  a p p e a r  t o  s h o w  a  
s t r o n g  c o r r e l a t i o n  t o  t h e  i n c i d e n c e  o f  p e r i o p e r a t i v e  
c o m p l i c a t i o n s  b u t  n o t  p o s t - o p .  c o m p l i c a t i o n s .  M B  
s u g g e s t e d  t h a t  t h i s  w a s  p r o b a b l y  b e c a u s e  t h e  f o r m s  
a r e  o f t e n  c o m p l e t e d  a f t e r  t h e  o p e r a t i o n .  P W  & N J  
p r o t e s t e d  t h a t  t h i s  w a s  n o t  c o r r e c t  a n d  c o n f i r m e d  
t h a t  t h e y  a r e  c o m p l e t e d  p r e - o p e r a t i v e l y .
C V  e x p e c t e d  t o  s e e  a  c o r r e l a t i o n  b e t w e e n  a s s e s s m e n t  
o f  r i s k  a n d  i n c i d e n c e  o f  p o s t - o p .  c o m p l i c a t i o n s ,  
w h i c h  a s  y e t  h a s  n o t  a p p e a r e d -  t h i s  i s  p r o b a b l y  d u e  
t o  t h e  s m a l l  n u m b e r s  i n v o l v e d .
M B  d i s c u s s e d  t h e  a p p a r e n t  r e l a t i o n s h i p s  b e t w e e n  t h e  
a s s e s s m e n t  o f  r i s k  a n d  i n  p r e  a n d  p o s t - o p e r a t i v e  N H P  
s c o r e s .  T h o s e  p a t i e n t s  a s s e s s e d  a s  " h i g h  r i s k "  b y  t h e  
s u r g e o n s  h a v e  h i g h  p r e - o p  N H P  s c o r e s  a n d  s h o w  g o o d  
i m p r o v e m e n t s ,  w h i l s t  t h e  o p p o s i t e  i s  t r u e  f o r  t h o s e  
a s s e s s e d  a s  " l o w  r i s k " .  P W  s u g g e s t e d  t h a t  t h o s e  
p a t i e n t s  w h o  w e r e  a s s e s s e d  a s  " m e d i u m  r i s k "  a n d  w h o  d i d  
n o t  s h o w  b i g  i m p r o v e m e n t s  o v e r  t h i s  t i m e  p e r i o d ,  a r e  
p e r h a p s  a  s e p a r a t e  c a t e g o r y  o f  p a t i e n t s  t h a t  m a y  h a v e  
b o w e l  p r o b l e m s  a s  o p p o s e d  t o  g a l l  b l a d d e r  d i s e a s e .
b )  B o w e l  P r o b l e m s
M B  d i s c u s s e d  t h e  i n c i d e n c e  o f  b o w e l  p r o b l e m s .  I t  h a d  
b e e n  n o t e d  i n  p r e v i o u s  m e e t i n g s  t h a t  r e p o r t e d  b o w e l  
p r o b l e m s  w e r e  o f t e n  w o r s e  a f t e r  t h e  o p e r a t i o n  t h a n  
b e f o r e .  T h e  r e s u l t s  ( w h i c h  a p p e a r  t o  b e  i n t e r n a l l y  
c o n s i s t e n t )  s h o w e d  t h a t  t h e  i n c i d e n c e  o f  d i a r r h o e a  & 
c o n s t i p a t i o n  a r e  r o u g h l y  e q u a l ,  a t  f o l l o w - u p .
C V  p o i n t e d  o u t  t h a t  o n e  m i g h t  e x p e c t  a  h i g h e r  i n c i d e n c e  
o f  d i a r r h o e a ,  d u e  t o  t h e  c o n t i n u o u s  f l o w  o f  f l u i d  i n t o  
t h e  d u o d e n u m  a n d  h e n c e  i n t o  t h e  b o w e l ,  w h i c h  o c c u r s  a f t e r  
c h o l e c y s t e c t o m y .
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c )  V a l i d a t i o n s
M B  r e p o r t e d  t h a t  t h e  v a l i d a t i o n s  h a v e  b e e n  s t a r t e d  
c o m p a r i n g  t h e  N H P  f o r  p r e - a d m i s s i o n ,  t o  t h e  N H P  c o m p l e t e d  
i n  h o s p i t a l .  I n i t i a l  r e s u l t s  s h o w  v e r y  g o o d  c o r r e l a t i o n s  
b e t w e e n  t h e  t w o  s c o r e s .
J G  r e p o r t e d  t h a t  i n t e r v i e w s  w i t h  1 5  p a t i e n t s  h a v e  
n o w  b e e n  c a r r i e d  o u t ,  i n  o r d e r  t o  v a l i d a t e  t h e  
q u e s t i o n n a i r e s  u s e d  t o  c o l l e c t  d a t a  o n  a d m i s s i o n  a n d  
a t  f o l l o w - u p .
T h e r e  w e r e  n o  f u r t h e r  c o m m e n t s  o n  t h i s  m a t t e r .
G e n e r a l  R e s u l t s
M B  d i s c u s s e d  t h e  m a i n  r e p o r t  w i t h  t h e  s u r g e o n s .  H e  
p o i n t e d  o u t  t h a t  a  s m a l l  n u m b e r  o f  p a t i e n t s  h a d  b e e n  
m i s s e d ,  m a i n l y  d u e  t o  u n e x p e c t e d ,  o r  e m e r g e n c y  
a d m i s s i o n s .
C V  a n d  P W  d i s c u s s e d  t h e  p r o b l e m  o f  c l a s s i f y i n g  t h e  
i n d i c a t i o n s  f o r  s u r g e r y  a n d  r e p o r t e d  t h a t  t h e y  f o u n d  
t h i s  d i f f i c u l t .  T h e y  a p p e a r e d  p a r t i c u l a r l y  c o n c e r n e d  
a b o u t  t h e  h i g h  p r o p o r t i o n  o f  p a t i e n t s  w h o  h a v e  b e e n  
c l a s s i f i e d  a s  a s y m p t o m a t i c ,  w h e n  p r o b a b l y  t h e y  h a v e  h a d  
a t  l e a s t  o n e  e p i s o d e  o f  b i l i a r y  c o l i c  i n  t h e  p a s t .  I t  
w a s  a g r e e d  t h a t  J G  w o u l d  i n v e s t i g a t e  t h i s  f u r t h e r .
C V  s u g g e s t e d  t h a t  b e t t e r  i n d i c a t i o n  c a t e g o r i e s  w o u l d  b e :
A c u t e  -  c h o l e c y s t i t i s  
b i l i a r y  c o l i c  
-  p a n c r e a t i t i s
C h r o n i c
H e  f e l t  t h a t  i t  w o u l d  b e  n e c e s s a r y  t o  r e - c a t e g o r i s e  
r e t r o s p e c t i v e l y  a t  a  l a t e r  s t a g e .
L e n g t h  o f  S t a y
P W  p o i n t e d  o u t  t h a t  2  d a y s  a p p e a r e d  a n  e x c e s s i v e l y  l o n g  
p r e - o p  s t a y  a n d  C V  s t a t e d  t h a t  h e  p r e f e r s  t o  h a v e  h i s  
p a t i e n t s  i n  e a r l y .  H o w e v e r ,  h e  f e e l s  t h a t  t h e  p o s t - o p  
s t a y  i s  m o r e  i m p o r t a n t  a n d  g e n e r a l l y ,  t h i s  s e e m s  t o  b e  
d e c r e a s i n g .
C o m p l i c a t i o n s
T h e r e  w a s  a  g e n e r a l  f e e l i n g  t h a t  t h e  i n c i d e n c e  o f  p o s t ­
o p  c o m p l i c a t i o n s  i s  l o w .  M B  w a s  s u r p r i s e d  a t  t h e  
a p p a r e n t l y  h i g h  i n c i d e n c e  o f  u r i n e  r e t e n t i o n ,  b u t  t h e  
s u r g e o n s  a g r e e d  t h a t  t h i s  i s  o n e  o f  t h e  m o s t  c o m m o n  p o s t ­
o p  c o m p l i c a t i o n s .
P W  p o i n t e d  o u t  t h a t  a  l o t  o f  t h e  p a t i e n t s  h a v e  s e v e r a l  
m e d i c a l  p r o b l e m s  a n d  t h e r e f o r e  w i l l  s h o w  a  h i g h  i n c i d e n c e  
o f  p r o b l e m s  a t  f o l l o w - u p ,  w h i c h  m a y  o f t e n  n o t  b e  r e l a t e d  
t o  t h e  c h o l e c y s t e c t o m y .
N J  e n q u i r e d  a s  t o  w h e t h e r  o r  n o t  t h e r e  w a s  a n y  
i n f o r m a t i o n  o n  r e t a i n e d  s t o n e s ,  a s  t h e  F R H  h a v e  h a d  a  
1 5  -  2 0 %  i n c i d e n c e  o f  t h i s  i n  t h e  p a s t .  C V  s t a t e d  t h a t  
t h e  a c c e p t e d  i n c i d e n c e  i s  a b o u t  8 %  w o r l d w i d e .
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M B  r e p l i e d  t h a t  h e  c o u l d  n o t  r e c a l l  a n y  s u c h  
i n c i d e n c e ,  b u t  t h a t  C A S P E  w i l l  r e c h e c k  t h e  d a t a .
T h e  s u r g e o n s  f e e l  t h a t  t h i s  i s  a  p o s i t i v e  s t a t e m e n t  
o n  t h e  r e s u l t s .
R e s u l t s  a t  12 m o n t h  f o l l o w  u p
T h e  r e s u l t s  a t  1 2  m o n t h  a p p e a r  t o  b e  s i m i l a r  t o  t h o s e  a t
3 / 1 2  a n d  t h e  i m p r o v e m e n t s  s e e n  p o s t - o p  a p p e a r  t o  b e  
h o l d i n g .  T h e  s l i g h t  d e t e r i o r a t i o n s  c o u l d  p e r h a p s  b e  
e x p l a i n e d  b y  t h e  o c c u r r e n c e  o f  o t h e r  i l l n e s s  a n d  t h e  n e e d
o f  s o m e  p a t i e n t s  t o  b e  " i n t r i n s i c a l l y  s i c k "  ( P W ) .
M B  f e l t  t h a t  t h e  i n d i c a t i o n s  a t  p r e s e n t  w e r e  t h a t ,  p e r h a p s  
1 2 / 1 2  d a t a  c o l l e c t i o n  c o u l d  b e  s t o p p e d .  J W  s t a t e d  t h a t  
p r o b l e m s  w i t h  n o n -  r e s p o n d e r s  t o  1 2 / 1 2  f o l l o w  u p  c r e a t e s  
a  l o t  o f  w o r k .  G S  f e l t  t h a t  t h e  c o l l e c t i o n  o f  1 2 / 1 2  
f o l l o w  u p  d a t a  s h o u l d  b e  c o n t i n u e d  u n t i l  t h e r e  a r e  
l a r g e r  n u m b e r s .  I t  w a s  a g r e e d  t o  c o n t i n u e  t h e  a n n u a l  
f o l l o w - u p  a t  l e a s t  u n t i l  E a s t e r .
E x c e p t i o n  r e p o r t
M B  e n q u i r e d  i f  e x c e p t i o n  r e p o r t s  o n  p a t i e n t s  w h o  d i d n ' t  
r e s p o n d  w e r e  u s e f u l  i n  i d e n t i f y i n g  g e n e r a l l e s s o n s  a n d  
a r e a s  f o r  i m p r o v i n g  p r a c t i c e .  P W  a g r e e d  t h a t  t h e s e  
p a t i e n t s  n e e d  t o  b e  i d e n t i f i e d ,  b u t  t h e y  d i d  n o t  a s  y e t  
c o n t r i b u t e  a n y  g e n e r a l  l e s s o n s .
G S  a s k e d  i f  r e p o r t i n g  o n  t h e s e  e x c e p t i o n s  w o u l d  a l l o w  t h e  
s u r g e o n s  t o  l e a r n  f r o m  t h e m .  A l t h o u g h  t h e r e  w a s  
a g r e e m e n t  t h a t  t h e  i n f o r m a t i o n  i s  i n t e r e s t i n g ,  i t  w a s  
f e l t  t h a t  i t  w o u l d  n o t  a f f e c t  p r a c t i c e .
C V  s t r e s s e d  t h e  a i m s  o f  t h e  s t u d y  a s  t h e  f e a s i b i l i t y  o f  
o u t c o m e s  m o n i t o r i n g ,  a n d  t h a t  u s i n g  t h e  r e s u l t s  t o  
c h a n g e  p r a c t i c e  ( e g .  p a t i e n t  s e l e c t i o n  c r i t e r i a )  w a s  
u n l i k e l y .  I t  w a s  p o i n t e d  o u t  t h a t  i f  t h e r e  w a s  
c o m p a r a t i v e  d a t a  a v a i l a b l e  f r o m  a n o t h e r  u n i t ,  w h i c h  
s h o w e d  b e t t e r  o u t c o m e s ,  t h e n  t h e  r e s u l t  c o u l d  b e  m o r e  
u s e f u l  i n  c h a n g i n g  p r a c t i c e .
F u n d i n g
F u n d i n g  o f  t h e  C A S P E  p r o j e c t  w a s  d i s c u s s e d .  I t  w a s  
d e c i d e d  t o  c a r r y  o n  w i t h  d a t a  c o l l e c t i o n  u n t i l  M a r c h  1 9 9 1 ,  
e s p e c i a l l y  a s  a n  u n u s u a l l y  s m a l l  n u m b e r  o f  
c h o l e c y s t e c t o m i e s  h a v e  b e e n  p e r f o r m e d  i n  r e c e n t  m o n t h s ,  
d u e  t o  b e d  c l o s u r e s .
O t h e r  a r e a s  w e r e  d i s c u s s e d  a s  p o s s i b l e  e x t e n s i o n s  o f  t h e  
o u t c o m e s  r e s e a r c h ,  s h o u l d  f u n d i n g  b e c o m e  a v a i l a b l e .
T h o s e  s u g g e s t e d  b y  t h e  s u r g e o n s  w e r e :
-  c o l o - r e c t a l  s u r g e r y ,  a s  c o m m o n .
-  d a y  c a s e  s u r g e r y  f o r  h e r n i a s ,  a s  t h i s  i s  a n  i n c r e a s i n g  
a r e a .
J u l i e  G o o d f e l l o w .  1 5 / 1 / 9 1 .
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Appendix 6(a) FREEMAN HOSPITAL DIABETIC CLINIC 
FORM 1 NEW PATIENT OUTCOMES
PATIENT IDENTIFIERS 
HOSPITAL No:
Surname:
Date of birth: (d/m/y) 
. . . . /  / . . .
Used name: 
Sex (M/F)
Year diagnosed
Insulin treated? 
l=Yes, 2=No
NEW REFERRAL OR INSULIN-STARTER (1/2) .....
Date of visit:....................  Starting insulin(l)
Referred by (GP/Cons init)........  On insulin now(l)......Year
started....
New or known diagnosis ( 1/2 )........ On OHA now (1)........ Year
started....
FH of diabetes(Y/N) OHA in past(l) Years to
Weight (kg) 
Height (m)
BMI
Urine protein.
Attended/attending already, or known problem(0/l)
Cardiology 
Ophthalmology 
Smoking
Drugs-Anti-failure, 
Anti-BP 
Anti-angina., 
Anti-lipid .,
Nephrology 
Vascular 
Symptoms : 
Angina 
Claudication 
Neuropathic 
Impotence
Lower Limbs
Poor feet/nails 
Ulcer/infection 
Amputation 
Foot pulses
Blood pressure
Eyes
VA
Cataract
Background
Maculopathy
Advanced
R
. . / .
L
. . / .
Highest recent glucose 
HbAl
Creatinine
Comments/past medical history
Cholesterol/HDL ... 
Triglyceride ... 
Microalbumin ration
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FORM 2 DIABETES 3 MONTH FOLLOW UP - NEW PATIENTS
Name: Date:
Weight :............kg
BP :..... /.......
HbAl :.............
HvpOQlavcaemia last month:
Self-treated 
Other treated
Referrals:
Chirop
Nephrol
Neurol
Choi I
None[
[ 1 
[ 1 
[ ]
AM PM
[ ] [ 1
[ 1 [ ]
Cardiol (
Ophthalmol ( 
Other.......
EVE NT 
] [ ]
1 [ 1
Seen by.
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FORM 3 NON-INSULIN DEPENDENT DIABETIC PATIENT QUESTIONNAIRE
P A T I E N T  I D E N T I F I C A T I O N  
D A T E :  /  /
P L E A S E  R E A D  T H E  F O L L O W I N G  I N S T R U C T I O N S  B E F O R E  A N S W E R I N G  A N Y  
Q U E S T I O N S •
1 .  O n  t h e  f o l l o w i n g  p a g e s  y o u  w i l l  f i n d  s o m e  q u e s t i o n s  a n d  
s t a t e m e n t s  a b o u t  d i a b e t e s .
2 .  E a c h  q u e s t i o n  a n d  s t a t e m e n t  i s  f o l l o w e d  b y  a  n u m b e r  o f  
c h o i c e s .
3 .  Y o u  s h o u l d  c h o o s e  f r o m  t h e s e  c h o i c e s  o n e  o r  m o r e  w h i c h  
y o u  t h i n k  c o r r e c t l y  a n s w e r s  t h e  q u e s t i o n  o r  c o m p l e t e s  
t h e  s t a t e m e n t .
F O R  E X A M P L E :
Q  M o s t  p e o p l e  n o r m a l l y  t r a v e l  
t o  a n d  f r o m  w o r k  b y  ........................
B u s / T r a i n  [  X  ] 
H o r s e  [  ]
C a r / M o t o r c y c l e / S c o o t e r  [  X  ]
B i c y c l e  [  X  ]  
A i r c r a f t  [  ]
I  d o  n o t  k n o w  [  ]
I n  t h i s  e x a m p l e  t h e  T H R E E  c h o i c e s  w h i c h  m o s t  p e o p l e  w o u l d  
a g r e e  c o r r e c t l y  c o m p l e t e s  t h e  s t a t e m e n t  a r e  m a r k e d  t h u s  [  X  ]
4 . I f  y o u  c a n n o t  a n s w e r  a  q u e s t i o n  o r  c o m p l e t e  a  s t a t e m e n t  
p l e a s e  m a k e  s u r e  t o  p u t  a  c r o s s  n e x t  t o  " I  d o  n o t  k n o w ” .
5 . P l e a s e  a t t e m p t  t o  a n s w e r  a l l  t h e  q u e s t i o n s  e v e n  t h o u g h  
s o m e  m a y  s e e m  n o t  t o  a p p l y  t o  y o u .
6 . M a k e  s u r e  y o u  a n s w e r  t h e  q u e s t i o n s  o n  a l l  o f  t h e  p a g e s  
T H A N K  Y O U .
P L E A S E  T U R N  O V E R
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Q l .  W h i c h  o f  t h e  f o l l o w i n g  i s  t r u e  a b o u t  d i a b e t e s ?
A  l i t t l e  s u g a r  i n  t h e  u r i n e  i s  a  g o o d  t h i n g  
I t  c a n  b e  c o n t r o l l e d  w i t h  t r e a t m e n t  
Y o u  w i l l  h a v e  i t  f o r  t h e  r e s t  o f  y o u r  l i f e  
T h e r e  c a n  b e  t o o  m u c h  s u g a r  i n  t h e  b l o o d  
Y o u r  b o d y  d o e s  n o t  m a k e  e n o u g h  i n s u l i n
I  d o  n o t  k n o w
Q 2 .  T a b l e t s  f o r  t h e  t r e a t m e n t  o f  d i a b e t e s
M a y  b e  i n c r e a s e d  b y  t h e  d o c t o r  i f  u r i n e  t e s t s
a r e  p o s i t i v e  [  ]
H e l p  l o w e r  t h e  a m o u n t  o f  s u g a r  i n  t h e  b l o o d  [  ]
N e e d  n o t  b e  t a k e n  i f  a  m e a l  h a s  b e e n  m i s s e d  [  ]
M a y  b e  s t o p p e d  b y  t h e  d o c t o r  i f  u r i n e  t e s t s  a r e
n e g a t i v e  [  ]
I  d o  n o t  k n o w  [ ]
Q 3 .  W h y  d o  d i a b e t i c s  t e s t  t h e i r  u r i n e ?
T o  k n o w  i f  t h e  d i a b e t e s  i s  u n d e r  c o n t r o l  [  ]
T o  k n o w  t h a t  t h e  k i d n e y s  a r e  w o r k i n g  p r o p e r l y  [  ]
T o  m e a s u r e  t h e  l e v e l  o f  i n s u l i n  i n  t h e  u r i n e  [  ]
T o  c h e c k  f o r  b l o o d  i n  t h e  u r i n e  [  ]
I  d o  n o t  k n o w  [  ]
Q 4 . I f  a  u r i n e  t e s t  s h o w s  2 %  ( + + + + )  s u g a r  t h i s  m o s t  
l i k e l y  m e a n s  a  d i a b e t i c  h a s  . . . .
S l i g h t l y  h i g h  b l o o d  s u g a r  l e v e l  
A  l o w  b l o o d  s u g a r  l e v e l  
A  h i g h  b l o o d  s u g a r  l e v e l  
A  n o r m a l  b l o o d  s u g a r  l e v e l  
I  d o  n o t  k n o w
Q 5 .  T h e  c o r r e c t  w a y  f o r  a  d i a b e t i c  t o  c a r e  f o r  
t o e n a i l s  i s  . . . .
T o  c u t  t h e m  e v e r y  7  t o  8  w e e k s  
T o  c u t  t h e m  s t r a i g h t  a c r o s s  
T o  c u t  t h e m  v e r y  s h o r t  
T o  u s e  a  m a g n i f y i n g  g l a s s  i f  e y e s i g h t  i s  p o o r  
T o  c l e a n  f r e e  e d g e s  a f t e r  c u t t i n g
I  d o  n o t  k n o w
Q 6 .  M i n o r  i n j u r i e s  t o  t h e  f e e t  a r e  m o r e  l i k e l y  t o  
g e t  i n f e c t e d  w h e n  t h e  b l o o d  s u g a r  l e v e l s  . . . .
O c c a s i o n a l l y  g e t  t o o  l o w  
A r e  l o w  a l l  t h e  t i m e  
A r e  h i g h  m u c h  o f  t h e  t i m e  
O c c a s i o n a l l y  g e t  t o o  h i g h  
I  d o  n o t  k n o w
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Q 7 .  F o o d s  c o n t a i n i n g  r e f i n e d  s u g a r  . . . .
A l w a y s  c a u s e  b l o o d  s u g a r  l e v e l s  t o  g e t  t o o  l o w  [  ]
R a i s e  b l o o d  s u g a r  l e v e l s  q u i c k e r  t h a n  s t a r c h y
f o o d s  [  ]
W i l l  h a v e  n o  e f f e c t  o n  b l o o d  s u g a r  l e v e l s  [  ]
A r e  s l o w e r  t h a n  s t a r c h y  f o o d  i n  r a i s i n g  b l o o d
s u g a r  l e v e l s  [  ]
I  d o  n o t  k n o w  [  ]
Q 8 .  W h i c h  o f  t h e  f o l l o w i n g  c o n t a i n s  s u g a r ?
F r u i t  s q u a s h  
C h o c o l a t e  m o u s s e  
I n s t a n t  p u d d i n g  
C o w s '  m i l k  
P a r s n i p  
I  d o  n o t  k n o w
Q 9 .  W h i c h  o f  t h e  f o l l o w i n g  i s  h i g h  f a t  f o o d ?
C o t t a g e  c h e e s e  
S k i m m e d  m i l k  
S a l a d  c r e a m  
C h e d d a r  c h e e s e  
I  d o  n o t  k n o w
Q I O .  H i g h  b l o o d  s u g a r  l e v e l s  c a n  b e  c a u s e d  b y  . . . .
A  d e l a y e d  m e a l  
B e i n g  l e s s  a c t i v e  t h a n  u s u a l  
D r i n k i n g  a l c o h o l  
G e t t i n g  a n  i n f e c t i o n  
E m o t i o n a l  s t r e s s  
I  d o  n o t  k n o w
Q l l .  K e e p i n g  d i a b e t e s  w e l l  c o n t r o l l e d  o v e r  t h e  y e a r s  
c a n  l o w e r  t h e  r i s k  o f  d a m a g e  t o  . . . .
T h e  s t o m a c h  
N e r v e s  i n  t h e  f e e t  
T h e  k i d n e y s  
T h e  l u n g s  
T h e  e y e s  
T h e  h e a r i n g  
I  d o  n o t  k n o w
P L E A S E  T U R N  O V E R
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Q 1 2 .  C o m m o n  s y m p t o m s  o f  l o w  b l o o d  s u g a r s  a r e  . . . .
F e e l i n g  h u n g r y  a n d  s w e a t i n g  
B l u r r e d  v i s i o n  
F e e l i n g  s i c k  a n d  t h i r s t y  
S l u r r e d  s p e e c h  
P a s s i n g  a  l o t  o f  u r i n e  
I  d o  n o t  k n o w
Q 1 3 .  H a r d e n i n g  a n d  n a r r o w i n g  o f  t h e  a r t e r i e s  i s  a  
p r o b l e m
N o t  s e e n  v e r y  o f t e n  i n  d i a b e t i c s  
W h i c h  i s  o n l y  s e e n  i n  d i a b e t i c s  
W h i c h  c a n  o c c u r  e a r l i e r  i n  d i a b e t i c s  
N o  w o r s e  f o r  d i a b e t i c s  t h a n  n o n - d i a b e t i c s
I  d o  n o t  k n o w
Q 1 4 .  S o m e  c o m m o n  s y m p t o m s  o f  v e r y  h i g h  b l o o d  s u g a r  
l e v e l s  a r e  . . . .
F e e l i n g  f a i n t  
B l u r r i n g  o f  v i s i o n  
P a s s i n g  m o r e  u r i n e  t h a n  u s u a l  
A  h e a d a c h e  a n d  f e e l i n g  i r r i t a b l e
F e e l i n g  t h i r s t y  
F e e l i n g  s i c k  a n d  v o m i t i n g  
I  d o  n o t  k n o w
Q 1 5 .  Y o u r  u r i n e  o r  b l o o d  t e s t s  h a v e  s t a r t e d  t o  s h o w  
i n c r e a s e d  s u g a r ,  y o u  . . . .
S h o u l d  r e s t  f o r  4 - 5  h o u r s  [  ]
S h o u l d  c h e c k  y o u r  d i e t  i s  c o r r e c t  [  ]
S h o u l d  c h e c k  f o r  a n y  i n f e c t i o n s  [ ]
M a y  n e e d  t o  e a t  l e s s  a t  m e a l  t i m e s  [  ]
I  d o  n o t  k n o w  [  ]
Q 1 6 .  W h e n  a  d i a b e t i c  s m o k e s  t h e  e f f e c t  i t  h a s  i s  . . . .
T o  i n c r e a s e  t h e  r i s k  o f  d a m a g e  t o  b l o o d  v e s s e l s  [  ]
I n c r e a s e d  r i s k  o f  p o o r  b l o o d  c i r c u l a t i o n  i n  l e g s  [  ]
T o  i n c r e a s e  t h e  r i s k  o f  h e a r t  d i s e a s e  [  ]
T o  c a u s e  p r o b l e m s  w i t h  w e i g h t  c o n t r o l  [  ]
N o  w o r s e  t h a n  f o r  a  n o n - d i a b e t i c  [  ]
I  d o  n o t  k n o w  [  ]
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Appendix 6(b)
CASPE/Freeman Outcome study
Diabetes Outcome Report January 1991- Annual Review Cases
A. Introduction
B. Cross section of clinic popoulation 1987-1990
C. Changes in laboratory indicators 1988-1989 and 1989-1990
D. Changes in clinical indicators 1988-1989 and 1989-1990.
E. Cases not receiving annual review
Appendix 1 - Definitions of patient types, high,low etc. 
Appendix 11 - Results annual reviews a. Metabolic indicators
b. Clinical indicators
Contact: Martin Bardsley, Donna Swinden,Freeman x26473 
Angela Skinner, NGH Diabetic Unit 
Martin Bardsley, Jim Coles, CASPE 071-229-8739.
A. Introduction
The following report reviews outcomes/changes in patient health for the Freeman diabetes 
clinic. The data concerns the 1989 annual review clinic and changes that occurred over 
the preceding year. In addition data on the first six months of 1990 is presented.
Our aims are to explore:
the appropriateness of these views on outcome and as descriptions of 
performance.
identify whether the results are better/worse than expected.
explore whether looking at outcomes can improve practice and 
management and so lead to better quality care.
B. Cross Sectional views of the clinic population 
Tables
B l=  Cross section 1987. (n=430)
B2= Cross Section 1988. (n=547)
B3= Cross section 1989. (n=637)
B4= Cross section 1990 Jan to July (n=426).
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Tables B1 to B4 show for separate years the distribution across a range of key variables 
for the cases who had an annual review. New cases who have only just been logged onto 
the database have been excluded. The values represent the percentage of that patient type 
with particular scores on each variable.
Cases have been split into four patient/treatment types (see Appendix I)
Y= Insulin treated, age at diagnosis < =35 
I = Insulin treated, age at diagnosis >35 
T = Patients on tablets 
D=Patients on diet only
Briefly the tables suggest:
Sex - remained approximately stable at between 50-60% male, fewer males being in the 
insulin (dx < 35) group and with slightly more men on diet only.
Age - remained stable with marked differences between treatment groups.
The proportion of elderly cases in the insulin (Dx > 35) appears to be rising.
HbAl -There are some fluctuations between years -1988 being the ’best’. The results for 
1989 and 1990 are disappointing. The increase in the insulin (dx < 35) group from 1989 
to 1990 seems particularly alarming.
Cholesterol - Generally stable with an increase in the incidence of non-recording in 1989. 
By 1990 27% of cases had values over 6.5
BMI - gradually worsening from 32% to 44% greater then 27.5 kg/m2. The changes 
appear in all patient groups.
BP - Until 1990 the results looked stable. The last six months have seen a rise in
patients high on both systolic and diastolic.
Visual acuity - stable at around 10% of cases with some visual impairment
Circulation - stable, about 30% having some problem, 15% having claudication or worse.
Eyes - stable, 25% with abnormal fundi, 5-8% maculopathy, 5-7% proliferative 
retinopathy.
Angina - Slight increase from 15% to 18% over the years.
Neuropathic symptoms - shows some fluctuations 17-24% but no clear trend
Biothesiometer - erratic (and with patchy recording). There have been some differences 
in the calibration of the machines and the validity of comparisons over these time scales
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must be doubtful.
Smoking - stable at around 15-20% smokers
Albustix - Erratic ranging from 5-13%, this is presumably a reflection of changes in the 
calibration of the assay.
C. Changes in laboratory indicators 1988-1989 and 1989-1990
Tables Cl - Changes 1988 to 1989 n=483 
C2 - Changes 1989 to 1990 n=280
Tables Cl and C2 present the changes in patients between successive annual reviews. 
The tables are split into five subsections the first summarises all cases, the next four 
sections give results for the individual treatment types.
Each table shows for a range of indicators the number of valid cases available (and 
underneath the proportion of the total) followed by the number of cases classified as 
unsatisfactory (Hi) in the first year and then the second. The numbers who have changed 
during the year are then shown.
For example table Cl - change 1988 to 1989.
A total of 483 cases came to both annual reviews. We have 443 of these (92%) with two 
valid HbAl values. Of these 157 (35%) were ’unsatisfactory’ 
in 1988, whilst 213 (48%) were unsatisfactory in 1989.
195 were low at the start and stayed low, 122 were high and stayed high,
35 got ’better’ moving from high to low, 91 got ’worse’ moving from low to high.
Comments:
HbAl - there is no net fall in patients classified as high over the year -rather patients 
appear worse. Approximately 80 patients have got ’worse’ with only 30 getting ’better’ 
leaving a net change of 50 - spread across all patient types. The proportion classified as 
high in both years varies by patient type ranging from 10% of diet patients to 44% of 
Insulin (age at dx<35).
The changes during 1989 appear alarming. Contact with the lab suggest that there has 
been a shift in average HbAl levels of about 1 unit % during the year yet there have 
been no conscious change in the assay procedures. The changes for the first six months 
of 1990 are not as abnormal though still in the ’wrong direction’.
Cholesterol - There is some general improvement - fewer patients over 6.5 in the second 
year. Once again the proportion high in both years seems large at 11-20% in 1989 and 
up to 28% of diet cases in 1990. In 1989 there appeared net improvements in the diet
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and insulin (dx > 35) groups, these are not seen in 1990.
BMI - as with HbAl more patients getting ’worse’ than ’better’ - particularly in the Diet 
and Insulin (age at dx > 35) group where 43% and 57% are over the 27.5 kg/m2 
threshold in 1990 with very little change.
This general view of the ’stability’ of the annual review population is the same as that 
from the earlier report. Is this what we should expect for the future? Are there ways in 
which we can construct better indicators eg concentrating on just the very unsatisfactory 
patients?
D. Changes in clinical indicators 1988-1989 and 1989-1990.
Tables D l. - Changes 1988-1989 n=483 
D2. - Changes 1989-1990 n=280
Tables D l and D2 deal with the changes in the incidence of clinical problems between 
successive annual reviews. As changes in this group tend to be slower and more difficult 
to control less detail is given.
Table D l charts the incidence of the clinical problems expressed as a percentage of the 
total cases. The figure in brackets represents the change from the previous year (ie 1988 
values minus 1989 values).
Thus in 1989 67% of patients had an ok blood pressure, this was 3% less than 1989.
Comments:
Blood Pressure - In general more patients had problems in the second year than the first 
(for both 1988 and 1989). These numbers appear rather unstable, which may reflect the 
relatively smaller numbers in each sample.
Visual Acuity - shows marked changes in three categories - presumably reflecting the 
deterioration in eyesight one might expect of a population of this age. Nevertheless, for 
those of whose who don’t wear glasses these numbers seem alarming.
Circulation - Once again the difference between the younger and the older patient types 
is marked. The observed incidence of absent pulses shows some fluctuation which are 
no doubt due to the problems of consistent measurement. The totals across all case types 
show much more stability and relatively little change year on year. It appears that with 
these numbers of cases it is not realistic to try and assess the rate at which these problems
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will arise within one year. Longer time periods should be adopted though these run into 
problems with the size and nature of the sample - relatively few cases will have 
observations over say 3-4 years.
Retinopathies - The incidence of abnormal fundi (background retinop) appears fairly 
stable with markedly higher values in the Insulin (dx < 35) group, and lower in the diet 
group. This pattern is not repeated in the incidence of maculopathy or proliferative 
retinopathy where the Insulin (dx > 25) and tablet groups score worse. Once again with 
low numbers it is difficult to be certain of the rate of change in any one year.
Neuropathies - The observation of neuropathic symptoms in approximately one quarter 
of cases seems quite reliable, with the insulin (dx > 35) groups faring rather worse than 
the others. There appear to be relatively large increases during 1988 - especially amongst 
the diet group, given that this condition is potentially reversible (or so I am told) this 
seems rather alarming.
The biothesiometer readings are again unreliable and show massive swings -probably due 
to the calibration and the high incidence of ’not recorded’.
Nephropathies - the albustix figures are showing some rather erratic behaviour as 
observed earlier, with relatively large increases in positive results in 1989 yet relatively 
large decreases in 1988. I would suggest the creatinine gives a clearer message.
Smoking - Though the proportion of smokers seems fairly stable somewhere between 15- 
20% of the total, there are a higher proportion in the younger insulin (dx < 35) group.
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E.NON-ATTENDERS FOR ANNUAL REVIEW 1989
In 1989 16 patients defaulted from the annual review clinic and were not seen in the 
regular clinic. A further 50 patients were not sent an annual review appointment and 
were not seen in the regular clinic - they are being chased at the moment.
Data was collected from 80-85 % of the patients who were attending the regular review 
clinic but did not attend for annual review in 1989 - a total of 123 records. HbAl and 
BMI were the only metabolic indicators collected as others were not recorded in a 
sufficient number of patients to allow analysis. The data collected was the last recorded 
in 1989 (or the first in 1990 if there were no records after September 1989), and values 
12-15 months previously.
As with the annual review analysis, the patients have been split into four patient/treatment 
groups:
HbAl
Table El shows the percentages of cases classified as either high or low in 1988 and 1989, 
with respect to HbAl (cut off value = 8.75%). Values in brackets show comparable 
annual review percentages.
TABLE El
Lo Lo Hi Lo Lo Hi Hi Hi
All 32 (44) 10 (8) 23 (21) 35 (28)
Ins(dx<35) 6 (27) 10 (8) 31 (21) 53 (44)
Ins(dx>35) 14 (31) 9 (8) 36 (20) 41 (42)
Tablet 36 (41) 14 (10) 18 (21) 32 (28)
Diet 72 (64) 8 (5) 8 (20) 12 (10)
As with the annual review attenders there is an overall rise (of 13%) in those patients 
classified as high over the year. However the proportion of patients high over both years 
is greater (35% v. 28%) and the proportion of patients remaining low over both years is 
smaller (32% v. 44%) than the patients who received annual reviews - these points are 
more marked in both insulin treated groups.
BMI
Table E2 - % of cases classified as high or low in 1988 and 1989 with respect to BMI - 
Cut-off = 27.5 kgm-2. Figures in brackets 
show comparable annual review percentages.
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TABLE E2
Lo Lo Hi Lo Lo Hi Hi Hi
TOTAL 56 (55) 4 (4) 6 (7) 34 (34)
Ins(dx<35) 75 (79) 6 (3) 3 (3) 16 (14)
Ins(dx>35) 54 (58) 0 (3) 18 (12) 27 (27)
Tablet 50 (50) 2 (5) 0 (5) 48 (39)
Diet 44 (43) 8 (4) 8 (10) 40 (43)
There is no significant difference between patients who receive an annual review and 
those who do not, whether you look at the group as a whole or look at different 
patient/treatment groups.
As with annual review attenders there is a slight overall rise in the proportion of patients 
classified as high over the year.
EYES. FEET AND BP
Table E3 shows the percentage of patients in whose notes it was documented that their 
eyes, feet and blood pressure had been checked, either in the routine clinic or during an 
in-patient stay.
TABLE E3
% checked Eyes Feet BP
TOTAL 31 32 68
Ins(dx<35) 25 13 34
Ins(dx>35) 54 59 82
Tablet 34 34 82
Diet 12 28 76
It is worrying that only 1/3 of the patients have their eyes and feet checked if they do not 
receive an annual review, and 2/3 of the patients have their blood pressure monitored. 
On the whole the diet only patients are the least monitored, and the insulin (age at 
dx > 35) are more closely observed.
SUMMARY Non Annual review Cases
Although patients weight does not seem to be affected if they do not receive an annual 
review, the data contained in Tables Dl and D3 serve to stress the importance of all 
diabetics having an annual check. So that the HbAl levels will be lowered slightly and 
to ensure that their eyes, feet and blood pressure are monitored annually to detect early 
signs of abnormality.
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Appendix I
Categorical Variables - coded when subset created:
BP Female Male
age < = 3 0  > 1 4 0  >85 >145 >90
age < =40 > 1 5 0  >90 >150 >90
age >40 > 1 6 0  >90 >160 >90
otherwise > 160 >90 >160 >90
Values roughly equate to 95th percentiles for normal populations where over 160/90.
Scored BPSUM 1= systolic, 2 = diastolic , 3=both
Visual Acuity (best eye)
0 = better than 6A2
1 =better than 6/36 and less than 6/12
2 = worse than 6/36 or counting fingers or seeing light
9 = none of the above (quite a lot)
Circulation
0=ok
1 = absent pulses (left or right)
2 = claudication 
3 = ulcers
4 = amputation (any)
Retinopathy:
Abnormal fundi = Yes/No Fundi abnormal or background retinopathy
(R or L retinal haemorrhages, hard exudates, venous abnormalities 
soft exudates)
Proliferative = Yes/No Proliferative
(R or L venous abnormalities, vitreous haemorrhages) 
Maculopathy = Yes/No Maculopathy
Angina Yes/No
Smoking Yes/No .. any smoking
Neuropathy Yes/No .. neuropathic symptoms
Claudication Yes/No
Impotence Yes/No or nor relevant
Biothesiometer Yes/No = <25 left or right 
Albustix Yes= any positive
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Continuous Variables:
1. HbAl(%)
0 = No value
1 = Satisfactory > 0  and <8.75
2 = Unsatisfactory >8.75 and <9.5
3 = Poor > 10.0
2.BMI 0 = No value
1 = Satisfactory <25
2 = Unsatisfactory >25 and <27.5
3 = Poor >27.5
3. Choi 0 = No value
1 = Satisfactory >5.2
2 = Unsatisfactory >5.2 and <6.5
3 = Poor >6.5
4. CholHDL
0 = No value
1 = Poor <0.9
2 = Unsatisfactory 0.9-1.1
3 = Good >1.1
5. Triglyc
0 = No value
1 = Satisfactory <2.5
2 = Unsatisfactory 2.5-4
3 = Poor > 4 Poor
6. Creatinine
1 = <125
2 = >125
7. Microalbumen
1 = <3.5 
2=3.5- 10
3 = > 10 Poor
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Table B1 Cross Section 1987
Ins
Coluin Percentages(X)
Ins Tab
No
Dx<35
88
Dx>35
56
let
150
Diet
136
Total
430
Male 56.8 55.4 59.3 65.4 60
Female 43.2 44.6 40.7 34.6 40
Age (Not rec) 4.5 5.4 2.7 0.7 3
<40 yrs 71.6 17.9 2.7 5.1 20
40-59 yrs 18.2 35.7 30.0 35.3 30
60-69 yrs 4.5 26.8 34.7 32.4 27
>70 yrs 1.1 14.3 30.0 26.5 21
HbAl (Not rec) 3.4 8.9 5.3 7.4 6
<= 7.5 25.0 12.5 27.3 41.2 29
7.5 - 8.75 27.3 17.9 26.0 23.5 24
8.75 - 10.0 19.3 30.4 21.3 14.0 20
> 10.0 25.0 30.4 20.0 14.0 20
Cholesterol (N/R) 3.4 3.6 5.3 2.2 4
<=5.2 54.5 32.1 20.7 31.6 33
5.2 - 6.5 26.1 42.9 40.7 41.2 38
>6.5 15.9 21.4 33.3 25.0 26
BMI (Not rec) 1.1 1.8 2.7 0.7 2
<=25 55.7 55.4 43.3 26.5 42
25 - 27.5 26.1 25.0 20.7 27.2 24
>27.5 17.0 17.9 33.3 45.6 32
Choi HDL (N/R) 20.5 16.1 20.0 16.2 18
>1.1 54.5 53.6 28.0 31.6 38
0.9 - 1.1 19.3 17.9 18.7 20.6 19
<=0.9 5.7 12.5 33.3 31.6 24
Creatinine (N/R) 2.3 8.9 8.7 5.1 6
<=125 97.7 75.0 80.7 86.8 85
>125 0.0 16.1 10.7 8.1 8
Triglycerides (N/R 6.8 5.4 7.3 5.1 6
<=2.5 79.5 73.2 40.7 64.0 60
2.5 - 4.0 5.7 12.5 35.3 21.3 22
>4.0 8.0 8.9 16.7 9.6 12
Dx<35
88
Dx>35
56
let
150
Diet
136
Total
430
Microalbuien (N/R 98.9 100.0 100.0 99.3 100
<=3.5 0.0 0.0 0.0 0.0 0
3.5 - 10.0 1.1 0.0 0.0 0.7 0
>10.0 0.0 0.0 0.0 0.0 0
Blood Pressure Ok 87.5 87.5 66.7 66.9 74
Systolic high 4.5 3.6 22.0 18.4 15
Diastoloic high 5.7 0.0 2.7 4.4 3
S ♦ D high 2.3 5.4 6.7 8.1 6
Not recorded 0.0 3.6 2.0 2.2 2
Visual acuity Ok 92.0 89.3 84.7 90.4 89
6/12 to 6/36 2.3 5.4 12.7 7.4 8
Worse than 6/36 1.1 0.0 2.0 0.0 1
Other/not rec 4.5 5.4 0.7 2.2 3
Circulation Ok 70.5 57.1 56.0 64.0 62
Pulses 28.4 28.6 22.0 22.8 24
Claudication 0.0 3.6 14.7 8.8 8
Ulcer 0.0 0.0 5.3 2.2 3
Amputation 1.1 10.7 2.0 2.2 3
Eyes - Ab. fundi 28.4 37.5 30.7 14.0 26
Not observe 0.0 0.0 0.0 0.0 0
Maculopathy 3.4 3.6 8.0 3.7 5
Proliferati 10.2 7.1 8.0 2.9 7
Angina 2.3 12.5 18.7 19.9 15
Neuropath. Symptom 9.1 30.4 19.3 20.6 19
Biothesiometer <25 78.4 41.1 27.3 27.9 40
Not recorded 3.4 8.9 4.0 5.9 5
Albustix +ve 21.6 8.9 14.0 9.6 13
Not recorded 0.0 0.0 0.0 0.0 0
Smoking (any) 22.7 28.6 20.7 11.8 19
Ins Ins Tab
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Table B2 ..Cross-Section 1988
Colum Percentages(X)
Ins Ins Tab
No=
Dx<35
105
Dx>35
80
let
189
Diet
173
Total
547
Male 58.1 62.5 55.6 67.6 61
Female 41.9 37.5 44.4 32.4 39
Age (Not rec) 1.9 1.3 1.1 7.5 3
<40 yrs 69.5 16.3 1.1 2.3 17
40-59 yrs 25.7 37.5 32.3 34.7 33
60-69 yrs 2.9 28.8 34.9 27.7 26
>70 yrs 0.0 16.3 30.7 27.7 22
HbAl (Not rec) 4.8 2.5 2.6 6.4 4
<= 7.5 21.9 22.5 32.3 60.7 38
7.5 - 8.75 21.9 27.5 24.9 17.9 22
8.75 - 10.0 29.5 26.3 17.5 8.1 18
> 10.0 21.9 21.3 22.8 6.9 17
Cholesterol (N/R) 1.0 0.0 3.2 1.7 2
<=5.2 54.3 28.8 20.1 28.3 31
5.2 - 6.5 29.5 41.3 40.7 37.0 37
>6.5 15.2 30.0 36.0 32.9 30
BMI (Not rec) 0.0 2.5 3.2 3.5 3
<=25 54.3 41.3 31.7 26.6 36
25 - 27.5 26.7 28.8 22.2 26.6 25
>27.5 19.0 27.5 42.9 43.4 36
Choi HDL (Not rec) 9.5 22.5 15.9 12.7 15
>1.1 64.8 46.3 34.4 39.3 44
0.9 - 1.1 20.0 16.3 21.2 20.8 20
<=0.9 5.7 15.0 28.6 27.2 22
Creatinine (N/R) 6.7 7.5 5.3 5.8 6
<=125 90.5 83.8 84.1 86.7 86
>125 2.9 8.8 10.6 7.5 8
Triglycerides (N/R) 1.9 2.5 5.3 1.7 3
<=2.5 86.7 57.5 41.3 61.8 59
2.5 - 4.0 9.5 17.5 34.4 23.1 24
>4.0 1.9 22.5 19.0 13.3 14
No=
Dx<35
105
Dx>35
80
let
189
Diet
173
Total
547
Nicroalbunen (N/R) 51.4 41.3 54.0 53.8 52
<=3.5 0.0 0.0 0.0 0.0 0
3.5 - 10.0 47.6 55.0 42.3 45.7 46
>10.0 1.0 3.8 3.7 0.6 2
Blood Pressure Ok 87.6 81.3 62.4 64.2 71
Systolic high 1.9 7.5 21.7 19.7 15
Diastoloic high 6.7 6.3 6.3 4.6 6
S ♦ D high 2.9 3.8 8.5 9.2 7
Not recorded 1.0 1.3 1.1 2.3 1
Visual acuity (OK) 94.3 88.8 91.5 91.9 92
6/12 to 6/36 2.9 6.3 3.7 3.5 4
Worse than 6/36 1.0 0.0 2.1 0.6 1
Other/not rec 1.0 5.0 2.6 4.0 3
Circulation Ok 91.4 72.5 63.0 71.1 72
Pulses 3.8 7.5 18.0 9.2 11
Claudication 1.9 12.5 13.8 13.9 11
Ulcer 1.0 3.8 1.6 1.2 2
Amputation 1.0 3.8 3.7 4.6 3
Eyes - Ab fundi 30.5 35.0 30.7 17.9 27
Not observe 0.0 0.0 0.0 0.0 0
Maculopathy 3.8 7.5 10.1 4.6 7
Proliferati 8.6 7.5 8.5 2.9 7
Angina 2.9 11.3 20.6 18.5 15
Neuropath. Symptom 9.5 28.8 17.5 15.0 17
Biothesiometer <25 71.4 35.0 24.3 29.5 37
Not recorded 10.5 10.0 10.1 9.8 10
Albustix +ve 17.1 16.3 13.8 9.8 14
Not recorded 4.8 3.8 1.6 2.3 3
Smoking (any) 27.6 21.3 18.0 16.2 20
Column Percentages(X) 
Ins Ins Tab
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Table B3. Cross Section 1989
Colunn Percentages (%)
Ins Ins Tab 
Dx<35 Dx>35 let Diet Total
No b 122 1 1 0 209 196 637
Male 59.8 56.4 57.4 62.2 59
Female 40.2 43.6 42.6 37.8 41
Age (Not rec) 0.0 0.9 1.0 2.0 1
<40 yrs 68.0 8.2 1.9 3.1 16
40-59 yrs 25.4 46.4 31.6 29.6 32
60-69 yrs 4.9 27.3 35.9 35.7 28
>70 yrs 1.6 18.2 30.1 29.6 22
HbAl (Not rec) 3.3 2.7 4.3 5.6 4
<= 7.5 14.8 18.2 26.8 48.0 30
7.5 - 8.75 20.5 20.0 23.9 24.5 23
8.75 - 10.0 33.6 28.2 17.2 14.3 21
> 10.0 27.9 31.8 28.2 7.7 22
Cholesterol (N/R) 9.0 11.8 6.7 12.2 10
<=5.2 50.0 31.8 25.4 21.9 30
5.2 - 6.5 27.0 40.0 34.9 42.9 37
>6.5 13.9 17.3 33.5 23.0 24
BMI (Not rec) 0.8 4.5 3.8 2.6 3
<=25 45.9 37.3 31.6 20.9 32
25 - 27.5 32.8 24.5 19.1 23.5 24
>27.5 20.5 34.5 45.9 53.1 41
Choi HDL (Not rec) 18.0 24.5 21.1 32.7 25
>1.1 59.0 39.1 30.6 27.6 37
0.9 - 1.1 11.5 14.5 22.0 14.8 16
<=0.9 11.5 22.7 26.8 25.0 23
Creatinine (N/R) 5.7 6.4 5.3 5.6 6
<=125 91.8 79.1 84.2 86.7 86
>125 2.5 15.5 11.0 7.7 9
Triglycerides (N/R) 9.0 11.8 8.1 12.2 10
<=2.5 82.0 60.9 48.8 47.4 57
2.5 - 4.0 6.6 15.5 27.8 28.1 22
>4.0 2.5 12.7 15.8 12.2 12
Ins Ins Tab
Dx<35 Dx>35 let Diet Total
122 110 209 1 % 637
Nicroalbuaen (Not 99.2 100.0 100.5 99.5 100
<=3.5 0.0 0.0 0.0 0.0 0
3.5 - 10.0 0.8 0.9 0.0 0.5 0
>10.0 0.0 0.0 0.0 0.0 0
Blood Pressure Ok 86.9 79.1 66.5 66.8 73
Systolic high 6.6 10.0 21.1 14.3 14
Diastolic high 3.3 3.6 6.7 6.6 5
S + D high 1.6 7.3 5.3 11.2 7
Not recorded 1.6 0.9 1.0 1.0 1
Visual acuity (OK) 95.1 93.6 91.4 91.8 93
6/12 to 6/36 2.5 5.5 5.7 4.1 5
Worse than 6/36 0.8 0.9 1.9 1.0 1
Other/not rec 1.6 0.9 1.4 3.1 2
Circulation Ok 89.3 69.1 63.6 68.4 71
Pulses 7.4 14.5 17.2 14.3 14
Claudication 1.6 10.0 15.3 14.8 12
Ulcer 0.8 1.8 1.0 1.5 1
Amputation 0.8 5.5 3.3 1.0 3
Eyes - Ab fundi 27.9 28.2 26.3 15.8
Not observe 0.0 0.0 0.0 0.0 0
Maculopathy 4.1 7.3 8.6 3.1 6
Proliferati 7.4 6.4 6.2 3.6 6
Angina 3.3 18.2 23.4 21.9 18
Neuropath. Symptom 16.4 28.2 27.3 22.4 24
Biothesiometer <25 46.7 18.2 24.4 24.5 28
Not recorded 35.2 48.2 43.1 44.4 43
Albustix +ve 3.3 3.6 7.2 3.6 5
Not recorded 0.0 0.0 0.0 0.0 0
Smoking (any) 18.9 20.0 14.4 14.8 16
24
369
Table B4 1990 Cross section (to July)
Column Percentages(X)
Ins Ins Tab 
Dx<35 Dx>35 let Diet Total
No= 77 86 143 120 426
Male 49.4 54.7 54.5 65.8 57
Female 50.6 45.3 45.5 34.2 43
Age (Not rec) 0.0 0.0 0.0 0.0 0
<40 yrs 66.2 7.0 1.4 1.7 14
40-59 yrs 28.6 40.7 31.5 28.3 32
60-69 yrs 2.6 30.2 37.1 35.0 29
>70 yrs 2.6 22.1 30.1 35.0 25
HbAl (Not rec) 2.6 1.2 4.2 1.7 3
<= 7.5 16.9 17.4 23.1 45.0 27
7.5 - 8.75 13.0 25.6 23.8 27.5 23
8.75 - 10.0 26.0 31.4 21.0 16.7 23
> 10.0 41.6 24.4 28.0 9.2 24
Cholesterol (N/R) 1.3 2.3 2.8 0.8 2
<=5.2 46.8 39.5 19.6 22.5 29
5.2 - 6.5 37.7 34.9 44.1 45.8 42
>6.5 14.3 23.3 33.6 30.8 27
BMI (Not rec) 0.0 4.7 0.0 1.7 1
<=25 45.5 37.2 26.6 18.3 30
25 - 27.5 27.3 19.8 25.9 24.2 24
>27.5 27.3 38.4 47.6 55.8 44
Choi HDL (Not rec) 1.3 5.8 4.2 1.7 3
>1.1 76.6 57.0 43.4 42.5 52
0.9 - 1.1 13.0 16.3 27.3 20.0 20
<=0.9 9.1 20.9 25.2 35.8 24
Creatinine (N/R) 5.2 8.1 10.5 5.8 8
<=125 92.2 81.4 83.2 83.3 85
>125 2.6 10.5 6.3 10.8 8
Triglycerides (N/R) 1.3 2.3 2.8 0.8 2
<=2.5 84.4 73.3 50.3 60.0 64
2.5 - 4.0 11.7 10.5 32.2 27.5 23
>4.0 2.6 14.0 14.7 11.7 12
Ins Ins Tab
Dx<35 Dx>35 let Diet Total
77 86 143 120 426
67.5 72.1 62.2 70.0 67
23.4 15.1 20.3 18.3 19
6.5 8.1 11.2 9.2 9
2.6 4.7 6.3 2.5 4
76.6 65.1 60.8 50.8 62
11.7 17.4 14.7 23.3 17
5.2 7.0 6.3 8.3 7
2.6 9.3 18.2 16.7 13
3.9 1.2 0.0 0.8 1
92.2 82.6 81.8 85.0 85
6.5 16.3 12.6 12.5 12
0.0 1.2 5.6 1.7 3
1.3 0.0 0.0 0.8 0
93.5 70.9 64.3 66.7 72
3.9 11.6 16.8 15.0 13
2.6 15.1 14.0 14.2 12
0.0 2.3 2.8 1.7 2
0.0 0.0 2.1 2.5 1
31.2 25.6 35.0 13.3 26
0.0 0.0 0.0 0.0 0
5.2 7.0 11.9 4.2 8
1.3 4.7 10.5 2.5 5
5.2 15.1 26.6 19.2 18
16.9 32.6 20.3 25.8 24
74.0 50.0 50.3 57.5 57
19.5 9.3 4.9 10.0 10
10.4 10.5 9.8 7.5 9
1.3 1.2 0.0 0.0 0
29.9 24.4 13.3 15.8 19
Nicroalbuaen (N/R) 
<=3.5
3.5 - 10.0 
> 10.0
Blood Pressure Ok
Systolic high 
Diastolic high 
S + D high 
Not recorded
Visual acuity (OK) 
6/12 to 6/36 
Worse than 6/36 
Other/not rec
Circulation Ok 
Pulses
Claudication
Ulcer
Amputation
Eyes - Ab. fundi
Not observe 
Maculopathy 
Proliferati
Angina
Neuropath. Symptom
Biothesiometer <25 
Not recorded
Albustix +ve 
Not recorded
Smoking (any)
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Table Cl (a) Changes In Lab indicators 1988-1989
All cases Total=483
NB. Hi=Unsatisfactory (not always high)
No. unsatisf. Changes 88 to 89
Total 88 89 LoLo Hilo LoHi HiHi
HbAl 443 157 213 195 35 91 122
92% 35% 48% 44% 8% 21% 28%
Choi HDL 360 138 142 107 35 31 187
75% 38% 39% 52% 9% 10% 30%
Body Has 461 175 190 252 19 34 156
95% 38% 41% 55% 4% 7% 34%
Choleste 441 148 129 256 56 37 92
91% 34% 29% 58% 13% 8% 21%
Greatini 425 39 50 364 11 22 28
88% 9% 12% 86% 3% 5% 7%
Triglyce 435 184 164 216 55 35 129
90% 42% 38% 50% 13% 8% 30%
Hicroalb 60 1 12 47 1 12 0
12% 2% 20% 78% 2% 20% 0%
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Table C l (b) Changes In lab Indicators 1988-1989
Insulin treated (Age at diagnosis >35 years) Total=69
No. unsatisf. Changes 88 to 89
Total 88 89 LoLo Hilo LoHi HiHi
HbAl 65 32 40 20 5 13 27
94% 49% 62% 31% 8% 20% 42%
Choi HDL 45 15 14 12 2 3 28
65% 33% 31% 62% 7% 4% 27%
Body Mas 66 20 26 38 2 8 18
96% 30% 39% 58% 3% 12% 27%
Choleste 62 23 19 35 8 4 15
90% 37% 31% 56% 13% 6% 24%
Creatini 63 7 8 52 3 4 4
91% 11% 13% 83% 5% 6% 6%
Triglyce 60 27 20 29 11 4 16
87% 45% 33% 48% 18% 7% 27%
Microalb 9 0 2 7 0 2 0
Insulin treated (Age at 
No.
diagnosis 
unsatisf.
<35 years) Total=92 
Changes 88 to 89
Total 88 89 LoLo HiLo LoHi HiHi
HbAl 85 44 55 23 7 18 37
92% 52% 65% 27% 8% 21% 44%
Choi HDL 71 12 11 5 6 7 53
77% 17% 15% 75% 10% 8% 7%
Body Mas 91 16 16 72 3 3 13
99% 18% 18% 79% 3% 3% 14%
Choleste 84 16 13 64 7 4 9
91% 19% 15% 76% 8% 5% 11%
Creatini 80 3 5 73 2 4 1
87% 4% 6% 91% 3% 5% 1%
Triglyce 83 8 8 69 6 6 2
90% 10% 10% 83% 7% 7% 2%
Microalb 12 0 1 11 0 1 0
Treated by ta b le t Total=171
Total 88 89 LoLo HiLo LoHi HiHi
HbAl 158 60 77 65 16 33 44
92% 38% 49% 41% 10% 21% 28%
Choi HDL 131 63 66 52 14 11 54
77% 48% 50% 41% 8% 11% 40%
Body Mas 159 71 71 80 8 8 63
93% 45% 45% 50% 5% 5% 40%
Choleste 156 59 60 77 19 20 40
91% 38% 38% 49% 12% 13% 26%
Creatini 150 16 25 124 1 10 15
88% 11% 17% 83% 1% 7% 10%
Triglyce 153 89 80 52 21 12 68
89% 58% 52% 34% 14% 8% 44%
Microalb 20 1 4 15 1 4 0
Treated by diet only Total cases=151
Total 88 89 LoLo HiLo LoHi HiHi
HbAl 135 21 41 87 7 27 14
89% 16% 30% 64% 5% 20% 10%
Choi HDL 113 48 51 38 13 10 52
75% 42% 45% 46% 9% 12% 34%
Body Mas 145 68 77 62 6 15 62
96% 47% 53% 43% 4% 10% 43%
Choleste 139 50 37 80 22 9 28
92% 36% 27% 58% 16% 6% 20%
Creatini 132 13 12 115 5 4 8
87% 10% 9% 87% 4% 3% 6%
Triglyce 139 60 56 66 17 13 43
92% 43% 40% 47% 12% 9% 31%
Microalb 19 0 5 14 0 5 0
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Table C2(a) Changes in lab indicators 1989-Jul 1990
A U  cases Total=280
No. high in Changes 89 to J90
Total 89 J90 LoLo HiLo LoHi 1HiHi
HbAl 263 124 140 92 31 47 93
94% 47% 53% 35% 12% 18% 35%
Chol HDL 193 69 67 52 15 17 109
69% 36% 35% 56% 9% 8% 27%
Body Mas 273 124 126 136 11 13 113
98% 45% 46% 50% 4% 5% 41%
Choleste 251 67 73 164 14 20 53
90% 27% 29% 65% 6% 8% 21%
Creatini 247 25 25 215 7 7 18
88% 10% 10% 87% 3% 3% 7%
Triglyce 249 80 75 147 27 22 53
89% 32% 30% 59% 11% 9% 21%
Microalb 0 0 0 0 0 0 0
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Table C2(b) Changes in Lab indicators 1989-July 1990
Insulin treated (Age at diagnosis >35 years) Total=59
No. high in Changes 89 to J90
Total 89 J90 LoLo Hilo LoHi 1HiHi
HbAl 57 35 31 14 12 8 23
97% 61% 54% 25% 21% 14% 40%
Choi HDL 41 14 14 11 3 3 24
69% 34% 34% 59% 7% 7% 27%
Body Has 56 22 22 31 3 3 19
95% 39% 39% 55% 5% 5% 34%
Choleste 53 10 13 40 0 3 10
90% 19% 25% 75% 0% 6% 19%
Great ini 53 8 7 45 1 0 7
90% 15% 13% 85% 2% 0% 13%
Triglyce 53 13 14 36 3 4 10
90% 25% 26% 68% 6% 8% 19%
Microalb 0 0 0 0 0 0 0
Insulin treated (Age at diagnosis <35 years) Total=50
No. high in Changes 89 to J90
Total 89 J90 LoLo HiLo LoHi HiHi
HbAl 46 34 38 7 1 5 33
92% 74% 83% 15% 2% 11% 72%
Choi HDL 44 9 9 7 2 2 33
88% 20% 20% 75% 5% 5% 16%
Body Mas 50 15 14 31 5 4 10
100% 30% 28% 62% 10% 8% 20%
Choleste 45 6 7 37 1 2 5
90% 13% 16% 82% 2% 4% 11%
Greatini 45 0 2 43 0 2 0
90% 0% 4% 96% 0% 4% 0%
Triglyce 45 5 5 37 3 3 2
90% 11% 11% 82% 7% 7% 4%
Microalb 0 0 0 0 0 0 0
No. high in Changes 89 to J90
Total 89 J90 LoLo HiLo LoHi HiHi
HbAl 74 34 41 25 8 15 26
91% 46% 55% 34% 11% 20% 35%
Choi HDL 54 20 22 15 7 5 27
67% 37% 41% 50% 9% 13% 28%
Body Mas 79 35 37 41 1 3 34
98% 44% 47% 52% 1% 4% 43%
Choleste 73 23 25 41 7 9 16
90% 32% 34% 56% 10% 12% 22%
Great ini 66 8 7 56 3 2 5
81% 12% 11% 85% 5% 3% 8%
Triglyce 71 31 33 29 9 11 22
88% 44% 46% 41% 13% 15% 31%
Microalb 0 0 0 0 0 0 0
Treated by diet only Total cases=90
No. high in Changes 89 to J90
Total 89 J90 LoLo HiLo LoHi HiHi
HbAl 86 21 30 46 10 19 11
96% 24% 35% 53% 12% 22% 13%
Choi HDL 54 26 22 19 3 7 25
60% 48% 41% 46% 13% 6% 35%
Body Mas 88 52 53 33 2 3 50
98% 59% 60% 38% 2% 3% 57%
Choleste 80 28 28 46 6 6 22
89% 35% 35% 58% 8% 8% 28%
Greatini 83 9 9 71 3 3 6
92% 11% 11% 86% 4% 4% 7%
Triglyce 80 31 23 45 12 4 19
89% 39% 29% 56% 15% 5% 24%
Microalb 0 0 0 0 0 0 0
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Table D1 Incidence of clinical complications 1988-1989
Percentage 89 [X change 88 to(-) 89 ]
Variable Total Ins dx<35 Ins Dx>35 Tablet Diet
Number cases» 483 98 83 177 129
BP ok 67% 3] 85% t 13 66% [ 83 64% [ 03 57% [ 73
BP Sys 17% -13 8% [ -53 19% t-113 18% [ 43 19% [ 13
BP Dias 5% 0] 3% C 33 4% [ 53 5% [ 03 9% [ -53
BP Both 10% -2] 1% [ 33 11% I -53 10% [ -33 14% [ -43
BP NotRec 1% 1] 3% [ -23 0% C 23 0% [ 13 1% [ 13
V Acuity ok 88% 4] 96% C -13 87% [ 23 84% [ 73 86% C 83
6/12 to 6/36 9% -5] 3% [ -13 11% [ -63 9% [ -33 11% I -93
Worse 6/36 2% -1] 0% [ 13 1% I -13 4% [ -23 2% [ -23
Not Rec 1% 23 1% [ 13 1% C 53 1% [ 13 1% I 23
Circul Ok 70% 43 92% I 03 70% [ 23 63% [ 13 60% [ 113
Pulses 15% -53 7% I -33 11% [ -23 19% [ -33 17% [ -93
Claudic 11% 03 0% [ 23 12% [ -23 12% [ 23 18% [ -23
Ulcer 1% 03 0% [ 13 1% I 23 1% [ 03 2% [ -23
Amputation 3% 03 1% I 03 6% [ 03 3% [ 03 3% [ 23
Not Rec 0% 03 0% [ 03 0% [ 03 0% [ 03 0% [ 03
Fundi Ok 74% -13 62% I 53 75% [ -73 72% [ -23 84% [ 03
Abnormal 26% 13 38% I -53 25% [ 73 26% [ 23 16% [ 03
Not rec 0% 03 0% [ 03 0% [ 03 0% [ 03 0% [ 03
Maculopathy No 92% 13 94% C 23 89% [ 43 88% [ -13 96% [ 13
Yes 8% -13 6% [ -23 11% C -43 10% [ 13 4% [ -13
Not Rec 0% 03 0% C 03 0% C 03 0% I 03 0% C 03
Prolif Retinop No 94% -13 95% [ -53 94% [ 03 91% [ -13 96% I 23
Yes 6% 13 5% [ 53 6% [ 03 7% [ 13 4% [ -23
Not Rec 0% 03 0% [ 03 0% I 03 0% [ 03 0% [ 03
Angina No 80% 53 98% [ 03 80% I 53 75% [ 83 73% [ 43
Yes 20% -53 2% [ 03 20% [ -53 23% [ -83 27% [ -43
Not Rec 0% 03 0% [ 03 0% C 03 0% [ 03 0% [ 03
Neur Symps No 76% 73 88% [ 23 66% [ 73 74% [ 63 74% [ 123
Yes 24% -73 12% [ -23 34% C -83 23% I -63 26% [-123
Not Rec 0% 03 0% [ 03 0% [ 13 1% [ 03 0% [ 13
Biothesiom <25 26% 273 6% [ 103 33% [ 273 31% [ 573 29% [ 353
>25 45% -83 68% [ 43 37% [ -83 38% [ 73 39% [-123
Not Rec 30% -193 26% [•143 30% [■183 29% [-123 33% [•233
Albustix -ve 93% -83 94% t-123 95% [■173 90% [ -63 93% [ -13
+ve 6% 73 4% [ 113 5% I 123 7% [ 63 7% [ 03
Not Rec 0% 23 1% [ 23 0% [ 53 0% [ 13 0% [ 13
Smoking No 83% -23 77% C -33 86% [ -63 83% [ -33 84% [ 23
Yes 17% 23 23% [ 33 14% [ 63 15% I 33 16% [ -23
Not Rec 0% 03 OX [ 03 0% [ 03 0% [ 03 0% [ 03
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Table D2 Incidence of clinical complications 1989-July 1990
Percentage 90 
Variable
[ % change 89 to(-) 90 ]
Total Ins dx<35 Ins Dx>35 Tablet Diet
Number cases= 280 56 61 89 79
BP Ok 61% 14] 73% 141 66% 151 56% C 151 52% C 181
BP Sys 18% -6] 14% -91 18% -101 13% [ 11 24% [ -81 -
BP Dias 6% -1] 4% -21 8% -31 3% C 21 8% [ -41 -
BP Both 13% -7] 4% 01 7% -21 21% c-131 15% [ -61 -
BP NotRec 2% 0] 5% -41 2% 01 0% [ 11 1% [ 01
Vis Ac Ok 83% 8] 91% 21 82% 111 73% [ 111 84% [ 61
VA 6/12 to 36 14% -9] 7% -41 18% -111 16% [ -91 14% t -91 -
VA Worse 6/36 2% -1] 0% 21 0% 01 6% [ -31 1% [ 01 -
VA Not Rec 1% 1] 2% 01 0% 01 0% [ 31 1% C 31
Circul Ok 71% -1] 95% -91 67% 31 62% [ 11 65% [ 01
Puises 14% 0] 4% 51 11% 21 18% [ -41 18% [ 01 -
Claudic 12% 0] 2% 21 18% -71 12% [ 21 14% [ 11 -
Ulcer 1% 1] 0% 21 3% 01 0% [ 11 1% C 01 -
Amput 1% 0] 0% 01 0% 21 2% [ 01 3% [ -11 -
Not rec 0% 0] 0% 01 0% 01 0% [ 01 0% [ 01
Fundi Ok 74% 4] 62% 2 1 79% -51 65% [ 11 85% [ 01
Fundi Ab 26% -4] 37% -2 1 21% 51 29% [ -11 15% [ 01 -
Not rec. 0% 0] 0% 01 0% 01 0% [ 01 0% [ 01 -
Maculop No 93% 4] 96% 41 92% 51 84% [ 61 96% C 01
Tes 7% -41 4% -41 8% -51 10% [ -61 4% [ 01 -
Not Rec 0% 0] 0% 01 0% 01 0% [ 01 0% [ 01 -
Prolif Ret No 96% -2] 98% -41 97% -21 89% [ -21 97% [ 01
Tes 4% 2] 2% 41 3% 21 6% [ 21 3% [ 01
Not Rec 0% 0] 0% 01 0% 01 0% [ 01 0% [ 01
Angina No 80% 2] 96% -41 82% 31 69% [ 31 73% C 31
Angina Yes 20% -2] 4% 41 18% -31 26% [ -31 27% C -31
Not Rec 0% 0] 0% 01 0% 01 0% [ 01 0% [ 01
Neur Symp No 75% 0] 84% -51 67% 21 74% [ -21 70% C 61
Neur Symp Yes 25% -1] 16% 41 33% -21 20% [ 21 30% C -61
Not Rec 0% 0] 0% 21 0% 01 0% [ 01 0% [ 01
Biothes<25 32% 111 5% 271 43% 21 37% [ 161 35% C 181
Biothes>25 57% -371 77% -451 48% -411 51% [-271 53% c-341
Not Rec 11% 261 18% 181 10% 391 7% [ 391 11% [ 161
Albustix -ve 89% 81 86% 121 90% 31 83% [ 91 92% [ 61
Albutsix +ve 10% -61 11% -91 10% -31 10% C -71 8% [ -61
Not Rec 0% 01 2% -21 0% 01 0% [ 01 0% [ 01
Smoking No 81% -11 66% 21 75% -21 82% [ -11 90% [ -31
Smoking Yes 19% 11 34% -21 25% 21 12% [ 11 10% [ 31
Not Rec 0% 01 0% 01 0% 01 0% [ 01 0% t 01
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Appendix 6(c) Minutes of CASPE Diabetes Outcomes Meeting 
Friday 11th January, 1991 at 12.00 a.m.
Present: -
Martin Bardsley Ann Wilson 
Donna Swinden Felicity Tunbridge
Judy Wilboume Philip Home 
Alison McCallum
Apologies from:- Angela Skinner
Sally Marshall 
Gill Sanders
Agenda
1. New Staff and functions.
2. Annual review data - HbAl assays
- Multi-hospital meeting?
3. G.P’s study.
4. Progress on Insulin starters.
5. New patients - latest results.
6. Health status survey results.
7. More Information to Patients? Progress.
8. Any other business.
9. Progress - writing papers.
Minutes
1. Introduced to Ann Wilson - the new ‘H’ grade Audit Nurse employed by the 
Diabetic Unit. PH explained that National Audit is designed to assess whether it 
is feasible to collect information on performance indicators in different diabetes 
centres.
It is partly funded by the Department of Health. Ann will not be directly involved 
with CASPE. Angela’s replacement is Niamh Hanlon, who will be starting later this 
month. She will be more involved with CASPE.
2a HbAl assays - reference the shift of 0.7%. PH has been in touch with biochemists. 
The higher mean level of 0.5 in 1989 also affecte the RVI. The RVI data is more 
reliable due to pregnant patient monitoring. PH has a graph that demonstrates that 
the HbAl levels at the RVI and the Freeman moved in unison during 1989. 20% 
of patients had been reclassified as a result of the change in levels. This is a
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"massive problem" and the biochemists concluded that the assay must be ditched.
Internal quality control is month by month, and therefore the bias is absorbed. It 
is a general problem as there is only one supplier of reagents. AM suggested 
writing this up as a paper and PH agreed.
2b Multi - hospital meeting. Martin has produced a series of tables on the Annual 
Review data. He suggests circulating annual review data only and omitting 3/12 
follow up data for the moment.
PH agrees and would like to see 1990 data for purpose of Writing papers FT & PH 
suggest a separate report for new patients.
Those patients that do not come to the Annual Review Clinic have been identified 
and coded by DS. MB will get DM report completed. DS to ring Shelagh on Friday 
18th Jan, to remind PH to organise a multi- hospital meeting.
3. FT - things are going well with GP study. Tables are automated. Needs to update 
for the 3rd practise. Waiting for 1990 data from all three practices. Computer 
program - need to introduce ability to cope with CP’s that do not do certain 
measures. GP’s have found the study helpful. PH - asked GP’s for short summaries 
on the usefulness of the study - about one side of A4 - with an emphasis on the 
changes they have made. MB - wants to put FT’s work into final report.
FT - information collected by Diabetes Facilitator is useful as it can help correct 
BML measurements used by one practise that wasn’t measuring patient heights. FT 
looking for fourth practise. Thinks there are problems. MB thinks there is mileage 
for a wider basis but not sure if it is possible here. PH suggests that a Central 
Database is needed and study could benefit from BDA involvement.
PH is to look at form design.
Action on GP’s to be agreed by next meeting.
4. FT - negative news in that is is impossible to collect data retrospectively. The 
good news prospective collection works well, particularly if it is done when JW 
has the notes. JW identifies insulin starters (from 1/01/91) and 200 forms are 
completed:- patient personal data and present diabetic status, plus Bradley’s 
Health Questionnaire. JW said some patients have requested greater 
clarification when talking about ‘treatment’. AM had problems with 
questionnaire but very difficult to change it, PH said not to clarify the 
question, let the patient use their own interpretation. JW was having problems 
with the questionnaire herself as regards defining medical problems as 
opposed to diagnosis and suggested contacting FT/PH when completing forms.
FT & PH both agreed. PH suggested that FT catches patients in clinic. Also 
patients need to be caught later on after initial recruitment. Need to decide 
how to do this and when.
MB was not sure whether 3/12 follow up will be useful as CASPE are thinking of 
dropping 3/12 SIP collection. He suggested a Treatment Satisfaction Questionnaire
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might be useful at 3/12 follow up - the same one as the initiil questionnaire. Also 
a 12/12 follow up, plus relevant metabolic data. Complications cam be looked at 
during annual review. Metabolic data to be collected pre-insulin, one year and 
following year. AMc suggests health status rather than treatment satisfaction. Little 
experience of treatment satisfaction in diabetes studies. MB suggested trying health 
status questionnaire in addition to treatment satisfaction questionnaire.
5. New patient latest results are out of sync, with Annual Review data. No great 
change in SIP’s to 3/12 or to 12/12. Education questionnaire wasn’t scored 
correctly but is now. Need to look at scores in relation to other measurements. 
Significant differences seen between educated and non-educated patients but no large 
quantitative differences.
MB suggested dropping 3/12 follow up. It was agreed by the rest meeting. FT 
asked in the clinical data was ok? DS said there were no problems. JW asked is 
it necessary to do pre-education questionnaires with new NIDDMs, MB said yes. 
JW the 1st group of insulin starters have nearly completed education course. 
Questionnaires will be sent to their homes.
6. Sue Astelle’s work - there were no significant differences between clinic completion 
and post. Order doesn’t matter. Reminders vs. immediate responders - no real 
differences. Non-responders probably are different (MB). Most people score 0 in 
the different dimensions. The Bradley has a more even distribution as would be 
expected at it is specially designed for diabetes.
AMc was not sure what well-being measures. Usefulness may be limited as scores 
do not always reflect how patient feels at the time, as opposed to generally 
throughout one’s life. Treatment groups have large differences on all scores except 
emotional reaction, social isolation and treatment satisfaction.
MB discussed briefly report on SA’s study. He concluded that Bradley, is not 
useful at all in relation to clinical indicators.
AMc has 3 interviews left to do, and will finish coding.
7. Still in progress. Trying to identify holes in information - inspired by BDA 
meeting. Need to decide who to send questionnaires to.
8. There was no other business.
9. PH needs to look at MB’s reports/data and will write some papers.
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Appendix 7(a) Data collection form ANGIOPLASTY (PTCA) 
QUESTIONNAIRE NO 1
Pre-operative Assessment
PATIENT IDENTIFICATION:
Name.................. .
Address............... .
Hospital No:..........
Age...................
Telephone No:.........
Date: [ / / ]
Ward: [ ]
G.P.Name.......
Address........
Telephone No:...
Severity of angina I II III IV [
Significant current/past disease
Time since beginning of anginal pain
Previous myocardial infarction 
Previous CABG 
Previous PTCA
Chronic respiratory disease 
History of congestive heart failure 
History of hypertension 
Current (or previous) smoker 
History of hyperlipidaemia
Years Months
[ 1 [ ]
Yes No
Current Medications
Specify Dosage
1
2
3
4
Freouencv/dav For what condition
Summary: Single (S) Double (B) Double + (B+) Triple (T) [ )
Indications from coronary angiography
Artery involved specify Percentage (%) Stenosis
50 - 70 71 - 90 >90
Left main [ ] [ ] [ ]
Left anterior descending [ 1 [ ] [ 1
Right coronary artery [ ] [ 1 [ ]
Circumflex [ ] [ ] ( ]
Vein graft [ 1 [ ] [ 1
Other specify..... [ ] [ ] [ ]
Vessel involvement (summary) Single Two Triple
[ ] ( ] [ ]
Ventricular Function Poor Moderate Good
[ ] [ ] [ ]
Summary Indications: Stable Angina [ ]
Unstable Angina (Emergency) ( ]
Myocardial Infarction ( ]
Other (specify) ...................
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QUESTIONNAIRE 2
HERE ARE SOME QUESTIONS ABOUT YOUR ABILITY TO EXERCISE
1 Pi) HOW FAR DO YOU WALK EACH DAY?
Please tick one 
box only
drive everywhere? ( ]
never leave the house? [ ]
walk less than 200 yards? [ ]
walk less than quarter of a mile? [ ]
walk less than half a mile? [ ]
walk more than half a mile? [ ]
If more than half a mile, what is the furthest you walk each day?
[ ] miles
B) WHAT IS IT THAT LIMITS YOUR EXERCISE?
Angina [ ]
Shortness of breath [ ]
Fatigue [ ]
Other ( ]
Please specify.
C) ARE YOU MORE OR LESS ACTIVE THANWHEN YOU FIRST SUFFERED WITH ANGINA?
More active [ ]
Less active [ ]
D) DO YOU STILL SUFFER WITH ANGINAL CHEST PAIN?
If "NO” leave the next page. NO [ ]
Go on to the final 3 pages.
If "YES" complete the next page YES [ ]
and the final 3 pages.
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HERE ARE SOME GENERAL QUESTIONS ABOUT CHEST PAIN/ANGINA 
GIVE THE ANSWER THAT BEST DESCRIBES HOW YOU ARE AT PRESENT
DO YOU EXPERIENCE CHEST PAIN WITH ANY OF THESE ACTIVITIES?
- performing unusually strenuous activities eg. hill walking, 
washing your car, sports like squash/badminton etc., running.
OR
- performing heavy work eg. labouring, rushing for a bus with 
shopping, washing windows/spring cleaning, digging the garden.
Yes ( ]
No ( ]
Dont know [ ]
WOULD YOU EXPERIENCE CHEST PAIN WHEN YOU.....?
- climb stairs quickly (more than one flight)
OR - walk up-hill with out slowing down
OR - walk more than 400 yards on the flat at a normal pace
(keeping up with your friends).
Yes ( 1
No [ ]
Dont know ( ]
WOULD YOU EXPERIENCE CHEST PAIN IF YOU WERE TO PERFORM THESE ACTIVITIES IN:
- in cold or windy conditions
OR - when angry, upset or emotionally stressed
OR - after meals
Yes [ ]
No ( ]
Dont know [ ]
WOULD YOU EXPERIENCE CHEST PAIN IF YOU WERE TO....?
- walk less than 400 yards on the flat at a normal pace
(keeping up with your friends)
OR - climb one flight of stairs or less
OR - walk up-hill at a slowed pace (such that your friends
have to wait for you).
Yes [ ]
No [ )
Dont know [ j
DO YOU EXPERIENCE CHEST PAIN WITH ALL PHYSICAL ACTIVITY?
eg. washing, dressing, any walking (ie. less than 20 yards)
Yes [ )
No ( ]
Dont know ( ]
THANK YOU FOR YOUR HELP
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ANGIOPLASTY (PTCA) QUESTIONNAIRE NO 3
FREEMAN CASPE OUTCOME STUDY
Procedure Details 
Date of procedure: [ / /  1
Procedure Indication: 
Stable angina Elective 
Unstable angina Emergency 
Mayocardial Infarction 
Previous CABG 
Previous PTCA
Operating Cardiologist
Patient Identification;
Ncime................................................
Address..............
Hospital No.
Complexity of PTCA Risk of problems: Low
[ 1
Medium High 
[ 1 [ ]
Successfully dilated? 
1
Yes 
[ ]
[ ]
[ ]
No 
[ ]
[ ]
( ]
Number of lesions attempted 1
[ ]
2
[ ]
3
[ ]
4 or more 
( ]
Number of catheters used [ ]
Were there any problems during the procedure? [ 
Please specify
Yes No 
[ ]
Post PTCA hospital outcome 
(including complications)
1 Success and routine discharge
2 Angina requiring repeat PTCA
3 Haemorrhage requiring transfusion
4 CABG - emergency
5 CABG - elective
6 Myocardial infarction
7 Death
Yes No
Other complications (specify)
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QUESTIONNAIRE 4
FREEMAN HOSPITAL CASPE OUTCOMES STUDY
3 - 12 MONTH ANGIOPLASTY fPTCAl OUESTIONNAIRE
PATIENTS NAME ........................... DATE ( / /
Address..................................
Hospital No...............................
Drug Treatment
Could you indicate your current drug treatment and dose.
DRUG DOSAGE FREQUENCY
1. per day
2. per day
3. per day
4. per day
5. per day
HOSPITAL RE-ADMISSION
YES NO
Have you been seen at a hospital
Accident fit Emergency (A & E) Department since
your operation? [ ] [ ]
If yes, why?........................................
Have you been re-admitted to hospital since your 
operation? [ ] [ ]
If ves. please name the hospital.....................
and date.....................
If ves, what was the reason for your admission?
Chest pain [ ]
Heart attack [ ]
Repeat angioplasty [ ]
Coronary artery surgery (CABG) ( ]
Other specify.......................................
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Appendix 7 (b) Angioplasty report - December 1990
INTRODUCTION
T h i s  i s  t h e  s e c o n d  r e p o r t  o f  t h e  a n g i o p l a s t y  o u t c o m e s  
s t u d y .  I t  i n c l u d e s  d a t a  c o l l e c t e d  o v e r  a n  1 8  m o n t h  p e r i o d ,  
b e g i n n i n g  i n  J a n u a r y  1 9 8 9 .  T h e  t o t a l  n u m b e r  o f  p a t i e n t s  
i n c l u d e d  i n  t h e  r e p o r t  i s  1 8 9 ,  w h o  h a v e  a l l  r e a c h e d  a t  
l e a s t  t h e  3  m o n t h  f o l l o w - u p  s t a g e .
T h e  o u t c o m e  i n d i c a t o r s  a r e ,  a s  r e p o r t e d  i n  t h e  f i r s t  
r e p o r t :
-  A n g i o g r a p h i c  s u c c e s s  -  v e s s e l s  d i l a t e d .
-  R a t e  o f  C A B G .
-  S u r v i v a l .
-  N o  r é a d m i s s i o n s .
-  D e c r e a s e d  a n g i n a  s c o r e  a t  f o l l o w - u p .
-  I n c r e a s e d  w a l k i n g  d i s t a n c e  a t  f o l l o w - u p .
-  I m p r o v e m e n t  i n  g e n e r a l  h e a l t h  s t a t u s  ( N o t t i n g h a m  H e a l t h  
P r o f i l e ) .
-  D e c r e a s e d  m e d i c a t i o n  a t  f o l l o w - u p .
P R E S E N T I N G  C H A R A C T E R I S T I C S
1 /  A g e  & s e x  d i s t r i b u t i o n
T h e  s a m p l e  c o n s i s t s  o f  m a l e  a n d  f e m a l e  p a t i e n t s  d i s t r i b u t e d  i n  
t h e  f o l l o w i n g  p r o p o r t i o n s :
m a l e  =  7 6 . 5 %  f e m a l e  =  2 3 . 5 %
T h e  m e a n  a g e  i s  5 3  y e a r s ,  w i t h  a  r a n g e  o f  2 8  -  7 4  y e a r s .
2 /  T y p e  o f  a n g i n a
T h e  p a t i e n t s  w e r e  c l a s s i f i e d  a s  s u f f e r i n g  f r o m  e i t h e r  S t a b l e  
o r  U n s t a b l e  A n g i n a  P e c t o r i s .
s t a b l e  =  6 5 %  
u n s t a b l e  =  3 5 %
3 /  V e s s e l s  a t t e m p t e d  & s t e n o s i s  s e v e r i t y
T a b l e  1 . 1  -  N o s .  o f  v e s s e l s  s t e n o s e d  a n d  s e v e r i t y  o f  s t e n o s e s  
( n o . p a t i e n t s = 1 8 9 ) .
STENOSIS
SEVERITY
LAO LMAIN RCA CIRCX DIAG OBTUSE
A = 50-70% 14 1 11 9 1 2
B = 71-90% 40 0 12 13 2 0
C > 90% 61 0 33 21 6 1
*  T h e r e  w a s  o n e  v e i n  g r a f t  r e p o r t e d  t o  b e  s t e n o s e d  > 9 0 % .
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T h e  m o s t  c o m m o n l y  s t e n o s e d  v e s s e l s  a r e  t h e  L A D  a r t e r y ,  
f o l l o w e d  b y  t h e  R C A  a n d  t h e n  t h e  C i r c u m f l e x  a r t e r y .
I s  t h i s  a s  e x p e c t e d ?
4 /  C l a s s  o f  a n g i n a
A n g i n a  h a s  b e e n  c l a s s i f i e d  a c c o r d i n g  t o  t h e  C a n a d i a n  A n g i n a  
C l a s s i f i c a t i o n  s y s t e m  o n  a  s c a l e  o f  1  t o  4  (  1 =  l e a s t  s e v e r e  
a n d  4  =  m o s t  s e v e r e ) .
T h e  p e r c e n t a g e s  o f  p a t i e n t s  i n  t h e s e  c l a s s e s  a r e :
C l a s s  1  
C l a s s  2  
C l a s s  3  
C l a s s  4
-  3 %
-  2 6 %
-  1 3 %
-  3 3 %
T h e  r e m a i n i n g  2 6 %  w e r e  n o t  
a b l e  t o  b e  c l a s s i f i e d  a s  
t h e y  d i d  n o t  s u c c e s s f u l l y  
c o m p l e t e  t h e  p a i n  
q u e s t i o n n a i r e .
5 /  M e d i c a t i o n
M e d i c a t i o n  w a s  a s s e s s e d  u s i n g  a  s i m p l e  s c a l e  o f  1  t o  6  ( 1 =  
s i n g l e  t h e r a p y  a n d  5 [ &  6 ]  =  t r i p l e  t h e r a p y  ) .  T h e  p e r c e n t a g e  
o f  p a t i e n t s  o n  t r i p l e  t h e r a p y  f o r  a n g i n a  w a s  4 4 % .
R E S U L T S
1 /  I M M E D I A T E  O U T C O M E S  
T a b l e  2 . 1
OUTCOME
CATEGORY
STABLE/
OIL.
UNST/ DIL. X STABLE/
FAIL
UNSTA
/FAIL
X
DIED IN HOSP. 0 1 0.6 1 0 3.8
CABG IN HOSP. 0 1 0.6 4 5 35
MI IN HOSP. 0 1 0.6 0 0 0.0
REDO IN HOSP. 0 1 0.6 0 0 0.0
T h e  t o t a l  n u m b e r  o f  p a t i e n t s  
2 6 = u n s u c c e s s f u l ) .
=  1 8 9  ( 1 6 3 = s u c c e s s f u l ;
- T h e r e  w a s  a n  8 8 %  i n i t i a l  s u c c e s s  r a t e ,  o r  d i l a t i o n  r a t e  
( 8 9 %  f o r  s t a b l e  p a t i e n t s  a n d  8 6 %  f o r  u n s t a b l e  p a t i e n t s ) .
- W h e n  t h e  n u m b e r  o f  s t e n o s e d  v e s s e l s  i s  o b s e r v e d  w i t h  t h e  
n u m b e r  o f  v e s s e l s  t h a t  a r e  d i l a t e d  a n d  f a i l e d ,  t h e r e  a r e  
a  h i g h e r  p r o p o r t i o n  o f  f a i l u r e s  a m o n g  t h e  d o u b l e  a n d  
t r i p l e  v e s s e l  g r o u p s  -  i s  t h i s  a s  e x p e c t e d ?
T a b l e  2 . 2
OUTCOME N0.VESS.=1 N0.VESS.=2 N0.VESS.=3 TOTAL NOS.
DILATED 92X 82X 71X 134
FAILED 8X 18X 29X 19
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W h e n  t h e  v e s s e l s  a t t e m p t e d  a r e  o b s e r v e d  w i t h  t h e  r a t e  o f  
s u c c e s s  a n d  f a i l u r e ,  t h e r e  d o  n o t  a p p e a r  t o  b e  s i g n i f i c a n t  
d i f f e r e n c e s .  S e e  t a b l e  2 . 3 :
T a b l e  2 . 3  -  N o .  v e s s e l s  d i l a t e d / f a i l e d
VESSEL
DILATED
NOS.
FAILED
NOS.
% FAILED
LAO 88 12 12%
RCA 38 10 21%
DIAG 7 2 22%
LMAIN 1 0 0%
OBTUSE 4 1 20%
CIRCX 32 5 14%
A g e  & S e x
T h e r e  i s  a  d i f f e r e n c e  i n  t h e  m e a n  a g e s  o f  p a t i e n t s  w h o s e  
p r o c e d u r e  w a s  e i t h e r  s u c c e s s f u l  o r  u n s u c c e s s f u l :
-  d i l a t e d  =  5 0 . 3  y e a r s
-  f a i l e d  =  6 1 . 7  y e a r s .
T h e r e  d o  n o t  a p p e a r  t o  b e  a n y  r e a l  d i f f e r e n c e s  b e t w e e n  t h e  
p r o p o r t i o n  o f  f e m a l e s  i n  t h e  s a m p l e s :
-  d i l a t e d  =  2 5 %  f e m a l e .
-  f a i l e d  =  2 1 %  f e m a l e .
2 /  O U T C O M E S  T O  3  M O N T H S
T a b l e  3 . 1  -  O u t c o m e s  f r o m  d i s c h a r g e  t o  3  
m o n t h s ( n o . = 1 8 9 )
OUTCOME
CATEGORY
STAB/
DIL.
UNST/
DIL.
%
($)
STABL/FAI
L
UNSTA/
FAIL
%
(#)
OK TO 3m 90 43 81.6 6 2 30.8
DIED TO 3m 0 1 0.6 0 0 0.0
CABG TO 3m 0 2 1.2 3 2 19.2
PTCA TO 3m 5 2 4.3 0 0 0.0
READMIT 3m 9 4 8.0 0 0 0.0
$  p a t i e n t s  s u c c e s s f u l  =  1 6 3 ;  #  - p a t i e n t s  u n s u c c e s s f u l  =  2 6
a /  R é a d m i s s i o n s
T o t a l  r é a d m i s s i o n s  i n  t h e  s u c c e s s f u l  g r o u p ( i n c l u d i n g  t h o s e  
r e a d m i t t e d  w i t h  m a j o r  c a r d i a c  e v e n t s :  C A B G ,  M I ,  P T C A )  =  
1 9 / 1 6 3  =  1 1 . 6 % .
O t h e r  r e a s o n s  f o r  a d m i s s i o n  w e r e  r e p o r t e d  a s :
-  g a s t r o s c o p y .
-  k i d n e y  t r a n s p l a n t .
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-  g a s t r i c  r e f l u x .
-  c h e s t  p a i n  /  r p t . a n g i o g r a m s .
b /  P T C A  t o  3 m
T h e  7  p a t i e n t s  w h o  u n d e r w e n t  a  r e p e a t  P T C A  t o  3  m o n t h s  h a d  
a  r e p e a t  p r o c e d u r e  t o  t h e  o r i g i n a l  v e s s e l  -  w h i c h  w a s  
s u c c e s s f u l  i n  a l l  c a s e s  o n  b o t h  o c c a s i o n s .
c / S t e n o s i s  s e v e r i t y  & v e s s e l s
A  s i m p l e  s t e n o s i s  s c o r e  w a s  g i v e n  t o  t h e  v e s s e l s .  T h i s  w a s  
c a l c u l a t e d  b y :  
-  1  p o i n t  f o r  < 7 0 %
-  2  p o i n t s  f o r  7 0 - 9 0 %
-  3  p o i n t s  f o r  > 9 0 % ....................................
T h i s  w a s  t h e n  s u m m e d  a c r o s s  a l l " s t e n o s e d " v e s s e l s .  
T a b 3 . 2
PATIENT OUTCOME DILATED AV.STEN. FAILED AV.STEN.
STAB./CABG/PTCA 2.2 3.6
STAB. -OK TO 3m 2.6 3.8
UNSTAB. -DIED 5.5 /
UNSTAB. -CABG/PTCA 3.1 2.8
UNSTAB. -OK TO 3m 3.0 3.5
STAB. -DIED / 5.0
T h o s e  w h o  d i e d  h a v e  t h e  h i g h e s t  s t e n o s i s  s c o r e s .  A l s o ,  
t h o s e  w h o  a r e  s u c c e s s f u l l y  d i l a t e d ,  h a d  l o w e r  s c o r e s  t h a n  
t h o s e  w h o  f a i l e d ,  a l t h o u g h  n u m b e r s  a r e  s m a l l .
d /  T y p e  o f  a n g i n a
T h e  g e n e r a l  p i c t u r e  i s  p o s i t i v e .  M a n y  m o r e  p a t i e n t s  s h o w  
a n  i m p r o v e m e n t  i n  a n g i n a  s c o r e  f r o m  a d m i s s i o n  t o  3  m . - s e e  
t a b l e  3 . 3 .
T a b l e  3 . 3  -  % I V  a t  p r e s e n t a t i o n  a n d  a t  3 / 1 2  f o l l o w - u p
PATIENT TYPE BETTER (%) SAME (%) WORSE (%) %IV
BEFORE
%IV
AFTER
STABLE/DIL. 52.6 42.1 5.3 33.3% 14.0%
UNSTABLE/DIL. 46.7 33.3 20.0 44.4% 20.0%
CABG 62.5 25.0 12.5 45.5% 13.0%
READMITTED 50.0 33.3 16.7 44.4% 17.0%
FAILED PTCA 25.0 50.0 25.0 40.0% 25.0%
There appears to be a marked difference between the incidence of class IV angina in the stable 
and unstable groups (33.3% compared to 44.4%), and both groups show a reduction to 3 months. The 
pain dimension of the Nottingham Health Profile supports the reduction in the percentage of 
patients on Triple therapy before and after PTCA (for both stable and unstable patients): 
mean NHP pain score 
before at 3m
Stable 26.33 11.52
Unstable 25.56 15.26
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e/ Medication 
Table 3.5
PATIENT TYPE BETTER
(%)
SAME
(%)
WORSE
(%)
X  Tx 
BEFORE
X Tx
AT 3m
STABLE/DIL. 36.3 42.5 21.3 42.9 47.5
UNSTABLE/DIL. 16.7 45.8 37.5 26.7 52.5
CABG 58.3 25.0 16.7 41.2 33.3
READMITTED 45.5 36.4 18.2 45.5 63.6
FAILED PTCA 20.0 80.0 0 62.5 100.0
T h e  p e r c e n t a g e s  o f  p a t i e n t s  o n  T r i p l e  T h e r a p y ,  i n  g e n e r a l ,  
h a v e  i n c r e a s e d  f r o m  p r e s e n t a t i o n  t o  3  m o n t h  f o l l o w - u p  -  
e s p e c i a l l y  f o r  t h e  u n s t a b l e ,  t h e  r e a d m i t t e d  a n d  t h e  f a i l e d  
g r o u p s  ( t h i s  h a s  b e e n  n e c e s s a r y  t o  p r o d u c e  a n  i m p r o v e m e n t  
i n  a n g i n a  s c o r e s  -  s e e  t a b l e  3 . 4  ) .  I t  i s  i n t e r e s t i n g  t o  
n o t e  t h a t  t h e  s t a b l e  d i l a t e d  g r o u p  (  w h o s e  P T C A  w a s  
s u c c e s s f u l  ) d o  n o t  i m p r o v e  t h e  p o t e n c y  o f  m e d i c a t i o n  
a f t e r w a r d s .
f /  G e n e r a l  w e l l - b e i n g
F i g u r e  3 . 1  -  M e a n  N H P  s c o r e s  b e f o r e
& a t  3 m  a f t e r  P T C A
5 0
4 0
3 5
3 0
2 5
20
1 5
10
5
0
p a i n  m o b .  s l e e p  e n e r g y  e m o t .  s o d s  p t . I I
0  p r e s e n t a t i o n  
X  3  m o n t h s
T h e  N o t t i n g h a m  H e a l t h  P r o f i l e  h a s  b e e n  u s e d  a s  a  m e a s u r e  o f  
g e n e r a l  w e l l - b e i n g .  E a c h  i t e m  i s  s c o r e d  f r o m  0  t o  1 0 0 ,  w i t h  0  
b e i n g  t h e  m o s t  h e a l t h y  s c o r e  a n d  1 0 0  b e i n g  t h e  l e a s t  h e a l t h y  
s c o r e .
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A s  c a n  b e  s e e n  f r o m  F i g u r e  3 . 1 ,  t h e r e  i s  a  g e n e r a l  i m p r o v e m e n t  
i n  w e l l - b e i n g  ( r e d u c t i o n  i n  N H P  s c o r e s )  o v e r  t h e  f o l l o w - u p  
p é r i o d e  t h i s  i s  f o r  a l l  p a t i e n t s  - s u c c e s s e s  a n d  f a i l u r e s ) .  
S l e e p  a n d  s o c i a l  i s o l a t i o n  s h o w  s l i g h t  r i s e s  i n  N H P  s c o r e ,  b u t  
n e i t h e r  a p p e a r  t o  b e  s i g n i f i c a n t .
g /  A c t i v i t y  l e v e l s
T h e  p e r c e n t a g e  o f  p a t i e n t s  t h a t  r e p o r t  a n  i n c r e a s e  i n  a c t i v i t y  
l e v e l  t o  3  m o n t h s  i s  4 7 % .  3 8 %  o f  p a t i e n t s  r e p o r t  a  d e c r e a s e
i n  a c t i v i t y  l e v e l  f r o m  p r e s e n t a t i o n  t o  3  m o n t h s .  T h i s  i s  
c o n f i r m e d  b y  t h e  m o b i l i t y  d i m e n s i o n  o f  t h e  N H P :
A t  a d m i s s i o n  -  m e a n  s c o r e  = 2 1  
A t  3 m  -  m e a n  s c o r e  =  1 3 . 8 9
3 /  O U T C O M E S  T O  1 2  M O N T H S  ( P a t i e n t s  w h o  h a v e  c o m p l e t e d  1 2 m ) .  
T a b l e  4 . 1  -  O u t c o m e s  f r o m  p r e s e n t a t i o n  t o  1 2 / 1 2  - n o . = 9 9
OUTCOME STAB/ UNST/ X STAB/ UNST/ X
CATEGORY DIL. DIL. <S) FAIL FAIL (#)
NON-RESP. 1 1 2.3 0 0 0.0
DIED-HOSP. 0 0 1.1 1 0 8.3
CABG-HOSP. 0 0 0.0 4 1 41.7
DIED-12/12 0 1 1.1 0 0 0.0
OK - 12/12 30 11 47.0 0 1 8.3
CABG-12/12 3 3 8.0 1 2 25.0
MI-12/12 1 0 1.1 0 1 8.3
REDO-12/12 9 5 17.3 0 0 0.0
READ-12/12 10 10 22.9 1 0 8.3
$  - p a t i e n t s  s u c c e s s f u l  = 8 7 ;  #  -  p a t i e n t s  u n s u c c e s s f u l  =  1 2
a /  R é a d m i s s i o n s  t o  1 2  m o n t h s
I n  t o t a l ,  4 8 . 4 %  o f  t h e  s u c c e s s f u l  p a t i e n t s  w h o  h a v e  
r e a c h e d  1 2  m o n t h  f o l l o w - u p  h a v e  b e e n  r e a d m i t t e d  t o  
h o s p i t a l  d u r i n g  t h e  y e a r .  O f  t h e s e ,  5 4 %  h a v e  h a d  m a j o r  
c a r d i a c  e v e n t s  ( 2 6 . 4 %  o f  t o t a l  t h a t  h a v e  r e a c h e d  1 2  m o n t h  
f o l l o w - u p )  i . e .  C A B G ,  r e - d o  P T C A ,  o r  M I .  T h e  o t h e r  r e a s o n s  
r e p o r t e d  f o r  a d m i s s i o n  i n c l u d e :
-  C h e m o t h e r a p y  c a t h e t e r  i n s e r t i o n .
-  D fit C .
-  C h e s t  i n f e c t i o n .
-  V i r u s  i n f e c t i o n .
-  S e v e r a l  c h e s t  p a i n s  a n d  r e p e a t
a n g i o g r a m s .
A l t o g e t h e r ,  5 5 %  o f  t h e  p a t i e n t s  w h o  a r e  s t a b l e  a t  
p r e s e n t a t i o n  a n d  w h o  r e a c h  1 2  m o n t h  f o l l o w - u p  d o  n o t
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r e p o r t  a n y  c a r d i a c  e v e n t s  c o m p a r e d  t o  3 4 %  f o r  t h e  u n s t a b l e  
g r o u p .
T h e r e  a r e  n o  n e w  c a s e s  o f  d e a t h  t o  1 2  m o n t h  f o l l o w - u p ,  
w i t h  a l l  d e a t h s  o c c u r r i n g  d u r i n g  t h e  f i r s t  3  m o n t h s  a f t e r  
P T C A .
b /  P T C A  t o  1 2  m o n t h s
O f  t h o s e  p a t i e n t s  w h o  u n d e r w e n t  a  s e c o n d  a n g i o p l a s t y  t o  1 2  
m o n t h s ,  t h e  m a j o r i t y  h a d  a  r e d o  t o  t h e  o r i g i n a l  v e s s e l  
d i l a t e d  ( w h i c h  w a s  s u c c e s s f u l  a t  o r i g i n a l  a t t e m p t ) .  A l l  
r e d o  a n g i o p l a s t i e s  w e r e  s u c c e s s f u l .
c /  A n g i n a  C l a s s
T h e  p e r c e n t a g e  o f  p a t i e n t s  w h o  b e l o n g  t o  c l a s s  I V  i n  t h e  
C a n a d i a n  A n g i n a  C l a s s i f i c a t i o n  a t  1 2  m o n t h s  r e m a i n s  
f a i r l y  s t a b l e  f r o m  3  m o n t h s  a n d  t h e r e f o r e  i s  l o w e r  t h a n  t h e  
p e r c e n t a g e  o f  c l a s s  I V  p a t i e n t s  a t  p r e s e n t a t i o n .  T h e  m e a n  N H P  
p a i n  d i m e n s i o n  s c o r e s  s h o w  a  d e c r e a s e  t o  3 m  a n d  i n  t h o s e  
r e a c h i n g  1 2 m  f o l l o w - u p ,  t h i s  i m p r o v e m e n t  i s  m a i n t a i n e d  ( s e e  
F i g u r e  4 . 1 ) .
d /  M e d i c a t i o n
T h e  p e r c e n t a g e  o f  p a t i e n t s  w h o  a r e  t a k i n g  T r i p l e  T h e r a p y  
m e d i c a t i o n  a t  1 2  m o n t h s  d e c r e a s e s  f r o m  3  m o n t h s ,  e s p e c i a l l y  i n  
t h e  s t a b l e  d i l a t e d  g r o u p  (  4 7 . 5 %  a t  3 / 1 2  t o  2 4 %  a t  1 2 / 1 2 ) .  
T h o s e  w h o  a r e  r e a d m i t t e d  t o  1 2 / 1 2  a l s o  s h o w  a  d e c r e a s e  i n  t h e  
p o t e n c y  o f  m e d i c a t i o n  t a k e n  f r o m  3 / 1 2 ,  b u t  t h e  d e g r e e  o f  
c h a n g e  i s  n o t  s o  l a r g e  ( 6 3 . 6 %  t o  5 0 % ) .  I t  t h e r e f o r e  a p p e a r s  
t h a t  t h e  m e d i c a t i o n  p r e s c r i b e d  i s  n o t  r e d u c e d  s i g n i f i c a n t l y  
u n t i l  a f t e r  3 / 1 2  f r o m  t h e  P T C A  a n d  t h a t  t h o s e  p a t i e n t s  w h o  a r e  
r e a d m i t t e d  c o n t i n u e  t o  t a k e  m o r e  p o t e n t  m e d i c a t i o n .
e /  G e n e r a l  W e l l - b e i n g
F i g u r e  4 . 1  -  M e a n  N H P  s c o r e s  a t  C m ,  
3 m  & 1 2 m  f o r  p a t i e n t s .
0  p r e s e n t a t i o n  
X  3  m o n t h s  
*  1 2  m o n t h s
3 5
3 0
2 5
20
1 5
0*10 X *
5 X *
0*
0
p a i n  m o b .  s l e e p  e n e r g y  e m o t .  s o l s ,  p t i l
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T h e  m e a n  N H P  s c o r e s  f o r  t h o s e  w h o  h a v e  r e a c h e d  1 2  m o n t h  
f o l l o w - u p  s h o w  a  g e n e r a l  i m p r o v e m e n t  f r o m  p r e s e n t a t i o n  t o  
1 2  m o n t h s ,  a l t h o u g h  e n e r g y ,  s l e e p  a n d  m o b i l i t y  s c o r e s  h a v e  
c r e p t  u p  f r o m  3  m o n t h s .
W h e n  t h e  s c o r e s  a r e  b r o k e n  d o w n  f u r t h e r  i n t o  o u t c o m e  
c a t e g o r i e s  t o  1 2  m o n t h s ,  t h e  r e s u l t s  c a n  b e  s u m m a r i s e d  a s  
f o l l o w s :
C A B G :  -  g o o d  i m p r o v e m e n t s  i n  p a i n ,  s l e e p  a n d  p a r t i I  t o
1 2  m o n t h s ,  a f t e r  i n i t i a l  w o r s e n i n g  a t  3  m o n t h s .
M I :  -  o n l y  2  p a t i e n t s .  M u c h  w o r s e  t o  1 2  m o n t h s .
R e - P T C A  -  b i g  i m p r o v e m e n t s  i n  a l l  c a t e g o r i e s  t o  1 2  
m o n t h s .
O K :  -  g e n e r a l l y  b e t t e r  t h a n  p r e s e n t a t i o n ,  a l t h o u g h
s o m e  w o r s e n i n g  f r o m  3  m o n t h s  i n  m o s t
c a t e g o r i e s .
f /  A c t i v i t y  l e v e l s
4 5 %  o f  p a t i e n t s  w h o  r e a c h  1 2  m o n t h  f o l l o w - u p  r e p o r t  a n
i m p r o v e m e n t  i n  a c t i v i t y  l e v e l ,  w h i l e  3 3 %  r e p o r t  b e i n g  l e s s
a c t i v e  t h a n  a t  a d m i s s i o n .
T h e  m e a n  N H P  s c o r e s  o f  t h e s e  p a t i e n t s  f o r  t h e  m o b i l i t y  
d i m e n s i o n  c o n f i r m  t h i s :
A t  a d m i s s i o n  -  m e a n  s c o r e  =  1 0 . 3 3
A t  1 2  m o n t h s  -  m e a n  s c o r e  =  8 . 4 5 .
D I S C U S S I O N
T w o  a r t i c l e s  h a v e  r e c e n t l y  b e e n  p u b l i s h e d  w h i c h  l o o k  a t  
1 2  m o n t h  o u t c o m e s  f o l l o w i n g  P T C A .  T h e  f i r s t  s t u d y  r e p o r t s  
o n  1 0 0  c o n s e c u t i v e  p a t i e n t s  t o  u n d e r g o  P T C A  a t  T h e  
B r o m p t o n  (  G l a z i e r  e t  a l , 1 9 9 0  ) .  T h e  o t h e r  s t u d y  f o l l o w e d  
u p  4 0 6  s t a b l e  a n d  2 0 2  u n s t a b l e  p a t i e n t s  f o r  a  p e r i o d  o f  3 6  
m o n t h s  a f t e r  P T C A ,  a t  M a i n z ,  W . G e r m a n y  (  R u p p r e c h t  e t  
a l , 1 9 9 0 ) .
T h e  p r o p o r t i o n s  o f  s t a b l e  a n d  u n s t a b l e  p a t i e n t s  i n  t h e  
s t u d i e s  w a s  a s  f o l l o w s :
-  C A S P E / F r e e m a n  s t a b = 6 5 % ,  u n s t a b = 3 5 %
-  G l a z i e r  s t a b = 8 4 % ,  u n s t a b = 1 6 %
-  R u p p r e c h t  s t a b = 6 7 % ,  u n s t a b = 3  3 %
A l l  s t u d i e s  i n c l u d e d  a  h i g h  p r o p o r t i o n  o f  p a t i e n t s  w i t h  
m u l t i v e s s e l  d i s e a s e .
T h e  i n c i d e n c e  o f  d e a t h  d i d  n o t  v a r y  g r e a t l y  a c r o s s  t h e  
s t u d i e s .  I n  o u r  o u t c o m e  s t u d y ,  t h e r e  w a s  a  1 . 2 %  d e a t h  r a t e  
t o  3  m o n t h s  ( 2  o u t  o f  3  d e a t h s  i n  h o s p i t a l )  a n d  n o  f u r t h e r  
d e a t h s  t o  1 2  m o n t h s .  G l a z i e r  r e p o r t e d  1  d e a t h  i n  h o s p i t a l  
a n d  n o  m o r e  d e a t h s  a t  1 2  m o n t h s  ( 1 % )  ,  w h i l e  R u p p e c h t
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r e p o r t e d  0 . 5 %  d e a t h  r a t e  i n  h o s p i t a l  a n d  a  f u r t h e r  1 . 5 %  t o  
1 2  m o n t h s  (  w i t h  a  f u r t h e r  1 . 8 %  c a r d i a c  d e a t h s  t o  3 6  
m o n t h s ) .
T h e  i n c i d e n c e  o f  C A B G  d u r i n g  t h e  h o s p i t a l  p e r i o d  v a r i e d  
b e t w e e n  t h e  s t u d i e s .  R u p p r e c h t  r e p o r t e d  a n  i n c i d e n c e  o f  
3 . 5 % ,  G l a z i e r  r e p o r t e d  4 %  a n d  F r e e m a n  r e p o r t e d  0 . 6 % ( f o r  
t h o s e  w h o s e  P T C A  w a s  s u c c e s s f u l .
T h e  F r e e m a n  s t u d y  w a s  t h e  o n l y  o n e  t o  f o l l o w - u p  a t  3  
m o n t h s  - t h e r e f o r e  n o  c o m p a r i s o n s  c a n  b e  m a d e  a t  3 m .
T o  1 2  m o n t h s ,  t h e  r a t e  o f  C A B G  w a s  t h e  s a m e  a t  F r e e m a n  a n d  
T h e  B r o m p t o n  ( 8 %  ) a n d  R u p p r e c h t  r e p o r t e d  a  s l i g h t l y  
l o w e r  r a t e  o f  6 . 9 % .
N o n - f a t a l  M I  w a s  r e p o r t e d  a s  l e s s  t h a n  1 %  a t  F r e e m a n  t o  3  
m o n t h s  a n d  o n l y  1 . 1 %  o f  t h o s e  r e a c h i n g  1 2  m o n t h  f o l l o w - u p .  
T h i s  c o m p a r e s  t o  4 %  i n c i d e n c e  i n  h o s p i t a l  a n d  a  f u r t h e r  1 %  
a t  1 2  m o n t h s  b y  G l a z i e r  a n d  3 . 3 %  a n d  1 . 2 %  r e s p e c t i v e l y  
o v e r  t h e  s a m e  p e r i o d s  b y  R u p p r e c h t .
T h e  r e - a n g i o p l a s t y  r a t e  a t  1 2  m o n t h s  v a r i e d  b e t w e e n  1 1 . 5 %  
( R u p p r e c h t )  t o  1 5 %  ( G l a z i e r )  t o  1 7 . 3 %  ( F r e e m a n ) .
T h e  F r e e m a n / C A S P E  o u t c o m e s  r e s e a r c h  i s  t h e  o n l y  s t u d y  o f  
t h e  t h r e e  t o  a t t e m p t  t o  m e a s u r e  p a t i e n t  w e l l - b e i n g .
A r e  t h e s e  r e s u l t s  a s  o n e  m i g h t  e x p e c t ?
D o  t h e  r e s u l t s  c o m p a r e  t o  t h e  o t h e r  s t u d i e s  a s  e x p e c t e d ?  
D o  t h e y  h i g h l i g h t  a n y  a r e a s  w h i c h  h a v e  n o t  b e e n  c o v e r e d  
a d e q u a t e l y ?
R e f e r e n c e s
G l a z i e r  J . J .  e t  a l  -  " C l i n i c a l  o u t c o m e  f o l l o w i n g  b a l l o o n  
a n g i o p l a s t y  i n  1 0 0  c o n s e c u t i v e  p a t i e n t s  w i t h  m u l t i v e s s e l  
c o r o n a r y  a r t e r y  d i s e a s e "
J . R o y a l  C o l l .  P h y s .  o f  L o n d o n .  V o l 2 4 # 4 . p 2 9 2 - 2 9 4 , O c t . 1 9 9 0 .
R u p p r e c h t  H . J .  e t  a l  -  " S h o r t  a n d  l o n g - t e r m  o u t c o m e  a f t e r  P T C A  
i n  p a t i e n t s  w i t h  s t a b l e  a n d  u n s t a b l e  a n g i n a "  E u r o p e a n  H e a r t  
J o u r n a l  V o l . l l . p 9 6 4 - 9 7 3 , 1 9 9 0 .
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Appendix 7(c) Notes the meeting between CASPE/Cardiologists 
H e l d  o n  T h u r s d a y  2 8 t h  F e b r u a r y  1 9 9 1
P r e s e n t :
M r .  M .  B a r d s l e y  D r .  G .  S a n d e r s
M r s .  J .  G o o d f e l l o w  D r .  P .  M o u n s e y
D r .  D .  R e i d  D r .  G .  P a r r y
M r .  W r i g h t s o n  D r .  M .  F a r r e r
D r .  M .  G r i f f i t h s  D r .  B e x t o n
M r .  H e d l e y - B r o w n  P r o f .  C a m p b e l l
D r .  F u r n i s s
I n t r o d u c t i o n :
D r .  R e i d  d e s c r i b e d  t h e  h i s t o r y  o f  P T C A  p r o c e d u r e s  a t  t h e  F R H .  
M r .  B a r d s l e y  t h e n  d e s c r i b e d  t h e  b a s i c  o u t c o m e  i n d i c a t o r s  f o r  
s u c c e s s f u l  a n g i o p l a s t y  a n d  p r e s e n t e d  t h e  r e s u l t s  o f  t h e  
p r o j e c t  t o  3  m o n t h  f o l l o w - u p  a n d  1 2 m o n t h  f o l l o w - u p .
D i s c u s s i o n :
I t  w a s  a s k e d  i f  t h e  r é a d m i s s i o n s  i n c l u d e d  t h o s e  a d m i t t e d  w i t h  
m a j o r  c a r d i a c  e v e n t s  e g .  f o r  C A B G  o r  M I .  D r .  R e i d  s a i d  t h a t  
h e  h a d  c h e c k e d  t h o s e  a d m i t t e d  t o  S m o n t h  f o l l o w - u p  a n d  t h a t  t h e  
m a j o r i t y  o f  c h e s t  p a i n s  r e p o r t e d ,  w e r e  i n f a c t  n o n - c a r d i a c  i n  
o r i g i n .  H e  e x p l a i n e d  t h a t  b y  c h e c k i n g  o u t  t h e s e  p a t i e n t  -  
r e p o r t e d  e v e n t s ,  h e  i s  a t t e m p t i n g  t o  " h a r d e n  u p "  t h e  o u t c o m e s .
T h e  l a c k  o f  a  d e c r e a s e  i n  t h e  p o t e n c y  o f  m e d i c a t i o n  w a s  
c o m m e n t e d  o n  a n d  t h e  g r o u p  a g r e e d  t h a t  i t  p r o b a b l y  r e f l e c t s  
t h e  p o l i c y  o f  F R H ,  t o  n o t  r e d u c e  m e d i c a t i o n .
T h e r e  w a s  a  g e n e r a l  c o n c e r n  t h a t  t h e  N H P  m a y  n o t  b e  r e l i a b l e  
o v e r  t i m e  a n d  t h e r e f o r e  t h e  g r o u p  w e r e  r e a s s u r e d  t h a t  t h e  
t e s t - r e t e s t  v a l i d a t i o n s  s h o w e d  g o o d  c o r r e l a t i o n s .
A n o t h e r  c o n c e r n  w a s  t h a t  b e c a u s e  t h e  w e i g h t i n g  o f  s c o r e s  i s  
n o n - l i n e a r ,  t h o s e
w h o  s c o r e  h i g h e r  h a v e  a  g r e a t e r  p o t e n t i a l  f o r  i m p r o v e m e n t  t h a n  
t h o s e  w h o  s c o r e  l o w .  H o w e v e r ,  M r .  B a r d s l e y  e x p l a i n e d  t h a t  
a l t h o u g h  t h e r e  i s  a  s l i g h t  r e g r e s s i o n  t o  t h e  m e a n ,  t h i s  c a n n o t  
f u l l y  e x p l a i n  t h e  l a r g e  i m p r o v e m e n t s  s e e n  i n  t h e  m a j o r i t y  o f  
t h e  p a t i e n t s .
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D r .  R e i d  w a s  a s k e d  h i s  o w n  f e e l i n g s  a b o u t  t h e  N H P  -  h e  r e p l i e d  
t h a t  a l t h o u g h  i t  s h o w s  t h o s e  p a t i e n t s  w h o  a r e  n o t  f e e l i n g  
b e t t e r ,  i t  d o e s n ' t  d i f f e r e n t i a t e  b e t w e e n  t h o s e  w h o  a r e  
r e a d m i t t e d  w i t h  r e a l  c a r d i a c  a n d  n o n - c a r d i a c  p a i n .  T h e r e f o r e ,  
h e  f e l t  t h a t  h a r d  o u t c o m e s  a r e  b e t t e r .  M r .  B a r d s l e y  r e p l i e d  
t h a t  t h e s e  " h a r d  o u t c o m e s "  d e s c r i b e  t h e  h e a l t h  s e r v i c e  p r o c e s s  
a n d  n o t  t h e  p a t i e n t .  T h e  c a r d i o l o g i s t s  f e l t  t h a t  t h e  N H P  
f a l l s  d o w n  a s  a n  o u t c o m e  m e a s u r e  o n  t h o s e  p a t i e n t s  w h o  h a v e  
m u l t i p l e  p r o b l e m s  a n d  a r e  n o t  e x p e c t e d  t o  d o  w e l l ,  a s  t h e y  
a p p e a r  n o t  t o  s h o w  a n  i m p r o v e m e n t ,  a l t h o u g h  t h e  s t e n o s i s  m a y  
b e  r e d u c e d .  D r .  S a n d e r s  r e s p o n d e d  b y  s a y i n g  t h a t  t h i s  m a y ,  i n  
f a c t ,  b e  i t ' s  s t r o n g  p o i n t  -  t h e  p a t i e n t s  p e r c e p t i o n  o f  t h e i r  
i l l n e s s  b e i n g  i m p o r t a n t .  A s  a n  e x a m p l e  s h e  c i t e d  t h e  k n e e  
r e p l a c e m e n t  p a t i e n t s  w h o  d o  n o t  p r o g r e s s  a s  e x p e c t e d ,  a f t e r  
w h a t  i s  a p p a r e n t l y  a  " g o o d  r e s u l t " .  T h e  o r t h o p a e d i c  s u r g e o n s  
a r e  n o w  l o o k i n g  a t  c o m m o n  c h a r a c t e r i s t i c s  i n  t h o s e  w h o  d o  n o t  
p r o g r e s s ,  w h i c h  m a y  p o s s i b l y  l e a d  t o  a  c h a n g e  i n  t h e i r  
p a t i e n t  s e l e c t i o n  c r i t e r i a .
D r .  R e i d  w a s  a s k e d  i f  h e  c a n  p i c k  o u t  p a t i e n t s  f r o m  t h o s e  
r e f e r r e d  f o r  P T C A  w h o  a r e  l i k e l y  n o t  t o  d o  w e l l .  H e  f e l t  t h a t  
h e  c o u l d  d o  s o  w i t h  s o m e  p a t i e n t s  a n d  n o t  w i t h  o t h e r s .
A l t h o u g h  t h e  t i m e  f o r  d i s c u s s i o n  w a s  l i m i t e d ,  t h e  r e s p o n s e  t o  
t h e  p r e s e n t a t i o n  o f  r e s u l t s  w a s  f a i r l y  p o s i t i v e ,  w i t h  s e v e r a l  
c l i n i c i a n s  e x p r e s s i n g  a  k e e n  i n t e r s t  -  e s p e c i a l l y  i n  t h e  u s e  
o f  t h e  N H P .
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Appendix 8(a) Data collection proforma Orthopaedics 
(Patient Label Here Please)
Height ins/cm Weight lbs/kg
INDICATION FOR SURGERY (Tick only one):
Osteoarthritis.........
Rheumatoid arthritis....
Avascular necrosis......
Congenital dislocation... 
Traumatic arthritis.....
] Trauma (fracture).......
] Ankylosing spondilitis... 
) Post-infection arthritis.
] Psoriatic arthritis .
1 Other................. .
PROPOSED SURGERY:
New OR Revision
ONLY IF REVISION
Previous
    Operation Currant
Oper Loose Infect Tech Other This Team Implant
No. of _____ Reason
Knee L [ ] [ ] [ ] [ ] [ ] [ ] [ 3 [ 3
Knee R [ 1 I ] [ ] [ ] [ ] [ 3 [ 3 [ 3
Hip L [ ] [ ] [ ] [ ] [ ] [ ] [ 3 [ 3
Hip R [ ] t ] [ ] [ ] [ ] [ ] [ 3 [ 3
PREVIOUS SURGERY: Write the year of the most recent operation in any appropriate slot.
Hip L Hip R Knee L Knee R Ankle L Ankle R Foot L Foot R
Join
Replace
Arthrod
Other
SIGNIFICANT CURRENT/CHRONIC DISEASE: (Tick where appropriate)
Arthritis Upper Limb: 
Arthritis Lower Limb:
Right [ 
Right [
Left
Left
Spine; Cervical [ ] Thoracic ( ]
[ ]
[ ]
Lumbar [ 1
Write in the codes for up to 5 current/chronic diseases from the list 
below.
] [ ] [
1 Peripheral Vascular Disease 11
2 Myocardial Infarction 12
3 Hypertension 13
4 Angina 14
5 Stroke 15
6 TIA 16
7 Neurological Disorder 17
8 Asthma
9 COAD
10 Malignancy 99 Other.
Peptic Ulcer 
Hiatus Hernia 
Lower GI 
Diabetes 
Renal Failure 
Recurrent UTI 
Prostatism
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FREEMAN /CASPE JOINT REPLACEMENT STUDY (2 of 2)
(Patient Label Here Please)
Post-operative form (attached to pink case-mix form) 
SIGNIFICANT COMPLICATIONS DURING THE OPERATION 
MAIN OPERATION:
Surgical
Anaesthetic
YES 
[ 1 
[ ]
SECONDARY OPERATION 1:
YES
Surgical [ ]
Anaesthetic [ ]
SECONDARY OPERATION 2:
YES
Surgical [ ]
Anaesthetic [ ]
SECONDARY OPERATION 3:
YES
Surgical ( ]
Anaesthetic [ ]
NO
1
1
NO
1
1
NO
1
1
NO
1
1
If yes, specify 
If yes, specify
If yes, specify 
If yes, specify
If yes, specify 
If yes, specify
If yes, specify 
If yes, specify
SIGNIFICANT POST-OPERATIVE COMPLICATIONS:
Write in the codes for up to 5 post-op.complications from the list below. 
[ ] [ 1 [ ] [ ] [ ]
Wound infection
Post-op bleeding
D.V.T. / Pulmonary embolus
Respiratory infection/complication
Cardiovascular complication (MI)
CNS complication (stroke)
Urinary complication (retention/infection)
Septicaemia
Renal failure
99 Other (specify).......... .
Significant = a condition that prolongs the expected length of stay 
requires extra clinical resources 
(nursing, diagnostic tests, extra theatre 
time)
Completed by. Date
Date of assessment/out-patlent appointment
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(Patient Label Here Please)
WALKING PAIN 
No pain at any time 
No pain on walking 
Mild pain on walking 
Moderate pain on walking 
Severe pain on walking
REST PAIN 
No pain at rest 
Mild pain at rest 
Moderate pain at rest 
Severe pain at rest
CLIMB STAIRS 
Without support 
With support 
Cannot climb stairs
TRANSFERS 
Without support 
With support 
Cannot transfer
FLEXION DEFORMITY 
No deformity 
< 5 degrees 
5 - 10 degrees 
> 10 degrees
INSTABILITY
None
Mild (0-5 degrees) 
Moderate (5-15 degrees) 
Severe (> 15 degrees)
EXTENSION LAG 
5 degrees 
10 degrees 
15 degrees
Pre-Op.
ARTHROPLASTY: Condylar [ ]
Stabiliser [ ]
3 month 12 month
Post-Op. Post-Op. SIDE: Left [ ] Right [ ]
Kinemax Cemented [ ] 
Kinemax Uncemented [ ]
ASSESSMENT DATE:
Smonth 12month 
Pre-Op Post-Op Post-Op
WALK/STAND FUNCTION 
Walk and stand unlimited [ 
Walk 400 yards,stand l/2hr( 
Walk<400 yards,stand<l/2hr[ 
Walk < 100 yards (
Cannot walk (
MUSCLE STRENGTH 
Excellent-cannot break 
quadriceps (
Fair-moves through arc of 
motion [
Poor-cannot move through 
arc (
RANGE OF MOTION:DEGREES OF ARC
VALGUS DEGREES OVER NORMAL....
VARUS DEGREES OVER NORMAL...
ASSISTED BY: One stick [
One crutch [
Two crutches [
Unable to use crutches [
PATELLO-FEMORAL CREPITUS
(one only)
SITE OF PAIN 
(can be 
multiple)
Audible
Palpable
Absent
Global
Medial
Lateral
Posterior
Anterior
1 [ 
] [ 
] [ 
] [ 
] [
] [ 
] [ 
] [ 
] [
] [ 
1 [ 
] [ 
] [ 
] [ 
] ( 
] [ 
] [
1 [ 
] [ 
] [ 
] [ 
] [
] [ 
] [ 
] [
] [ 
] [ 
] [ 
] [ 
] [ 
] [ 
] [ 
] [
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FREEMAN/CASPE JOINT REPLACEMENT STUDY KNEE X - RAY EVALUTIONS 
(Patient Label Here Please)
PRE-OPERATIVE X - RAY EVALUATION: 
[ ]
]
DATE SIDE: Left
Right[
Tibio-femoral angle:
MARK Y IN ANY SLOT WHERE CONDITION IS PRESENT
Sclerosis Osteophyte Collapse Cyst
Medial femoral
Medial tibial
Lateral femoral
Lateral tibial
Patello-femoral
POST-OPERATIVE X - RAY EVALUATION:
DATE:
Standing tibio-femoral alignment: 
Tibial prosthesis roll back:
3 - month Post-OP 12- month Post-Op
Tibial radiolucent line: 1mm
Zone 1 [ ]
Zone 2 [ ]
Zone 3 [ ]
Zone 4 [ ]
Zone 5 [ 1
Zone 6 [ ]
Zone 7 [ ]
: Im
Zone 1 [ ]
Zone 2 [ ]
Zone 3 [ ]
Zone 4 [ 1
Zone 5 [ ]
Anterior Flange: 
(one only)
Patello-femoral 
Joint position 
(one only)
Patello-femoral 
Joint condition
Proud
Flush
Cutback
Neutral
Neutrolateral
Lateral
Subluxed
Dislocated
Normal
Fragmented
2mm
1
1
1
1
1
1
1
2mm
1
1
1
>2mm
]
1
1
1
]
1
1
>2mm
1
1
1
]
1
1mm 
[ 1 [
[ ] [
[ ] [
[ ] [
[ 1 [
[ ] [
[ 1 [
1mm
1
1
1
2mm >2mm 
1 ( ]
] [ 
] [ 
] [ 
] [ 
] [ 
] [
[ ] [ 
[ 1 [
2mm >2mm 
] [ ]
] [ 
] [ 
] [ 
] (
t
[
[
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Appendix 8(b) Orthopaedics Report August 1990 
B a s i c  d a t a
P r e s e n t i n g  c h a r a c t e r i s t i c s .  T a b l e  1 .
O A R A 0 t h ,
N o .  c a s e s 8 5 6 7 3 6
% M a l e 4 8 % 1 3 % 1 9 %
% r e v i s i o n s : 5 % 1 2 % -
% a r t h r i t i s
2  s i t e s :
3  s i t e s :
1 5 %
5 %
3 4 %
4 9 %
-
A g e < 6 0
6 0 - 6 9
> 6 9
1 6 %
3 6 %
4 8 %
3 8 %
3 8 %
2 3 %
5 0 %
2 8 %
2 1 %
C o - m o r b i d i t i e s
N o n e :
O n e  :
> o n e :
4 4 %
2 9 %
2 6 %
4 5 %
1 5 %
1 5 %
9 7 %
3 %
P o s t - o p  :  1 2 %  7 %
c o m p l i c a t i o n s
M o s t  c o m m o n  c o - m o r b i d i t i e s :
1 1  2 7  c a s e s  P e p t i c  u l c e r
3  2 6  c a s e s  H y p e r t e n s i o n
1 2  1 1  c a s e s  H i a t u s  h e r n i a
4  8  c a s e s  A n g i n a
2  6  c a s e s  P r e v i o u s  M I
1 4  6  c a s e s  D i a b e t e s
C o m m o n  p o s t - O p  c o m p l i c a t i o n s
3  c a s e s  P o s t - o p  b l e e d i n g  C e l l u l i t i t i s
2  c a s e s  C V  c o m p / M I  H a e m a t o m a
1  c a s e  P e r i p h .  u l c e r  U r i n e  r e t e n t i o n
O e s a p h a g i t i s  D V T / P E
S l o w  k n e e  f l e x i o n  
S p i n e - f e l l  o u t  o f  b e d  
D y s p e p s i a  k n o w n  D V  
S u r g  M U A  s l o w  m o b i l
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K n e e  s c o r e
* T h e r e  i s  a  s i g n i f i c a n t  i m p r o v e m e n t  i n  K n e e  s c o r e s  t o  t h r e e  
m o n t h s  a f t e r  t h e  o p e r a t i o n .  O A  a n d  R A  c a s e s  r e s p o n d i n g  i n  a  
s i m i l a r  w a y .
* M e n  h a v e  s l i g h t l y  h i g h e r  s c o r e s  t h a n  w o m e n  -  b o t h  b e f o r e  a n d  
a f t e r  t h e  o p e r a t i o n .
* T h e  y o u n g e r  a g e  g r o u p  ( u n d e r  6 0 )  d o  s l i g h t l y  l e s s  w e l l .
* T h e  p r e s e n c e  o f  a  s i n g l e  c o - m o r b i d i t y  d o e s  n o t  a p p e a r  t o  m a k e  
m u c h  d i f f e r e n c e  t o  t h e  s c o r e s ,  h o w e v e r  t h e  g r o u p  o f  p a t i e n t s  
w i t h  m o r e  t h a n  o n e  c o - m o r b i d i t y  f a r e  l e s s  w e l l .
♦ P o s t - o p e r a t i v e  c o m p l i c a t i o n s  d o  n o t  a p p e a r  t o  b e  a f f a e c t i n g  
t h e  s c o r e s  a t  t h r e e  m o n t h s
P r e - s c o r e P o s t - s c o r e
A l l  1 2 2 4 0 . 3  ( 1 . 5 ) 7 2 . 9  ( 2 . 6 )
O A  8 3 4 3 . 2 7 1 . 6
R A  6 4 4 0 . 9 7 1 . 4
0 t h .  2 2 3 0 . 7 7 8 . 6
M e n 4 7 7 4
W o m e n 3 7 6 7
A g e < 6 0 3 8 . 7 6 3 . 2
6 0 - 7 0 3 5 . 4 7 8 . 4
> 7 0 4 5 . 5 6 7 . 0
n o  c o - m o r b i d . 4 0 . 0 7 3 . 2
o n e 4 2 . 0 8 3 . 7
t w o 4 0 . 9 5 9 . 8
P o s t - o p  c o m p l i c a t i o n s ;
Y e s 4 3 . 7 7 3 . 0
N o 4 0 . 7 7 0 . 7
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N H P  S c o r e s :
* A s  w i t h  t h e  k n e e  s c o r e  t h e r e  a r e  s i g n i f c a n t  i m p r o v e m e n t s  o n  
t h e  N H P  -  o n  a l l  d i m e n s i o n s  -  i n c l u d i n g  t h e  ' s o c i a l  o n e s ' .  A s  
y o u  m i g h t  e x p e c t  p a i n  s h o w s  t h e  b e s t  i m p r o v e m e n t  f o l l o w e d  b y  
m o b i l i t y  a n d  e n e r g y .
♦ T h e r e  a r e  n o  e n o r m o u s  d i f f e r e n c e  i n  t h e  r e l a t i v e  i m p r o v e m e n t s  
o f  O A  a n d  R A  p a t i e n t s
* A s  b e f o r e  t h e r e  a r e  s o m e  a g e  e f f e c t s  -  t h e  6 0 - 7 0  b a n d  
g e n e r a l l y  d o i n g  b e t t e r  t h a n  t o  i n d e r  6 0 ' s  o r  o v e r  7 0 ' s .  T h e  
r e a s o n s  a r e  s t i l l  m y s t e r i o u s .
♦ T h e r e  a r e  s o m e  i n t e r e s t i n g  a n d  q u i t e  m a r k e d  s e x  d i f f e r e n c e s .  
M e n  t e n d  t o  s c o r e  l o w e r  p r e - o p e r a t i v e l y  a n d  p o s t - o p e r a t i v e l y .
N H P  s c o r e s
B e f o r e 4 -3  m n t h s
E n e r g y 4 3 . 0 2 8 . 0
P a i n 6 3 . 4 3 1 . 6
E m o t i o n  R 2 3 . 3 1 2 . 7
S l e e p 5 0 . 6 3 9 . 9
S o c  I s o l 1 3 . 9 8 . 0
M o b i l i t y 4 6 . 7 3 1 . 6
P a r t  I I 4 1 . 7 3 0 . 2
A l l  s i g  < p . 0 1
C h a n g e s  i n  N H P  s c o r e  f r o m  p r e - o p  t o t h r e e  m o n t h s l a t e r
( l a r g e r  p o s i t i v e  v a l u e s = g r e a t e r i m p r o v e m e n t )
N H P  s c o r e s  A g e  g r o u p s
O A R A  < 6 0 6 0 - 7 0 > 7 0
E n e r g y 9 . 8 2 0 . 1  1 7 . 7 1 3 . 5 1 8 . 4
P a i n 3 5 . 8 3 0 . 7  2 7 . 6 4 7 . 3 2 9 . 4
E m o t i o n  R 8 . 4 1 4 . 0  1 3 . 2 1 2 . 1 7 . 3
S l e e p 1 2 . 5 1 1 . 6  5 . 8 1 7 . 0 6 . 3
S o c  I s o l 9 . 6 3 . 4  —3 . 6 7 . 8 8 . 5
M o b i l i t y 1 6 . 3 1 1 . 0  6 . 1 2 2 . 3 7 . 3
P a r t  I I 1 7 . 7 3 . 6  1 3 . 5 1 6 . 1 9 . 0
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Pre op NHP 
Scores
SEX
F M
Energy
Pain
Emot Reacs 
Sleep 
Soc Isol 
MobiIi ty 
Part II
40.0 
61.6 
21.2 
49.7 
12.4
48.0 
38.3
51.9
67.0 
30.7
49.6 
16.4
53.7
44.0
34.6
57.3
22.3 
44.2
13.7
38.8 
45.5
Post op NHP 
Scores
SEX
F M
Energy 26.6 33.0 16.6
Pain 36.0 31.6 23.4
Emot r 13.0 14.2 7.3
Sleep 40.9 40.8 21.6
Soc Isol 7.2 10.1 2.8
Mobi I 30.1 38.0 24.9
Pt II 30.1 32.7 23.6
Postop preop
SEX
F M
Energy 13.07 19.07 10.15
Pain 25.27 36.79 34.05
Emot R 10.01 12.27 7.99
Sleep 11.38 5.31 21.43
Soc Isol 7.70 3.24 7.77
Mobi I 18.63 13.09 12.23
Pt II 9.03 9.87 20.32
SCORE1 SC0RE2 DSCORE
Mean Mean Mean
SEX
42 79 35.84
F 37 67 31.93
M 47 74 28.27
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Additional questions.
Does Pre-op Xray evaluation reflect lower Knee scores? No.
The preop Xray evaluation was scored simply by adding up the number of reported abnormalities by site. 
With 4 posssible abnormalities (sclerosis,osteophyte,collapse,cyst) and 5 sites gives a maximum of 20. 
This scoring may be nonsense. There appears to be no clear relationship between the extent of damage 
(recorded in this way) and the presenting knee score.
Summaries of SCORE1 By levels of PREOPX
Variable Value Label Mean Std Dev Cases
For Entire Population 40.6982 16.8805 169
No evaluation (assume ok) 32.9615 21.5471 26
No. abnormaliites 0 43.3030 17.1177 66
1 41.0000 0.0 1
2 36.0000 18.3848 2
3 39.0000 12.2882 3
4 44.3750 9.5350 16
5 41.5714 15.9881 7
6 43.0000 14.4827 9
7 41.0000 9.7234 12
8 37.1111 22.6740 9
9 45.0000 10.1653 4
10 55.2500 13.3010 4
11 29.6667 15.8850 3
12 29.0000 16.4924 5
(No visible relationship to outcome)
Does post-op Xray evaluation (translucent zones) reflect lower knee scores? No.
The post-op x-ray was scored for the number of translucent zones - dies this make senses - and the idea 
tested that higher scores would result in lower post-operative knee scores and worse outcomes 
(improvements on knee score).
There is no observable relationship (at this stage).
Summaries of Improvement in Knee score.
By levels of POSTOPX
Variable Value Label Mean Std Dev Cases
For Entire Population 32.7131 33.2259 122
Not available assume ok 3.2381 37.6522 21
0 Zones 40.6800 29.5818 75
1 Zone 27.1250 23.1235 8
2 43.5714 36.4274 7
3 17.0000 11.6905 4
4 28.0000 0.0 1
5 45.0000 27.7849 3
6 26.0000 1.4142 2
7 67.0000 0.0 1
404
Appendix 8(c) Notes of Outcome meeting- Jan 1991 Orthopaedics
F R E E M A N / C A S P E  O R T H O P A E D I C  M E E T I N G
P r e s e n t :  S t e v e  S m i t h
I a n  P i n d e r  
M a r t i n  B a r d s l e y  
D o n n a  S w i n d e n  
G i l l  S a n d e r s
1 . D a t a  C o l l e c t i o n .
M B  i n f o r m e d  S S  a n d  I P  o f  t h e  c u r r e n t  C A S P E  p o s i t i o n  a s  
r e g a r d i n g  f u n d i n g .  B o t h  w e r e  k e e n  t o  c o n t i n u e  d a t a  c o l l e c t i o n  
i n  t h e  m e a n t i m e .  D S  i n f o r m e d  I P  t h a t  s o m e  a n n u a l  r e v i e w  f o r m s  
h a d  n o t  b e e n  c o m p l e t e d ,  a n d  I P  a g r e e d  t o  c o m p l e t e  t h e m  
r e t r o s p e c t i v e l y  f r o m  t h e  n o t e s / x  r a y s  w h i l s t  D S  w o u l d  p o s t  o u t  
N H P s  t o  t h e  r e s p e c t i v e  p a t i e n t s .  A p a r t  f r o m  t h a t ,  d a t a  
c o l l e c t i o n  w a s  g o i n g  w e l l  w i t h  3 0 0  p a t i e n t s  i n  t h e  s t u d y ,  7 7  
o f  w h i c h  h a d  r e a c h e d  t h e  A n n u a l  R e v i e w  s t a g e .
2 . M r .  L e n .  F e n w i c k ' s  c o m m e n t s  a t  t h e  r e c e n t  S t e e r i n g  G r o u p  
M e e t i n g  w e r e  p a s s e d  o n  t o  I P  a n d  S S  b y  G S .  T h e s e  c o m m e n t s  
r e g a r d e d  p r e s e n t i n g  s o m e  h a r d  d a t a  t o  c o l l e a g u e s  I P  a n d  S S  
w o u l d  l i k e  t o  s e e  s o m e  r e c e n t  r e s u l t s  b e f o r e
g o i n g  a n y  f u r t h e r .  S S  m e n t i o n e d  t h a t  F r a n k  S i b l e y  h a d  w r i t t e n  
a  p a p e r  o n  t h e  o u t c o m e s  o f  3 0  k n e e  r e p l a c e m e n t  p a t i e n t s .  M r .  
S i b l e y  w i l l  b e  w r i t i n g  t o  M B  i n  t h e  n e a r  f u t u r e .  S S  w i l l  g e t  
a  c o p y  o f  h i s  p a p e r  f o r  C A S P E .  S S  a n d  I P  s u g g e s t  w r i t i n g  a  
p a p e r  w h e n  1 0 0  a n n u a l  r e v i e w s  h a v e  b e e n  c o m p l e t e d .
I P  w a n t s  t o  t a l k  a b o u t  o u t c o m e s  o f  k n e e  r e p l a c e m e n t s  a t  t h e  
s u r g i c a l  s u b - g r o u p  o f  t h e  n e x t  B r i t i s h  S o c i e t y  o f  R h e u m a t o l o g y  
M e e t i n g .
3 .  M B  m e n t i o n e d  t h a t  v a l i d a t i o n s  o f  t h e  k n e e  s c o r e  f o r m s  a n d  
t h e  N H P  f o r m s  h a d  b e e n  c a r r i e d  o u t  u s i n g  n o t e s  a n d  i n t e r v i e w s  
a s  c o m p a r i s o n s .  M B  d i d  n o t  h a v e  t h e  r e s u l t s  w i t h  h i m  b u t  
t h e r e  s e e m e d  t o  b e  a  r e a s o n a b l e  m a t c h .
4 . R e s u l t s  -  T h e  A u g u s t  R e p o r t .
M B  t a l k e d  t h r o u g h  t h e  r e p o r t .  T h e  f a c t  t h a t  y o u n g e r  p a t i e n t s  
d o  s l i g h t l y  l e s s  w e l l  o n  t h e  k n e e  s c o r e  w a s  p i c k e d  o u t  b y  S S  
a n d  I P .  T h e y  b o t h  s h o w e d  c o n c e r n  o v e r  t h i s  g r o u p  a n d  w o u l d  
l i k e  t o  i n v e s t i g a t e  i t  f u r t h e r .  I t
w a s  s u g g e s t e d  t h a t  M B  l o o k s  a t  d i f f e r e n t  a g e  g r o u p s  w i t h i n  a n d  
b e t w e e n  R H  a n d  O A  p a t i e n t s .  M B  s a i d  h e  w o u l d  i d e n t i f y  t h o s e  
y o u n g e r  p a t i e n t s  t h a t  w e r e  n o t  r e s p o n d i n g  a s  w e l l  a n d  w e  w o u l d  
l o o k  a t  t h e m  i n  f u r t h e r  d e t a i l .  S S  s u g g e s t e d  t h a t  j u s t  o n e  o r  
t w o  p a t i e n t s  c o u l d  d r a g  t h e  w h o l e  g r o u p  d o w n .  H e  m e n t i o n e d  
l i t i g a t i o n s ,  p s y c h i a t r i c  i l l n e s s ,  h y p o c h o n d r i a s i s  a n d  
u n r e a l i s t i c  e x p e c t a t i o n  a s  p o s s i b l e  c a u s e s  o f  n o n - r e s p o n s e .  I P  
a n d  S S  w e r e  i n t e r e s t e d  t o  c o m p a r e  t h e  r e l a t i v e  i m p r o v e m e n t s  o f  
R A  a n d  O A  p a t i e n t s  a t  a n n u a l  r e v i e w .  M B  p o i n t e d  o u t  t h a t  k n e e
405
s c o r e s  c o r r e s p o n d  w i t h  N H P
s c o r e s .  I P  a n d  S S  w o u l d  l i k e  t h i s  d e m o n s t r a t e d  w i t h  g r e a t e r  
c l a r i t y .
T h e r e  w a s  f u r t h e r  s p e c u l a t i o n  o v e r  t h e  d i f f e r e n c e s  i n  k n e e  
s c o r e s  b e t w e e n  m e n  a n d  w o m e n ,  w i t h  l i t t l e  c o n c l u s i o n .
M B  h a d  s e v e r a l  q u e s t i o n s  a b o u t  t h e  X  r a y  d a t a  c o l l e c t e d .  I P  
c o n f e s s e d  t h a t  i t  w a s  p r o b l e m a t i c  t o  i n t e r p r e t .  T h e  p r e - o p  X  
r a y  i n d i c a t o r s  a r e  n o t  d i s c r i m i n a t i v e  e n o u g h .  I P  w o n d e r e d  
w h e t h e r  l a r g e  t i b - f e m o r a l  a n g l e s  e q u a t e  w i t h  l o w  k n e e  s c o r e s .  
M B  t o  h a v e  a  l o o k .
S S  m e n t i o n e d  t h a t  p o s t - o p  X  r a y  i n d i c a t o r s  s u c h  a s  t h e  
r a d i o l u c e n t  l i n e s  w e r e  o n l y  s i g n i f i c a n t  w h e n  t w o  o b s e r v a t i o n s  
w e r e  c o m p a r e d .  T h e r e f o r e  n e e d s  t o  b e  a  l o n g i t u d i n a l  s t u d y .  M B  
t h e n  d r e w  a t t e n t i o n  t o  t h e  c a s e  h i s t o r i e s  o f  t h o s e  p a t i e n t s  
w h o  s h o w e d  p o o r  i m p r o v e m e n t  o n  N H P ,  k n e e  s c o r e  o r  h a d  s u f f e r e d  
p o s t - o p e r a t i v e  c o m p l i c a t i o n s .  S S  a n d  I P  f o u n d  t h a t  t h e  m a i n  
v a l u e  o f  t h i s  e x e r c i s e  w a s  t h a t  i t  s h o w e d  t h a t  D e e p  V e i n  
T h r o m b o s e s  a r e  n o t  a  b i g  p r o b l e m  i n  k n e e  r e p l a c e m e n t  s u r g e r y .
5 .  M B  t a l k e d  t h r o u g h  h i s  N H P  g r a p h s .  S S  a n d  I P  w o u l d  b e  
i n t e r e s t e d  t o  s e e  h o w  t h e  k n e e  r e p l a c e m e n t  r e s u l t s  c o m p a r e  a t  
a n n u a l  r e v i e w .  I t  w a s  a g r e e d  t o  p r o d u c e  a  n e w  r e p o r t  w h e n  1 0 0  
a n n u a l  r e v i e w s  h a v e  b e e n  c o m p l e t e d  a n d  f o r  a  d i s c u s s i o n  t o  
t a k e  p l a c e  i n  l i g h t  o f  t h a t .
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Appendix 8(d) - RHEUMATOLOGY PROJECT
R H E U M A T O L O G Y  F O L L O W - U P  Q U E S T I O N N A I R E
T h e  q u e s t i o n s  o n  t h i s  p a g e  r e f e r  t o  t h e  s t a t e  o f  y o u r  h e a l t h
f o l l o w i n g  y o u r  a d m i s s i o n  t o  t h e  F r e e m a n  H o s p i t a l  a p p r o x i m a t e l y
o n e  y e a r  a g o .
( F o r  q u e s t i o n s  1  & 2  p l e a s e  t i c k  a p p r o p r i a t e  b o x )
1 .  D o  y o u  f e e l  y o u r  s t a y  i n  h o s p i t a l  i m p r o v e d  t h e  s t a t e  o f  
y o u r  h e a l t h  i n  g e n e r a l ?
Y e s  [  ]
N o  [  ]
I  d o n ' t  k n o w  [  ]
2 .  D o  y o u  f e e l  y o u r  s t a y  i n  h o s p i t a l  i m p r o v e d  y o u r  a r t h r i t i s ?
Y e s  [  ]
N o  [  ]
I  d o n ' t  k n o w  [  ]
3 .  F o r  t h e  f o l l o w i n g  q u e s t i o n s  p l e a s e  c i r c l e  t h e  n u m b e r  o n  
t h e  s c a l e  w h i c h  m o s t  a c c u r a t e l y  r e f l e c t s  y o u r  p r e s e n t  
s t a t e :
( 0  =  v e r y  m u c h  b e t t e r  t h a n  o n e  y e a r  a g o ,  6  =  v e r y  m u c h  
w o r s e  t h a n  o n e  y e a r  a g o ) .
a )  How well controlled do you feel your arthritis is now?
M u c h  b e t t e r  t h a n  M u c h  w o r s e  t h a n
o n e  y e a r  a g o  0  1 2  3  4  5  6  o n e  y e a r  a g o
b) How often have you felt the level of pain you 
experience has been unacceptably high?
M u c h  l e s s  o f t e n  M u c h  m o r e  o f t e n
t h a n  o n e  y e a r  a g o  0  1 2  3  4  5  6  t h a n  o n e  y e a r  a g o
c )  How well do you feel you understand your arthritis now?
M u c h  m o r e  t h a n  0  1 2  3  4  5  6  M u c h  l e s s  t h a n
o n e  y e a r  a g o  o n e  y e a r  a g o .
PLEASE TURN OVER
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4 .  W h a t  d o  y o u  s e e  a s  y o u r  m a i n  p r o b l e m s  d u e  t o  y o u r  
a r t h r i t i s ?  ( P l e a s e  s t a t e  i n  o r d e r  o f  s e v e r i t y ) ,
1)
2 )
3)
5 .  D o  y o u  h a v e  a n y  h e a l t h  p r o b l e m s ,  o t h e r  t h a n  t h o s e  d u e  t o  
y o u r  a r t h r i t i s ?  ( P l e a s e  s t a t e  i n  o r d e r  o f  s e v e r i t y ) .
1)
2 )
3)
6 )  W h i c h  o f  t h e  f o l l o w i n g  s o c i a l  s e r v i c e s  d o  y o u  r e c e i v e ?  
( T i c k  a n y  t h a t  a p p l y ) .
H o m e  h e l p  
M e a l s  o n  W h e e l s  
B a t h  a t t e n d a n t
[  ]  D i s t r i c t  n u r s e
[  ]  D a y  c e n t r e
C
O t h e r  ( p l e a s e  s p e c i f y )
T h a n k  v o u  f o r  v o u r  h e l p .
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